Details of Disease

General Information of Disease (ID: DISK8246)

• Disease Name: Glioblastoma multiforme
• Disease Class: 2A00: Brain cancer
• Disease Hierarchy:
  DIS01GPL: Grass pollen hypersensitivity
  DISK8246: Glioblastoma multiforme
• ICD Code:
  ICD-11: ICD-11: 2A00.0
  ICD-9: ICD-9: 191
  Expand ICD-11: 'XH0MB1
  Expand ICD-9: 191
• Disease Identifiers:
  MONDO ID: MONDO_0018177
  MESH ID: D005909
  UMLS CUI: C0017636
  MedGen ID: 42228
  HPO ID: HP:0012174
  Orphanet ID: 360
  SNOMED CT ID: 1163375002

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 1 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Immuncell-LC	DMKZCTE	Approved	NA	[1]

This Disease is Treated as An Indication in 55 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Aldoxorubicin	DMHKCIS	Phase 3	NA	[2]
Enzastaurin	DM5H0R9	Phase 3	Small molecular drug	[3]
ICT-107	DMBIZ7H	Phase 3	Vaccine	[4]
Inno-LC-01	DMIKN9P	Phase 3	NA	[5]
Rindopepimut	DMP6IMQ	Phase 3	NA	[6]
Toca 511/Toca FC	DM65FF6	Phase 3	NA	[2]
VB-111	DMX04CA	Phase 3	NA	[7]
TOCA-511	DMUKEC9	Phase 2/3	NA	[8]
99mTc-DI-DD3B6/22-80B3	DM0XJJ2	Phase 2	Small molecular drug	[9]
ABT-414	DMGUTPN	Phase 2	Antibody	[10]
AFTVac	DMD3XMG	Phase 2	Vaccine	[11]
ANG1005	DMV5ENT	Phase 2	NA	[2]
Antineoplaston A-10	DMZ38GK	Phase 2	Small molecular drug	[12]
Antineoplaston AS2-1	DMY7N6J	Phase 2	NA	[12]
AR-67	DM8A71F	Phase 2	Small molecular drug	[13]
Autologous dendritic cell vaccine, St Anna Children's Hospital	DMPH08R	Phase 2	NA	[14]
Cancer vaccine	DM03BGT	Phase 2	NA	[15]
Carboxyamidotriazole orotate	DMN5JCX	Phase 2	NA	[16]
Cotara	DMSCHEZ	Phase 2	NA	[2]
Coxsackievirus A21	DM2K5VP	Phase 2	NA	[17]
G-series prophage vaccine	DMR0LWA	Phase 2	NA	[18]
GMB-Vax	DMOE8F4	Phase 2	NA	[19]
Her2-targeted autologous T-cell therapy	DMQTREC	Phase 2	NA	[20]
Lexibulin	DMLEX1D	Phase 2	NA	[21]
MEDI-575	DMI9WVM	Phase 2	Antibody	[22]
Poly-ICLC	DM2570B	Phase 2	Small molecular drug	[23]
Prophage cancer vaccine	DM3L1C6	Phase 2	NA	[24]
TPI-287	DMC5TV6	Phase 2	Small molecular drug	[25]
Verubulin	DMBQC3L	Phase 2	Small molecular drug	[2]
ACT 001	DMDHIHX	Phase 1/2	NA	[26]
Brain dendritic cell-based vaccine	DMP6PCS	Phase 1/2	NA	[27]
CAR-T cells targeting GD2	DMFCPG0	Phase 1/2	CAR T Cell Therapy	[28]
CAR-T cells targeting MucI	DMBPN4K	Phase 1/2	CAR T Cell Therapy	[28]
EGFRvIII CAR	DMC284G	Phase 1/2	NA	[29]
NEO100	DMI7SUU	Phase 1/2	NA	[30]
Toca 511 + Toca FC combination	DMQS3VQ	Phase 1/2	NA	[31]
124I-8H9	DM5ZC0E	Phase 1	Antibody	[32]
ADU-623	DM8OKPU	Phase 1	NA	[33]
AMG 595	DMJFKW3	Phase 1	NA	[34]
AMG 596	DM4G1SP	Phase 1	Antibody	[35]
Anti-EGFRvIII CAR T cells	DM73920	Phase 1	CAR T Cell Therapy	[36]
Anti-PD-L1 CSR T cells	DMWIJL1	Phase 1	CAR T Cell Therapy	[37]
CAR-T cells targeting EGFRviii	DMRSG04	Phase 1	CAR T Cell Therapy	[28]
Dendritic cell vaccine	DMSPJ8T	Phase 1	NA	[38]
EGFRvIII CAR T cells	DM6XWV4	Phase 1	CAR T Cell Therapy	[39]
Gene therapy, IFN-b	DMJP83V	Phase 1	NA	[40]
IMA-950	DMMPTJA	Phase 1	NA	[41]
KX2-361	DML4H05	Phase 1	NA	[42]
LG631	DM3W0BU	Phase 1	NA	[2]
Litenimod	DMESZQU	Phase 1	NA	[43]
MB-103	DMS0P5O	Phase 1	CAR T Cell Therapy	[44]
Mibefradil	DMU9VDS	Phase 1	Small molecular drug	[2]
Modified adenovirus delta24-RGD	DM2S1LG	Phase 1	NA	[45]
MV-CEA	DM1FUAR	Phase 1	NA	[46]
SB-313-xTZ	DMDB108	Phase 1	NA	[47]

This Disease is Treated as An Indication in 7 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
BMP-4	DMDFQOO	Investigative	NA	[48]
Bone morphogenetic protein-4	DMU78BE	Investigative	NA	[49]
NMHSS1-1	DMU3S98	Investigative	NA	[49]
Parvovirus H-1	DMCNDB5	Investigative	NA	[49]
PMX-700	DMZCSF1	Investigative	NA	[50]
PR-P	DMIM9ZI	Investigative	NA	[49]
SG-1311	DMPVW0N	Investigative	NA	[49]

Molecular Interaction Atlas (MIA) of This Disease

This Disease Is Related to 875 DTT Molecule(s)

Gene Name	DTT ID	Evidence Level	Mode of Inheritance	REF
ACACB	TTY84UG	Limited	Altered Expression	[51]
ADAM17	TT6AZXG	Limited	Biomarker	[52]
ADAMTS5	TTXSU2Y	Limited	Altered Expression	[53]
ADRA1A	TTNGILX	Limited	Biomarker	[54]
ADRA2B	TTWM4TY	Limited	Biomarker	[54]
ANO1	TTOJI4S	Limited	Biomarker	[55]
APOA4	TTNC3WS	Limited	Biomarker	[56]
ASPA	TT6TLZP	Limited	Altered Expression	[57]
ATF4	TTQCKWT	Limited	Biomarker	[58]
ATP2A2	TTE6THL	Limited	Altered Expression	[59]
BCAT2	TTF9OQ6	Limited	Biomarker	[60]
BCL2A1	TTGT9C7	Limited	Altered Expression	[51]
BMI1	TTIPNSR	Limited	Biomarker	[61]
BRD4	TTSRAOU	Limited	Biomarker	[62]
BRS3	TTKYEPM	Limited	Biomarker	[54]
BSG	TT5UJWD	Limited	Biomarker	[63]
BUB1	TT78309	Limited	Biomarker	[64]
CALCRL	TTY6O0Q	Limited	Altered Expression	[65]
CAPN1	TT1WBIJ	Limited	Biomarker	[66]
CASP5	TTWR48J	Limited	Biomarker	[67]
CBR1	TTVG0SN	Limited	Biomarker	[68]
CCL5	TT9DWLC	Limited	Biomarker	[69]
CCR5	TTJIH8Q	Limited	Altered Expression	[69]
CD160	TTOFEAS	Limited	Altered Expression	[70]
CD163	TTTZ9DE	Limited	Altered Expression	[71]
CD33	TTJVYO3	Limited	Biomarker	[72]
CD40	TT1ERKL	Limited	Biomarker	[73]
CD69	TTPQE9F	Limited	Altered Expression	[74]
CDC20	TTBKFDV	Limited	Altered Expression	[75]
CDC42BPA	TT5Z0EF	Limited	Altered Expression	[76]
CDC7	TTSMTDI	Limited	Biomarker	[77]
CDK18	TTUMFAR	Limited	Altered Expression	[78]
CHEK1	TTTU902	Limited	Biomarker	[79]
CS	TTZA6B3	Limited	Altered Expression	[80]
CSNK1E	TTA8PLI	Limited	Biomarker	[81]
CTSB	TTF2LRI	Limited	Biomarker	[82]
DCK	TTJOCE4	Limited	Biomarker	[83]
DDR1	TTI1FPZ	Limited	Biomarker	[84]
DGKA	TTGL8F0	Limited	Biomarker	[85]
DNMT3A	TTJUALD	Limited	Altered Expression	[86]
DRD2	TTEX248	Limited	Biomarker	[87]
DUSP1	TTG8HIM	Limited	Altered Expression	[88]
EDNRB	TT3ZTGU	Limited	Biomarker	[89]
EEF2K	TT1QFLA	Limited	Biomarker	[90]
EIF2AK1	TTRUJBV	Limited	Biomarker	[91]
EPAS1	TTWPA54	Limited	Altered Expression	[92]
F2R	TTL935N	Limited	Biomarker	[93]
FABP4	TTHWMFZ	Limited	Biomarker	[94]
FADS2	TTT2VDU	Limited	Biomarker	[95]
FCGR2B	TT5RWKQ	Limited	Biomarker	[96]
FDFT1	TTFQEO5	Limited	Biomarker	[97]
FN1	TTPJ921	Limited	Biomarker	[98]
GCH1	TTLSWP6	Limited	Biomarker	[99]
GDF2	TTAP4T1	Limited	Biomarker	[100]
GLB1	TTNGJPH	Limited	Altered Expression	[101]
GLO1	TTV9A7R	Limited	Biomarker	[102]
GLUL	TTURQ2G	Limited	Altered Expression	[103]
GOT1	TTU507L	Limited	Altered Expression	[57]
GPRC6A	TTI1PRE	Limited	Biomarker	[104]
GRIA1	TTVPQTF	Limited	Biomarker	[105]
GRIK2	TT0K5RG	Limited	Biomarker	[106]
GRM1	TTVBPDM	Limited	Biomarker	[107]
GRM3	TT8A9EF	Limited	Altered Expression	[107]
HSP90AB1	TTH5YN2	Limited	Altered Expression	[108]
IDUA	TT0IUKX	Limited	Altered Expression	[109]
IFNA2	TTSIUJ9	Limited	Therapeutic	[110]
IGFBP3	TTZHNQA	Limited	Biomarker	[111]
IL13RA1	TTNEAMG	Limited	Altered Expression	[112]
ITGA4	TTJMF9P	Limited	Biomarker	[113]
ITGAE	TTH0Z37	Limited	Biomarker	[114]
ITK	TT3C80U	Limited	Biomarker	[115]
KAT6A	TT6O1J0	Limited	Altered Expression	[116]
KCNA5	TTW0CMT	Limited	Altered Expression	[117]
KCNMA1	TTE87WJ	Limited	Altered Expression	[118]
KDM1A	TTNR0UQ	Limited	Altered Expression	[119]
KLF4	TTTI53X	Limited	Altered Expression	[92]
KLK4	TT4319X	Limited	Biomarker	[120]
LASP1	TTZJA87	Limited	Altered Expression	[121]
LGR5	TTTSGRH	Limited	Biomarker	[122]
LIMK1	TTWL9TY	Limited	Biomarker	[123]
LIN28A	TTO50LN	Limited	Biomarker	[124]
LPAR2	TTB7Y8I	Limited	Biomarker	[54]
LPAR3	TTE2YJR	Limited	Biomarker	[104]
MAD1L1	TTNE9U7	Limited	Genetic Variation	[125]
MARCKS	TTHRM39	Limited	Biomarker	[126]
MBP	TT2RY5P	Limited	Altered Expression	[127]
MDM4	TT9OUDQ	Limited	Biomarker	[128]
MELK	TTBZOTY	Limited	Altered Expression	[129]
MKNK2	TTRECN3	Limited	Biomarker	[130]
MMP1	TTMX39J	Limited	Altered Expression	[93]
MMP15	TTNSTO3	Limited	Biomarker	[131]
MRGPRX1	TTIX6PK	Limited	Biomarker	[104]
MSH2	TTCAWRT	Limited	Genetic Variation	[132]
MSI2	TTTXQF6	Limited	Biomarker	[133]
MST1R	TTBQ3OC	Limited	Biomarker	[134]
MTAP	TTDBX7N	Limited	Altered Expression	[135]
MYH2	TTBIL13	Limited	Biomarker	[136]
NCL	TTK1V5Q	Limited	Biomarker	[137]
NFKBIA	TTSHAEB	Limited	Biomarker	[138]
NOTCH3	TTVX7IA	Limited	Biomarker	[139]
NOX4	TTQRBSJ	Limited	Altered Expression	[140]
NRP1	TTIPJCB	Limited	Biomarker	[141]
OXER1	TT7WBSV	Limited	Biomarker	[104]
OXTR	TTSCIUP	Limited	Biomarker	[142]
PAM	TTF4ZPC	Limited	Altered Expression	[65]
PARG	TT39J16	Limited	Genetic Variation	[143]
PARP3	TTD8MEH	Limited	Biomarker	[144]
PBK	TTMY6BZ	Limited	Altered Expression	[145]
PCNA	TTLG1PD	Limited	Altered Expression	[146]
PDE4A	TTZ97H5	Limited	Biomarker	[147]
PKD2L1	TTAHD89	Limited	Biomarker	[148]
PLOD2	TT8MEUD	Limited	Altered Expression	[149]
PPID	TTNAFOU	Limited	Biomarker	[150]
PPIF	TTRFQTB	Limited	Biomarker	[150]
PRKCG	TTRFOXJ	Limited	Biomarker	[151]
PRKCI	TTWJTHX	Limited	Biomarker	[152]
PTBP1	TTWMX0U	Limited	Biomarker	[153]
PTPN6	TT369M5	Limited	Altered Expression	[154]
RAD51	TTC0G1L	Limited	Altered Expression	[155]
RBPJ	TT72D4Z	Limited	Biomarker	[156]
RICTOR	TT143WL	Limited	Biomarker	[157]
RSPO3	TT7HJTF	Limited	Biomarker	[158]
RXFP1	TTMAHD1	Limited	Biomarker	[54]
SATB1	TTLFRIC	Limited	Biomarker	[159]
SEMA3A	TTVKD3S	Limited	Altered Expression	[160]
SERPINH1	TTPSWQG	Limited	Biomarker	[161]
SIRT2	TTLKF5M	Limited	Biomarker	[162]
SKP2	TT5B2EO	Limited	Biomarker	[163]
SLC12A3	TTP362L	Limited	Biomarker	[164]
SLC16A3	TTG6VD5	Limited	Biomarker	[165]
SLC6A8	TTYUHB5	Limited	Biomarker	[166]
SLC7A11	TTBZMIO	Limited	Altered Expression	[167]
SPHK2	TTCN0M9	Limited	Biomarker	[168]
SPRY1	TT0PSN6	Limited	Biomarker	[169]
SSTR4	TTAE1BR	Limited	Biomarker	[54]
ST14	TTPRO7W	Limited	Biomarker	[170]
STAT6	TTWOE1T	Limited	Biomarker	[171]
STC2	TT4EFTR	Limited	Altered Expression	[172]
TDO2	TTXNCBV	Limited	Altered Expression	[173]
TENT4B	TTB5R6M	Limited	Biomarker	[174]
TIGIT	TTWNL74	Limited	Altered Expression	[175]
TIRAP	TTKU0LS	Limited	Biomarker	[176]
TNFSF13	TTOI1RM	Limited	Biomarker	[177]
TPT1	TT3PTB6	Limited	Biomarker	[178]
TRPM7	TTFPVZO	Limited	Biomarker	[179]
TRPM8	TTXDKTO	Limited	Biomarker	[180]
TTK	TTP7EGM	Limited	Altered Expression	[109]
TXN	TTZJ5U9	Limited	Biomarker	[181]
USP13	TTVJIO2	Limited	Biomarker	[182]
USP5	TTGYTMA	Limited	Biomarker	[183]
VEGFC	TT0QUFV	Limited	Biomarker	[184]
VTCN1	TTCK85E	Limited	Altered Expression	[185]
XPO1	TTCJUR4	Limited	Biomarker	[186]
ZWINT	TTWY768	Limited	Biomarker	[187]
ABCC3	TTVLG21	Disputed	Biomarker	[188]
ADAM8	TTQWYMD	Disputed	Altered Expression	[189]
ALOX5	TTSJ6Q4	Disputed	Biomarker	[138]
BBC3	TT7JUKC	Disputed	Biomarker	[190]
CALR	TTUZ7OA	Disputed	Biomarker	[191]
CASP7	TTM7Y45	Disputed	Biomarker	[192]
CDC25B	TTR0SWN	Disputed	Altered Expression	[193]
CNTF	TTGEM5Q	Disputed	Biomarker	[194]
DLK1	TTF4AVB	Disputed	Biomarker	[195]
EBP	TT4VQZX	Disputed	Biomarker	[196]
EZR	TTE47YC	Disputed	Altered Expression	[197]
FOSL1	TTY8LZG	Disputed	Altered Expression	[198]
G6PC	TTBQMJ8	Disputed	Biomarker	[199]
GAL	TTXZAJ5	Disputed	Altered Expression	[200]
GLI2	TT045OH	Disputed	Biomarker	[201]
GPNMB	TT7315J	Disputed	Biomarker	[202]
HOXB13	TTZ6I58	Disputed	Biomarker	[203]
HSF1	TTN6STZ	Disputed	Altered Expression	[204]
L1CAM	TTC9D3K	Disputed	Altered Expression	[205]
MAOB	TTGP7BY	Disputed	Altered Expression	[206]
MDK	TTV8UE7	Disputed	Biomarker	[207]
MMP9	TT6X50U	Disputed	Altered Expression	[146]
MTR	TTUTO39	Disputed	Genetic Variation	[208]
PFKFB3	TTTHMQJ	Disputed	Biomarker	[209]
PRLR	TTBPXMA	Disputed	Biomarker	[210]
SLC15A3	TTAYPWS	Disputed	Biomarker	[211]
SLC22A8	TTTQR47	Disputed	Biomarker	[212]
SLC37A4	TT1KPBZ	Disputed	Biomarker	[199]
SPARC	TTBQFM7	Disputed	Biomarker	[213]
SREBF1	TTER0UB	Disputed	Biomarker	[97]
SREBF2	TTRQ4AP	Disputed	Altered Expression	[214]
STS	TTHM0R1	Disputed	Genetic Variation	[215]
TOP1	TTGTQHC	Disputed	Biomarker	[216]
TOP2A	TTCGY2K	Disputed	Biomarker	[217]
TRPV2	TTBECWA	Disputed	Biomarker	[218]
ACKR3	TTRQJTC	moderate	Biomarker	[219]
ANGPT2	TTKLQTJ	moderate	Biomarker	[220]
ANGPTL3	TT59GO7	moderate	Altered Expression	[221]
ANXA2	TT4YANI	moderate	Biomarker	[222]
APEX1	TTHGL48	moderate	Biomarker	[223]
AQP1	TTSF1KH	moderate	Biomarker	[224]
ARF1	TT70KXY	moderate	Posttranslational Modification	[225]
ARRB1	TTMVD4A	moderate	Altered Expression	[226]
AURKA	TTPS3C0	moderate	Biomarker	[227]
BACH1	TT2ME4S	moderate	Altered Expression	[228]
BCAT1	TTES57P	moderate	Altered Expression	[57]
BMP1	TT0L58T	moderate	Altered Expression	[229]
CAD	TT2YT1K	moderate	Biomarker	[230]
CCK	TT90CMU	moderate	Biomarker	[231]
CCL21	TTLZK1U	moderate	Genetic Variation	[232]
CCN2	TTIL516	moderate	Biomarker	[233]
CD22	TTM6QSK	moderate	Biomarker	[234]
CD47	TT28S46	moderate	Biomarker	[235]
CD58	TT5KSBY	moderate	Biomarker	[236]
CD70	TTNCIE0	moderate	Biomarker	[237]
CD79B	TTBN5I7	moderate	Genetic Variation	[238]
CDK1	TTH6V3D	moderate	Biomarker	[239]
CHEK2	TT9ABMF	moderate	Biomarker	[240]
CLDN4	TTMTS9H	moderate	Biomarker	[241]
CSNK2A2	TT7GR5W	moderate	Biomarker	[242]
CTH	TTLQUZS	moderate	Biomarker	[243]
CTSG	TTQAJF1	moderate	Altered Expression	[244]
CX3CR1	TT2T98G	moderate	Biomarker	[245]
DEK	TT1NMGV	moderate	Posttranslational Modification	[246]
DFFB	TT2SRE0	moderate	Altered Expression	[230]
E2F2	TT5FYX0	moderate	Biomarker	[247]
F11R	TT3C8EG	moderate	Altered Expression	[248]
FABP5	TTNT2S6	moderate	Biomarker	[249]
FER	TTRA9G0	moderate	Altered Expression	[250]
FGF1	TTMY81X	moderate	Posttranslational Modification	[251]
FLT1	TT1VAUK	moderate	Biomarker	[252]
GAPDH	TTUGSWA	moderate	Altered Expression	[253]
GPR55	TTNET8J	moderate	Biomarker	[254]
GRN	TT0LWE3	moderate	Biomarker	[255]
GSK3B	TTRSMW9	moderate	Biomarker	[256]
HDAC4	TTTQGH8	moderate	Biomarker	[257]
HDAC7	TTMUEK1	moderate	Altered Expression	[258]
HDAC9	TT8M4E1	moderate	Altered Expression	[259]
HMGB1	TTWQYB7	moderate	Biomarker	[260]
HPSE	TTR7GJO	moderate	Altered Expression	[261]
HSPA8	TTMQL3K	moderate	Posttranslational Modification	[262]
HSPB3	TTLH8WG	moderate	Biomarker	[263]
IDO1	TTZJYKH	moderate	Biomarker	[264]
ITGAV	TTT1R2L	moderate	Biomarker	[265]
KAT2B	TTVK7SB	moderate	Biomarker	[266]
KDM1B	TT8VP2T	moderate	Altered Expression	[267]
KLRK1	TTLRN4A	moderate	Biomarker	[268]
KYNU	TTWQM3J	moderate	Biomarker	[269]
LDLR	TTH0DUS	moderate	Biomarker	[270]
LILRB1	TTC0QRJ	moderate	Altered Expression	[271]
LNPEP	TTY2KP7	moderate	Biomarker	[62]
LRP6	TTSXOWE	moderate	Altered Expression	[272]
LSS	TT7O8ZA	moderate	Biomarker	[273]
MAN2A1	TT34DCN	moderate	Altered Expression	[250]
MAP3K11	TTETX6Q	moderate	Biomarker	[274]
MAP3K20	TTTUZ3O	moderate	Biomarker	[275]
MAPKAPK2	TTMUG9D	moderate	Biomarker	[276]
MLH1	TTISG27	moderate	Altered Expression	[277]
NAMPT	TTD1WIG	moderate	Altered Expression	[278]
NCAM1	TTVXPHT	moderate	Genetic Variation	[236]
NECTIN4	TTPO9EG	moderate	Altered Expression	[279]
NEK2	TT3VZ24	moderate	Biomarker	[280]
NFKB1	TTUIZKC	moderate	Biomarker	[73]
OPRL1	TTNT7K8	moderate	Altered Expression	[281]
OSM	TTIVXSE	moderate	Biomarker	[282]
PDK1	TTCZOF2	moderate	Altered Expression	[283]
PGR	TTUV8G9	moderate	Altered Expression	[284]
PKMYT1	TTB4PAZ	moderate	Biomarker	[285]
PLK1	TTH4IP0	moderate	Altered Expression	[286]
PRKCB	TTYPXQF	moderate	Biomarker	[287]
PRKCE	TT57MT2	moderate	Biomarker	[236]
PRKCZ	TTBSN0L	moderate	Altered Expression	[288]
RARG	TT1Q3IE	moderate	Biomarker	[289]
RECK	TTRZBW7	moderate	Altered Expression	[290]
ROR2	TTUDPCI	moderate	Altered Expression	[272]
S100B	TTQ0V86	moderate	Genetic Variation	[291]
SGK1	TTTV8EJ	moderate	Biomarker	[292]
SLC22A3	TTG2UMS	moderate	Biomarker	[115]
SLC52A2	TT6TKEN	moderate	Biomarker	[293]
SOX5	TTXHSZK	moderate	Biomarker	[294]
SP1	TTZEP6S	moderate	Biomarker	[295]
TAAR1	TTIU98M	moderate	Biomarker	[296]
TACC3	TTQ4UFD	moderate	Biomarker	[297]
TCF3	TTULOD8	moderate	Biomarker	[298]
TEP1	TTQGAVX	moderate	Biomarker	[299]
TGFB3	TTWOMY8	moderate	Altered Expression	[300]
TGM2	TT2F4OL	moderate	Biomarker	[301]
TLR9	TTSHG0T	moderate	Altered Expression	[302]
TNFAIP3	TT5W0IO	moderate	Biomarker	[303]
TNFSF4	TTBW580	moderate	Altered Expression	[304]
TYMS	TTP1UKZ	moderate	Biomarker	[187]
VANGL1	TT18WJB	moderate	Biomarker	[305]
VEGFB	TTPJQHE	moderate	Biomarker	[306]
WEE1	TTJFOAL	moderate	Biomarker	[307]
WNK1	TTJ9UMX	moderate	Biomarker	[308]
ABCA1	TTJW1GN	Strong	Biomarker	[309]
ABCC1	TTOI92F	Strong	Biomarker	[128]
ABCC4	TTUEAFL	Strong	Altered Expression	[310]
ABCG2	TTIMJ02	Strong	Biomarker	[311]
ACAT1	TTK3C21	Strong	Biomarker	[312]
ADAM10	TTVXEGU	Strong	Altered Expression	[313]
ADAM9	TTTYQNS	Strong	Biomarker	[314]
ADAMTS1	TTS2TEI	Strong	Altered Expression	[315]
ADAMTS4	TTYG6BU	Strong	Altered Expression	[53]
ADCYAP1	TTW4LYC	Strong	Altered Expression	[316]
ADCYAP1R1	TT5OREU	Strong	Altered Expression	[317]
ADM	TTV14YH	Strong	Posttranslational Modification	[318]
AGRP	TT4DE1O	Strong	Altered Expression	[319]
AGXT	TTF5NVW	Strong	Biomarker	[320]
AIF1	TT12MEP	Strong	Altered Expression	[321]
AKT2	TTH24WI	Strong	Biomarker	[322]
ALKBH5	TTOHB1M	Strong	Biomarker	[323]
ALPI	TTHYMUV	Strong	Genetic Variation	[324]
AMOT	TTI48OS	Strong	Altered Expression	[325]
ANG	TTURHFP	Strong	Altered Expression	[326]
ANGPT1	TTWNQ1T	Strong	Biomarker	[327]
ANGPTL4	TTWALY5	Strong	Altered Expression	[328]
ANTXR2	TTOD34I	Strong	Biomarker	[329]
ANXA5	TT2Z83I	Strong	Biomarker	[227]
APLN	TT87D3J	Strong	Altered Expression	[330]
APLNR	TTJ8E43	Strong	Biomarker	[330]
APP	TTE4KHA	Strong	Biomarker	[331]
AQP9	TTQEI32	Strong	Altered Expression	[332]
ARSA	TTYQANR	Strong	Biomarker	[333]
ASIC3	TTLGDIS	Strong	Genetic Variation	[334]
ATM	TTKBM7V	Strong	Altered Expression	[335]
ATR	TT8ZYBQ	Strong	Biomarker	[78]
AURKB	TT9RTBL	Strong	Altered Expression	[336]
AXL	TTZPY6J	Strong	Altered Expression	[337]
BAK1	TTFM7V0	Strong	Biomarker	[338]
BCHE	TT3MSAO	Strong	Genetic Variation	[339]
BCL2L2	TTQ79W8	Strong	Biomarker	[340]
BECN1	TT5M7LN	Strong	Altered Expression	[341]
BIRC3	TTAIWZN	Strong	Altered Expression	[342]
BMP7	TTKOBRA	Strong	Biomarker	[343]
BMX	TTN2I9E	Strong	Biomarker	[344]
BRD2	TTDP48B	Strong	Biomarker	[345]
BTG1	TTL7N2W	Strong	Biomarker	[346]
BTK	TTGM6VW	Strong	Biomarker	[347]
CA12	TTSYM0R	Strong	Biomarker	[348]
CA2	TTANPDJ	Strong	Biomarker	[349]
CA9	TT2LVK8	Strong	Altered Expression	[93]
CALCR	TTLWS2O	Strong	Altered Expression	[350]
CASP2	TT12VNG	Strong	Altered Expression	[351]
CASP9	TTB6T7O	Strong	Altered Expression	[352]
CASR	TTBUYHA	Strong	Genetic Variation	[353]
CAV1	TTXUBN2	Strong	Altered Expression	[354]
CBL	TT7QT13	Strong	Genetic Variation	[355]
CBX7	TTBN3HC	Strong	Biomarker	[356]
CCL11	TTCF05Y	Strong	Biomarker	[357]
CCL22	TTBTWI1	Strong	Biomarker	[358]
CCN1	TTPK79J	Strong	Altered Expression	[359]
CCNA2	TTAMQ62	Strong	Altered Expression	[360]
CCNB1	TT9P6OW	Strong	Biomarker	[361]
CCND3	TT1JXNR	Strong	Biomarker	[362]
CCNE1	TTCEJ4F	Strong	Biomarker	[363]
CCR1	TTC24WT	Strong	Biomarker	[364]
CD200	TT0BE68	Strong	Biomarker	[365]
CD248	TTYJWT7	Strong	Altered Expression	[366]
CD276	TT6CQUM	Strong	Biomarker	[367]
CD34	TTZAVYN	Strong	Biomarker	[368]
CD44	TTWFBT7	Strong	Biomarker	[369]
CD74	TTCMYP9	Strong	Altered Expression	[370]
CD86	TT53XHB	Strong	Biomarker	[371]
CD9	TTZEIBV	Strong	Biomarker	[372]
CDC25A	TTLZS4Q	Strong	Biomarker	[373]
CDC25C	TTESBNC	Strong	Biomarker	[374]
CDH11	TTRGWZC	Strong	Biomarker	[375]
CDH2	TT1WS0T	Strong	Altered Expression	[376]
CDH5	TTXLCFO	Strong	Biomarker	[377]
CDK2	TT7HF4W	Strong	Biomarker	[378]
CDK3	TTMYWL7	Strong	Altered Expression	[379]
CDK4	TT0PG8F	Strong	Altered Expression	[380]
CDK5	TTL4Q97	Strong	Biomarker	[381]
CDK7	TTQYF7G	Strong	Biomarker	[382]
CDK9	TT1LVF2	Strong	Posttranslational Modification	[383]
CDKN1A	TT9GUW0	Strong	Altered Expression	[384]
CDKN2C	TTBRUGA	Strong	Biomarker	[385]
CEACAM3	TTPX7I5	Strong	Biomarker	[386]
CEBPB	TTUI35N	Strong	Biomarker	[387]
CFLAR	TTJZQYH	Strong	Biomarker	[388]
CHRM2	TTYEG6Q	Strong	Biomarker	[389]
CHST15	TTFK7E1	Strong	Biomarker	[390]
CHUK	TT1F8OQ	Strong	Biomarker	[391]
CLCN3	TT8XNZ7	Strong	Altered Expression	[392]
CLIC1	TT8KZG6	Strong	Altered Expression	[393]
CMA1	TT8VUE0	Strong	Biomarker	[165]
CNP	TT71P0H	Strong	Biomarker	[394]
CNTN2	TT2Z1WB	Strong	Biomarker	[331]
COL18A1	TT63DI9	Strong	Biomarker	[395]
CPB2	TTP18AY	Strong	Altered Expression	[396]
CPE	TTXPWO6	Strong	Biomarker	[397]
CREB1	TTH4AN3	Strong	Altered Expression	[398]
CREBBP	TTFRCTK	Strong	Genetic Variation	[399]
CRTC2	TTFWETR	Strong	Biomarker	[400]
CRYAB	TT7RUHB	Strong	Biomarker	[401]
CRYZ	TTP6UO8	Strong	Biomarker	[402]
CSE1L	TTTRULD	Strong	Biomarker	[403]
CSF1R	TT7MRDV	Strong	Biomarker	[404]
CSNK2A1	TTER6YH	Strong	Genetic Variation	[405]
CSPG4	TT7MYXI	Strong	Biomarker	[406]
CTAG1A	TTE5ITK	Strong	Biomarker	[407]
CTLA4	TTI2S1D	Strong	Biomarker	[408]
CTSD	TTPT2QI	Strong	Biomarker	[409]
CTSL	TT36ETB	Strong	Altered Expression	[410]
CTSS	TTUMQVO	Strong	Biomarker	[411]
CUL3	TTPCU0Q	Strong	Biomarker	[412]
CXCL8	TTCTE1G	Strong	Biomarker	[92]
CXCR6	TT2BVUA	Strong	Biomarker	[54]
CYP46A1	TT4EB85	Strong	Biomarker	[413]
DBH	TTYIP79	Strong	Biomarker	[414]
DCN	TTB3XAN	Strong	Altered Expression	[415]
DDX58	TTVB0O3	Strong	Biomarker	[416]
DHCR24	TTTK0NH	Strong	Biomarker	[417]
DHPS	TTBO2A9	Strong	Altered Expression	[418]
DICER1	TTTEOPU	Strong	Biomarker	[419]
DKK3	TTY2ZV6	Strong	Biomarker	[272]
DLL4	TTV23LH	Strong	Altered Expression	[420]
DNM2	TTVRA5G	Strong	Biomarker	[421]
DPYSL2	TTZCW3T	Strong	Altered Expression	[422]
DRD5	TTS2PH3	Strong	Altered Expression	[423]
DYRK1A	TTSBVFO	Strong	Altered Expression	[424]
E2F1	TTASI04	Strong	Biomarker	[425]
E2F3	TTWIJYH	Strong	Altered Expression	[426]
EBI3	TTJF68X	Strong	Genetic Variation	[427]
ECE1	TTQ9RYT	Strong	Biomarker	[428]
EDNRA	TTKRD0G	Strong	Altered Expression	[429]
EGFL7	TT7WD0H	Strong	Biomarker	[430]
EGLN1	TT9ISBX	Strong	Biomarker	[431]
EGR1	TTE8LGD	Strong	Altered Expression	[432]
EIF2AK2	TTXEZJ4	Strong	Altered Expression	[433]
EIF2AK4	TT9U4EP	Strong	Altered Expression	[434]
EIF4E2	TT2ZSKV	Strong	Biomarker	[435]
EIF4EBP1	TTKGEBL	Strong	Biomarker	[436]
EIF5A	TTIVCNR	Strong	Biomarker	[437]
EIF5A2	TTH53G9	Strong	Altered Expression	[418]
ELAVL1	TTPC9D0	Strong	Altered Expression	[438]
ENG	TTB30LE	Strong	Biomarker	[439]
ENPEP	TT9PBIL	Strong	Biomarker	[440]
ENPP1	TTZTIWS	Strong	Biomarker	[441]
ENTPD1	TTYM8DJ	Strong	Altered Expression	[442]
EPHA1	TTLFZVU	Strong	Biomarker	[443]
EPHA2	TTRJB2G	Strong	Biomarker	[444]
EPHA3	TTHS2LR	Strong	Altered Expression	[445]
EPHA4	TTG84D3	Strong	Biomarker	[446]
EPHA7	TTAHTVG	Strong	Biomarker	[447]
EPHA8	TTHZ2LW	Strong	Altered Expression	[448]
EPHB2	TTKPV6O	Strong	Altered Expression	[449]
ERAP1	TT60XFL	Strong	Altered Expression	[450]
EREG	TTYSB89	Strong	Biomarker	[451]
ERN1	TTKIAT3	Strong	Biomarker	[452]
ESRRB	TTKF0XS	Strong	Altered Expression	[239]
ETS1	TTTGPSD	Strong	Altered Expression	[453]
ETS2	TT9AH0M	Strong	Biomarker	[327]
EZH2	TT9MZCQ	Strong	Biomarker	[84]
F10	TTCIHJA	Strong	Biomarker	[454]
FAP	TTGPQ0F	Strong	Altered Expression	[455]
FASLG	TTO7014	Strong	Biomarker	[456]
FAT1	TTGUJYV	Strong	Altered Expression	[115]
FBXW7	TT29KY7	Strong	Biomarker	[457]
FCGRT	TTKLPHO	Strong	Biomarker	[458]
FDPS	TTIKWV4	Strong	Altered Expression	[459]
FDXR	TT3W4IX	Strong	Biomarker	[460]
FECH	TTQ6VF4	Strong	Biomarker	[461]
FGF2	TTGKIED	Strong	Biomarker	[462]
FGF7	TTFY134	Strong	Biomarker	[463]
FGFR3	TTST7KB	Strong	Altered Expression	[464]
FGFR4	TT1KX2S	Strong	Biomarker	[465]
FGL2	TTYBS89	Strong	Biomarker	[466]
FHL1	TTI7ENL	Strong	Altered Expression	[467]
FKBP4	TTHY0FT	Strong	Biomarker	[468]
FKBP5	TT0J5KQ	Strong	Biomarker	[468]
FOLH1	TT9G4N0	Strong	Biomarker	[469]
FOLR1	TTVC37M	Strong	Altered Expression	[470]
FOSL2	TT689IR	Strong	Biomarker	[471]
FOXC2	TTLBAP1	Strong	Altered Expression	[472]
FOXM1	TTD3KOX	Strong	Altered Expression	[473]
FOXO1	TTLRVIA	Strong	Altered Expression	[474]
FPR1	TT5Y4EM	Strong	Biomarker	[475]
FSCN1	TTTRS9B	Strong	Biomarker	[476]
FST	TTDNM9W	Strong	Biomarker	[477]
FTO	TTFW3BT	Strong	Biomarker	[478]
FUS	TTKGYZ9	Strong	Biomarker	[479]
FUT4	TTNV1KZ	Strong	Altered Expression	[480]
FZD10	TTP1S2F	Strong	Altered Expression	[481]
FZD7	TTUQMO5	Strong	Altered Expression	[482]
G3BP1	TTG0R8Z	Strong	Biomarker	[483]
GABRA1	TT1MPAY	Strong	Altered Expression	[484]
GCLM	TTNFESW	Strong	Altered Expression	[485]
GDF15	TT4MXVG	Strong	Altered Expression	[486]
GDNF	TTF23ML	Strong	Biomarker	[487]
GFAP	TTI6FFX	Strong	Biomarker	[488]
GGH	TTZJRL0	Strong	Altered Expression	[489]
GGT7	TT62BC7	Strong	Altered Expression	[490]
GJA3	TTFZRG0	Strong	Altered Expression	[491]
GJB6	TTAU8SJ	Strong	Biomarker	[492]
GLI1	TTJOMH6	Strong	Altered Expression	[493]
GLIPR1	TTEQF1O	Strong	Altered Expression	[494]
GNRH1	TT0ID4A	Strong	Altered Expression	[495]
GNRHR	TT8R70G	Strong	Altered Expression	[496]
GPD1	TTKTEAH	Strong	Biomarker	[497]
GPI	TT19JIZ	Strong	Altered Expression	[498]
GRIA2	TTWM461	Strong	Altered Expression	[499]
GRIA4	TTPJR0G	Strong	Biomarker	[500]
GRK3	TT5A4DX	Strong	Altered Expression	[501]
GRK5	TTTCXO0	Strong	Biomarker	[502]
GRM2	TTXJ47W	Strong	Biomarker	[500]
GRPR	TTC1MVT	Strong	Biomarker	[503]
GSN	TTUH7OM	Strong	Biomarker	[56]
GSR	TTEP6RV	Strong	Biomarker	[504]
HAX1	TT21BYA	Strong	Biomarker	[505]
HBEGF	TT15SL0	Strong	Biomarker	[506]
HDAC1	TT6R7JZ	Strong	Altered Expression	[507]
HDAC3	TT4YWTO	Strong	Biomarker	[508]
HDAC5	TTUELN5	Strong	Posttranslational Modification	[509]
HDAC6	TT5ZKDI	Strong	Biomarker	[510]
HGF	TT4V2JM	Strong	Biomarker	[511]
HGFAC	TTD96RW	Strong	Biomarker	[512]
HHAT	TT1VNCG	Strong	Biomarker	[513]
HIF1A	TTSN6QU	Strong	Biomarker	[514]
HIPK2	TTOB49C	Strong	Biomarker	[515]
HK2	TTK02H8	Strong	Biomarker	[516]
HLA-G	TTLKFB3	Strong	Biomarker	[517]
HMGA1	TTBA219	Strong	Altered Expression	[518]
HMGA2	TTSTVM0	Strong	Biomarker	[519]
HMGB2	TTA78JQ	Strong	Altered Expression	[520]
HMOX2	TTWZRL4	Strong	Altered Expression	[521]
HNF1A	TT01M3K	Strong	Altered Expression	[522]
HNRNPA1	TTPJ9XK	Strong	Altered Expression	[523]
HNRNPA2B1	TT8UPW6	Strong	Biomarker	[134]
HOXA11	TTEX4ZA	Strong	Biomarker	[524]
HOXA13	TTN26OM	Strong	Biomarker	[525]
HSP90AA1	TT78R5H	Strong	Biomarker	[526]
HSP90B1	TTFPKXQ	Strong	Biomarker	[527]
HSPA5	TTW26OG	Strong	Altered Expression	[528]
HSPA9	TTMTPG3	Strong	Biomarker	[529]
HSPB1	TT9AZWY	Strong	Biomarker	[263]
HSPB8	TTY0OJN	Strong	Biomarker	[530]
HTR7	TTO9X1H	Strong	Biomarker	[531]
IAPP	TTHN8EM	Strong	Genetic Variation	[324]
ICOS	TTE5VP6	Strong	Biomarker	[532]
ID1	TTBXVDE	Strong	Biomarker	[533]
ID2	TTW8A5N	Strong	Altered Expression	[534]
IGFBP2	TTU4QSN	Strong	Biomarker	[535]
IGFBP6	TTLAYV8	Strong	Altered Expression	[536]
IGFBP7	TTUQ01B	Strong	Altered Expression	[493]
IKBKB	TTJ3E9X	Strong	Altered Expression	[537]
IL13RA2	TTMPZ7V	Strong	Biomarker	[538]
IL16	TTW4R0B	Strong	Biomarker	[539]
IL2	TTF89GD	Strong	Biomarker	[540]
IL20	TTNZMY2	Strong	Altered Expression	[541]
IL24	TT1EPXZ	Strong	Biomarker	[542]
IL31RA	TT9HPX0	Strong	Biomarker	[543]
IL4R	TTDWHC3	Strong	Altered Expression	[544]
ILK	TT7ALZG	Strong	Biomarker	[545]
IMPDH2	TTTB4UP	Strong	Altered Expression	[546]
IRS1	TTAJSQ0	Strong	Biomarker	[547]
IRS2	TTF95B8	Strong	Altered Expression	[548]
ITCH	TT5SEWD	Strong	Biomarker	[549]
ITGA2	TTSJ542	Strong	Biomarker	[550]
ITGA5	TTHIZP9	Strong	Biomarker	[265]
ITGA6	TT165T3	Strong	Biomarker	[551]
ITGAM	TTB69FJ	Strong	Biomarker	[552]
ITGB3	TTJA1ZO	Strong	Biomarker	[553]
JUN	TTS7IR5	Strong	Biomarker	[508]
KCNH1	TT9XKUC	Strong	Altered Expression	[554]
KCNH2	TTQ6VDM	Strong	Biomarker	[555]
KCNJ3	TTGM19J	Strong	Biomarker	[556]
KCNK9	TTL4FMB	Strong	Biomarker	[557]
KDM5A	TTIG67W	Strong	Altered Expression	[558]
KDM6B	TTDIJUQ	Strong	Biomarker	[559]
KDR	TTUTJGQ	Strong	Biomarker	[330]
KHDRBS1	TTAT6C7	Strong	Biomarker	[560]
KIF11	TTBGTCW	Strong	Biomarker	[561]
KIR2DS2	TTV3CFI	Strong	Biomarker	[562]
KIT	TTX41N9	Strong	Biomarker	[563]
KLK6	TTLPF4X	Strong	Altered Expression	[564]
KPNB1	TTHOJ5F	Strong	Biomarker	[388]
LAG3	TTNVXAW	Strong	Biomarker	[565]
LAMP1	TTC214J	Strong	Biomarker	[409]
LANCL2	TTMK3EX	Strong	Altered Expression	[566]
LAPTM4B	TTEJQT0	Strong	Biomarker	[567]
LGALS1	TTO3NYT	Strong	Biomarker	[568]
LGALS3	TTFPQV7	Strong	Genetic Variation	[569]
LGMN	TTPTWV5	Strong	Biomarker	[570]
LIF	TTGZ5WN	Strong	Biomarker	[571]
LIMK2	TTASMD8	Strong	Biomarker	[123]
LMO2	TTFX379	Strong	Altered Expression	[572]
LRP1	TTF2V7I	Strong	Biomarker	[573]
LTB4R	TTN53ZF	Strong	Biomarker	[574]
LTBR	TTFO0PM	Strong	Biomarker	[575]
MAGEA1	TT63M7Q	Strong	Altered Expression	[576]
MAGEA2	TTOZT28	Strong	Biomarker	[577]
MALT1	TTCI81G	Strong	Biomarker	[578]
MAP2K7	TT6QY3J	Strong	Biomarker	[510]
MAP3K1	TTW8TJI	Strong	Biomarker	[579]
MAP3K21	TTSW9YL	Strong	Biomarker	[580]
MAPK11	TT73U6C	Strong	Biomarker	[581]
MAPK3	TT1MG9E	Strong	Altered Expression	[449]
MAPK8	TT0K6EO	Strong	Altered Expression	[582]
MAPK9	TT3IVG2	Strong	Biomarker	[583]
MAPKAP1	TTWDKCL	Strong	Genetic Variation	[584]
MARK2	TTAJ45Y	Strong	Biomarker	[585]
MAZ	TT059DA	Strong	Biomarker	[586]
MBTPS1	TTNSM2I	Strong	Biomarker	[587]
MC4R	TTD0CIQ	Strong	Genetic Variation	[588]
MCM6	TTQGKSD	Strong	Genetic Variation	[589]
MCOLN1	TT9XBVO	Strong	Biomarker	[590]
MERTK	TTO7LKR	Strong	Altered Expression	[591]
METAP2	TTZL0OI	Strong	Biomarker	[592]
MGAT1	TTYJRN5	Strong	Altered Expression	[593]
MIA	TT5HNVS	Strong	Biomarker	[594]
MIF	TT6804T	Strong	Biomarker	[595]
MKI67	TTB4UNG	Strong	Biomarker	[596]
MMP11	TTZW4MV	Strong	Altered Expression	[597]
MMP12	TTXZ0KQ	Strong	Altered Expression	[598]
MMP14	TTJ4QE7	Strong	Biomarker	[599]
MPL	TTIHYA4	Strong	Biomarker	[600]
MRC1	TTKV8W5	Strong	Genetic Variation	[601]
MSI1	TTSM4BA	Strong	Biomarker	[602]
MSLN	TT4RXME	Strong	Biomarker	[603]
MYB	TT8V13P	Strong	Biomarker	[604]
MYC	TTNQ5ZP	Strong	Altered Expression	[426]
MYCN	TT9JBY5	Strong	Altered Expression	[605]
NAPRT	TTVR1FW	Strong	Altered Expression	[606]
NCR1	TTQNRJM	Strong	Altered Expression	[607]
NDUFA13	TTRU1NG	Strong	Biomarker	[608]
NEDD8	TTNDC4K	Strong	Altered Expression	[609]
NEDD9	TT1UREA	Strong	Biomarker	[610]
NEK8	TT8AH9I	Strong	Biomarker	[611]
NEK9	TTM57AW	Strong	Biomarker	[612]
NELL1	TT7H4BF	Strong	Biomarker	[141]
NES	TTHZ752	Strong	Altered Expression	[613]
NFKB2	TTKLNRV	Strong	Biomarker	[73]
NOTCH2	TT82FVD	Strong	Biomarker	[614]
NPM1	TTHBS98	Strong	Biomarker	[615]
NPTX2	TTNJ5A6	Strong	Posttranslational Modification	[616]
NR1I2	TT7LCTF	Strong	Biomarker	[293]
NR1I3	TTRANFM	Strong	Genetic Variation	[353]
NR4A2	TT9HKN3	Strong	Biomarker	[617]
NRAS	TTW2R9X	Strong	Biomarker	[618]
NRP2	TTRXUVC	Strong	Altered Expression	[619]
NTRK1	TTTDVOJ	Strong	Altered Expression	[620]
NTSR1	TTTUMEP	Strong	Biomarker	[621]
NUAK2	TTHVOTQ	Strong	Altered Expression	[622]
ORAI1	TTE76YK	Strong	Altered Expression	[623]
PABPC1	TTHC8EF	Strong	Altered Expression	[624]
PAK1	TTFN95D	Strong	Altered Expression	[625]
PARP1	TTVDSZ0	Strong	Biomarker	[626]
PAX5	TTA4REJ	Strong	Biomarker	[627]
PCSK6	TT75LN9	Strong	Altered Expression	[628]
PDE4D	TTSKMI8	Strong	Genetic Variation	[629]
PDGFA	TTSM78N	Strong	Altered Expression	[630]
PDGFRB	TTI7421	Strong	Biomarker	[631]
PDK3	TTDEQIP	Strong	Altered Expression	[632]
PDXP	TT9UYG4	Strong	Biomarker	[633]
PECAM1	TT4EZB2	Strong	Altered Expression	[634]
PFKFB2	TTQYVKD	Strong	Biomarker	[635]
PGF	TT48I1Y	Strong	Biomarker	[636]
PHB	TT6U071	Strong	Biomarker	[637]
PIM1	TTTN5QW	Strong	Biomarker	[638]
PIN1	TTJNTSI	Strong	Biomarker	[639]
PKM	TT4LOT8	Strong	Biomarker	[640]
PLAUR	TTNOSTX	Strong	Altered Expression	[641]
PLCB1	TTLPGU7	Strong	Altered Expression	[642]
PLCG1	TT6T4JI	Strong	Altered Expression	[643]
PLD2	TTRLMKF	Strong	Biomarker	[644]
PLG	TTP86E2	Strong	Altered Expression	[300]
PLK2	TT976FS	Strong	Posttranslational Modification	[645]
PLK4	TTGPNZQ	Strong	Biomarker	[646]
PLP2	TTK5OG6	Strong	Altered Expression	[647]
PLXDC1	TTPSK7A	Strong	Biomarker	[648]
PML	TTLH9NY	Strong	Biomarker	[649]
PNP	TTMCF1Y	Strong	Altered Expression	[650]
POSTN	TT8ALTZ	Strong	Altered Expression	[651]
PPARA	TTJ584C	Strong	Altered Expression	[652]
PPIB	TT6ZFQ4	Strong	Biomarker	[653]
PPP1CA	TTFLH0E	Strong	Altered Expression	[654]
PRKAR1A	TTNAHEX	Strong	Genetic Variation	[353]
PRKCA	TTFJ8Q1	Strong	Biomarker	[655]
PRKCD	TT7A1BO	Strong	Biomarker	[656]
PRKDC	TTK3PY9	Strong	Biomarker	[657]
PRMT1	TTVOJAI	Strong	Biomarker	[658]
PRMT5	TTR1D7X	Strong	Biomarker	[135]
PRNP	TTY5F9C	Strong	Biomarker	[659]
PSIP1	TTH9LDP	Strong	Biomarker	[73]
PTGS1	TT8NGED	Strong	Altered Expression	[660]
PTK2	TTON5IT	Strong	Posttranslational Modification	[661]
PTK2B	TTTEFBV	Strong	Altered Expression	[662]
PTN	TTA9EJK	Strong	Biomarker	[663]
PTP4A3	TT7YM8D	Strong	Altered Expression	[664]
PTPN14	TTNIR6C	Strong	Biomarker	[665]
PTPN2	TTY8PUS	Strong	Altered Expression	[666]
PTPRZ1	TT4SEA8	Strong	Biomarker	[663]
RAC1	TT2M9CG	Strong	Biomarker	[667]
RAC3	TT9BQ50	Strong	Biomarker	[668]
RACK1	TTJ10AL	Strong	Biomarker	[669]
RALBP1	TTVSRUA	Strong	Altered Expression	[670]
REG3A	TTL4H8N	Strong	Biomarker	[671]
RHOB	TT6LPFO	Strong	Biomarker	[672]
RIPK1	TTVJHX8	Strong	Biomarker	[303]
RIPK2	TTCQ2E5	Strong	Altered Expression	[673]
RNMT	TTG45HY	Strong	Biomarker	[674]
ROBO1	TTND1YP	Strong	Biomarker	[675]
ROCK1	TTZN7RP	Strong	Biomarker	[676]
ROS1	TTSZ6Y3	Strong	Biomarker	[677]
RPS6KA1	TTIXKA4	Strong	Altered Expression	[678]
RPS6KA2	TT0ZW9O	Strong	Altered Expression	[678]
RPS6KA3	TTUM2ZR	Strong	Altered Expression	[678]
RPS6KA6	TT3KYWB	Strong	Altered Expression	[678]
RPS6KB1	TTG0U4H	Strong	Biomarker	[679]
RRM2	TT1S4LJ	Strong	Biomarker	[217]
RTN4R	TTVRZUO	Strong	Biomarker	[680]
RUNX1	TTWIN3H	Strong	Altered Expression	[681]
RUNX3	TTKCVO7	Strong	Biomarker	[682]
S100A4	TTPR5SX	Strong	Biomarker	[683]
S100A6	TT716MY	Strong	Altered Expression	[684]
S100A9	TT0TMQG	Strong	Altered Expression	[685]
S1PR1	TT9JZCK	Strong	Altered Expression	[686]
SELP	TTE5VG0	Strong	Altered Expression	[687]
SERPINE1	TTTO43N	Strong	Biomarker	[688]
SERPING1	TTVQ6R9	Strong	Altered Expression	[689]
SETD2	TTPC3H4	Strong	Biomarker	[690]
SFRP4	TTX8I1Y	Strong	Biomarker	[691]
SIRT3	TTVZLIJ	Strong	Biomarker	[692]
SIRT5	TTH0IOD	Strong	Altered Expression	[693]
SIRT6	TTUXYWF	Strong	Altered Expression	[694]
SLC12A4	TTJ8C67	Strong	Altered Expression	[695]
SLC16A1	TTN1J82	Strong	Biomarker	[165]
SLC1A1	TTG2A6F	Strong	Altered Expression	[696]
SLC1A3	TT8WRDA	Strong	Biomarker	[697]
SLC1A5	TTF7WRM	Strong	Biomarker	[698]
SLC38A1	TT1YE9Z	Strong	Biomarker	[698]
SLC38A3	TTMAVJQ	Strong	Biomarker	[698]
SLC38A5	TTC8YPT	Strong	Biomarker	[698]
SLC46A1	TTY8Z2E	Strong	Altered Expression	[470]
SLC5A2	TTF8JAT	Strong	Altered Expression	[699]
SLC5A5	TTW7HI9	Strong	Genetic Variation	[700]
SLC7A5	TTPH2JB	Strong	Biomarker	[701]
SLC9A1	TTGSEFH	Strong	Altered Expression	[702]
SLIT2	TTDWK85	Strong	Biomarker	[476]
SMAD1	TT9GR53	Strong	Altered Expression	[703]
SMN1	TT8QL6X	Strong	Biomarker	[704]
SOCS1	TT8COJM	Strong	Biomarker	[705]
SOCS3	TTI0ME6	Strong	Biomarker	[705]
SORT1	TTRX9AV	Strong	Biomarker	[256]
SOX2	TTCNOT6	Strong	Altered Expression	[706]
SPHK1	TTOHFIY	Strong	Altered Expression	[707]
SPOCK1	TTF23RE	Strong	Altered Expression	[708]
SQSTM1	TTOT2RY	Strong	Biomarker	[638]
SRC	TT6PKBN	Strong	Biomarker	[709]
SRGN	TTCHB06	Strong	Biomarker	[710]
SRPK1	TTU3WV6	Strong	Biomarker	[711]
ST8SIA4	TTDP8YM	Strong	Biomarker	[712]
STC1	TTDLUER	Strong	Biomarker	[713]
STK17A	TTEYF03	Strong	Altered Expression	[714]
SULF2	TTLQTHB	Strong	Biomarker	[715]
TACR1	TTZPO1L	Strong	Biomarker	[716]
TAP1	TT7JZI8	Strong	Altered Expression	[717]
TDGF1	TTN7HMG	Strong	Biomarker	[718]
TEK	TT9VGXW	Strong	Biomarker	[719]
TENT4A	TT0XZ4Q	Strong	Altered Expression	[720]
TERF1	TT1Y6J2	Strong	Biomarker	[721]
TERF2	TT5XSLT	Strong	Biomarker	[722]
TF	TT8WXAV	Strong	Altered Expression	[723]
TGFA	TTTLQFR	Strong	Genetic Variation	[724]
TGFB2	TTI0KH6	Strong	Biomarker	[725]
TGFBR1	TTP4520	Strong	Biomarker	[389]
THBS1	TTKI0H1	Strong	Altered Expression	[726]
TK1	TTP3QRF	Strong	Biomarker	[727]
TKTL1	TTNQ1J3	Strong	Altered Expression	[728]
TLR1	TTW14D0	Strong	Biomarker	[729]
TMSB4X	TTMVAIU	Strong	Biomarker	[730]
TNC	TTUCPMY	Strong	Biomarker	[731]
TNFRSF10A	TT5WLRX	Strong	Posttranslational Modification	[732]
TNFRSF10B	TTW20TU	Strong	Biomarker	[733]
TNFRSF11A	TT3K9S2	Strong	Posttranslational Modification	[734]
TNFRSF12A	TTKPS7V	Strong	Altered Expression	[735]
TNFRSF13B	TTL9OD4	Strong	Genetic Variation	[736]
TNFSF12	TTBTDM1	Strong	Altered Expression	[737]
TP53BP1	TTX4UE9	Strong	Biomarker	[106]
TPX2	TT0PHL4	Strong	Biomarker	[738]
TRAF6	TTCDR6M	Strong	Altered Expression	[739]
TREM2	TTQRMSJ	Strong	Altered Expression	[740]
TRH	TT2Z39D	Strong	Altered Expression	[741]
TRIM24	TT9Q7AE	Strong	Biomarker	[742]
TRIM27	TTTO3QN	Strong	Biomarker	[743]
TRIM28	TTQ2BKV	Strong	Biomarker	[744]
TRIM59	TT613U4	Strong	Biomarker	[745]
TRPM2	TTEBMN7	Strong	Altered Expression	[746]
TRPV1	TTMI6F5	Strong	Biomarker	[747]
TSPO	TTPTXIN	Strong	Biomarker	[748]
TUSC2	TTJ8O14	Strong	Altered Expression	[749]
TYMP	TTO0IB8	Strong	Altered Expression	[750]
TYR	TTULVH8	Strong	Altered Expression	[731]
TYRP1	TTFRV98	Strong	Genetic Variation	[751]
UGCG	TTPHEX3	Strong	Biomarker	[752]
ULK3	TTYENHQ	Strong	Biomarker	[753]
USP1	TTG9MT5	Strong	Biomarker	[754]
USP10	TT5IH09	Strong	Altered Expression	[755]
USP7	TTXU3EQ	Strong	Altered Expression	[756]
USP8	TT1J07C	Strong	Biomarker	[549]
UTRN	TTNO1VA	Strong	Biomarker	[757]
VCP	TTHNLSB	Strong	Biomarker	[758]
VDAC1	TTAMKGB	Strong	Altered Expression	[759]
VEGFD	TTOM5H4	Strong	Altered Expression	[760]
VIPR1	TTCL30I	Strong	Biomarker	[761]
WNT5A	TTKG7F8	Strong	Biomarker	[762]
XIAP	TTK3WBU	Strong	Biomarker	[763]
YAP1	TT8UN2D	Strong	Altered Expression	[473]
YES1	TT0SQ8J	Strong	Altered Expression	[764]
ZNF217	TTY3BRA	Strong	Altered Expression	[765]
ACTG1	TTGAZF9	Definitive	Biomarker	[766]
AGR2	TT9K86S	Definitive	Biomarker	[767]
AHSG	TTKF4WV	Definitive	Biomarker	[768]
ALCAM	TT2AFT6	Definitive	Biomarker	[769]
ARAF	TT5TURO	Definitive	Altered Expression	[643]
AREG	TT76B3W	Definitive	Biomarker	[770]
ARG2	TTV1AG6	Definitive	Altered Expression	[771]
ASIC1	TTRJYB6	Definitive	Biomarker	[772]
ATG7	TTLVB9Z	Definitive	Biomarker	[773]
ATP7B	TTOPO51	Definitive	Altered Expression	[774]
BACE1	TTJUNZF	Definitive	Altered Expression	[775]
BCL6	TTC9YX5	Definitive	Altered Expression	[776]
BDKRB1	TTG5QIA	Definitive	Biomarker	[777]
CAPN2	TTG5QB7	Definitive	Biomarker	[778]
CCL3	TT8I4WB	Definitive	Biomarker	[779]
CCR3	TTD3XFU	Definitive	Biomarker	[780]
CD46	TTMS7DF	Definitive	Biomarker	[781]
CDK6	TTO0FDJ	Definitive	Biomarker	[294]
CDKL1	TTBTI6P	Definitive	Altered Expression	[782]
CEACAM5	TTY6DTE	Definitive	Biomarker	[700]
CHAT	TTKYFSB	Definitive	Altered Expression	[464]
CPS1	TT42M75	Definitive	Biomarker	[783]
CTSK	TTDZN01	Definitive	Altered Expression	[784]
CXCR1	TTMWT8Z	Definitive	Biomarker	[785]
DGKZ	TTSBBXL	Definitive	Altered Expression	[786]
DIABLO	TTN74LE	Definitive	Biomarker	[787]
DIO1	TTU3X26	Definitive	Genetic Variation	[788]
EIF2AK3	TT79U1M	Definitive	Biomarker	[789]
ERBB3	TTSINU2	Definitive	Biomarker	[790]
FANCA	TTV5HJS	Definitive	Genetic Variation	[791]
FLT4	TTDCBX5	Definitive	Biomarker	[148]
FTH1	TT975ZT	Definitive	Altered Expression	[792]
GALR1	TTX3HNZ	Definitive	Biomarker	[793]
GALR2	TTBPW3J	Definitive	Biomarker	[793]
IGFBP5	TTDWEA8	Definitive	Altered Expression	[325]
IRF3	TTYR7OH	Definitive	Biomarker	[794]
ITGB8	TTIF29E	Definitive	Altered Expression	[795]
JAG2	TTOJY1B	Definitive	Biomarker	[796]
KDM2A	TT8XTY2	Definitive	Biomarker	[797]
LAMC2	TTNS7H3	Definitive	Biomarker	[798]
LDHA	TTW76JE	Definitive	Biomarker	[799]
LY96	TT8S9AV	Definitive	Biomarker	[800]
MAP3K2	TTIX0ZU	Definitive	Biomarker	[801]
MAP4K4	TT6NI13	Definitive	Biomarker	[802]
MMP16	TTNP4CU	Definitive	Altered Expression	[803]
MSR1	TT2TDH9	Definitive	Biomarker	[804]
NCK1	TTMA3VF	Definitive	Biomarker	[805]
NOP2	TTBLG3H	Definitive	Biomarker	[806]
NT5E	TTK0O6Y	Definitive	Altered Expression	[807]
NTN1	TT0AH4L	Definitive	Biomarker	[808]
OLR1	TTKSND3	Definitive	Biomarker	[809]
PAK4	TT7Y3BZ	Definitive	Altered Expression	[810]
PDE1C	TTW2HRK	Definitive	Biomarker	[811]
PDGFC	TTOABM9	Definitive	Altered Expression	[630]
PIM3	TTCGOIN	Definitive	Biomarker	[812]
PRKD1	TTSLUMT	Definitive	Biomarker	[813]
RASA1	TTPNZ1F	Definitive	Biomarker	[806]
ROCK2	TTGWKQJ	Definitive	Altered Expression	[814]
SCAP	TTL6U2P	Definitive	Biomarker	[815]
SLC3A2	TT5CZSM	Definitive	Biomarker	[816]
TACSTD2	TTP2HE5	Definitive	Biomarker	[817]
TDP1	TT64IHJ	Definitive	Biomarker	[818]
TFRC	TT8MG4S	Definitive	Altered Expression	[819]
TNFSF14	TTKVENM	Definitive	Biomarker	[820]
TNKS	TTVUSO7	Definitive	Altered Expression	[821]
TRPA1	TTELV3W	Definitive	Altered Expression	[822]
UBA3	TTXZEUS	Definitive	Altered Expression	[609]
VCAM1	TTHCEF6	Definitive	Altered Expression	[823]
WT1	TTZ8UT4	Definitive	Altered Expression	[824]

This Disease Is Related to 22 DTP Molecule(s)

Gene Name	DTP ID	Evidence Level	Mode of Inheritance	REF
SLC25A3	DTCRIWV	Limited	Biomarker	[825]
SLC3A1	DTBCKVM	Limited	Biomarker	[826]
SLC12A2	DTHKL3Q	Disputed	Biomarker	[675]
SLC17A7	DTNK0FR	moderate	Biomarker	[827]
SLC20A1	DTMULXV	moderate	Altered Expression	[828]
SLC39A9	DTJH79E	moderate	Biomarker	[829]
ABCB6	DTF9Y2V	Strong	Altered Expression	[830]
ABCC5	DTYVM24	Strong	Altered Expression	[310]
ATP7A	DT0LT17	Strong	Biomarker	[831]
SLC16A8	DT39AOM	Strong	Genetic Variation	[832]
SLC25A23	DTLQ0EZ	Strong	Altered Expression	[833]
SLC25A37	DTLBGTZ	Strong	Biomarker	[834]
SLC26A3	DTN1FMD	Strong	Altered Expression	[835]
SLC27A3	DTEW95J	Strong	Biomarker	[836]
SLC2A3	DT9SQ3L	Strong	Biomarker	[837]
SLC4A1	DTB0Q3P	Strong	Biomarker	[838]
SLC7A13	DTMWE5P	Strong	Biomarker	[320]
SLC7A7	DTE4HJ8	Strong	Biomarker	[839]
SLC8A2	DTUASRF	Strong	Biomarker	[840]
SLC9A9	DT8LP62	Strong	Altered Expression	[841]
SLC18A1	DTM953D	Definitive	Altered Expression	[842]
SLC22A5	DT3HUVD	Definitive	Altered Expression	[843]

This Disease Is Related to 36 DME Molecule(s)

Gene Name	DME ID	Evidence Level	Mode of Inheritance	REF
ACSS2	DEE76VW	Limited	Genetic Variation	[844]
CYP27A1	DEBS639	Limited	Altered Expression	[845]
GGCT	DEKW6PB	Limited	Biomarker	[846]
NT5C2	DE1DOKJ	Limited	Biomarker	[847]
PON2	DEHJU7E	Limited	Altered Expression	[848]
PRODH	DEVJIHS	Limited	Genetic Variation	[849]
THOP1	DE95LJC	Limited	Biomarker	[850]
UGDH	DE48Q2Z	Limited	Biomarker	[851]
APRT	DE2MV1R	moderate	Biomarker	[852]
BAAT	DERA3OF	moderate	Altered Expression	[853]
GSTT1	DE3PKUG	moderate	Biomarker	[854]
PLPP1	DE6WXTH	moderate	Biomarker	[855]
TGM5	DEW8QEH	moderate	Biomarker	[856]
ACP3	DEDW5H6	Strong	Biomarker	[671]
AKR1B10	DEP6GT1	Strong	Biomarker	[857]
CRMP1	DE0EUXB	Strong	Biomarker	[757]
CYP27B1	DE3FYEM	Strong	Biomarker	[858]
CYP4B1	DEMF740	Strong	Biomarker	[859]
FAAH	DEUM1EX	Strong	Biomarker	[747]
GCLC	DESYL1F	Strong	Altered Expression	[485]
GLS	DE3E0VT	Strong	Biomarker	[860]
HIF1AN	DEY1CBW	Strong	Biomarker	[861]
HPGD	DEHKSC6	Strong	Biomarker	[68]
ME1	DE97WM8	Strong	Biomarker	[862]
MT1A	DE5ME8A	Strong	Posttranslational Modification	[863]
MTRR	DE6NIY9	Strong	Altered Expression	[864]
PARK7	DEPOVCH	Strong	Altered Expression	[865]
PCYT1A	DEQYXD4	Strong	Altered Expression	[866]
PSAT1	DEBS17P	Strong	Biomarker	[409]
PTGDS	DER3H9C	Strong	Biomarker	[867]
SULT1A1	DEYWLRK	Strong	Biomarker	[712]
UGP2	DE4U39Y	Strong	Genetic Variation	[868]
UPRT	DE20ETR	Strong	Biomarker	[869]
HK1	DEDMAGE	Definitive	Altered Expression	[870]
NNMT	DECVGJ3	Definitive	Biomarker	[871]
SAT1	DEMWO83	Definitive	Biomarker	[872]

This Disease Is Related to 1322 DOT Molecule(s)

Gene Name	DOT ID	Evidence Level	Mode of Inheritance	REF
ABCA13	OTTHTUQN	Limited	Altered Expression	[873]
ADAM19	OTH88TXU	Limited	Biomarker	[874]
ADRM1	OTOU4EY6	Limited	Biomarker	[120]
AFDN	OTTRU341	Limited	Biomarker	[875]
AHNAK	OT6KH1WG	Limited	Biomarker	[876]
AKT1S1	OT4JHN4Y	Limited	Posttranslational Modification	[877]
ALDH7A1	OTV57BZD	Limited	Biomarker	[878]
ALG2	OT77B384	Limited	Biomarker	[879]
ALKBH1	OTADGU5D	Limited	Biomarker	[880]
ANXA7	OTLMD0TK	Limited	Biomarker	[881]
APCDD1	OTV9AD0L	Limited	Biomarker	[882]
ARNT2	OTAQD3YV	Limited	Biomarker	[883]
ASCL1	OTI4X44G	Limited	Biomarker	[605]
ATP5F1A	OT3FZDLX	Limited	Altered Expression	[884]
ATP5F1B	OTLFZUQK	Limited	Altered Expression	[884]
B3GAT1	OTXFP98E	Limited	Altered Expression	[70]
BAG1	OTRQNIA4	Limited	Altered Expression	[885]
BCAN	OTPVY3ZR	Limited	Altered Expression	[53]
BTF3	OT5ZZFJL	Limited	Altered Expression	[886]
C1D	OTI9PMN1	Limited	Biomarker	[573]
C1QTNF8	OTU5Z3YK	Limited	Biomarker	[54]
C9	OT7I5FDX	Limited	Biomarker	[56]
CAMK2A	OTJGX19T	Limited	Biomarker	[151]
CAMK2B	OTS9YK3E	Limited	Altered Expression	[887]
CAVIN1	OTFO915U	Limited	Altered Expression	[354]
CCDC6	OTXRQDYG	Limited	Biomarker	[888]
CCHCR1	OT22C116	Limited	Biomarker	[91]
CCL18	OT7JYSK9	Limited	Biomarker	[889]
CCN4	OT69BER9	Limited	Biomarker	[890]
CCNH	OTKDU3SR	Limited	Biomarker	[106]
CCRL2	OT5PX0RX	Limited	Biomarker	[91]
CD109	OTDADBM4	Limited	Biomarker	[891]
CD226	OT4UG0KB	Limited	Altered Expression	[892]
CD68	OTOYEY3J	Limited	Altered Expression	[678]
CDC42	OT5QBC5M	Limited	Biomarker	[893]
CENPU	OTQ4TZRS	Limited	Biomarker	[894]
CHAC1	OTJGE772	Limited	Altered Expression	[895]
CHD5	OTS5EVHH	Limited	Altered Expression	[896]
COPS6	OTG9AAG0	Limited	Biomarker	[897]
CTBP1	OTVYH2DH	Limited	Altered Expression	[898]
CTHRC1	OTV88X2G	Limited	Biomarker	[899]
CUX1	OTU1LCNJ	Limited	Biomarker	[900]
CXCL6	OTFTCQ4O	Limited	Altered Expression	[901]
DAAM1	OT0VHIYZ	Limited	Biomarker	[902]
DCC	OT2C1SHW	Limited	Altered Expression	[903]
DCX	OTISR7K3	Limited	Biomarker	[904]
DEGS1	OT4WXPKW	Limited	Biomarker	[905]
DEUP1	OTXLM86J	Limited	Biomarker	[106]
DIAPH3	OTPOT23F	Limited	Biomarker	[906]
DIRAS1	OT07F6PE	Limited	Altered Expression	[907]
DLGAP3	OT0GR2F6	Limited	Altered Expression	[908]
DOCK4	OTH3XY8B	Limited	Altered Expression	[909]
DST	OTHZBM4X	Limited	Biomarker	[910]
DUOX1	OTQ2AEW0	Limited	Biomarker	[911]
DUOXA1	OTNG3HH4	Limited	Biomarker	[912]
DUSP6	OT4H6RKW	Limited	Altered Expression	[913]
DVL3	OTPRROHJ	Limited	Biomarker	[914]
DYNC2H1	OTLC8K6B	Limited	Biomarker	[915]
EFEMP1	OTZVUOOB	Limited	Biomarker	[916]
EFNA2	OTEAUKRX	Limited	Altered Expression	[917]
EIF4A3	OTYYFE7K	Limited	Biomarker	[918]
ELF4	OT167PR5	Limited	Biomarker	[919]
ELFN2	OT9C5F0K	Limited	Altered Expression	[920]
ELK1	OTH9MXD6	Limited	Altered Expression	[921]
ELMO2	OTKDOC2M	Limited	Biomarker	[922]
EMP2	OTPS2H0L	Limited	Biomarker	[923]
EMP3	OTODMJ1D	Limited	Altered Expression	[924]
ERCC1	OTNPYQHI	Limited	Biomarker	[925]
ERVFRD-1	OT3064D7	Limited	Biomarker	[926]
ESS2	OTZ08VCZ	Limited	Biomarker	[927]
EXO1	OTI87RS5	Limited	Biomarker	[928]
FAH	OTGZA1YR	Limited	Biomarker	[929]
FNDC3B	OTBILGDR	Limited	Altered Expression	[930]
FOSB	OTW6C05J	Limited	Genetic Variation	[931]
FOXD1	OT80PRHS	Limited	Biomarker	[932]
FSD1	OT8P6PT3	Limited	Altered Expression	[933]
FSD1L	OTBQ48RF	Limited	Altered Expression	[933]
GLUD2	OTF3GGYY	Limited	Altered Expression	[934]
GOLGA4	OTCMEHNJ	Limited	Altered Expression	[901]
GOT2	OT6XBWN0	Limited	Biomarker	[935]
GPR151	OT7EACU6	Limited	Biomarker	[104]
GPR42	OTEB0ROY	Limited	Biomarker	[54]
GRP	OT8JDFNI	Limited	Biomarker	[936]
HBP1	OTDPGGDV	Limited	Biomarker	[937]
HES1	OT8P19W2	Limited	Biomarker	[139]
HM13	OTGEO1LP	Limited	Altered Expression	[938]
HMGB3	OTCJ2EZY	Limited	Biomarker	[939]
HMMR	OT4M0JTZ	Limited	Biomarker	[940]
HNRNPC	OT47AK4C	Limited	Altered Expression	[134]
HNRNPDL	OTB3BFCV	Limited	Altered Expression	[134]
HOXA1	OTMSOJ7D	Limited	Biomarker	[941]
HOXC11	OT8NMHM6	Limited	Biomarker	[942]
HOXC9	OT60K4M0	Limited	Altered Expression	[943]
HOXD10	OT0NOWU2	Limited	Biomarker	[944]
IKBKE	OT5VYOSM	Limited	Biomarker	[945]
ING5	OTRNNSFM	Limited	Biomarker	[946]
JPT1	OT6CRZEU	Limited	Biomarker	[120]
KDM2B	OTDMCVW7	Limited	Biomarker	[947]
KDM6A	OTZM3MJJ	Limited	Altered Expression	[948]
KHSRP	OTDHZARB	Limited	Biomarker	[949]
KLF16	OTTPV4NB	Limited	Altered Expression	[950]
KLRC3	OT9EPHV3	Limited	Altered Expression	[951]
KMT2E	OTYOLNOG	Limited	Biomarker	[952]
LCN1	OT8BWXTV	Limited	Biomarker	[357]
LGR6	OTPZ1PWR	Limited	Biomarker	[104]
LRRC59	OT6BQJ5E	Limited	Biomarker	[106]
LRRC8A	OT23OE7H	Limited	Biomarker	[953]
LTBP4	OTC8WL2V	Limited	Biomarker	[954]
MACIR	OTPSW8Y8	Limited	Biomarker	[106]
MAL	OTBM30SW	Limited	Biomarker	[176]
MAP1B	OTVXW089	Limited	Biomarker	[955]
MAP1LC3B	OTUYHB84	Limited	Altered Expression	[956]
MMRN1	OT7ZNYHT	Limited	Biomarker	[916]
MPEG1	OT7DAO0F	Limited	Altered Expression	[109]
MPG	OTAHW80B	Limited	Biomarker	[54]
MPST	OTCDPH5D	Limited	Biomarker	[957]
MRGPRX3	OTRKCCDS	Limited	Biomarker	[104]
MRGPRX4	OTOBHZVA	Limited	Biomarker	[104]
MRPL41	OTG5URO4	Limited	Biomarker	[958]
MTFR2	OTLOR68D	Limited	Biomarker	[959]
MTSS1	OT5DTDO2	Limited	Genetic Variation	[960]
MX2	OT05NF37	Limited	Genetic Variation	[961]
MYL9	OT6B22JB	Limited	Biomarker	[962]
NANS	OTMQ2FUH	Limited	Biomarker	[963]
NAP1L1	OTI7WBZV	Limited	Altered Expression	[964]
NCR2	OT2H13BX	Limited	Altered Expression	[965]
NDRG1	OTVO66BO	Limited	Altered Expression	[571]
NDRG2	OT5L6KD7	Limited	Biomarker	[966]
NDST1	OT9E10W2	Limited	Altered Expression	[967]
NEFL	OTQESJV4	Limited	Biomarker	[968]
NEU1	OTH9BY8Y	Limited	Altered Expression	[969]
NEURL1	OT2C4P70	Limited	Altered Expression	[969]
NEUROD2	OTJMMX9K	Limited	Biomarker	[970]
NFATC1	OT4TMERS	Limited	Altered Expression	[971]
NIBAN2	OTVDQSPI	Limited	Biomarker	[352]
NIF3L1	OT4MP90J	Limited	Biomarker	[99]
NKD1	OTY3MO97	Limited	Biomarker	[972]
NLK	OT2LETFS	Limited	Altered Expression	[973]
NME2	OTCYGLHV	Limited	Biomarker	[974]
NOX1	OTZPJQCC	Limited	Biomarker	[911]
NOX5	OTHTH59G	Limited	Biomarker	[911]
NR1D2	OT9CVF41	Limited	Biomarker	[975]
NTS	OTPGDNQS	Limited	Biomarker	[976]
NUDT21	OTZHKWAR	Limited	Altered Expression	[625]
OLIG1	OTIMFI31	Limited	Altered Expression	[977]
OPTN	OT2UXWH9	Limited	Altered Expression	[964]
P4HB	OTTYNYPF	Limited	Biomarker	[978]
PDCD6	OT2YA5M8	Limited	Altered Expression	[879]
PDCD6IP	OTS8T6A7	Limited	Altered Expression	[979]
PDCL	OTDNHIXG	Limited	Biomarker	[980]
PDIA6	OT8YBR17	Limited	Biomarker	[981]
PFKFB4	OTQYEXL2	Limited	Biomarker	[209]
PHF19	OTF6RUCR	Limited	Altered Expression	[982]
PHF5A	OTS94JFM	Limited	Biomarker	[983]
PHLDB1	OTIRCB6I	Limited	Genetic Variation	[984]
PIAS3	OT3TWH9R	Limited	Biomarker	[985]
PIWIL1	OT7CRGZ3	Limited	Biomarker	[986]
PIWIL4	OTDA9MY0	Limited	Genetic Variation	[986]
POLD4	OTG578YH	Limited	Biomarker	[987]
POLE4	OTCMWUT6	Limited	Biomarker	[987]
POLK	OTKZ38JH	Limited	Altered Expression	[720]
PRUNE2	OTGW2974	Limited	Altered Expression	[951]
PTBP2	OTF4S7NE	Limited	Biomarker	[988]
PTGFRN	OTBG4SA2	Limited	Altered Expression	[989]
PTPN3	OTSLZBVY	Limited	Altered Expression	[825]
PTPRU	OTHDO0QG	Limited	Biomarker	[825]
QKI	OTTAUGLB	Limited	Biomarker	[990]
RAB25	OTW0W6NP	Limited	Biomarker	[991]
RAC2	OTAOHFNH	Limited	Biomarker	[668]
RALGAPA1	OTHT5DW0	Limited	Biomarker	[299]
RAMP3	OTX6XLLM	Limited	Biomarker	[65]
RAN	OT2TER5M	Limited	Biomarker	[992]
RASD1	OT2BAJHK	Limited	Biomarker	[991]
RCC2	OTUJVTLS	Limited	Biomarker	[993]
RELB	OTU3QYEF	Limited	Biomarker	[994]
RMDN3	OTKO7AUM	Limited	Altered Expression	[956]
RND1	OTOC223Z	Limited	Biomarker	[995]
RNF138	OTPU0CO4	Limited	Biomarker	[996]
RPL5	OTM8EBRI	Limited	Altered Expression	[997]
RPL8	OTHMZ1R9	Limited	Biomarker	[998]
RPS15	OT0WYZYG	Limited	Altered Expression	[907]
RPS27	OTFXKY7P	Limited	Altered Expression	[109]
RSPO2	OT3HHXU0	Limited	Biomarker	[158]
RSU1	OTO5GHT1	Limited	Altered Expression	[999]
RTEL1	OTI3PJCT	Limited	Genetic Variation	[984]
RWDD3	OTE76DY5	Limited	Altered Expression	[1000]
SARDH	OTQ49Q27	Limited	Altered Expression	[1001]
SDCBP	OTS3NCC5	Limited	Biomarker	[1002]
SEMA6A	OTDQ7QAW	Limited	Biomarker	[1003]
SEPTIN14	OTCM6DDO	Limited	Biomarker	[1004]
SERPINA3	OT9BP2S0	Limited	Biomarker	[56]
SETMAR	OTE2MIMZ	Limited	Biomarker	[1005]
SGTA	OTKOJ3JB	Limited	Biomarker	[1006]
SLC16A4	OT1YXBKC	Limited	Biomarker	[165]
SLC22A10	OTUVJI3H	Limited	Biomarker	[106]
SLFN11	OTJWFPMY	Limited	Biomarker	[1007]
SMG1	OTTS3SXE	Limited	Altered Expression	[1008]
SNAI1	OTDPYAMC	Limited	Biomarker	[1009]
SOAT1	OTB4Y5RJ	Limited	Biomarker	[312]
SOS1	OTTCWXC3	Limited	Biomarker	[1010]
SPINT1	OT1CLR5L	Limited	Biomarker	[1011]
SPINT2	OTQV7BKQ	Limited	Altered Expression	[1012]
SPRY2	OTH0CRCZ	Limited	Biomarker	[1013]
SRGAP1	OTL89HGW	Limited	Altered Expression	[1014]
SRL	OT7IEBWZ	Limited	Altered Expression	[1001]
SRRT	OTMYPSWV	Limited	Biomarker	[1015]
STAG2	OTR6X1Q7	Limited	Genetic Variation	[1016]
SUZ12	OT655XF8	Limited	Biomarker	[1017]
TAS2R38	OTX5MM36	Limited	Biomarker	[888]
TBX2	OTTOT7A9	Limited	Biomarker	[1018]
TEAD4	OTJS0T2B	Limited	Biomarker	[1019]
TESC	OTI8C76M	Limited	Biomarker	[164]
TET1	OTZDHT1D	Limited	Biomarker	[1020]
THEM4	OTSIZU8Y	Limited	Posttranslational Modification	[1021]
TIGAR	OTR7NMRJ	Limited	Biomarker	[1022]
TIMP3	OTDGQAD1	Limited	Biomarker	[682]
TINAGL1	OTZZO56M	Limited	Biomarker	[1023]
TLE1	OT50MRZ1	Limited	Biomarker	[895]
TMEM135	OT63ZT3X	Limited	Biomarker	[106]
TMEM176A	OTOZDWXX	Limited	Biomarker	[1024]
TMEM59	OTX4EKES	Limited	Biomarker	[1025]
TNFRSF19	OTTVT4MB	Limited	Altered Expression	[1026]
TNFRSF6B	OTKAN9G7	Limited	Altered Expression	[1027]
TP53I3	OTSCM68G	Limited	Biomarker	[958]
TPD52L2	OTTOG0NK	Limited	Biomarker	[1028]
TRAF1	OTTLM5RU	Limited	Altered Expression	[1029]
TRAF3IP2	OTLLZERL	Limited	Altered Expression	[1030]
TRAM1	OT3I0H8E	Limited	Biomarker	[1031]
TRIM9	OTKYG33W	Limited	Biomarker	[1032]
TRMT11	OTRK0IOR	Limited	Biomarker	[106]
TSPAN31	OT8WQ83R	Limited	Biomarker	[963]
ADGRA2	OTBT4W36	Disputed	Altered Expression	[1033]
AMELX	OTIN26MM	Disputed	Biomarker	[1034]
APOD	OTT77XW8	Disputed	Altered Expression	[1035]
ARFGEF1	OTPAU0L4	Disputed	Altered Expression	[1036]
ARFGEF2	OTM3CQZT	Disputed	Altered Expression	[1036]
ASAH1	OT1DNGXL	Disputed	Biomarker	[1037]
ATG4B	OTQ4RNRM	Disputed	Biomarker	[1038]
BDH2	OTDD7G8S	Disputed	Altered Expression	[1035]
C1QTNF1	OT7I7KHC	Disputed	Genetic Variation	[1039]
CBX3	OTOP9RLD	Disputed	Altered Expression	[1040]
CCL13	OTNX0JD0	Disputed	Biomarker	[189]
CD1C	OT4XINUJ	Disputed	Biomarker	[1041]
CDCA7L	OT1FFWKC	Disputed	Altered Expression	[1042]
COX8A	OTU0NR39	Disputed	Biomarker	[1043]
DCT	OTYVNTBG	Disputed	Biomarker	[1044]
DMXL1	OTWVL31L	Disputed	Altered Expression	[1035]
DNER	OT2GH2E5	Disputed	Altered Expression	[1045]
ECT2	OTQDUCT6	Disputed	Altered Expression	[1046]
EIF4G2	OTEO98CR	Disputed	Biomarker	[1047]
FSTL1	OT6KEZUD	Disputed	Biomarker	[1048]
GSC	OT4DH7PR	Disputed	Biomarker	[1049]
HJURP	OTWMV16B	Disputed	Biomarker	[1050]
HLA-DPB1	OTW8JHU2	Disputed	Genetic Variation	[1051]
HOXB7	OTC7WYU8	Disputed	Altered Expression	[1052]
HPR	OTXSC9UB	Disputed	Biomarker	[1053]
ING4	OT0VVG4V	Disputed	Altered Expression	[1054]
L2HGDH	OTW6C712	Disputed	Genetic Variation	[1055]
LAT	OTZC1XZ1	Disputed	Biomarker	[701]
LRIG2	OTDUBLIH	Disputed	Biomarker	[1056]
MSC	OTBRPZL5	Disputed	Biomarker	[834]
NINJ1	OTLRZ1EU	Disputed	Biomarker	[1057]
NOC2L	OTNT7R33	Disputed	Biomarker	[1058]
NUCB2	OTHO6JWN	Disputed	Biomarker	[1059]
NUP98	OTNT12G2	Disputed	Altered Expression	[1060]
OPCML	OT93PQ6Y	Disputed	Altered Expression	[1061]
PCGF1	OTHOU68T	Disputed	Altered Expression	[1062]
PEA15	OTKCKTSX	Disputed	Altered Expression	[1063]
PIK3R3	OTXGJ8N1	Disputed	Altered Expression	[1064]
PLEK	OTB73XXA	Disputed	Genetic Variation	[1065]
POLR1C	OT7DVQB0	Disputed	Biomarker	[1066]
PRRT2	OTCJUBDO	Disputed	Altered Expression	[1067]
PSD	OTUZIXUZ	Disputed	Biomarker	[1068]
PSD3	OTTN9B9O	Disputed	Altered Expression	[1035]
RAD18	OTQ9PLNT	Disputed	Altered Expression	[1069]
REST	OTLL92LQ	Disputed	Altered Expression	[115]
RPL17	OTTYMPS6	Disputed	Altered Expression	[1070]
SEC61G	OT7MJRXY	Disputed	Altered Expression	[1071]
SPATA2	OTOA45GL	Disputed	Altered Expression	[1070]
STK26	OTW4QE0D	Disputed	Biomarker	[1038]
STPG4	OT5K4UFL	Disputed	Altered Expression	[217]
TAC1	OTM842YW	Disputed	Biomarker	[716]
ADGRB1	OTJSEXRC	moderate	Biomarker	[1072]
ADGRG1	OTQBB8NT	moderate	Biomarker	[1073]
ADI1	OT8IOD03	moderate	Biomarker	[1074]
AJAP1	OTAAW121	moderate	Biomarker	[577]
AKAP1	OTIIB2JB	moderate	Altered Expression	[1075]
APC	OTKV0TIK	moderate	Biomarker	[1076]
ARHGAP26	OTNGQU7A	moderate	Biomarker	[1077]
ASPG	OT5E2EKR	moderate	Biomarker	[1078]
ATF6	OTAFHAVI	moderate	Biomarker	[1079]
ATG9A	OTAZWZH7	moderate	Altered Expression	[1080]
ATMIN	OTEADE76	moderate	Biomarker	[1081]
AVEN	OTGIN5YK	moderate	Biomarker	[1082]
BAG3	OTVXYUDQ	moderate	Altered Expression	[1083]
BATF2	OT4XBZC9	moderate	Biomarker	[1084]
BIRC6	OTCQJAB0	moderate	Biomarker	[1082]
BTG2	OTZF6K1H	moderate	Biomarker	[1085]
CAP1	OTYM8A2N	moderate	Biomarker	[62]
CAPG	OTJ86KI6	moderate	Altered Expression	[1086]
CD151	OTF3UZS7	moderate	Biomarker	[1087]
CD3D	OTRBLP0R	moderate	Altered Expression	[1088]
CDH19	OTH31KJO	moderate	Biomarker	[1089]
CDSN	OTQW4HV6	moderate	Altered Expression	[1090]
CHAF1A	OTXSSY4H	moderate	Biomarker	[266]
CILK1	OTWOYEYP	moderate	Biomarker	[275]
COL17A1	OTID5AH2	moderate	Altered Expression	[1091]
CREB3L2	OT09MHV0	moderate	Altered Expression	[1092]
CREBRF	OT2GK1HI	moderate	Altered Expression	[1093]
CRLF3	OTT9TMXN	moderate	Altered Expression	[782]
CSTA	OT1K68KE	moderate	Biomarker	[1094]
CSTB	OT3U0JF8	moderate	Biomarker	[1094]
CTCF	OT8ZB70U	moderate	Altered Expression	[1095]
CTNND2	OTYKE30Y	moderate	Biomarker	[1004]
CYB5R2	OTTLM7XN	moderate	Altered Expression	[1096]
CYLD	OT37FKH0	moderate	Biomarker	[1097]
CYP2A7	OTRJ3P2Z	moderate	Biomarker	[1098]
DCHS1	OTW3GX62	moderate	Biomarker	[1089]
DDX6	OTKWXVDY	moderate	Biomarker	[1099]
DNM3	OTDMUGCR	moderate	Biomarker	[1100]
DSTN	OTMXO4YB	moderate	Altered Expression	[1101]
EEF2	OTZ7SZ39	moderate	Altered Expression	[1102]
EIF3B	OTF67VPH	moderate	Altered Expression	[1103]
EMC6	OT9IHH51	moderate	Biomarker	[1104]
FLT3LG	OTU0YGC4	moderate	Biomarker	[114]
FOXG1	OTAW57J4	moderate	Biomarker	[895]
FOXN1	OTE80D6I	moderate	Biomarker	[1105]
FOXO3	OTHXQG4P	moderate	Biomarker	[1106]
FTL	OTYQA8A6	moderate	Biomarker	[1107]
GAB2	OTBFN705	moderate	Biomarker	[1108]
GABPB1	OTEXDEJN	moderate	Biomarker	[1109]
GORASP1	OTQS91S7	moderate	Biomarker	[1110]
GPC1	OTQKRSSV	moderate	Altered Expression	[1111]
H2BC12	OTQ8V0KG	moderate	Altered Expression	[1112]
H4C1	OTB71W46	moderate	Biomarker	[1113]
HACD1	OTEC7EP7	moderate	Biomarker	[62]
HARS2	OTC8X3H9	moderate	Genetic Variation	[1114]
HAUS5	OTJNBV1W	moderate	Altered Expression	[1115]
HECTD1	OTJ95JJS	moderate	Biomarker	[1116]
HOXA9	OTKNK5H0	moderate	Biomarker	[1117]
HSDL2	OT4IN0MV	moderate	Biomarker	[1118]
HSPB2	OTS01646	moderate	Biomarker	[263]
IARS1	OT9WXH5N	moderate	Altered Expression	[1119]
IGF2BP3	OTB97VIK	moderate	Biomarker	[1120]
INSM1	OTG8RV8E	moderate	Biomarker	[1121]
IRF9	OTK4MYQJ	moderate	Altered Expression	[782]
ITSN1	OT8YF3S5	moderate	Altered Expression	[1090]
JAG1	OT3LGT6K	moderate	Biomarker	[1122]
JMJD6	OTILR7E4	moderate	Altered Expression	[1123]
JUNB	OTG2JXV5	moderate	Altered Expression	[1124]
JUND	OTNKACJD	moderate	Altered Expression	[1124]
KAT5	OTL7257A	moderate	Biomarker	[1125]
KCNH4	OTHJ8WTU	moderate	Altered Expression	[921]
KCNH8	OT3I5FLB	moderate	Altered Expression	[921]
KIF14	OTXHT4JM	moderate	Biomarker	[1126]
KIF3A	OTMUBSSK	moderate	Biomarker	[1127]
KLF9	OTBFEJRQ	moderate	Biomarker	[1128]
LCP2	OT57KE22	moderate	Biomarker	[234]
LEF1	OTWS5I5H	moderate	Biomarker	[1129]
LGALS8	OT71LJ8T	moderate	Biomarker	[1130]
LGI1	OTPS77HO	moderate	Biomarker	[1131]
LRP1B	OT4YZG2N	moderate	Genetic Variation	[1132]
LRRC4	OT7XJ70N	moderate	Biomarker	[1133]
MFAP1	OTZN4FT3	moderate	Biomarker	[852]
MGAT5	OTU4DD4G	moderate	Biomarker	[1134]
MPZL2	OTKFNDUI	moderate	Biomarker	[1135]
MSX1	OT5U41ZP	moderate	Biomarker	[1136]
MUC13	OTWKS9MF	moderate	Biomarker	[1137]
MXI1	OTUQ9E0D	moderate	Genetic Variation	[236]
MYBPH	OTQJBPUR	moderate	Altered Expression	[1138]
MYO1C	OT69L39Y	moderate	Biomarker	[1139]
NAA30	OTE56C5T	moderate	Biomarker	[1140]
NAB2	OTG4BDF3	moderate	Biomarker	[1141]
NANOG	OTUEY1FM	moderate	Altered Expression	[1142]
NBN	OT73B5MD	moderate	Biomarker	[1143]
NFKBIZ	OTU728KS	moderate	Biomarker	[1144]
NLRP2	OTJA81JU	moderate	Biomarker	[1143]
NOG	OTGRHHPG	moderate	Biomarker	[1145]
NOP53	OTA2YKO6	moderate	Biomarker	[1146]
OTUD4	OT7U62SW	moderate	Biomarker	[1147]
PAFAH1B1	OT9T2TCJ	moderate	Altered Expression	[1148]
PAX6	OTOC9876	moderate	Altered Expression	[1149]
PCBP2	OTXCN9CG	moderate	Biomarker	[1150]
PCDH8	OTDDOQM2	moderate	Altered Expression	[1151]
PHF20	OTCBVH5P	moderate	Biomarker	[1152]
PI4K2A	OTL9L6MX	moderate	Genetic Variation	[1153]
PICK1	OT8QE6EU	moderate	Altered Expression	[1154]
PNOC	OTJEAADN	moderate	Biomarker	[281]
POU1F1	OTXT8A5C	moderate	Altered Expression	[828]
PPP1R1C	OTVH6BND	moderate	Altered Expression	[1155]
PRC1	OTHD0XS0	moderate	Biomarker	[1156]
PRDX1	OTZ3BEC4	moderate	Posttranslational Modification	[1157]
PRMT8	OT3MRK62	moderate	Biomarker	[1158]
PTBP3	OTVVYKIF	moderate	Biomarker	[1159]
PTF1A	OT7SWA57	moderate	Altered Expression	[782]
PTPA	OTRGFOI7	moderate	Biomarker	[1160]
RBBP4	OTG3BT3M	moderate	Biomarker	[1161]
REV3L	OT0OP8EJ	moderate	Biomarker	[1162]
RHOC	OTOLE1FT	moderate	Altered Expression	[1163]
RNF123	OTL59S8J	moderate	Biomarker	[610]
RNF41	OTN1DQOY	moderate	Biomarker	[305]
ROMO1	OTIEYVBW	moderate	Biomarker	[1164]
RPS11	OTILZE44	moderate	Biomarker	[1165]
RPS20	OTI8052R	moderate	Biomarker	[1165]
SAV1	OTSAEV92	moderate	Altered Expression	[1166]
SCGB3A1	OTIR98RB	moderate	Biomarker	[1147]
SCYL1	OTQ0IN7P	moderate	Biomarker	[610]
SERP1	OT60XXUP	moderate	Altered Expression	[1167]
SERPINB6	OT7G55IK	moderate	Biomarker	[62]
SH3GL2	OTOE443G	moderate	Biomarker	[1168]
SKA1	OTDYJ12A	moderate	Biomarker	[1169]
SMARCA1	OT0Y6PTU	moderate	Genetic Variation	[1170]
SMARCB1	OT2LP7LJ	moderate	Biomarker	[1171]
SNAPC2	OTN0EL6L	moderate	Biomarker	[1172]
SNRPB	OT3UJ4ZU	moderate	Altered Expression	[1173]
SORBS1	OTWH8762	moderate	Biomarker	[62]
SOX7	OTOZOFAG	moderate	Biomarker	[1174]
SYNE1	OTSBSLUH	moderate	Posttranslational Modification	[1175]
SYT1	OTVTPOI6	moderate	Biomarker	[1110]
TAT	OT2CJ91O	moderate	Biomarker	[1176]
TFDP1	OT6RZ7VT	moderate	Biomarker	[1177]
TFEB	OTJUJJQY	moderate	Altered Expression	[1178]
TICAM2	OTK7GIJ5	moderate	Biomarker	[1179]
TMED7	OTONO8E6	moderate	Biomarker	[1179]
TMPO	OTL68EL4	moderate	Altered Expression	[1180]
TNMD	OTHLVA9G	moderate	Biomarker	[1097]
TNS3	OTPG2D8Z	moderate	Biomarker	[1181]
TRIT1	OTCU9FS5	moderate	Biomarker	[1182]
TRMT6	OT4DEXG6	moderate	Altered Expression	[1183]
TRMT61A	OTMIXQQ6	moderate	Altered Expression	[1183]
TSGA13	OT81V4LS	moderate	Altered Expression	[1184]
TSPAN33	OTH6C0WU	moderate	Biomarker	[1185]
ACACA	OT5CQPZY	Strong	Altered Expression	[409]
ACP1	OTJ9CKLU	Strong	Biomarker	[1186]
ACSL5	OT3L9XO3	Strong	Biomarker	[1187]
ACTB	OT1MCP2F	Strong	Biomarker	[1188]
ACTC1	OTJU04B1	Strong	Altered Expression	[1189]
ACTG2	OTRDWUO0	Strong	Biomarker	[766]
ACTL8	OTUDD0QT	Strong	Biomarker	[1190]
ACTN4	OTCNZAJ5	Strong	Biomarker	[1191]
ACTR3	OT05LJSH	Strong	Altered Expression	[1192]
ADAM12	OTZKOTDB	Strong	Biomarker	[1193]
ADAM23	OTVWT6JZ	Strong	Biomarker	[1194]
ADAR	OTQNOHR8	Strong	Genetic Variation	[1195]
ADARB1	OTGKSZEV	Strong	Altered Expression	[1060]
ADARB2	OTDJKS39	Strong	Genetic Variation	[1196]
ADD3	OTDRSHAZ	Strong	Altered Expression	[1197]
ADGRB3	OT1EWGRW	Strong	Altered Expression	[1198]
ADGRL4	OTN1GAG7	Strong	Biomarker	[1199]
ADIPOR1	OT65ZFZN	Strong	Altered Expression	[1200]
ADIPOR2	OT2HDTL8	Strong	Altered Expression	[1200]
AEBP1	OTBI1RZ6	Strong	Altered Expression	[1201]
AGAP2	OTEYO9TM	Strong	Altered Expression	[1202]
AGGF1	OTA7U2T8	Strong	Biomarker	[1203]
AGO2	OT4JY32Q	Strong	Altered Expression	[1204]
AHI1	OT8K2YWY	Strong	Biomarker	[1205]
AIFM1	OTKPWB7Q	Strong	Altered Expression	[1206]
AIM2	OT86QUI8	Strong	Posttranslational Modification	[1207]
AIMP1	OTTA5C3U	Strong	Biomarker	[1208]
AJUBA	OTNW7YPK	Strong	Altered Expression	[1209]
ALDH1A3	OT1C9NKQ	Strong	Biomarker	[1210]
ALDH3A1	OTAYZZE6	Strong	Biomarker	[1211]
ALKBH2	OTSQW0BG	Strong	Biomarker	[1212]
ALPP	OTZU4G9W	Strong	Genetic Variation	[324]
AMFR	OTQRX7LC	Strong	Genetic Variation	[1213]
AMH	OT5FH4BD	Strong	Biomarker	[1214]
AMOTL2	OTRCTKV9	Strong	Biomarker	[468]
ANGPT4	OT881M3K	Strong	Biomarker	[1215]
ANGPTL2	OTB6JG41	Strong	Biomarker	[857]
ANKRD36B	OT3MW415	Strong	Biomarker	[1216]
ANKS4B	OT1MREUS	Strong	Biomarker	[857]
ANO6	OTTA5KQJ	Strong	Biomarker	[1217]
ANOS1	OTZJT4KN	Strong	Biomarker	[1218]
ANP32B	OT3SQMLU	Strong	Biomarker	[1219]
APAF1	OTJWIVY0	Strong	Biomarker	[787]
API5	OTYX9YCZ	Strong	Altered Expression	[1220]
APLP2	OTTFE53M	Strong	Altered Expression	[1221]
APOBEC3A	OTYO6F5P	Strong	Altered Expression	[1192]
APPL2	OT9S4C4K	Strong	Altered Expression	[1222]
AQP8	OT99JKME	Strong	Altered Expression	[1223]
ARF4	OT3GMDHA	Strong	Biomarker	[1224]
ARHGAP1	OT0H2ZBZ	Strong	Altered Expression	[1225]
ARHGAP21	OT6XY8Y9	Strong	Altered Expression	[1225]
ARHGEF11	OTDOMEH6	Strong	Altered Expression	[1226]
ARHGEF2	OTBQTFRT	Strong	Altered Expression	[1227]
ARHGEF26	OTX0U8PX	Strong	Altered Expression	[1227]
ARHGEF28	OT3F32IU	Strong	Altered Expression	[673]
ARHGEF7	OT9BPJCL	Strong	Biomarker	[73]
ARR3	OTRZ00CH	Strong	Genetic Variation	[353]
ART1	OT7FBG5W	Strong	Altered Expression	[1228]
ASAP1	OT4DLRYY	Strong	Biomarker	[671]
ASAP2	OTGEXULW	Strong	Biomarker	[671]
ASCC1	OTH4VAP9	Strong	Biomarker	[73]
ASIC4	OT5POMCQ	Strong	Biomarker	[334]
ASPM	OTKXQMNA	Strong	Biomarker	[1229]
ASS1	OT4ZMG0Q	Strong	Posttranslational Modification	[1230]
ATAD2B	OTQMSTTC	Strong	Altered Expression	[1231]
ATF1	OT251CI0	Strong	Altered Expression	[379]
ATN1	OTNZFLKY	Strong	Biomarker	[1232]
ATP1A3	OTM8EG6H	Strong	Altered Expression	[1233]
ATP1B2	OTYTBYVU	Strong	Altered Expression	[1234]
ATP6AP2	OT0IABVV	Strong	Altered Expression	[1235]
ATP6V0A2	OTJBDX0Y	Strong	Biomarker	[1236]
ATRX	OT77RSQW	Strong	Genetic Variation	[1237]
AXIN1	OTRGZGZ5	Strong	Biomarker	[1238]
AZIN2	OT8OB7CG	Strong	Biomarker	[1239]
B3GNT5	OTA0DE43	Strong	Altered Expression	[1240]
BAALC	OTUZSRVF	Strong	Altered Expression	[1241]
BAD	OT63ERYM	Strong	Biomarker	[287]
BCAR1	OTKT2C2N	Strong	Biomarker	[1242]
BCCIP	OTFFKG79	Strong	Biomarker	[1243]
BCL2L11	OTNQQWFJ	Strong	Altered Expression	[1244]
BCL2L12	OTS6IFZY	Strong	Biomarker	[1245]
BCL2L13	OT2VRFTM	Strong	Altered Expression	[1246]
BCL3	OT1M5B95	Strong	Biomarker	[1247]
BEX2	OT4G5SIC	Strong	Biomarker	[1248]
BHLHE22	OTZUQY5L	Strong	Altered Expression	[1249]
BHLHE40	OTITX14U	Strong	Altered Expression	[1250]
BHLHE41	OTY9GJ1Y	Strong	Biomarker	[1251]
BMPR1B	OTGFN0OD	Strong	Biomarker	[194]
BNIP3	OT4SO7J4	Strong	Biomarker	[1252]
BRCC3	OTK0ZN7Y	Strong	Altered Expression	[1253]
BRMS1L	OTJIW47U	Strong	Biomarker	[1254]
BTBD2	OTAZ4DWD	Strong	Genetic Variation	[1255]
BTC	OTW4B2O0	Strong	Biomarker	[1256]
BTRC	OT2EZDGR	Strong	Biomarker	[1065]
BUB1B	OT8KME51	Strong	Altered Expression	[378]
BUB3	OTU91HAU	Strong	Altered Expression	[1257]
C12orf75	OTFVI3EY	Strong	Biomarker	[1048]
C4BPA	OTHNH6Y8	Strong	Altered Expression	[1258]
C6orf47	OTMKBNDD	Strong	Biomarker	[1259]
CADM1	OTRWG9QS	Strong	Biomarker	[1260]
CALM2	OTNYA92F	Strong	Altered Expression	[887]
CAMK2G	OTHD9KJG	Strong	Altered Expression	[1261]
CAMTA1	OTAN1S5B	Strong	Biomarker	[1262]
CANX	OTYP1F6J	Strong	Biomarker	[1263]
CAPNS1	OT95EBBD	Strong	Biomarker	[1264]
CARD14	OTADQHOV	Strong	Altered Expression	[1258]
CARF	OTWE0T6Q	Strong	Altered Expression	[1265]
CASK	OT8EF7ZF	Strong	Biomarker	[1012]
CAST	OTBXZZGF	Strong	Genetic Variation	[1266]
CAV2	OT1FGRQX	Strong	Altered Expression	[1267]
CBFA2T2	OTNOIB23	Strong	Biomarker	[764]
CBLL2	OTB4AD3V	Strong	Altered Expression	[1268]
CCDC8	OTO295IH	Strong	Biomarker	[1263]
CCL4	OT6B8P25	Strong	Biomarker	[74]
CCL8	OTCTWYN8	Strong	Biomarker	[1269]
CCN3	OTOW5YL4	Strong	Altered Expression	[1270]
CCNG2	OTII38K2	Strong	Biomarker	[1271]
CCNO	OT68CH0B	Strong	Biomarker	[1272]
CCR10	OT7ZWSSD	Strong	Altered Expression	[1273]
CCT3	OTL6EOS1	Strong	Biomarker	[1274]
CCT8	OTA7GQN9	Strong	Biomarker	[1275]
CD164	OTZ7FIU8	Strong	Altered Expression	[1276]
CD63	OT2UGZA9	Strong	Altered Expression	[1277]
CD8A	OTDWQJXK	Strong	Biomarker	[176]
CD8B	OTMZ1T7J	Strong	Altered Expression	[466]
CD93	OT6HZT6H	Strong	Biomarker	[1278]
CD99	OTPUZ5DE	Strong	Altered Expression	[1279]
CDC14B	OTAESVOZ	Strong	Biomarker	[1280]
CDK20	OTOLNN68	Strong	Altered Expression	[782]
CDO1	OTLG1P77	Strong	Biomarker	[1281]
CDS1	OT2F591M	Strong	Biomarker	[1282]
CEACAM7	OTKFDTZY	Strong	Biomarker	[386]
CELF2	OTLJJ4VT	Strong	Biomarker	[1283]
CEP350	OT5Q3AEA	Strong	Biomarker	[1284]
CEP55	OTGSG2PA	Strong	Altered Expression	[217]
CEP85L	OTSHJFOT	Strong	Biomarker	[1285]
CERS2	OTRAHYYP	Strong	Altered Expression	[1246]
CH25H	OT9S2BSW	Strong	Altered Expression	[1284]
CHD4	OTBDEHDP	Strong	Biomarker	[155]
CHD7	OTHNIZWZ	Strong	Altered Expression	[1286]
CHL1	OT6E6E8P	Strong	Biomarker	[1287]
CHSY1	OTB1XSSF	Strong	Altered Expression	[1288]
CIB1	OT4BVCRU	Strong	Altered Expression	[610]
CIC	OTFXCHNZ	Strong	Altered Expression	[1289]
CIP2A	OTVS2GXA	Strong	Biomarker	[1160]
CITED4	OTR6NHI2	Strong	Genetic Variation	[1290]
CLDN5	OTUX60YO	Strong	Altered Expression	[1291]
CLEC18B	OTW1BFMQ	Strong	Altered Expression	[1292]
CLEC5A	OT19WV30	Strong	Altered Expression	[146]
CLTC	OTBFASMA	Strong	Biomarker	[838]
CMAS	OTFQJG3C	Strong	Biomarker	[1293]
CMTM1	OTKN7E89	Strong	Biomarker	[1294]
CMTM2	OTSJISGF	Strong	Altered Expression	[1294]
CMTM3	OTS75IGC	Strong	Biomarker	[1294]
CMTM4	OTA3Z072	Strong	Altered Expression	[1294]
CNBP	OTTGM9NK	Strong	Altered Expression	[1295]
CNDP1	OTOYSQG7	Strong	Biomarker	[1296]
CNOT1	OTTEU05F	Strong	Posttranslational Modification	[1297]
COL11A2	OT3BQUBH	Strong	Biomarker	[626]
COL16A1	OTOWKUO2	Strong	Altered Expression	[1298]
COL4A3	OT6SB8X5	Strong	Biomarker	[1299]
COX2	OTTMVBJJ	Strong	Biomarker	[1300]
COX5A	OTP0961M	Strong	Altered Expression	[1301]
COX5B	OTDP94F3	Strong	Altered Expression	[1302]
COX7A2	OTVT146E	Strong	Altered Expression	[1303]
CPEB1	OTLCXC6H	Strong	Biomarker	[1304]
CPEB4	OTW1SCZW	Strong	Biomarker	[1305]
CPOX	OTIAY121	Strong	Altered Expression	[1301]
CPT1A	OTI862QH	Strong	Altered Expression	[1306]
CPT1C	OT8F1MBF	Strong	Altered Expression	[1306]
CRISP2	OT8HLTV5	Strong	Biomarker	[1307]
CRISPLD2	OTVSFHTL	Strong	Biomarker	[1308]
CRKL	OTOYSD1R	Strong	Biomarker	[1309]
CSHL1	OTQKU2F5	Strong	Biomarker	[1310]
CTAG1B	OTIQGW6U	Strong	Biomarker	[407]
CTNNA1	OTFC725Z	Strong	Altered Expression	[1311]
CTNNA3	OT9Z0P1E	Strong	Altered Expression	[1311]
CUL1	OTXPE1UZ	Strong	Altered Expression	[1312]
CXCL14	OTM189TA	Strong	Altered Expression	[1313]
CXCL17	OTRCEVIZ	Strong	Biomarker	[374]
CYB561	OT61GMNV	Strong	Biomarker	[414]
CYC1	OT0962IM	Strong	Altered Expression	[1314]
CYGB	OTX153DQ	Strong	Altered Expression	[1315]
D2HGDH	OTLHXW69	Strong	Genetic Variation	[1055]
DAB1	OTPL9MA3	Strong	Biomarker	[1316]
DAP3	OTNPEZYM	Strong	Altered Expression	[1317]
DAPK1	OTNCNUCO	Strong	Altered Expression	[943]
DAPK2	OTWODUQG	Strong	Biomarker	[757]
DAXX	OTX6O7PL	Strong	Biomarker	[1318]
DBI	OT884QY9	Strong	Biomarker	[1319]
DBN1	OTZVKG8A	Strong	Altered Expression	[1320]
DBT	OT4KZ5R9	Strong	Biomarker	[1321]
DCDC2	OTSUFH1H	Strong	Biomarker	[1322]
DCTN4	OTM7C943	Strong	Biomarker	[560]
DCTN6	OTI8PIN9	Strong	Biomarker	[1179]
DDB2	OTO8HVVB	Strong	Biomarker	[1323]
DDIT3	OTI8YKKE	Strong	Altered Expression	[1324]
DDX56	OTGURA53	Strong	Biomarker	[1325]
DECR1	OTCDIR6X	Strong	Altered Expression	[507]
DENR	OTXP9HOY	Strong	Biomarker	[757]
DEPP1	OTB36PHJ	Strong	Biomarker	[1326]
DES	OTI09KBW	Strong	Altered Expression	[1327]
DGKI	OTDZ602D	Strong	Posttranslational Modification	[1328]
DIAPH1	OTZBYPLH	Strong	Biomarker	[1329]
DIRAS3	OT3XHLQA	Strong	Biomarker	[1330]
DLC1	OTP8LMCR	Strong	Altered Expression	[1331]
DLD	OT378CU9	Strong	Biomarker	[1332]
DLX2	OTKC2DQ0	Strong	Altered Expression	[1333]
DNAJC5	OTCZDXAL	Strong	Biomarker	[1334]
DOCK1	OTCFV3ON	Strong	Biomarker	[922]
DOCK7	OTINNVQV	Strong	Biomarker	[1335]
DOCK9	OT84H8AD	Strong	Biomarker	[1336]
DOHH	OTDRAT3F	Strong	Altered Expression	[418]
DPF1	OTI4ZFP8	Strong	Biomarker	[1337]
DPF2	OTL0JH2C	Strong	Biomarker	[1338]
DPYSL4	OT3SBS2S	Strong	Genetic Variation	[1339]
DPYSL5	OT6F9T6F	Strong	Biomarker	[1340]
DRAM1	OTIJTXEN	Strong	Biomarker	[1341]
DSC3	OTYG47F8	Strong	Biomarker	[1342]
DUSP2	OTH54FMR	Strong	Altered Expression	[317]
DUSP4	OT6WAO12	Strong	Posttranslational Modification	[1343]
DVL2	OTMNYNCM	Strong	Biomarker	[1344]
DYM	OTQ670WI	Strong	Biomarker	[374]
E2F5	OT1XWING	Strong	Altered Expression	[1345]
EBF3	OTB0IWLW	Strong	Genetic Variation	[1346]
ECHS1	OTS0593S	Strong	Altered Expression	[1347]
EDN3	OTN7Q9BE	Strong	Altered Expression	[1348]
EFNB3	OT12WTXQ	Strong	Biomarker	[446]
EGFLAM	OTACZZJ0	Strong	Biomarker	[1349]
EIF3A	OTFABY9G	Strong	Altered Expression	[1350]
EIF3M	OTVWEV60	Strong	Altered Expression	[1351]
ELAVL2	OT6EJ8MQ	Strong	Genetic Variation	[145]
ELOVL2	OTDAF6U3	Strong	Biomarker	[1352]
EMC10	OTQ6S50X	Strong	Biomarker	[1353]
EMP1	OTSZHUHQ	Strong	Biomarker	[565]
EMX2	OT0V8OYK	Strong	Altered Expression	[1354]
ENDOG	OT5IM7B3	Strong	Biomarker	[1355]
ENTPD5	OTFH05B9	Strong	Altered Expression	[1356]
EPN3	OTNNYDT6	Strong	Biomarker	[1357]
EPS8	OTZ6ES6V	Strong	Altered Expression	[1358]
ERRFI1	OT7VZ2IZ	Strong	Biomarker	[1359]
ERVW-1	OTWV8DXJ	Strong	Biomarker	[1360]
ESD	OTUSIBPS	Strong	Altered Expression	[1361]
ESPL1	OTMGEVOK	Strong	Biomarker	[1362]
ETFA	OTXX61VZ	Strong	Genetic Variation	[1363]
ETV2	OTP5URZ8	Strong	Biomarker	[1364]
ETV4	OT8C98UZ	Strong	Altered Expression	[1365]
EVA1A	OTCY3Q2M	Strong	Biomarker	[1366]
EXOSC3	OTNCF906	Strong	Biomarker	[1263]
EXTL3	OT2BRUBN	Strong	Biomarker	[1367]
FABP7	OTRE2H4G	Strong	Altered Expression	[66]
FADD	OTV7GFHH	Strong	Biomarker	[1368]
FAM107A	OTBG61YZ	Strong	Biomarker	[1369]
FBLN7	OT1XRDP6	Strong	Altered Expression	[1370]
FBP1	OTQBANEP	Strong	Biomarker	[453]
FCGR2C	OTNLMNYB	Strong	Biomarker	[1371]
FEN1	OT6QGG7O	Strong	Altered Expression	[1372]
FERMT3	OTFQOT3C	Strong	Biomarker	[1373]
FEZF2	OTU4TXIW	Strong	Biomarker	[1048]
FGF13	OTHNNVSG	Strong	Altered Expression	[1374]
FGF5	OTQXGHBY	Strong	Biomarker	[1375]
FGF9	OT2SKDGM	Strong	Biomarker	[1376]
FHL2	OT0OAYWT	Strong	Altered Expression	[1377]
FHL5	OT6C00Z1	Strong	Biomarker	[766]
FLNC	OT3F8J6Y	Strong	Altered Expression	[1378]
FMOD	OT9EJ5H8	Strong	Biomarker	[487]
FOCAD	OT83QOSI	Strong	Altered Expression	[1379]
FOXK1	OTLZGS7J	Strong	Biomarker	[1380]
FRAT1	OT1PS84E	Strong	Biomarker	[1381]
FREM2	OTEK6BZR	Strong	Altered Expression	[1382]
FZD2	OT952ML1	Strong	Altered Expression	[1383]
G0S2	OT8FL49L	Strong	Altered Expression	[1384]
GABPA	OT9YB2SA	Strong	Altered Expression	[1385]
GADL1	OTJM4A0R	Strong	Biomarker	[1239]
GALNT14	OT9BSDDQ	Strong	Biomarker	[1386]
GALNT7	OTUJSCAO	Strong	Altered Expression	[1387]
GAS1	OTKJXG52	Strong	Altered Expression	[1388]
GDE1	OTU6FSBF	Strong	Altered Expression	[1389]
GFPT1	OTQBDO45	Strong	Biomarker	[1390]
GGPS1	OTVEHG28	Strong	Biomarker	[459]
GHRH	OT94U6MO	Strong	Biomarker	[1391]
GK5	OT65U8L1	Strong	Altered Expression	[1392]
GKN1	OT7ZYFQ9	Strong	Biomarker	[650]
GLI3	OTKDOE94	Strong	Altered Expression	[1393]
GLIS2	OTOUUV1X	Strong	Biomarker	[1394]
GLS2	OT08MSHL	Strong	Biomarker	[1395]
GLUD1	OTXKOCUH	Strong	Biomarker	[1396]
GNB3	OTA6HYBA	Strong	Genetic Variation	[1397]
GNL3	OTILGYO4	Strong	Biomarker	[1398]
GOLM1	OTOZSV6O	Strong	Altered Expression	[1399]
GOLPH3	OTDLGYM3	Strong	Biomarker	[1400]
GOPC	OTRBGH71	Strong	Biomarker	[677]
GPM6B	OT8Q1582	Strong	Biomarker	[1401]
GPR158	OTYOC1RQ	Strong	Altered Expression	[1402]
GPR37L1	OTOV08EV	Strong	Altered Expression	[1403]
GPX3	OT6PK94R	Strong	Altered Expression	[1404]
GSAP	OT33HG7E	Strong	Biomarker	[1405]
GTF2H1	OTCRXC6B	Strong	Biomarker	[560]
GTF2H4	OTPD1DIU	Strong	Biomarker	[73]
GZMM	OTEC5CWT	Strong	Biomarker	[563]
H2AX	OT18UX57	Strong	Biomarker	[1406]
H3C1	OTGBGOZW	Strong	Genetic Variation	[1407]
HAVCR2	OTOL603T	Strong	Biomarker	[408]
HEATR1	OTOWIB9Z	Strong	Biomarker	[1408]
HEATR3	OTB52FZ4	Strong	Genetic Variation	[832]
HELLS	OTVVV668	Strong	Biomarker	[426]
HEPACAM	OT1MJ51D	Strong	Altered Expression	[1409]
HERC5	OTZ5PR39	Strong	Altered Expression	[1410]
HEY1	OTJQL0I3	Strong	Altered Expression	[1411]
HHIP	OT77RQYS	Strong	Altered Expression	[1412]
HILPDA	OTEID3ZM	Strong	Altered Expression	[1413]
HLA-DRA	OT7KZMP2	Strong	Altered Expression	[1414]
HLA-E	OTX1CTFB	Strong	Altered Expression	[1415]
HLA-F	OT76CM19	Strong	Biomarker	[1416]
HNRNPL	OT0DJX74	Strong	Biomarker	[1191]
HOPX	OTBSR6C9	Strong	Biomarker	[1417]
HOXB1	OTGC0EKI	Strong	Genetic Variation	[1418]
HOXB2	OTTD6HMV	Strong	Biomarker	[1419]
HOXB3	OT9UC5PE	Strong	Altered Expression	[1420]
HOXB4	OTH1HRW5	Strong	Genetic Variation	[1418]
HOXB5	OTU74TB8	Strong	Genetic Variation	[1418]
HOXB6	OT3TFQ0U	Strong	Genetic Variation	[1418]
HOXB8	OTKHOD17	Strong	Biomarker	[1421]
HOXB9	OTMVHQOU	Strong	Genetic Variation	[1418]
HOXC10	OT5WF17M	Strong	Biomarker	[1422]
HOXC6	OTBCRAZV	Strong	Altered Expression	[1423]
HOXD9	OTZ4GVR1	Strong	Altered Expression	[1424]
HPCAL1	OTOBBFRD	Strong	Altered Expression	[1425]
HRG	OTPLUFOG	Strong	Biomarker	[1426]
HRK	OTR4GWJ0	Strong	Biomarker	[1427]
HSPA1A	OTKGIE76	Strong	Altered Expression	[1428]
HSPA4	OT5HR0AR	Strong	Biomarker	[1429]
HYOU1	OTBGBSOV	Strong	Biomarker	[1430]
ID4	OTPMJ39I	Strong	Altered Expression	[1431]
IFI27	OTI2XGIT	Strong	Biomarker	[1179]
IFNA1	OTPMKY0L	Strong	Altered Expression	[1432]
IFNA17	OTHXRYG3	Strong	Genetic Variation	[1433]
IFT57	OTXYC20V	Strong	Biomarker	[1434]
IGFALS	OTTWCZYM	Strong	Altered Expression	[1435]
IGFBP4	OT2HZRBD	Strong	Altered Expression	[1436]
IGSF8	OTU22IKI	Strong	Biomarker	[1437]
IL17B	OTS86H50	Strong	Altered Expression	[541]
IL17RD	OTKD9XST	Strong	Biomarker	[1438]
IL18R1	OT83XMPQ	Strong	Genetic Variation	[427]
IL22RA1	OTGVKLBR	Strong	Altered Expression	[1439]
IL34	OTZ15VVK	Strong	Biomarker	[1440]
ING1	OTEZBRKW	Strong	Altered Expression	[1441]
INPP5B	OT0SC8W5	Strong	Altered Expression	[98]
INPP5K	OTQFLQKA	Strong	Altered Expression	[98]
INPPL1	OTCDAVBQ	Strong	Altered Expression	[98]
IQGAP1	OTZRWTGA	Strong	Altered Expression	[468]
IRF7	OTC1A2PQ	Strong	Altered Expression	[1204]
ITGA10	OTM0V5AO	Strong	Biomarker	[1442]
ITGA2B	OT4Y17PY	Strong	Biomarker	[1443]
ITGA3	OTBCH21D	Strong	Biomarker	[1444]
ITGA7	OTTBTAYW	Strong	Biomarker	[1445]
ITGB5	OT21MF51	Strong	Biomarker	[1446]
ITIH4	OT460OO1	Strong	Biomarker	[1360]
ITPRID2	OTO3JDX5	Strong	Altered Expression	[1447]
KAT8	OT5LPQTR	Strong	Altered Expression	[1448]
KAZALD1	OTSFOX2H	Strong	Biomarker	[1449]
KBTBD7	OT1NIRLK	Strong	Biomarker	[412]
KDELR2	OT9QW7Q0	Strong	Biomarker	[1450]
KIF4A	OT3UWL7D	Strong	Altered Expression	[1451]
KIF5B	OTT34MT8	Strong	Biomarker	[1452]
KIF5C	OT35570Y	Strong	Biomarker	[1452]
KIF9	OT7W6VI1	Strong	Altered Expression	[1451]
KLF6	OTQY9S7F	Strong	Biomarker	[1453]
KMT2B	OTMMAZQX	Strong	Biomarker	[1454]
KMT2D	OTTVHCLY	Strong	Biomarker	[1454]
LAMA2	OTFROQWE	Strong	Biomarker	[1455]
LAMA3	OTFME7HT	Strong	Biomarker	[1456]
LAMC1	OTIG527N	Strong	Altered Expression	[1457]
LAPTM5	OT2XI2JG	Strong	Altered Expression	[678]
LARP4B	OT2HI0QE	Strong	Genetic Variation	[1458]
LCMT1	OTRJQ16X	Strong	Genetic Variation	[1459]
LGALS3BP	OT9AGQKH	Strong	Genetic Variation	[1460]
LGALS9	OT7MF91K	Strong	Altered Expression	[1461]
LHFPL3	OTG1EI22	Strong	Biomarker	[629]
LNX1	OTZWFMAZ	Strong	Biomarker	[1462]
LRG1	OTLD0KWA	Strong	Biomarker	[56]
LRIG1	OTY5HZN5	Strong	Altered Expression	[1463]
LRIG3	OT6TKZTU	Strong	Biomarker	[1464]
LRRN2	OTGP2DCY	Strong	Altered Expression	[1465]
LZTR1	OTIDM6XO	Strong	Biomarker	[1466]
MACC1	OTV3DLX0	Strong	Altered Expression	[1467]
MACF1	OTVIHD77	Strong	Biomarker	[1238]
MAF1	OTKB0N8Q	Strong	Altered Expression	[1468]
MAGED4B	OTO37U7W	Strong	Altered Expression	[576]
MAGT1	OTQSAV5C	Strong	Genetic Variation	[324]
MAK16	OTD546E5	Strong	Biomarker	[1469]
MAP2	OT6UYT3X	Strong	Biomarker	[1470]
MAP2K3	OTI2OREX	Strong	Biomarker	[1471]
MAP2K6	OTK13JKC	Strong	Biomarker	[1032]
MAPK8IP2	OTDUHLN0	Strong	Genetic Variation	[1472]
MARCHF9	OTWF84QT	Strong	Genetic Variation	[1473]
MARCKSL1	OT13J2FM	Strong	Biomarker	[1474]
MARK4	OT6Z2TGV	Strong	Altered Expression	[1475]
MAST2	OT85GLPP	Strong	Altered Expression	[1476]
MATK	OTVOJJLJ	Strong	Altered Expression	[1477]
MAX	OTKZ0YKM	Strong	Genetic Variation	[1478]
MBD2	OTUQPP0R	Strong	Biomarker	[1479]
MCAT	OTH07FIW	Strong	Biomarker	[165]
MCOLN2	OTU3V04B	Strong	Altered Expression	[1480]
MCRS1	OT8K2X8P	Strong	Altered Expression	[1481]
MCTS1	OT7SAOJP	Strong	Biomarker	[165]
MED25	OTDBY87B	Strong	Altered Expression	[1482]
MEOX2	OTKZCJCB	Strong	Altered Expression	[1483]
METTL3	OTSXP1M3	Strong	Biomarker	[1484]
MIB1	OT5C404P	Strong	Biomarker	[596]
MIIP	OT79EXZ7	Strong	Biomarker	[1485]
MINDY4	OTBZ2SZB	Strong	Biomarker	[224]
MIP	OTEBLU3E	Strong	Biomarker	[1486]
MKS1	OT83W5PB	Strong	Biomarker	[862]
MMP19	OTLSTT2B	Strong	Biomarker	[1487]
MMP24	OTF8T3JM	Strong	Altered Expression	[1488]
MMP25	OT3BG37V	Strong	Altered Expression	[1489]
MMP28	OTHQZXM1	Strong	Biomarker	[1487]
MNX1	OTXP9FH1	Strong	Biomarker	[1490]
MPC1	OT6DYFUO	Strong	Biomarker	[1491]
MPC2	OT0GHXGG	Strong	Biomarker	[1492]
MPP1	OTA2ENZQ	Strong	Biomarker	[1493]
MPRIP	OT5FV5NS	Strong	Biomarker	[1494]
MRPL58	OTPTWLZY	Strong	Biomarker	[1495]
MRPS30	OTDXIAGG	Strong	Biomarker	[671]
MRTFA	OTCVXASM	Strong	Biomarker	[1496]
MSH3	OTD3YPVL	Strong	Biomarker	[128]
MSH4	OTJZMG1Z	Strong	Genetic Variation	[1497]
MSH6	OT46FP09	Strong	Biomarker	[1498]
MSN	OTZJ4J6G	Strong	Altered Expression	[1499]
MT1E	OTXJKU4Y	Strong	Biomarker	[1500]
MT3	OTVCZ7HI	Strong	Altered Expression	[863]
MTPAP	OT6HQ02S	Strong	Biomarker	[671]
MUL1	OT2JC9YR	Strong	Altered Expression	[1268]
MXD1	OTS5CTHX	Strong	Biomarker	[1501]
MXD3	OT4U88UP	Strong	Altered Expression	[1502]
MXD4	OTUCXFRO	Strong	Altered Expression	[1503]
MYBL2	OTZ3JX8Q	Strong	Altered Expression	[1504]
MYRIP	OTH2TFYH	Strong	Altered Expression	[1505]
MYT1	OTC3660I	Strong	Altered Expression	[1506]
MYT1L	OTV45MAS	Strong	Altered Expression	[1506]
MZB1	OT071TET	Strong	Altered Expression	[316]
NCKIPSD	OT24UORN	Strong	Biomarker	[1205]
NCOR1	OT04XNOU	Strong	Biomarker	[1507]
NCOR2	OTY917X0	Strong	Biomarker	[1508]
NCR3	OT20M764	Strong	Biomarker	[607]
NDN	OTYBYJ82	Strong	Biomarker	[1509]
NECTIN1	OTTE5ZR6	Strong	Altered Expression	[1235]
NELL2	OTS4MJZ7	Strong	Altered Expression	[1510]
NEU3	OTQ5PQOW	Strong	Altered Expression	[1511]
NEU4	OTM16O9F	Strong	Altered Expression	[1512]
NFAT5	OTKIE59S	Strong	Biomarker	[1513]
NFATC2	OTK5T6HZ	Strong	Altered Expression	[1265]
NFIA	OTDHQ9CG	Strong	Altered Expression	[1514]
NFIB	OTX94PD0	Strong	Altered Expression	[1514]
NGB	OTW0SIUY	Strong	Altered Expression	[1515]
NKD2	OTCYT3I6	Strong	Biomarker	[1516]
NKIRAS2	OTNJXCJ0	Strong	Biomarker	[1517]
NLGN3	OTKDEC1Q	Strong	Altered Expression	[1518]
NLRP12	OTGR132Z	Strong	Biomarker	[1207]
NME3	OT0CA0GF	Strong	Altered Expression	[1519]
NMI	OTYVG3NM	Strong	Biomarker	[1520]
NMS	OTFYS4LO	Strong	Biomarker	[190]
NOB1	OTW0YNSL	Strong	Altered Expression	[1057]
NOVA1	OT6A9KHY	Strong	Biomarker	[1521]
NPAS2	OTMRT2TS	Strong	Altered Expression	[1505]
NPAS3	OT8D1ILB	Strong	Altered Expression	[1522]
NR2F2	OTJFS67N	Strong	Altered Expression	[1523]
NREP	OT2AZPKK	Strong	Altered Expression	[1524]
NT5DC2	OTPDRGGN	Strong	Biomarker	[1525]
NTN4	OTDRRMP3	Strong	Biomarker	[1526]
NUDT1	OTZSES3W	Strong	Biomarker	[1527]
NUMB	OTMB586Q	Strong	Altered Expression	[518]
NUP62	OTMN63DH	Strong	Biomarker	[560]
NUPR1	OT4FU8C0	Strong	Biomarker	[1528]
NUSAP1	OT85HIJ5	Strong	Altered Expression	[1529]
OCA2	OTDWIGBF	Strong	Biomarker	[1530]
OCRL	OTQ3L42N	Strong	Altered Expression	[98]
OGA	OT7ZBWT1	Strong	Altered Expression	[1531]
OIP5	OTI5C2DE	Strong	Altered Expression	[425]
OLIG2	OTMCN6D3	Strong	Altered Expression	[1532]
ORAI2	OTYISRYH	Strong	Altered Expression	[1533]
PAEP	OTQA0NV4	Strong	Biomarker	[1534]
PANK2	OTFBW889	Strong	Biomarker	[857]
PAPOLA	OTPHD65D	Strong	Biomarker	[671]
PARD3	OTH5BPLO	Strong	Biomarker	[1535]
PATZ1	OT0X9WGR	Strong	Altered Expression	[1536]
PAX7	OTDMQRPO	Strong	Altered Expression	[1537]
PBX3	OT8WMVM4	Strong	Biomarker	[1538]
PCDH10	OT2GIT0E	Strong	Biomarker	[1539]
PCLAF	OTMVIOUU	Strong	Altered Expression	[1540]
PDAP1	OTJSWMOD	Strong	Biomarker	[671]
PDCD10	OTCHJTSF	Strong	Biomarker	[1541]
PDCD4	OTZ6NXUX	Strong	Biomarker	[1542]
PDE12	OTCRN5TB	Strong	Altered Expression	[1543]
PDIA3	OTHPQ0Q3	Strong	Biomarker	[507]
PDLIM1	OT4EGCPG	Strong	Biomarker	[1544]
PDLIM5	OTLQVV22	Strong	Biomarker	[123]
PER3	OTVKYVJA	Strong	Altered Expression	[1505]
PFN1	OTHTGA1H	Strong	Posttranslational Modification	[1545]
PGAM1	OTZ5DB06	Strong	Biomarker	[453]
PGK1	OT6V1ICH	Strong	Altered Expression	[1546]
PHF14	OTZT3GV1	Strong	Altered Expression	[1547]
PHF3	OTNOYLG9	Strong	Biomarker	[1548]
PHF6	OT8DXI40	Strong	Altered Expression	[1549]
PHLDA2	OTMV9DPP	Strong	Biomarker	[1550]
PHLPP1	OTIFXW8D	Strong	Altered Expression	[1551]
PHYHIPL	OT9EIUGH	Strong	Biomarker	[1552]
PI15	OTPJL6ML	Strong	Altered Expression	[1308]
PI3	OT47MTC3	Strong	Altered Expression	[1553]
PIEZO1	OTBG1FU4	Strong	Biomarker	[1554]
PIK3C3	OTLUM9L7	Strong	Biomarker	[1555]
PIK3R2	OTZSUQK5	Strong	Biomarker	[764]
PIP4K2A	OTO9JO9U	Strong	Biomarker	[1556]
PJA1	OTFKTMEI	Strong	Biomarker	[1289]
PKD1	OT5ALRZ5	Strong	Altered Expression	[1557]
PKD2	OTIXBU8H	Strong	Biomarker	[1558]
PLAAT4	OTI66SAJ	Strong	Altered Expression	[1559]
PLEC	OTU4XDEG	Strong	Biomarker	[1560]
PLEKHB1	OTC7TNAX	Strong	Altered Expression	[708]
PLEKHM2	OT4ZYV73	Strong	Altered Expression	[98]
PLK5	OTW5YPKM	Strong	Posttranslational Modification	[1561]
PLOD3	OTT00T7Q	Strong	Altered Expression	[1562]
PLPP3	OTSSF7BK	Strong	Biomarker	[1563]
PLXNA4	OT5XKB3Q	Strong	Biomarker	[1564]
PMEPA1	OTY8Z9UF	Strong	Biomarker	[1565]
PMS2	OTNLWTMI	Strong	Altered Expression	[277]
PNO1	OT010GIS	Strong	Biomarker	[1469]
PODXL	OTPNQXF3	Strong	Biomarker	[1566]
POLD1	OTWO4UCJ	Strong	Biomarker	[239]
POLE	OTFM3MMU	Strong	Genetic Variation	[1567]
POLG2	OTDBMZJB	Strong	Biomarker	[1493]
POLL	OTZ24QGM	Strong	Altered Expression	[720]
POLR2F	OTF9T8I2	Strong	Altered Expression	[507]
POLR3B	OT3FS9MB	Strong	Genetic Variation	[1363]
POMGNT1	OTBNOUZC	Strong	Biomarker	[1568]
POTEF	OTV3WXYE	Strong	Altered Expression	[1569]
POU2F1	OTK7ELJ0	Strong	Altered Expression	[835]
POU5F1	OTDHHN7O	Strong	Altered Expression	[1570]
PPP1R12C	OT9Q86JO	Strong	Biomarker	[764]
PPP1R13B	OTC88VQO	Strong	Biomarker	[764]
PPP1R15A	OTYG179K	Strong	Biomarker	[1259]
PPP1R1B	OTSIJMQ9	Strong	Altered Expression	[1571]
PPP2R5E	OT8GPFT5	Strong	Altered Expression	[1572]
PRAP1	OT48QD82	Strong	Genetic Variation	[1124]
PRDM2	OT8L7CGX	Strong	Altered Expression	[1573]
PRELP	OT9EEBUJ	Strong	Biomarker	[1401]
PREX1	OTUTPVA9	Strong	Biomarker	[1574]
PRKAA2	OTU1KZPV	Strong	Altered Expression	[1575]
PRKD2	OTIFSVI8	Strong	Biomarker	[813]
PRKN	OTJBN41W	Strong	Altered Expression	[1268]
PRMT2	OT63JZCI	Strong	Altered Expression	[1576]
PROCR	OTRHED17	Strong	Altered Expression	[1577]
PROP1	OT8GF6N8	Strong	Altered Expression	[1578]
PROS1	OTXQWNOI	Strong	Altered Expression	[1579]
PRPS1	OTN3A6CN	Strong	Altered Expression	[1580]
PRSS55	OTXXWI5Y	Strong	Biomarker	[1307]
PSAP	OTUOEKY7	Strong	Biomarker	[1581]
PSG2	OT2EIXAI	Strong	Biomarker	[386]
PSMB4	OTOJ9OHA	Strong	Biomarker	[1582]
PSMD12	OTWICA51	Strong	Biomarker	[1493]
PSMD2	OT6HZHN7	Strong	Altered Expression	[1583]
PSMD9	OT6Y5CC3	Strong	Biomarker	[1179]
PSMG1	OTZ5I6UM	Strong	Altered Expression	[317]
PTPN12	OT5WA666	Strong	Biomarker	[1242]
PTPRD	OTZPJ3GX	Strong	Genetic Variation	[1584]
PTPRF	OTH5KF2D	Strong	Biomarker	[1585]
PUM2	OT2H7NXV	Strong	Biomarker	[346]
PVR	OT3N91T7	Strong	Altered Expression	[1586]
PXN	OTVMMUOF	Strong	Biomarker	[1587]
PYCARD	OT67RON3	Strong	Biomarker	[1588]
PYGO2	OTZHB2OI	Strong	Biomarker	[1589]
RAB27B	OTPF9D0K	Strong	Biomarker	[1590]
RAB38	OTU0NZU0	Strong	Genetic Variation	[1591]
RAB3A	OT2GIUO5	Strong	Altered Expression	[1592]
RABGEF1	OTWC3Z3R	Strong	Biomarker	[1593]
RAD51AP1	OTXM7UTD	Strong	Biomarker	[1594]
RAD51B	OTCJVRMY	Strong	Biomarker	[1595]
RAD54L	OTEGMAKG	Strong	Altered Expression	[77]
RANBP2	OTFG5CVF	Strong	Biomarker	[1044]
RANBP6	OT90MVD4	Strong	Posttranslational Modification	[1596]
RAP1A	OT5RH6TI	Strong	Biomarker	[1593]
RASGRP3	OTEMEV3P	Strong	Altered Expression	[1192]
RASL10A	OTEXTN6I	Strong	Altered Expression	[1597]
RASSF10	OTGB7EBG	Strong	Posttranslational Modification	[1598]
RAVER2	OT0MDL7K	Strong	Genetic Variation	[832]
RB1	OT9VMY7B	Strong	Genetic Variation	[1599]
RB1CC1	OTZK8PFX	Strong	Biomarker	[1600]
RBBP5	OT12W2MK	Strong	Biomarker	[1601]
RBBP8	OTRHJ3GI	Strong	Altered Expression	[1602]
RBM14	OTO9GMBD	Strong	Biomarker	[1603]
RBM3	OTAJ7R31	Strong	Biomarker	[1604]
RBMS3	OTFSC9MR	Strong	Biomarker	[1469]
RCAN1	OT1MVXC7	Strong	Biomarker	[1605]
RDX	OTNSYUN6	Strong	Altered Expression	[1606]
RECQL4	OT59LSW7	Strong	Biomarker	[1595]
RFC4	OTWALD2R	Strong	Biomarker	[187]
RGR	OTKCF5AZ	Strong	Biomarker	[680]
RHBDD1	OTL5J132	Strong	Biomarker	[1607]
RHBDF1	OTCQ7UDS	Strong	Genetic Variation	[832]
RHPN2	OTTYWMF6	Strong	Biomarker	[1608]
RINT1	OTMO19ZD	Strong	Biomarker	[1609]
RIOK1	OT1OS3H3	Strong	Altered Expression	[400]
RIOK2	OTQODJ7F	Strong	Altered Expression	[400]
RIOX1	OTN41QXP	Strong	Altered Expression	[1610]
RIOX2	OT2YFPI2	Strong	Biomarker	[1611]
RIPK3	OTL1D484	Strong	Biomarker	[1494]
RMC1	OT7K8MTJ	Strong	Altered Expression	[1612]
RMDN1	OTE1NB6U	Strong	Altered Expression	[956]
RMDN2	OTK5WSFI	Strong	Altered Expression	[956]
RNASE3	OTVE2XD1	Strong	Biomarker	[1613]
RNASEH2A	OT8G3G7K	Strong	Posttranslational Modification	[1614]
RNASEH2B	OT8KHYFY	Strong	Genetic Variation	[1195]
RND3	OTXMXPIH	Strong	Biomarker	[1615]
RNF139	OT0PR1X5	Strong	Biomarker	[1616]
ROBO3	OTPVG40S	Strong	Biomarker	[416]
RPA1	OT76POLP	Strong	Biomarker	[1617]
RPS3	OT0K3TMH	Strong	Biomarker	[996]
RPS6	OTT4D1LN	Strong	Biomarker	[299]
RRAS	OTBBF28C	Strong	Genetic Variation	[925]
RRBP1	OT4ZTPTM	Strong	Altered Expression	[1618]
RTKN	OTSS8XR6	Strong	Altered Expression	[893]
RTL10	OTHGB81W	Strong	Altered Expression	[1619]
S100A1	OT1F2G4J	Strong	Biomarker	[1620]
S100A10	OTI71243	Strong	Biomarker	[1263]
S100A11	OTI57KDN	Strong	Biomarker	[1621]
SALL2	OTQWI68Q	Strong	Biomarker	[1622]
SAMSN1	OT7N88T1	Strong	Altered Expression	[1623]
SART1	OTHMOGO1	Strong	Genetic Variation	[1624]
SCG5	OTXSJMT1	Strong	Biomarker	[1625]
SCNN1A	OTE2KVZV	Strong	Biomarker	[1626]
SCO1	OTC45UGB	Strong	Biomarker	[1627]
SCO2	OTJQQDRS	Strong	Altered Expression	[750]
SEL1L	OTC0FB7T	Strong	Altered Expression	[1628]
SEMA3B	OTCZCPMS	Strong	Altered Expression	[1629]
SEMA3C	OTEGUY7F	Strong	Biomarker	[1630]
SEMA3D	OTD5TJV1	Strong	Altered Expression	[1631]
SEMA3E	OTD4S36H	Strong	Altered Expression	[1631]
SEMA6B	OT3VVVUO	Strong	Altered Expression	[1632]
SEPTIN2	OT3G33TM	Strong	Biomarker	[1633]
SEPTIN4	OTD16B30	Strong	Altered Expression	[1580]
SEPTIN7	OTJI08YX	Strong	Biomarker	[1634]
SEPTIN9	OT1VMRFQ	Strong	Biomarker	[1633]
SERPINB1	OT5RDUFO	Strong	Altered Expression	[1635]
SERPINE2	OTYF5340	Strong	Biomarker	[1636]
SESN2	OT889IXY	Strong	Biomarker	[1637]
SFRP2	OT8GZ0CA	Strong	Posttranslational Modification	[1638]
SGSM3	OTIB1P8A	Strong	Altered Expression	[1639]
SH3BP4	OTVIRKW7	Strong	Genetic Variation	[1640]
SH3GL3	OTX6BOCN	Strong	Altered Expression	[1641]
SHC1	OT1J5IRN	Strong	Biomarker	[1642]
SHPRH	OTKCBWWS	Strong	Altered Expression	[1643]
SIAH1	OT29A838	Strong	Altered Expression	[515]
SIAH2	OTKED2XN	Strong	Altered Expression	[515]
SIM2	OT0QWHK4	Strong	Altered Expression	[1644]
SIX3	OTP5E3VU	Strong	Altered Expression	[1645]
SLAMF1	OTBTT3ZQ	Strong	Altered Expression	[1646]
SLC12A9	OTR7VRAK	Strong	Altered Expression	[384]
SLC22A18	OT9C3KR4	Strong	Altered Expression	[1647]
SLC2A4RG	OTW3LX8D	Strong	Biomarker	[1648]
SLC35F1	OTRXHR2P	Strong	Biomarker	[1649]
SLFN5	OTT1AESL	Strong	Altered Expression	[1432]
SLTM	OT0VRZA6	Strong	Biomarker	[674]
SLURP1	OT89YD2E	Strong	Biomarker	[1650]
SMAD2	OTC6VB4K	Strong	Biomarker	[1651]
SMARCA2	OTSGJ8SV	Strong	Biomarker	[1652]
SMARCAL1	OTTKXLUZ	Strong	Genetic Variation	[1653]
SMC1A	OT9ZMRK9	Strong	Biomarker	[1654]
SMN2	OT54RLO1	Strong	Biomarker	[704]
SMPX	OTLSHGBF	Strong	Biomarker	[1310]
SMR3B	OTL5HNM8	Strong	Biomarker	[664]
SMUG1	OT2YIOCQ	Strong	Biomarker	[1655]
SNAI2	OT7Y8EJ2	Strong	Altered Expression	[1656]
SNAI3	OTG9DI66	Strong	Altered Expression	[1657]
SNAP91	OTE3EXWZ	Strong	Biomarker	[1658]
SNED1	OTBQVXY5	Strong	Biomarker	[1659]
SNRPN	OTQB1ID1	Strong	Altered Expression	[1641]
SNW1	OTKWG3PS	Strong	Altered Expression	[98]
SOCS6	OT2O5ZBK	Strong	Biomarker	[621]
SOHLH1	OT3RBLSK	Strong	Biomarker	[1660]
SOX1	OTVI1RAR	Strong	Altered Expression	[1661]
SOX11	OT4LG7LA	Strong	Biomarker	[1662]
SOX17	OT9H4WWE	Strong	Altered Expression	[1663]
SOX3	OT1CRCOB	Strong	Biomarker	[1664]
SOX4	OTSS40SS	Strong	Biomarker	[1665]
SP100	OTN8SD5W	Strong	Altered Expression	[1666]
SPAG4	OTVXS2SM	Strong	Biomarker	[1667]
SPAG9	OT45AHMB	Strong	Altered Expression	[1668]
SPARCL1	OT74DWMV	Strong	Altered Expression	[1669]
SPG7	OT8OY9ST	Strong	Genetic Variation	[353]
SPHKAP	OT5RHUYJ	Strong	Altered Expression	[98]
SPRY3	OT0SHIZ6	Strong	Biomarker	[1670]
SPRY4	OT2VK9N0	Strong	Altered Expression	[1670]
SPZ1	OTQH8HJ5	Strong	Biomarker	[1307]
SRRM2	OTSIMMC9	Strong	Biomarker	[1469]
SRSF1	OTF61HOV	Strong	Altered Expression	[1671]
SRSF3	OTOFT707	Strong	Biomarker	[1672]
SSBP2	OTYG1G80	Strong	Biomarker	[1673]
ST13	OTNML6UP	Strong	Altered Expression	[782]
ST18	OTPRIMTA	Strong	Biomarker	[1674]
ST6GAL1	OT7US3NO	Strong	Altered Expression	[1675]
ST8SIA1	OTGND2YZ	Strong	Altered Expression	[1676]
STAT2	OTO9G2RZ	Strong	Altered Expression	[1677]
STEAP3	OTS9GZK5	Strong	Biomarker	[1678]
STING1	OTDAP4G0	Strong	Biomarker	[441]
STIP1	OT7TXLOX	Strong	Altered Expression	[1679]
STMN3	OT20F289	Strong	Altered Expression	[1680]
STYXL1	OTSPVITK	Strong	Biomarker	[1681]
SUCLG1	OTDCSPXH	Strong	Biomarker	[1410]
SUGP1	OT7W0EB8	Strong	Altered Expression	[1682]
SULF1	OTJCNCO0	Strong	Altered Expression	[715]
SWAP70	OTPHT2QD	Strong	Altered Expression	[1683]
SYBU	OT3FQV7N	Strong	Altered Expression	[956]
SYF2	OTY2ZW1H	Strong	Biomarker	[1684]
SYNJ1	OTTE02XC	Strong	Altered Expression	[98]
SYNJ2	OTLRHXP1	Strong	Altered Expression	[98]
SYNM	OTOI8TRJ	Strong	Biomarker	[1685]
SYT7	OTBWAOWY	Strong	Altered Expression	[1686]
TACC1	OTGX20TE	Strong	Genetic Variation	[1687]
TAX1BP3	OTQ6IB4T	Strong	Altered Expression	[893]
TCF7	OT1ID822	Strong	Altered Expression	[522]
TCFL5	OTJL4348	Strong	Biomarker	[1688]
TCHP	OTVDMHSY	Strong	Biomarker	[1689]
TCN2	OT41D0L3	Strong	Genetic Variation	[1690]
TCTN1	OTG5KEV8	Strong	Altered Expression	[1691]
TEAD1	OTK6971C	Strong	Biomarker	[1019]
TENM1	OTSKSU4V	Strong	Biomarker	[1692]
TERF2IP	OT3M5P3G	Strong	Biomarker	[1593]
TES	OTL8PP6V	Strong	Biomarker	[770]
TET3	OT76U3YF	Strong	Biomarker	[1693]
TFAM	OTXXV5V7	Strong	Altered Expression	[1694]
TFG	OT2KJENI	Strong	Genetic Variation	[1695]
TFPI2	OTZCRWOR	Strong	Altered Expression	[1696]
TGIF2	OTMKKE3W	Strong	Biomarker	[389]
TIMP1	OTOXC51H	Strong	Altered Expression	[216]
TIMP2	OT8S1RRP	Strong	Altered Expression	[1697]
TLCD3B	OTM6EPUS	Strong	Biomarker	[1246]
TLK2	OTZ09CG8	Strong	Altered Expression	[709]
TM7SF2	OTILU5S7	Strong	Genetic Variation	[1698]
TMEM71	OTA7W26O	Strong	Altered Expression	[1699]
TNN	OTQK2AMX	Strong	Altered Expression	[1700]
TNR	OTVJGAFN	Strong	Altered Expression	[1701]
TNS2	OTP72P0F	Strong	Altered Expression	[1702]
TPR	OTUBBA4W	Strong	Biomarker	[1703]
TRADD	OTBOSJHO	Strong	Biomarker	[1704]
TRAF2	OT1MEZZN	Strong	Biomarker	[1029]
TRAP1	OTNG0L8J	Strong	Biomarker	[692]
TREH	OTJE0NOY	Strong	Genetic Variation	[1705]
TRIB2	OTHSX3MX	Strong	Biomarker	[579]
TRIM13	OTQIUACB	Strong	Genetic Variation	[353]
TRIM14	OTLQKUG0	Strong	Altered Expression	[1706]
TRIM45	OTFDQT4E	Strong	Biomarker	[1707]
TRIM8	OTS6JFR0	Strong	Altered Expression	[1268]
TRIO	OT71X1AK	Strong	Altered Expression	[1708]
TRIOBP	OTGB5WHC	Strong	Altered Expression	[1709]
TSC1	OTFF4YZ7	Strong	Genetic Variation	[1710]
TSHZ1	OTYQ9ECW	Strong	Genetic Variation	[1711]
TSHZ3	OTAN7RY5	Strong	Altered Expression	[1712]
TSPAN8	OT1F68WQ	Strong	Biomarker	[1713]
TTC4	OTAPMYXU	Strong	Biomarker	[293]
ACOT7	OT7C68YV	Definitive	Biomarker	[766]
ACTBL2	OTD6B81U	Definitive	Biomarker	[766]
ADAMDEC1	OTMT7ZMG	Definitive	Biomarker	[1714]
ADGRE3	OTYNAQ75	Definitive	Biomarker	[1715]
ANKDD1A	OTPNBHZS	Definitive	Biomarker	[861]
AP5M1	OTDLWEBL	Definitive	Altered Expression	[1716]
ARL4C	OTQ3QNNU	Definitive	Altered Expression	[1717]
ASL	OTI2NGQR	Definitive	Biomarker	[1718]
ATG5	OT4T5SMS	Definitive	Altered Expression	[409]
ATP23	OT303R2T	Definitive	Altered Expression	[1719]
AXIN2	OTRMGQNU	Definitive	Altered Expression	[1720]
BNIP3L	OTJKOMXE	Definitive	Biomarker	[1721]
BRD8	OTIKS3PC	Definitive	Biomarker	[806]
CABP1	OTLSSRGG	Definitive	Biomarker	[1722]
CAMKMT	OTLJBRUW	Definitive	Biomarker	[1723]
CCT2	OTW1VV4E	Definitive	Biomarker	[1274]
CCT5	OTPZ38BT	Definitive	Biomarker	[1274]
CCT7	OTQNM3CY	Definitive	Biomarker	[1274]
CDH13	OTD2CYM5	Definitive	Biomarker	[610]
CDKN3	OTBE3H07	Definitive	Altered Expression	[814]
CEBPD	OTNBIPMY	Definitive	Biomarker	[1724]
CHPT1	OT4FJ0K3	Definitive	Biomarker	[1725]
CHTOP	OTMMNZ65	Definitive	Biomarker	[1726]
CLDN1	OT27KV99	Definitive	Biomarker	[1727]
CMYA5	OTYV0RME	Definitive	Biomarker	[1327]
CNTN3	OTC1274J	Definitive	Altered Expression	[1728]
COL3A1	OTT1EMLM	Definitive	Biomarker	[1729]
CREB3	OT9617UO	Definitive	Biomarker	[1730]
CTNND1	OTUMPSHR	Definitive	Biomarker	[806]
CXCL16	OTD49T9R	Definitive	Altered Expression	[1731]
DCBLD2	OTB71I02	Definitive	Altered Expression	[1732]
DEFB126	OT9NHGQE	Definitive	Biomarker	[800]
DHDDS	OTVLYBUS	Definitive	Biomarker	[1725]
DHX33	OTREUESJ	Definitive	Biomarker	[1733]
DIO2	OTGPNSLH	Definitive	Genetic Variation	[788]
DIP2A	OTXPTR8R	Definitive	Biomarker	[1734]
DLGAP1	OTF2PUUI	Definitive	Altered Expression	[1735]
DLGAP5	OTWCN39U	Definitive	Biomarker	[1736]
DPP3	OTUIVL1C	Definitive	Altered Expression	[1737]
DTX1	OTYX91DX	Definitive	Biomarker	[1738]
DUSP26	OTI7WIYN	Definitive	Altered Expression	[1739]
DYNC1I1	OTFX1KCG	Definitive	Altered Expression	[168]
E2F6	OT2PN28R	Definitive	Biomarker	[1740]
EFNB1	OT7JJW8P	Definitive	Altered Expression	[1741]
EFNB2	OT0DCUOM	Definitive	Posttranslational Modification	[1741]
ELK4	OTVSSEOE	Definitive	Altered Expression	[1742]
FA2H	OT8HA13U	Definitive	Biomarker	[747]
FBXO16	OTTEJJVJ	Definitive	Biomarker	[1743]
FOXP2	OTVX6A59	Definitive	Altered Expression	[1744]
FRZB	OTTO3DPY	Definitive	Biomarker	[914]
FZD6	OTBCPII8	Definitive	Biomarker	[1745]
GAB1	OTQKE6V4	Definitive	Biomarker	[1335]
GADD45A	OTDRV63V	Definitive	Altered Expression	[1746]
GATA6	OTO2BC0F	Definitive	Biomarker	[1747]
GINS3	OT8NVXTD	Definitive	Biomarker	[1748]
GMFB	OTR1JN1D	Definitive	Biomarker	[1749]
HNRNPU	OTLQN1E2	Definitive	Biomarker	[806]
HOXA10	OTB6GQ09	Definitive	Posttranslational Modification	[1750]
IER3	OTZJI5FZ	Definitive	Altered Expression	[1751]
IGF2BP2	OT4ZSEEE	Definitive	Biomarker	[1752]
IGSF1	OT3XD6U2	Definitive	Biomarker	[806]
IMMP2L	OT9WGAFD	Definitive	Biomarker	[1752]
INA	OT1D33T4	Definitive	Biomarker	[1753]
IRF5	OT8SIIAP	Definitive	Altered Expression	[1754]
ITGA9	OTHN1IKA	Definitive	Altered Expression	[1755]
ITGB4	OT28UK84	Definitive	Biomarker	[1756]
KPNA2	OTU7FOE6	Definitive	Altered Expression	[1757]
KRIT1	OT58AP1I	Definitive	Biomarker	[1723]
LRRFIP1	OTN7XAUD	Definitive	Altered Expression	[1758]
MAP1LC3A	OTPMGIU4	Definitive	Altered Expression	[1759]
MGP	OTZWU3FU	Definitive	Biomarker	[1760]
NAA25	OTS3QVF1	Definitive	Biomarker	[806]
NAPSA	OT6F8IAL	Definitive	Altered Expression	[814]
NDRG4	OTJBOTD8	Definitive	Biomarker	[966]
NEIL3	OTBCI2NS	Definitive	Biomarker	[1761]
NEO1	OTGJ1997	Definitive	Biomarker	[1762]
NHEJ1	OTYOO05J	Definitive	Biomarker	[1763]
NR2E1	OTW47GKM	Definitive	Biomarker	[781]
NSUN5	OTBN7RS8	Definitive	Biomarker	[806]
NUP43	OTDF5K8Y	Definitive	Altered Expression	[782]
PDIK1L	OTISF4KG	Definitive	Biomarker	[1764]
PDK4	OTCMHMBZ	Definitive	Altered Expression	[1765]
PFKM	OT1QY9JM	Definitive	Altered Expression	[1766]
PID1	OT5YJ7FI	Definitive	Biomarker	[1767]
PITX1	OTA0UN4C	Definitive	Altered Expression	[801]
POTEM	OT7L2HGH	Definitive	Biomarker	[766]
PPP1R1A	OTGTAGCV	Definitive	Biomarker	[1768]
PRIMA1	OT9ITT3P	Definitive	Biomarker	[1769]
PRKAA1	OT7TNF0L	Definitive	Altered Expression	[1575]
PRKAB1	OT1OG4QZ	Definitive	Altered Expression	[1575]
PROX1	OT68R6IO	Definitive	Altered Expression	[1770]
PSMC6	OTG8997V	Definitive	Altered Expression	[782]
PTPRT	OTV5TXNN	Definitive	Altered Expression	[1771]
RAB40B	OTCA9ZF5	Definitive	Biomarker	[1772]
RAI14	OT6USGBK	Definitive	Biomarker	[1773]
RAP1B	OTHEIIMM	Definitive	Biomarker	[1774]
RARRES1	OTETUPP5	Definitive	Biomarker	[408]
RASGRF1	OTNWJ7EN	Definitive	Biomarker	[1335]
RECQL	OTPCH3JH	Definitive	Biomarker	[1775]
RFX1	OTZUDMPR	Definitive	Biomarker	[1776]
RIN2	OTCY73U9	Definitive	Genetic Variation	[1777]
RNF168	OT6AZXX8	Definitive	Altered Expression	[135]
RPL36A	OT1LYV85	Definitive	Biomarker	[1359]
RPS15A	OT0BUA12	Definitive	Biomarker	[1778]
RRAD	OTW2O4GD	Definitive	Biomarker	[1097]
RYBP	OTZZ4P2Z	Definitive	Altered Expression	[1779]
SAR1A	OTSSRVGV	Definitive	Biomarker	[1780]
SERPINI1	OTUJHIJW	Definitive	Biomarker	[800]
SHC3	OT305NPA	Definitive	Altered Expression	[1781]
SIGLEC9	OTZC7SIM	Definitive	Biomarker	[1782]
SKI	OT4KJ8F6	Definitive	Biomarker	[1783]
SLN	OTERIU75	Definitive	Biomarker	[1784]
SPAST	OTIF3AJI	Definitive	Biomarker	[1249]
SPPL3	OT2HLJF6	Definitive	Biomarker	[1752]
SPTA1	OT1YMP65	Definitive	Biomarker	[1785]
STIM1	OT8CLQ1W	Definitive	Biomarker	[1786]
STIM2	OTYNXAW0	Definitive	Biomarker	[1787]
SUMO1	OTJFD4P5	Definitive	Biomarker	[1788]
TAPBP	OTL81AVZ	Definitive	Biomarker	[1789]
TBPL1	OT4I143E	Definitive	Genetic Variation	[751]
TCP1	OT1MGUX9	Definitive	Biomarker	[1274]
TIMP4	OT8A68SW	Definitive	Altered Expression	[1790]
TMEM18	OT05YQ1E	Definitive	Altered Expression	[1791]
TNFAIP8L3	OTHSBS1B	Definitive	Biomarker	[1792]
TNFRSF10C	OTVHOL9B	Definitive	Biomarker	[419]
TPI1	OT14KP4B	Definitive	Biomarker	[1793]
TPM3	OT5RU5G6	Definitive	Biomarker	[1794]
TRIM44	OT0B1T2B	Definitive	Biomarker	[1795]
TRIM48	OT2L4STK	Definitive	Biomarker	[1796]
TRIP6	OTIPA4ZR	Definitive	Biomarker	[1797]

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [3] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5693).
• [4] ClinicalTrials.gov (NCT01280552) A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM). U.S. National Institutes of Health.
• [5] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033527)
• [6] ClinicalTrials.gov (NCT01480479) Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma. U.S. National Institutes of Health.
• [7] VB-111 for cancer. Expert Opin Biol Ther. 2011 Dec;11(12):1669-76.
• [8] ClinicalTrials.gov (NCT02414165) P2/3 Randomized Study of Toca 511 & Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA. U.S. National Institutes of Health.
• [9] ClinicalTrials.gov (NCT00519506) A Phase II Study to Evaluate the Efficacy of ThromboView in the Detection of Pulmonary Emboli. U.S. National Institutes of Health.
• [10] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7970).
• [11] Phase II randomized trial of autologous formalin-fixed tumor vaccine for postsurgical recurrence of hepatocellular carcinoma. Clin Cancer Res. 2004 Mar 1;10(5):1574-9.
• [12] Phase II study of antineoplaston A10 and AS2-1 in children with recurrent and progressive multicentric glioma : a preliminary report. Drugs R D. 2004;5(6):315-26.
• [13] ClinicalTrials.gov (NCT01124539) Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma. U.S. National Institutes of Health.
• [14] ClinicalTrials.gov (NCT01213407) Dendritic Cell Cancer Vaccine for High-grade Glioma. U.S. National Institutes of Health.
• [15] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010155)
• [16] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032169)
• [17] Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma. Br J Haematol. 2007 Apr;137(2):133-41.
• [18] Vitespen: a preclinical and clinical review. Future Oncol. 2009 Aug;5(6):763-74.
• [19] Clinical pipeline report, company report or official report of Activartis Biotech.
• [20] Adoptive cell therapies for glioblastoma. Front Oncol. 2013 Nov 11;3:275.
• [21] ClinicalTrials.gov (NCT00664378) Efficacy Study of CYT997 in Multiple Myeloma. U.S. National Institutes of Health.
• [22] Clinical pipeline report, company report or official report of MedImmune (2011).
• [23] Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models. J Transl Med. 2007 Feb 12;5:10.
• [24] Clinical pipeline report, company report or official report of Agenus.
• [25] ClinicalTrials.gov (NCT02047214) Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy. U.S. National Institutes of Health.
• [26] ClinicalTrials.gov (NCT05053880) A Phase 1b/2a Study of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme. U.S.National Institutes of Health.
• [27] Clinical pipeline report, company report or official report of Northwest BioTherapeutics.
• [28] ClinicalTrials.gov (NCT03170141) Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme
• [29] ClinicalTrials.gov (NCT01454596) CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII. U.S. National Institutes of Health.
• [30] Clinical pipeline report, company report or official report of Neonc technologies.
• [31] Clinical pipeline report, company report or official report of Tocagen.
• [32] ClinicalTrials.gov (NCT01099644) Intraperitoneal Radioimmunotherapy With 131I-8H9 for Patients With Desmoplastic Small Round Cell Tumors and Other Solid Tumors Involving the Peritoneum. U.S. NationalInstitutes of Health.
• [33] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800039199)
• [34] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020588)
• [35] ClinicalTrials.gov (NCT03296696) Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma. U.S. National Institutes of Health.
• [36] ClinicalTrials.gov (NCT02844062) Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme
• [37] ClinicalTrials.gov (NCT02937844) Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme
• [38] Clinical studies and trials in cancer. Malaghan Institute of Medical Research.
• [39] ClinicalTrials.gov (NCT02664363) EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma
• [40] A phase I clinical trial of interferon-beta gene therapy for high-grade glioma: novel findings from gene expression profiling and autopsy. J Gene Med. 2008 Apr;10(4):329-39.
• [41] ClinicalTrials.gov (NCT01403285) Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma. U.S. National Institutes of Health.
• [42] ClinicalTrials.gov (NCT02326441) Safety, Tolerability & PK of KX2-361 in Subjects w Adv. Malignancies Refractory to Conventional Therapies. U.S. National Institutes of Health.
• [43] Clinical pipeline report, company report or official report of Oligovax SAS.
• [44] ClinicalTrials.gov (NCT03696030) HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases. U.S. National Institutes of Health.
• [45] Therapeutic concentrations of anti-epileptic drugs do not inhibit the activity of the oncolytic adenovirus Delta24-RGD in malignant glioma. J Gene Med. 2013 Mar-Apr;15(3-4):134-41.
• [46] Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer. Cancer Res. 2010 Feb 1;70(3):875-82.
• [47] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025449)
• [48] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4883).
• [49] The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
• [50] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2605).
• [51] Inhibition of Acetyl-CoA Carboxylase 1 (ACC1) and 2 (ACC2) Reduces Proliferation and De Novo Lipogenesis of EGFRvIII Human Glioblastoma Cells.PLoS One. 2017 Jan 12;12(1):e0169566. doi: 10.1371/journal.pone.0169566. eCollection 2017.
• [52] FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma.Cell Death Dis. 2018 May 1;9(5):469. doi: 10.1038/s41419-018-0482-4.
• [53] Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas.Int J Cancer. 2006 Jan 1;118(1):55-61. doi: 10.1002/ijc.21258.
• [54] C1q/TNF-related peptide 8 (CTRP8) promotes temozolomide resistance in human glioblastoma.Mol Oncol. 2018 Sep;12(9):1464-1479. doi: 10.1002/1878-0261.12349. Epub 2018 Aug 2.
• [55] The Mechanistic Role of the Calcium-Activated Chloride Channel ANO1 in Tumor Growth and Signaling.Adv Exp Med Biol. 2017;966:1-14. doi: 10.1007/5584_2016_201.
• [56] Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics.PLoS One. 2018 Mar 7;13(3):e0193799. doi: 10.1371/journal.pone.0193799. eCollection 2018.
• [57] In search of druggable targets for GBM amino acid metabolism.BMC Cancer. 2017 Feb 28;17(1):162. doi: 10.1186/s12885-017-3148-1.
• [58] Regulation of Integrated Stress Response Sensitizes U87MG Glioblastoma Cells to Temozolomide Through the Mitochondrial Apoptosis Pathway.Anat Rec (Hoboken). 2018 Aug;301(8):1390-1397. doi: 10.1002/ar.23839. Epub 2018 May 13.
• [59] High ATP2A2 expression correlates with better prognosis of diffuse astrocytic tumor patients.Oncol Rep. 2017 May;37(5):2865-2874. doi: 10.3892/or.2017.5528. Epub 2017 Mar 24.
• [60] Multistage Ultraviolet Photodissociation Mass Spectrometry To Characterize Single Amino Acid Variants of Human Mitochondrial BCAT2.Anal Chem. 2018 Aug 21;90(16):9904-9911. doi: 10.1021/acs.analchem.8b02099. Epub 2018 Aug 1.
• [61] The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastoma.Nat Commun. 2019 Jan 25;10(1):442. doi: 10.1038/s41467-019-08390-z.
• [62] A Novel Micro Cold Atmospheric Plasma Device for Glioblastoma Both In Vitro and In Vivo.Cancers (Basel). 2017 May 30;9(6):61. doi: 10.3390/cancers9060061.
• [63] Disruption of the monocarboxylate transporter-4-basigin interaction inhibits the hypoxic response, proliferation, and tumor progression.Sci Rep. 2017 Jun 27;7(1):4292. doi: 10.1038/s41598-017-04612-w.
• [64] Identification of hub genes and pathways in glioblastoma by bioinformatics analysis.Oncol Lett. 2019 Jan;17(1):1035-1041. doi: 10.3892/ol.2018.9644. Epub 2018 Oct 31.
• [65] Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo.Am J Pathol. 2002 Apr;160(4):1279-92. doi: 10.1016/S0002-9440(10)62555-2.
• [66] A positive feedback loop involving nuclear factor IB and calpain 1 suppresses glioblastoma cell migration.J Biol Chem. 2019 Aug 23;294(34):12638-12654. doi: 10.1074/jbc.RA119.008291. Epub 2019 Jul 1.
• [67] Long non-coding RNA CASP5 promotes the malignant phenotypes of human glioblastoma multiforme.Biochem Biophys Res Commun. 2018 Jun 12;500(4):966-972. doi: 10.1016/j.bbrc.2018.04.217. Epub 2018 May 2.
• [68] The prostanoid pathway contains potential prognostic markers for glioblastoma.Prostaglandins Other Lipid Mediat. 2018 Jul;137:52-62. doi: 10.1016/j.prostaglandins.2018.06.003. Epub 2018 Jun 30.
• [69] Cytokine CCL5 and receptor CCR5 axis in glioblastoma multiforme.Radiol Oncol. 2019 Nov 20;53(4):397-406. doi: 10.2478/raon-2019-0057.
• [70] Application of Neurokinin-1 Receptor in Targeted Strategies for Glioma Treatment. Part I: Synthesis and Evaluation of Substance P Fragments Labeled with (99m)Tc and (177)Lu as Potential Receptor Radiopharmaceuticals.Molecules. 2018 Oct 5;23(10):2542. doi: 10.3390/molecules23102542.
• [71] Analysis of immunobiologic markers in primary and recurrent glioblastoma.J Neurooncol. 2018 Apr;137(2):249-257. doi: 10.1007/s11060-017-2732-1. Epub 2018 Jan 4.
• [72] Effects of tumor grade and dexamethasone on myeloid cells in patients with glioma.Oncoimmunology. 2018 Aug 27;7(11):e1507668. doi: 10.1080/2162402X.2018.1507668. eCollection 2018.
• [73] Temozolomide Treatment Induces lncRNA MALAT1 in an NF-B and p53 Codependent Manner in Glioblastoma.Cancer Res. 2019 May 15;79(10):2536-2548. doi: 10.1158/0008-5472.CAN-18-2170. Epub 2019 Apr 2.
• [74] Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade.Oncoimmunology. 2017 Dec 12;7(3):e1407899. doi: 10.1080/2162402X.2017.1407899. eCollection 2018.
• [75] Identification of the potential oncogenes in glioblastoma based on bioinformatic analysis and elucidation of the underlying mechanisms.Oncol Rep. 2018 Aug;40(2):715-725. doi: 10.3892/or.2018.6483. Epub 2018 Jun 11.
• [76] A Novel Small-Molecule Inhibitor of MRCK Prevents Radiation-Driven Invasion in Glioblastoma.Cancer Res. 2018 Nov 15;78(22):6509-6522. doi: 10.1158/0008-5472.CAN-18-1697. Epub 2018 Oct 2.
• [77] CDC7-dependent transcriptional regulation of RAD54L is essential for tumorigenicity and radio-resistance of glioblastoma.Transl Oncol. 2018 Apr;11(2):300-306. doi: 10.1016/j.tranon.2018.01.003. Epub 2018 Feb 4.
• [78] Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma.Nat Commun. 2019 Jul 2;10(1):2910. doi: 10.1038/s41467-019-10993-5.
• [79] The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment.J Exp Clin Cancer Res. 2019 Oct 21;38(1):420. doi: 10.1186/s13046-019-1434-2.
• [80] Alterations of the levels of primary antioxidant enzymes in different grades of human astrocytoma tissues.Free Radic Res. 2018 Aug;52(8):856-871. doi: 10.1080/10715762.2018.1483580.
• [81] Casein Kinase 1 Epsilon Regulates Glioblastoma Cell Survival.Sci Rep. 2018 Sep 11;8(1):13621. doi: 10.1038/s41598-018-31864-x.
• [82] Cathepsin B contributes to radioresistance by enhancing homologous recombination in glioblastoma.Biomed Pharmacother. 2018 Nov;107:390-396. doi: 10.1016/j.biopha.2018.08.007. Epub 2018 Aug 9.
• [83] Detection of immune responses after immunotherapy in glioblastoma using PET and MRI.Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10220-10225. doi: 10.1073/pnas.1706689114. Epub 2017 Sep 5.
• [84] The synergistic effect of DZNEP, panobinostat and temozolomide reduces clonogenicity and induces apoptosis in glioblastoma cells.Int J Oncol. 2020 Jan;56(1):283-300. doi: 10.3892/ijo.2019.4905. Epub 2019 Oct 30.
• [85] Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha.Neuro Oncol. 2018 Jan 22;20(2):192-202. doi: 10.1093/neuonc/nox119.
• [86] miR-29s inhibit the malignant behavior of U87MG glioblastoma cell line by targeting DNMT3A and 3B.Neurosci Lett. 2015 Mar 17;590:40-6. doi: 10.1016/j.neulet.2015.01.060. Epub 2015 Jan 24.
• [87] The Dopamine D2 Receptor Contributes to the Spheroid Formation Behavior of U87 Glioblastoma Cells.Pharmacology. 2020;105(1-2):19-27. doi: 10.1159/000502562. Epub 2019 Oct 23.
• [88] MKP1 phosphatase is recruited by CXCL12 in glioblastoma cells and plays a role in DNA strand breaks repair.Carcinogenesis. 2020 Jun 17;41(4):417-429. doi: 10.1093/carcin/bgz151.
• [89] Expression of endothelin-1 and endothelin receptors in cultured human glioblastoma cells.J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S390-2. doi: 10.1097/00005344-200036051-00113.
• [90] Rottlerin inhibits cell growth and invasion via down-regulation of Cdc20 in glioma cells.Oncotarget. 2016 Oct 25;7(43):69770-69782. doi: 10.18632/oncotarget.11974.
• [91] DNA Repair Capacity in Multiple Pathways Predicts Chemoresistance in Glioblastoma Multiforme.Cancer Res. 2017 Jan 1;77(1):198-206. doi: 10.1158/0008-5472.CAN-16-1151. Epub 2016 Oct 28.
• [92] Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma.Cell Death Dis. 2019 Mar 29;10(4):292. doi: 10.1038/s41419-019-1387-6.
• [93] 4-Hydroxy-7-oxo-5-heptenoic acid lactone is a potent inducer of brain cancer cell invasiveness that may contribute to the failure of anti-angiogenic therapies.Free Radic Biol Med. 2020 Jan;146:234-256. doi: 10.1016/j.freeradbiomed.2019.11.009. Epub 2019 Nov 9.
• [94] FABP4 accelerates glioblastoma cell growth and metastasis through Wnt10b signalling.Eur Rev Med Pharmacol Sci. 2018 Nov;22(22):7807-7818. doi: 10.26355/eurrev_201811_16405.
• [95] Delta-6-desaturase inhibitor enhances radiation therapy in glioblastoma in vitro and in vivo.Cancer Manag Res. 2018 Dec 7;10:6779-6790. doi: 10.2147/CMAR.S185601. eCollection 2018.
• [96] IGFBP2 promotes immunosuppression associated with its mesenchymal induction and FcRIIB phosphorylation in glioblastoma.PLoS One. 2019 Sep 27;14(9):e0222999. doi: 10.1371/journal.pone.0222999. eCollection 2019.
• [97] Toxic effects of phytol and retinol on human glioblastoma cells are associated with modulation of cholesterol and fatty acid biosynthetic pathways.J Neurooncol. 2018 Feb;136(3):435-443. doi: 10.1007/s11060-017-2672-9. Epub 2017 Nov 20.
• [98] Lipid phosphatases SKIP and SHIP2 regulate fibronectin-dependent cell migration in glioblastoma.FEBS J. 2019 Mar;286(6):1120-1135. doi: 10.1111/febs.14769. Epub 2019 Feb 16.
• [99] Reactive species balance via GTP cyclohydrolase I regulates glioblastoma growth and tumor initiating cell maintenance.Neuro Oncol. 2018 Jul 5;20(8):1055-1067. doi: 10.1093/neuonc/noy012.
• [100] BMP9 counteracts the tumorigenic and pro-angiogenic potential of glioblastoma.Cell Death Differ. 2018 Nov;25(10):1808-1822. doi: 10.1038/s41418-018-0149-9. Epub 2018 Jul 5.
• [101] Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro.PLoS One. 2019 Mar 6;14(3):e0212455. doi: 10.1371/journal.pone.0212455. eCollection 2019.
• [102] Inhibition of GLO1 in Glioblastoma Multiforme Increases DNA-AGEs, Stimulates RAGE Expression, and Inhibits Brain Tumor Growth in Orthotopic Mouse Models.Int J Mol Sci. 2018 Jan 30;19(2):406. doi: 10.3390/ijms19020406.
• [103] AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro.PLoS One. 2019 Feb 4;14(2):e0211644. doi: 10.1371/journal.pone.0211644. eCollection 2019.
• [104] YAP and MRTF-A, transcriptional co-activators of RhoA-mediated gene expression, are critical for glioblastoma tumorigenicity.Oncogene. 2018 Oct;37(41):5492-5507. doi: 10.1038/s41388-018-0301-5. Epub 2018 Jun 11.
• [105] Glioblastoma invasion and NMDA receptors: A novel prospect.Physiol Int. 2019 Sep 1;106(3):250-260. doi: 10.1556/2060.106.2019.22. Epub 2019 Sep 30.
• [106] Identification of recurrent fusion genes across multiple cancer types.Sci Rep. 2019 Jan 31;9(1):1074. doi: 10.1038/s41598-019-38550-6.
• [107] Metabotropic glutamate receptors as a new therapeutic target for malignant gliomas.Oncotarget. 2017 Mar 28;8(13):22279-22298. doi: 10.18632/oncotarget.15299.
• [108] Identification of New Biomarkers Associated With IDH Mutation and Prognosis in Astrocytic Tumors Using NanoString nCounter Analysis System.Appl Immunohistochem Mol Morphol. 2018 Feb;26(2):101-107. doi: 10.1097/PAI.0000000000000396.
• [109] Molecular mechanism of point mutation-induced Monopolar spindle 1 (Mps1/TTK) inhibitor resistance revealed by a comprehensive molecular modeling study.PeerJ. 2019 Jan 21;7:e6299. doi: 10.7717/peerj.6299. eCollection 2019.
• [110] Phase I analysis of BCNU-impregnated biodegradable polymer wafers followed by systemic interferon alfa-2b in adults with recurrent glioblastoma multiforme.J Neurooncol. 2008 Dec;90(3):293-9. doi: 10.1007/s11060-008-9660-z. Epub 2008 Aug 5.
• [111] STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.J Neurosurg. 2014 Aug;121(2):374-83. doi: 10.3171/2014.4.JNS131198. Epub 2014 May 30.
• [112] Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor 1 and 2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.J Neurooncol. 2018 Feb;136(3):463-474. doi: 10.1007/s11060-017-2680-9. Epub 2017 Nov 22.
• [113] Radiogenomics Profiling for Glioblastoma-related Immune Cells Reveals CD49d Expression Correlation with MRI parameters and Prognosis.Sci Rep. 2018 Oct 30;8(1):16022. doi: 10.1038/s41598-018-34242-9.
• [114] CD103(+) Cell Growth Factor Flt3L Enhances the Efficacy of Immune Checkpoint Blockades in Murine Glioblastoma Model.Oncol Res. 2018 Mar 5;26(2):173-182. doi: 10.3727/096504017X14841698396865. Epub 2017 Jan 20.
• [115] FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.Int J Cancer. 2018 Feb 15;142(4):805-812. doi: 10.1002/ijc.31092. Epub 2017 Oct 17.
• [116] Histone Acetyltransferase KAT6A Upregulates PI3K/AKT Signaling through TRIM24 Binding.Cancer Res. 2017 Nov 15;77(22):6190-6201. doi: 10.1158/0008-5472.CAN-17-1388. Epub 2017 Oct 11.
• [117] Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas.Neurosci Lett. 2003 Jul 31;346(1-2):33-6. doi: 10.1016/s0304-3940(03)00562-7.
• [118] Overexpression of Large-Conductance Calcium-Activated Potassium Channels in Human Glioblastoma Stem-Like Cells and Their Role in Cell Migration.J Cell Physiol. 2017 Sep;232(9):2478-2488. doi: 10.1002/jcp.25592. Epub 2017 Apr 10.
• [119] Lysine-Specific Demethylase 1 (LSD1/KDM1A) Is a Novel Target Gene of c-Myc.Biol Pharm Bull. 2019;42(3):481-488. doi: 10.1248/bpb.b18-00892.
• [120] Phase II study of Dovitinib in recurrent glioblastoma.J Neurooncol. 2019 Sep;144(2):359-368. doi: 10.1007/s11060-019-03236-6. Epub 2019 Jul 11.
• [121] LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway.BMC Cancer. 2018 Jul 6;18(1):722. doi: 10.1186/s12885-018-4649-2.
• [122] LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients.J Pathol. 2019 Feb;247(2):228-240. doi: 10.1002/path.5186. Epub 2019 Jan 10.
• [123] Suppression of LIM Kinase 1 and LIM Kinase 2 Limits Glioblastoma Invasion.Cancer Res. 2020 Jan 1;80(1):69-78. doi: 10.1158/0008-5472.CAN-19-1237. Epub 2019 Oct 22.
• [124] Inhibition of neurotensin receptor 1 induces intrinsic apoptosis via let-7a-3p/Bcl-w axis in glioblastoma.Br J Cancer. 2017 Jun 6;116(12):1572-1584. doi: 10.1038/bjc.2017.126. Epub 2017 May 11.
• [125] Mutations in the mitotic check point gene, MAD1L1, in human cancers.Oncogene. 2001 May 31;20(25):3301-5. doi: 10.1038/sj.onc.1204421.
• [126] Myristoylated alanine rich protein kinaseC substrate is a potential cancer prognostic factor that regulates cell migration and invasion in glioblastoma.Oncol Rep. 2019 Apr;41(4):2464-2470. doi: 10.3892/or.2019.7009. Epub 2019 Feb 13.
• [127] Expression of the genes encoding myelin basic protein and proteolipid protein in human malignant gliomas.Clin Cancer Res. 1997 May;3(5):799-804.
• [128] Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma.J Nanobiotechnology. 2018 Apr 13;16(1):38. doi: 10.1186/s12951-018-0365-y.
• [129] Arrestin-3 interaction with maternal embryonic leucine-zipper kinase.Cell Signal. 2019 Nov;63:109366. doi: 10.1016/j.cellsig.2019.109366. Epub 2019 Jul 25.
• [130] Modulation of MKNK2 alternative splicing by splice-switching oligonucleotides as a novel approach for glioblastoma treatment.Nucleic Acids Res. 2018 Nov 30;46(21):11396-11404. doi: 10.1093/nar/gky921.
• [131] Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.Am J Pathol. 1999 Feb;154(2):417-28. doi: 10.1016/S0002-9440(10)65288-1.
• [132] Ultra-Mutation in IDH Wild-Type Glioblastomas of Patients Younger than 55 Years is Associated with Defective Mismatch Repair, Microsatellite Instability, and Giant Cell Enrichment.Cancers (Basel). 2019 Aug 30;11(9):1279. doi: 10.3390/cancers11091279.
• [133] MSI2-TGF-/TGF- R1/SMAD3 positive feedback regulation in glioblastoma.Cancer Chemother Pharmacol. 2019 Aug;84(2):415-425. doi: 10.1007/s00280-019-03892-5. Epub 2019 Jun 27.
• [134] Human cytomegalovirus ie2 affects the migration of glioblastoma by mediating the different splicing patterns of RON through hnRNP A2B1.Neuroreport. 2019 Aug 14;30(12):805-811. doi: 10.1097/WNR.0000000000001277.
• [135] A PRMT5-RNF168-SMURF2 Axis Controls H2AX Proteostasis.Cell Rep. 2019 Sep 17;28(12):3199-3211.e5. doi: 10.1016/j.celrep.2019.08.031.
• [136] Myosin IIA suppresses glioblastoma development in a mechanically sensitive manner.Proc Natl Acad Sci U S A. 2019 Jul 30;116(31):15550-15559. doi: 10.1073/pnas.1902847116. Epub 2019 Jun 24.
• [137] Targeted therapy of human glioblastoma via delivery of a toxin through a peptide directed to cell surface nucleolin.J Cell Physiol. 2018 May;233(5):4091-4105. doi: 10.1002/jcp.26205. Epub 2017 Dec 18.
• [138] A Hydroquinone-Based Derivative Elicits Apoptosis and Autophagy via Activating a ROS-Dependent Unfolded Protein Response in Human Glioblastoma.Int J Mol Sci. 2019 Aug 6;20(15):3836. doi: 10.3390/ijms20153836.
• [139] The Potential Roles of Long Noncoding RNAs (lncRNA) in Glioblastoma Development.Mol Cancer Ther. 2016 Dec;15(12):2977-2986. doi: 10.1158/1535-7163.MCT-16-0320. Epub 2016 Oct 26.
• [140] Reactive oxygen species production has a critical role in hypoxia-induced Stat3 activation and angiogenesis in human glioblastoma.J Neurooncol. 2015 Oct;125(1):55-63. doi: 10.1007/s11060-015-1889-8. Epub 2015 Aug 22.
• [141] miRNA-124-3p/neuropilin-1(NRP-1) axis plays an important role in mediating glioblastoma growth and angiogenesis.Int J Cancer. 2018 Aug 1;143(3):635-644. doi: 10.1002/ijc.31329. Epub 2018 Mar 2.
• [142] Downregulation of Oxytocin Receptor Decreases the Length of Projections Stimulated by Retinoic Acid in the U-87MG Cells.Neurochem Res. 2017 Apr;42(4):1006-1014. doi: 10.1007/s11064-016-2133-4. Epub 2016 Dec 19.
• [143] The human poly(ADP-ribose) glycohydrolase maps to chromosome 10q11.23-21.1 by fluorescence in situ hybridization.Hum Cell. 1998 Dec;11(4):243-6.
• [144] PARP3 interacts with FoxM1 to confer glioblastoma cell radioresistance.Tumour Biol. 2015 Nov;36(11):8617-24. doi: 10.1007/s13277-015-3554-4. Epub 2015 Jun 4.
• [145] PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma.J Mol Neurosci. 2020 Jan;70(1):56-64. doi: 10.1007/s12031-019-01400-1. Epub 2019 Oct 15.
• [146] C-type lectin domain family 5, member A (CLEC5A, MDL-1) promotes brain glioblastoma tumorigenesis by regulating PI3K/Akt signalling.Cell Prolif. 2019 May;52(3):e12584. doi: 10.1111/cpr.12584. Epub 2019 Mar 4.
• [147] Rolipram potentiates bevacizumab-induced cell death in human glioblastoma stem-like cells.Life Sci. 2017 Mar 15;173:11-19. doi: 10.1016/j.lfs.2017.02.005. Epub 2017 Feb 12.
• [148] Radioiodine-labeled anti-epidermal growth factor receptor binding bovine serum albumin-polycaprolactone for targeting imaging of glioblastoma.Oncol Rep. 2017 Nov;38(5):2919-2926. doi: 10.3892/or.2017.5937. Epub 2017 Sep 4.
• [149] Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 promotes hypoxia-induced glioma migration and invasion.Oncotarget. 2017 Apr 4;8(14):23401-23413. doi: 10.18632/oncotarget.15581.
• [150] A novel role of the mitochondrial permeability transition pore in (-)-gossypol-induced mitochondrial dysfunction.Mech Ageing Dev. 2018 Mar;170:45-58. doi: 10.1016/j.mad.2017.06.004. Epub 2017 Jul 3.
• [151] A 63 signature genes prediction system is effective for glioblastoma prognosis.Int J Mol Med. 2018 Apr;41(4):2070-2078. doi: 10.3892/ijmm.2018.3422. Epub 2018 Jan 25.
• [152] Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.Int J Cancer. 2016 Oct 15;139(8):1776-87. doi: 10.1002/ijc.30234. Epub 2016 Jul 7.
• [153] Discovery of physiological and cancer-related regulators of 3' UTR processing with KAPAC.Genome Biol. 2018 Mar 28;19(1):44. doi: 10.1186/s13059-018-1415-3.
• [154] Verbascoside Inhibits Glioblastoma Cell Proliferation, Migration and Invasion While Promoting Apoptosis Through Upregulation of Protein Tyrosine Phosphatase SHP-1 and Inhibition of STAT3 Phosphorylation.Cell Physiol Biochem. 2018;47(5):1871-1882. doi: 10.1159/000491067. Epub 2018 Jun 29.
• [155] CHD4 regulates the DNA damage response and RAD51 expression in glioblastoma.Sci Rep. 2019 Mar 14;9(1):4444. doi: 10.1038/s41598-019-40327-w.
• [156] CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.Br J Cancer. 2017 Jun 27;117(1):102-112. doi: 10.1038/bjc.2017.157. Epub 2017 Jun 1.
• [157] Evaluation of Akt and RICTOR Expression Levels in Astrocytomas of All Grades.J Histochem Cytochem. 2017 Feb;65(2):93-103. doi: 10.1369/0022155416675850. Epub 2016 Oct 28.
• [158] R-spodin2 enhances canonical Wnt signaling to maintain the stemness of glioblastoma cells.Cancer Cell Int. 2018 Oct 11;18:156. doi: 10.1186/s12935-018-0655-3. eCollection 2018.
• [159] miR-7-5p inhibits cell migration and invasion in glioblastoma through targeting SATB1.Oncol Lett. 2019 Feb;17(2):1819-1825. doi: 10.3892/ol.2018.9777. Epub 2018 Nov 28.
• [160] Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth.Cancer Res Treat. 2018 Jul;50(3):1009-1022. doi: 10.4143/crt.2017.315. Epub 2017 Nov 10.
• [161] HSP47 Promotes Glioblastoma Stemlike Cell Survival by Modulating Tumor Microenvironment Extracellular Matrix through TGF- Pathway.ACS Chem Neurosci. 2017 Jan 18;8(1):128-134. doi: 10.1021/acschemneuro.6b00253. Epub 2016 Oct 12.
• [162] SIRT2-mediated inactivation of p73 is required for glioblastoma tumorigenicity.EMBO Rep. 2018 Nov;19(11):e45587. doi: 10.15252/embr.201745587. Epub 2018 Sep 13.
• [163] A Derivate of Benzimidazole-Isoquinolinone Induces SKP2 Transcriptional Inhibition to Exert Anti-Tumor Activity in Glioblastoma Cells.Molecules. 2019 Jul 26;24(15):2722. doi: 10.3390/molecules24152722.
• [164] Mutations of the MAPK/TSC/mTOR pathway characterize periventricular glioblastoma with epithelioid SEGA-like morphology-morphological and therapeutic implications.Oncotarget. 2019 Jun 18;10(40):4038-4052. doi: 10.18632/oncotarget.27005. eCollection 2019 Jun 18.
• [165] An overview of MCT1 and MCT4 in GBM: small molecule transporters with large implications.Am J Cancer Res. 2018 Oct 1;8(10):1967-1976. eCollection 2018.
• [166] Clinical and dosimetric study of radiotherapy for glioblastoma: three-dimensional conformal radiotherapy versus intensity-modulated radiotherapy.J Neurooncol. 2018 Apr;137(2):429-438. doi: 10.1007/s11060-017-2735-y. Epub 2018 Jan 27.
• [167] Ibuprofen induces ferroptosis of glioblastoma cells via downregulation of nuclear factor erythroid 2-related factor 2 signaling pathway.Anticancer Drugs. 2020 Jan;31(1):27-34. doi: 10.1097/CAD.0000000000000825.
• [168] Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma.Oncogene. 2019 Feb;38(8):1151-1165. doi: 10.1038/s41388-018-0504-9. Epub 2018 Sep 24.
• [169] Meta-Analysis and Experimental Validation Identified FREM2 and SPRY1 as New Glioblastoma Marker Candidates.Int J Mol Sci. 2018 May 4;19(5):1369. doi: 10.3390/ijms19051369.
• [170] Mutant cytoskeletal and ECM peptides sensitive to the ST14 protease are associated with a worse outcome for glioblastoma multiforme.Biochem Biophys Res Commun. 2018 Sep 18;503(4):2218-2225. doi: 10.1016/j.bbrc.2018.06.141. Epub 2018 Jul 17.
• [171] Epigenetic downregulation of STAT6 increases HIF-1 expression via mTOR/S6K/S6, leading to enhanced hypoxic viability of glioma cells.Acta Neuropathol Commun. 2019 Sep 17;7(1):149. doi: 10.1186/s40478-019-0798-z.
• [172] MiR-184 Retarded the Proliferation, Invasiveness and Migration of Glioblastoma Cells by Repressing Stanniocalcin-2.Pathol Oncol Res. 2018 Oct;24(4):853-860. doi: 10.1007/s12253-017-0298-z. Epub 2017 Sep 8.
• [173] Tryptophan 2,3-Dioxygenase Expression Identified in Human Hepatocellular Carcinoma Cells and in Intratumoral Pericytes of Most Cancers.Cancer Immunol Res. 2020 Jan;8(1):19-31. doi: 10.1158/2326-6066.CIR-19-0040. Epub 2019 Dec 5.
• [174] Essential role for non-canonical poly(A) polymerase GLD4 in cytoplasmic polyadenylation and carbohydrate metabolism.Nucleic Acids Res. 2017 Jun 20;45(11):6793-6804. doi: 10.1093/nar/gkx239.
• [175] TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM.Oncoimmunology. 2018 May 24;7(8):e1466769. doi: 10.1080/2162402X.2018.1466769. eCollection 2018.
• [176] An Efficient Bivalent Cyclic RGD-PIK3CB siRNA Conjugate for Specific Targeted Therapy against Glioblastoma InVitro and InVivo.Mol Ther Nucleic Acids. 2018 Dec 7;13:220-232. doi: 10.1016/j.omtn.2018.09.002. Epub 2018 Sep 6.
• [177] APRIL is increased in serum of patients with brain glioblastoma multiforme.Eur Cytokine Netw. 2006 Dec;17(4):276-80.
• [178] LncRNA LINC01446 promotes glioblastoma progression by modulating miR-489-3p/TPT1 axis.Biochem Biophys Res Commun. 2018 Sep 10;503(3):1484-1490. doi: 10.1016/j.bbrc.2018.07.067. Epub 2018 Jul 17.
• [179] The vesicular transfer of CLIC1 from glioblastoma to microvascular endothelial cells requires TRPM7.Oncotarget. 2018 Sep 7;9(70):33302-33311. doi: 10.18632/oncotarget.26048. eCollection 2018 Sep 7.
• [180] Identification of the role of TRPM8 in glioblastoma and its effect on proliferation, apoptosis and invasion of the U251 human glioblastoma cell line.Oncol Rep. 2019 Oct;42(4):1517-1526. doi: 10.3892/or.2019.7260. Epub 2019 Aug 5.
• [181] SK channel activation potentiates auranofin-induced cell death in glio- and neuroblastoma cells.Biochem Pharmacol. 2020 Jan;171:113714. doi: 10.1016/j.bcp.2019.113714. Epub 2019 Nov 15.
• [182] Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination.J Exp Med. 2017 Jan;214(1):245-267. doi: 10.1084/jem.20151673. Epub 2016 Dec 6.
• [183] USP5 promotes tumorigenesis and progression of pancreatic cancer by stabilizing FoxM1 protein.Biochem Biophys Res Commun. 2017 Oct 7;492(1):48-54. doi: 10.1016/j.bbrc.2017.08.040. Epub 2017 Aug 12.
• [184] VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance.Neuro Oncol. 2018 Oct 9;20(11):1462-1474. doi: 10.1093/neuonc/noy103.
• [185] Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial.Cancer Immunol Immunother. 2018 Nov;67(11):1777-1788. doi: 10.1007/s00262-018-2232-y. Epub 2018 Aug 22.
• [186] Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems.Sci Rep. 2018 Oct 18;8(1):15383. doi: 10.1038/s41598-018-33784-2.
• [187] Genome-wide expression profiling of glioblastoma using a large combined cohort.Sci Rep. 2018 Oct 10;8(1):15104. doi: 10.1038/s41598-018-33323-z.
• [188] ABCC3 Expressed by CD56(dim) CD16(+) NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy.Int J Mol Sci. 2019 Nov 23;20(23):5886. doi: 10.3390/ijms20235886.
• [189] Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival.Biosci Rep. 2019 Jun 20;39(6):BSR20182361. doi: 10.1042/BSR20182361. Print 2019 Jun 28.
• [190] Hsp90 inhibitor NMS-E973 exerts the anticancer effect against glioblastoma via induction of PUMA-mediated apoptosis.Onco Targets Ther. 2018 Mar 20;11:1583-1593. doi: 10.2147/OTT.S160813. eCollection 2018.
• [191] Dexamethasone-Mediated Upregulation of Calreticulin Inhibits Primary Human Glioblastoma Dispersal Ex Vivo.Int J Mol Sci. 2018 Feb 14;19(2):572. doi: 10.3390/ijms19020572.
• [192] Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma.Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10703-8. doi: 10.1073/pnas.0712034105. Epub 2008 Jul 31.
• [193] Prognostic significance of CDC25B expression in gliomas.J Clin Pathol. 2006 Jul;59(7):725-8. doi: 10.1136/jcp.2005.029546.
• [194] Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells.Cancer Cell. 2008 Jan;13(1):69-80. doi: 10.1016/j.ccr.2007.12.005.
• [195] DLK1: increased expression in gliomas and associated with oncogenic activities.Oncogene. 2006 Mar 23;25(13):1852-61. doi: 10.1038/sj.onc.1209219.
• [196] Wild type p53-dependent transcriptional upregulation of cathepsin L expression is mediated by C/EBPα in human glioblastoma cells.Biol Chem. 2010 Sep;391(9):1031-40. doi: 10.1515/BC.2010.103.
• [197] Overexpression of ezrin inactivates NF2 tumor suppressor in glioblastoma.Neuro Oncol. 2010 Jun;12(6):528-39. doi: 10.1093/neuonc/nop060. Epub 2010 Feb 14.
• [198] The chloroethylating anticancer drug ACNU induces FRA1 that is involved in drug resistance of glioma cells.Biochim Biophys Acta. 2012 Jul;1823(7):1199-207. doi: 10.1016/j.bbamcr.2012.05.008. Epub 2012 May 15.
• [199] Silencing of the MT1-MMP/ G6PT axis suppresses calcium mobilization by sphingosine-1-phosphate in glioblastoma cells.FEBS Lett. 2008 Mar 5;582(5):799-804. doi: 10.1016/j.febslet.2008.01.061. Epub 2008 Feb 11.
• [200] Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses.J Neuropathol Exp Neurol. 2008 May;67(5):456-69. doi: 10.1097/NEN.0b013e318170f892.
• [201] Allopregnanolone Alters the Gene Expression Profile of Human Glioblastoma Cells.Int J Mol Sci. 2018 Mar 15;19(3):864. doi: 10.3390/ijms19030864.
• [202] Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):1970-82. doi: 10.1158/1078-0432.CCR-05-2797.
• [203] HOXB13 promotes proliferation, migration, and invasion of glioblastoma through transcriptional upregulation of lncRNA HOXC-AS3.J Cell Biochem. 2019 Sep;120(9):15527-15537. doi: 10.1002/jcb.28819. Epub 2019 May 6.
• [204] mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma.Oncogene. 2018 Feb 8;37(6):732-743. doi: 10.1038/onc.2017.360. Epub 2017 Oct 23.
• [205] Glioma malignancy is linked to interdependent and inverse AMOG and L1 adhesion molecule expression.BMC Cancer. 2019 Sep 12;19(1):911. doi: 10.1186/s12885-019-6091-5.
• [206] Monoamine Oxidase B Binding of 18F-THK5351 to Visualize Glioblastoma and Associated Gliosis: An Autopsy-Confirmed Case.Clin Nucl Med. 2019 Jun;44(6):507-509. doi: 10.1097/RLU.0000000000002564.
• [207] Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target.Exp Mol Med. 2019 Dec 6;51(12):1-11. doi: 10.1038/s12276-019-0351-y.
• [208] Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma.Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1195-202. doi: 10.1158/1055-9965.EPI-07-2733.
• [209] Prognostic Value of PFKFB3 to PFKFB4 mRNA Ratio in Patients With Primary Glioblastoma (IDH-Wildtype).J Neuropathol Exp Neurol. 2019 Sep 1;78(9):865-870. doi: 10.1093/jnen/nlz067.
• [210] An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation.PLoS One. 2019 May 7;14(5):e0215831. doi: 10.1371/journal.pone.0215831. eCollection 2019.
• [211] The proton-coupled oligopeptide transporters PEPT2, PHT1 and PHT2 mediate the uptake of carnosine in glioblastoma cells.Amino Acids. 2019 Jul;51(7):999-1008. doi: 10.1007/s00726-019-02739-w. Epub 2019 May 9.
• [212] Protein Expression and Functional Relevance of Efflux and Uptake Drug Transporters at the Blood-Brain Barrier of Human Brain and Glioblastoma.Clin Pharmacol Ther. 2020 May;107(5):1116-1127. doi: 10.1002/cpt.1710. Epub 2019 Dec 10.
• [213] RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomas.Acta Neuropathol. 2019 Aug;138(2):275-293. doi: 10.1007/s00401-019-02021-z. Epub 2019 May 6.
• [214] Activation of LXR Receptors and Inhibition of TRAP1 Causes Synthetic Lethality in Solid Tumors.Cancers (Basel). 2019 Jun 7;11(6):788. doi: 10.3390/cancers11060788.
• [215] Molecular profiling of long-term IDH-wildtype glioblastoma survivors.Neuro Oncol. 2019 Nov 4;21(11):1458-1469. doi: 10.1093/neuonc/noz129.
• [216] Overexpression of TIMP-1 and Sensitivity to Topoisomerase Inhibitors in Glioblastoma Cell Lines.Pathol Oncol Res. 2019 Jan;25(1):59-69. doi: 10.1007/s12253-017-0312-5. Epub 2017 Sep 30.
• [217] Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value.Biomed Res Int. 2019 Apr 15;2019:6581576. doi: 10.1155/2019/6581576. eCollection 2019.
• [218] The TRPV2 cation channels: from urothelial cancer invasiveness to glioblastoma multiforme interactome signature.Lab Invest. 2020 Feb;100(2):186-198. doi: 10.1038/s41374-019-0333-7. Epub 2019 Oct 25.
• [219] A Chimeric Antibody against ACKR3/CXCR7 in Combination with TMZ Activates Immune Responses and Extends Survival in Mouse GBM Models.Mol Ther. 2018 May 2;26(5):1354-1365. doi: 10.1016/j.ymthe.2018.02.030. Epub 2018 Mar 6.
• [220] Oligodendrocytes Up-regulate the Invasive Activity of Glioblastoma Cells via the Angiopoietin-2 Signaling Pathway.Anticancer Res. 2019 Feb;39(2):577-584. doi: 10.21873/anticanres.13150.
• [221] Clinical significance of angiopoietin-like protein 3 expression in patients with glioblastoma.Neoplasma. 2016;63(1):93-8. doi: 10.4149/neo_2016_011.
• [222] The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.J Exp Clin Cancer Res. 2019 Mar 21;38(1):133. doi: 10.1186/s13046-019-1132-0.
• [223] Decreased APE-1 by Nitroxoline Enhances Therapeutic Effect in a Temozolomide-resistant Glioblastoma: Correlation with Diffusion Weighted Imaging.Sci Rep. 2019 Nov 12;9(1):16613. doi: 10.1038/s41598-019-53147-9.
• [224] Association of aquaporin? with tumor migration, invasion and vasculogenic mimicry in glioblastoma multiforme.Mol Med Rep. 2018 Feb;17(2):3206-3211. doi: 10.3892/mmr.2017.8265. Epub 2017 Dec 12.
• [225] Association between epidermal growth factor receptor amplification and ADP-ribosylation factor 1 methylation in human glioblastoma.Cell Oncol (Dordr). 2017 Aug;40(4):389-399. doi: 10.1007/s13402-017-0329-5. Epub 2017 Jun 19.
• [226] Downregulation of -arrestin 1 suppresses glioblastoma cell malignant progression vis inhibition of Src signaling.Exp Cell Res. 2017 Aug 1;357(1):51-58. doi: 10.1016/j.yexcr.2017.04.023. Epub 2017 Apr 22.
• [227] Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cells.J Neurooncol. 2019 Jun;143(2):231-240. doi: 10.1007/s11060-019-03164-5. Epub 2019 Apr 22.
• [228] BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53.Sci Rep. 2016 Dec 21;6:39743. doi: 10.1038/srep39743.
• [229] LOX expression and functional analysis in astrocytomas and impact of IDH1 mutation.PLoS One. 2015 Mar 19;10(3):e0119781. doi: 10.1371/journal.pone.0119781. eCollection 2015.
• [230] An intrinsic DFF40/CAD endonuclease deficiency impairs oligonucleosomal DNA hydrolysis during caspase-dependent cell death: a common trait in human glioblastoma cells.Neuro Oncol. 2016 Jul;18(7):950-61. doi: 10.1093/neuonc/nov315. Epub 2016 Jan 10.
• [231] Hesperetin Induces Apoptosis in Human Glioblastoma Cells via p38 MAPK Activation.Nutr Cancer. 2020;72(3):538-545. doi: 10.1080/01635581.2019.1638424. Epub 2019 Jul 11.
• [232] Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo.JCI Insight. 2017 Dec 21;2(24):e92928. doi: 10.1172/jci.insight.92928.
• [233] Connective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-1-dependent activation of Smad/ERK signaling.Cell Death Dis. 2017 Jun 15;8(6):e2885. doi: 10.1038/cddis.2017.248.
• [234] The PPI network and clusters analysis in glioblastoma.Eur Rev Med Pharmacol Sci. 2015 Dec;19(24):4784-90.
• [235] Extracellular Matrix Protein Tenascin C Increases Phagocytosis Mediated by CD47 Loss of Function in Glioblastoma.Cancer Res. 2019 May 15;79(10):2697-2708. doi: 10.1158/0008-5472.CAN-18-3125. Epub 2019 Mar 21.
• [236] Identification and characterization of lncRNA mediated transcriptional dysregulation dictates lncRNA roles in glioblastoma.Oncotarget. 2016 Jul 19;7(29):45027-45041. doi: 10.18632/oncotarget.7801.
• [237] CD70, a novel target of CAR T-cell therapy for gliomas.Neuro Oncol. 2018 Jan 10;20(1):55-65. doi: 10.1093/neuonc/nox116.
• [238] Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas.Neuropathol Appl Neurobiol. 2016 Apr;42(3):279-90. doi: 10.1111/nan.12259. Epub 2015 Jul 20.
• [239] Estrogen-related receptor activation and isoform shifting by cdc2-like kinase inhibition restricts migration and intracranial tumor growth in glioblastoma.FASEB J. 2019 Dec;33(12):13476-13491. doi: 10.1096/fj.201901075R. Epub 2019 Sep 28.
• [240] H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma.Br J Cancer. 2018 Feb 20;118(4):522-533. doi: 10.1038/bjc.2017.461. Epub 2018 Jan 18.
• [241] Claudin 4-targeted nanographene phototherapy using a Clostridium perfringens enterotoxin peptide-photosensitizer conjugate.Acta Pharmacol Sin. 2017 Jun;38(6):954-962. doi: 10.1038/aps.2017.46. Epub 2017 May 29.
• [242] Casein kinase 2 regulates glioblastoma brain tumor-initiating cell growth through the -catenin pathway.Oncogene. 2015 Jul;34(28):3688-99. doi: 10.1038/onc.2014.299. Epub 2014 Sep 22.
• [243] Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine--lyase function.Oncol Rep. 2015 Mar;33(3):1465-74. doi: 10.3892/or.2015.3712. Epub 2015 Jan 13.
• [244] Exogenous cathepsin G upregulates cell surface MHC class I molecules on immune and glioblastoma cells.Oncotarget. 2016 Nov 15;7(46):74602-74611. doi: 10.18632/oncotarget.12980.
• [245] Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.Oncotarget. 2015 Jun 20;6(17):15077-94. doi: 10.18632/oncotarget.3730.
• [246] DEK proto-oncogene is highly expressed in astrocytic tumors and regulates glioblastoma cell proliferation and apoptosis.Tumour Biol. 2017 Jul;39(7):1010428317716248. doi: 10.1177/1010428317716248.
• [247] An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma.Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):E8247-E8256. doi: 10.1073/pnas.1610921114. Epub 2016 Dec 7.
• [248] Expression and prognostic value of JAM-A in gliomas.J Neurooncol. 2017 Oct;135(1):107-117. doi: 10.1007/s11060-017-2555-0. Epub 2017 Jul 4.
• [249] CRABP-II- and FABP5-independent responsiveness of human glioblastoma cells to all-trans retinoic acid.Oncotarget. 2015 Mar 20;6(8):5889-902. doi: 10.18632/oncotarget.3334.
• [250] MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice.Gastroenterology. 2017 Oct;153(4):1120-1132.e15. doi: 10.1053/j.gastro.2016.12.036. Epub 2017 Feb 27.
• [251] Activation of Aurora A kinase through the FGF1/FGFR signaling axis sustains the stem cell characteristics of glioblastoma cells.Exp Cell Res. 2016 Jun 10;344(2):153-66. doi: 10.1016/j.yexcr.2016.04.012. Epub 2016 Apr 30.
• [252] Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.World Neurosurg. 2018 Dec;120:e380-e391. doi: 10.1016/j.wneu.2018.08.080. Epub 2018 Aug 23.
• [253] A novel role for glyceraldehyde-3-phosphate dehydrogenase and monoamine oxidase B cascade in ethanol-induced cellular damage.Biol Psychiatry. 2010 May 1;67(9):855-63. doi: 10.1016/j.biopsych.2009.10.032. Epub 2009 Dec 22.
• [254] Concurrent activation of (2)-adrenergic receptor and blockage of GPR55 disrupts pro-oncogenic signaling in glioma cells.Cell Signal. 2017 Aug;36:176-188. doi: 10.1016/j.cellsig.2017.05.006. Epub 2017 May 8.
• [255] Progranulin promotes Temozolomide resistance of glioblastoma by orchestrating DNA repair and tumor stemness.Oncogene. 2015 Apr 2;34(14):1853-64. doi: 10.1038/onc.2014.92. Epub 2014 May 5.
• [256] Sortilin promotes glioblastoma invasion and mesenchymal transition through GSK-3/-catenin/twist pathway.Cell Death Dis. 2019 Feb 27;10(3):208. doi: 10.1038/s41419-019-1449-9.
• [257] HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells.Cancer Lett. 2017 Jul 1;397:1-11. doi: 10.1016/j.canlet.2017.03.028. Epub 2017 Mar 23.
• [258] Detection of proneural/mesenchymal marker expression in glioblastoma: temporospatial dynamics and association with chromatin-modifying gene expression.J Neurooncol. 2015 Oct;125(1):33-41. doi: 10.1007/s11060-015-1886-y. Epub 2015 Aug 14.
• [259] Live Cell Imaging Supports a Key Role for Histone Deacetylase as a Molecular Target during Glioblastoma Malignancy Downgrade through Tumor Competence Modulation.J Oncol. 2019 Aug 8;2019:9043675. doi: 10.1155/2019/9043675. eCollection 2019.
• [260] Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema.Mol Ther Oncolytics. 2018 Dec 6;12:93-102. doi: 10.1016/j.omto.2018.11.005. eCollection 2019 Mar 29.
• [261] Heparan Sulfate Biosynthetic System Is Inhibited in Human Glioma Due to EXT1/2 and HS6ST1/2 Down-Regulation.Int J Mol Sci. 2017 Nov 1;18(11):2301. doi: 10.3390/ijms18112301.
• [262] Inhibition of nestin suppresses stem cell phenotype of glioblastomas through the alteration of post-translational modification of heat shock protein HSPA8/HSC71.Cancer Lett. 2015 Feb 28;357(2):602-11. doi: 10.1016/j.canlet.2014.12.030. Epub 2014 Dec 16.
• [263] Delineation of crosstalk between HSP27 and MMP-2/MMP-9: A synergistic therapeutic avenue for glioblastoma management.Biochim Biophys Acta Gen Subj. 2019 Jul;1863(7):1196-1209. doi: 10.1016/j.bbagen.2019.04.015. Epub 2019 Apr 25.
• [264] Commentary: preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma by Garg et al. (2017).Oncoimmunology. 2018 Dec 13;8(3):1548242. doi: 10.1080/2162402X.2018.1548242. eCollection 2019.
• [265] Serum amyloid A1 in combination with integrin V3 increases glioblastoma cells mobility and progression.Mol Oncol. 2018 May;12(5):756-771. doi: 10.1002/1878-0261.12196. Epub 2018 Apr 17.
• [266] Effect of cancer-associated fibroblasts on the migration of glioma cells in vitro.Tumour Biol. 2015 Aug;36(8):5873-9. doi: 10.1007/s13277-015-3259-8. Epub 2015 Feb 25.
• [267] MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B.Cancer Cell. 2016 Jan 11;29(1):49-60. doi: 10.1016/j.ccell.2015.12.005.
• [268] NKG2D Controls Natural Reactivity of V9V2 T Lymphocytes against Mesenchymal Glioblastoma Cells.Clin Cancer Res. 2019 Dec 1;25(23):7218-7228. doi: 10.1158/1078-0432.CCR-19-0375. Epub 2019 Sep 10.
• [269] Methionine and Kynurenine Activate Oncogenic Kinases in Glioblastoma, and Methionine Deprivation Compromises Proliferation.Clin Cancer Res. 2016 Jul 15;22(14):3513-23. doi: 10.1158/1078-0432.CCR-15-2308. Epub 2016 Mar 2.
• [270] Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma.Chem Sci. 2017 Aug 1;8(8):5371-5384. doi: 10.1039/c7sc00732a. Epub 2017 May 23.
• [271] microRNAs: Potential glioblastoma radiosensitizer by targeting radiation-related molecular pathways.Mutat Res. 2019 Nov;816-818:111679. doi: 10.1016/j.mrfmmm.2019.111679. Epub 2019 Oct 21.
• [272] Blocking of the interaction between Wnt proteins and their co-receptors contributes to the anti-tumor effects of adenovirus-mediated DKK3 in glioblastoma.Cancer Lett. 2015 Jan 28;356(2 Pt B):496-505. doi: 10.1016/j.canlet.2014.09.045. Epub 2014 Oct 6.
• [273] Glucose transporter 1-mediated vascular translocation of nanomedicines enhances accumulation and efficacy in solid tumors.J Control Release. 2019 May 10;301:28-41. doi: 10.1016/j.jconrel.2019.02.021. Epub 2019 Mar 4.
• [274] EGFR Signals through a DOCK180-MLK3 Axis to Drive Glioblastoma Cell Invasion.Mol Cancer Res. 2017 Aug;15(8):1085-1095. doi: 10.1158/1541-7786.MCR-16-0318. Epub 2017 May 9.
• [275] The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance. Clin Cancer Res. 2010 Dec 15;16(24):6060-70.
• [276] The p38-MK2-HuR pathway potentiates EGFRvIII-IL-1-driven IL-6 secretion in glioblastoma cells.Oncogene. 2015 May 28;34(22):2934-42. doi: 10.1038/onc.2014.225. Epub 2014 Aug 4.
• [277] Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy.Neuro Oncol. 2017 Aug 1;19(8):1047-1057. doi: 10.1093/neuonc/nox026.
• [278] NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis.Oncotarget. 2017 Aug 28;8(59):99514-99530. doi: 10.18632/oncotarget.20577. eCollection 2017 Nov 21.
• [279] MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors.Mol Oncol. 2016 Nov;10(9):1387-1403. doi: 10.1016/j.molonc.2016.07.007. Epub 2016 Jul 28.
• [280] Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.J Clin Invest. 2017 Aug 1;127(8):3075-3089. doi: 10.1172/JCI89092. Epub 2017 Jul 24.
• [281] Nociceptin/orphanin FQ antagonizes lipopolysaccharide-stimulated proliferation, migration and inflammatory signaling in human glioblastoma U87 cells.Biochem Pharmacol. 2017 Sep 15;140:89-104. doi: 10.1016/j.bcp.2017.05.021. Epub 2017 Jun 2.
• [282] Mammalian target of rapamycin inhibitors, temsirolimus and torin 1, attenuate stemness-associated properties and expression of mesenchymal markers promoted by phorbol-myristate-acetate and oncostatin-M in glioblastoma cells.Tumour Biol. 2017 Mar;39(3):1010428317695921. doi: 10.1177/1010428317695921.
• [283] The PDK1/cJun pathway activated by TGF?induces EMT and promotes proliferation and invasion in human glioblastoma.Int J Oncol. 2018 Nov;53(5):2067-2080. doi: 10.3892/ijo.2018.4525. Epub 2018 Aug 14.
• [284] Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma.Neurosurg Rev. 2019 Jun;42(2):351-369. doi: 10.1007/s10143-018-0953-1. Epub 2018 Feb 17.
• [285] Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells.Cell Rep. 2015 Dec 22;13(11):2425-2439. doi: 10.1016/j.celrep.2015.11.021. Epub 2015 Dec 7.
• [286] The enhancement of siPLK1 penetration across BBB and its anti glioblastoma activity in vivo by magnet and transferrin co-modified nanoparticle.Nanomedicine. 2018 Apr;14(3):991-1003. doi: 10.1016/j.nano.2018.01.004. Epub 2018 Jan 12.
• [287] PKC- promotes glioblastoma cell survival by phosphorylating and inhibiting BAD through a phosphatidylinositol 3-kinase pathway.Biochim Biophys Acta. 2011 Jun;1813(6):1190-7. doi: 10.1016/j.bbamcr.2011.03.007. Epub 2011 Mar 17.
• [288] HOIL-1L functions as the PKC ubiquitin ligase to promote lung tumor growth.Am J Respir Crit Care Med. 2014 Sep 15;190(6):688-98. doi: 10.1164/rccm.201403-0463OC.
• [289] Construction and analysis of dynamic transcription factor regulatory networks in the progression of glioma.Sci Rep. 2015 Nov 3;5:15953. doi: 10.1038/srep15953.
• [290] Isolation and characterization of novel RECK tumor suppressor gene splice variants.Oncotarget. 2015 Oct 20;6(32):33120-33. doi: 10.18632/oncotarget.5305.
• [291] Functional assessment of a promoter polymorphism in S100B, a putative risk variant for bipolar disorder.Am J Med Genet B Neuropsychiatr Genet. 2011 Sep;156B(6):691-9. doi: 10.1002/ajmg.b.31211. Epub 2011 Jun 28.
• [292] A Large-Scale RNAi Screen Identifies SGK1 as a Key Survival Kinase for GBM Stem Cells.Mol Cancer Res. 2018 Jan;16(1):103-114. doi: 10.1158/1541-7786.MCR-17-0146. Epub 2017 Oct 9.
• [293] A Novel Compound Targeting Protease Receptor 1 Activators for the Treatment of Glioblastoma.Front Neurol. 2018 Dec 17;9:1087. doi: 10.3389/fneur.2018.01087. eCollection 2018.
• [294] Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.Oncogene. 2017 Oct 19;36(42):5861-5873. doi: 10.1038/onc.2017.182. Epub 2017 Jun 19.
• [295] MicroRNA?76a inhibits cell proliferation and invasion in glioblastoma multiforme by directly targeting specificity protein 1.Mol Med Rep. 2018 Jan;17(1):1583-1590. doi: 10.3892/mmr.2017.8089. Epub 2017 Nov 15.
• [296] New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection.Front Pharmacol. 2017 Dec 12;8:905. doi: 10.3389/fphar.2017.00905. eCollection 2017.
• [297] RGBM: regularized gradient boosting machines for identification of the transcriptional regulators of discrete glioma subtypes.Nucleic Acids Res. 2018 Apr 20;46(7):e39. doi: 10.1093/nar/gky015.
• [298] Transcription factor 3 controls cell proliferation and migration in glioblastoma multiforme cell lines.Biochem Cell Biol. 2016 Jun;94(3):247-55. doi: 10.1139/bcb-2015-0162. Epub 2016 Feb 22.
• [299] Overexpression of mTOR and p(240-244)S6 in IDH1 Wild-Type Human Glioblastomas Is Predictive of Low Survival.J Histochem Cytochem. 2018 Jun;66(6):403-414. doi: 10.1369/0022155417750838. Epub 2018 Jan 12.
• [300] Transforming growth factor- pathway activity in glioblastoma.Oncotarget. 2015 Mar 20;6(8):5963-77. doi: 10.18632/oncotarget.3467.
• [301] The complex role of transglutaminase 2 in glioblastoma proliferation.Neuro Oncol. 2017 Feb 1;19(2):208-218. doi: 10.1093/neuonc/now157.
• [302] Tumor Location and Survival Outcomes in Adult Patients with Supratentorial Glioblastoma by Levels of Toll-Like Receptor 9 Expression.World Neurosurg. 2017 Jan;97:279-283. doi: 10.1016/j.wneu.2016.10.015. Epub 2016 Oct 12.
• [303] miR-200a enhances TRAIL-induced apoptosis in gastric cancer cells by targeting A20.Cell Biol Int. 2018 May;42(5):506-514. doi: 10.1002/cbin.10924. Epub 2018 Jan 25.
• [304] OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.Mol Cancer. 2015 Feb 15;14:41. doi: 10.1186/s12943-015-0307-3.
• [305] Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination.Oncogene. 2017 Sep 7;36(36):5158-5167. doi: 10.1038/onc.2017.126. Epub 2017 May 8.
• [306] Angiogenic Gene Signature Derived from Subtype Specific Cell Models Segregate Proneural and Mesenchymal Glioblastoma.Front Oncol. 2017 Jul 11;7:146. doi: 10.3389/fonc.2017.00146. eCollection 2017.
• [307] ATP-binding cassette transporters limit the brain penetration of Wee1 inhibitors.Invest New Drugs. 2018 Jun;36(3):380-387. doi: 10.1007/s10637-017-0539-8. Epub 2017 Nov 17.
• [308] WNK1 kinase and its partners Akt, SGK1 and NBC-family Na(+)/HCO3(-) cotransporters are potential therapeutic targets for glioblastoma stem-like cells linked to Bisacodyl signaling.Oncotarget. 2018 Jun 5;9(43):27197-27219. doi: 10.18632/oncotarget.25509. eCollection 2018 Jun 5.
• [309] Anti-atherosclerotic effects of an improved apolipoprotein A-I mimetic peptide.Int J Cardiol. 2019 Dec 15;297:111-117. doi: 10.1016/j.ijcard.2019.08.043. Epub 2019 Aug 22.
• [310] Molecular and functional MDR1-Pgp and MRPs expression in human glioblastoma multiforme cell lines.Int J Cancer. 2002 Mar 10;98(2):173-80. doi: 10.1002/ijc.10135.
• [311] ABCG2-mediated suppression of chlorin e6 accumulation and photodynamic therapy efficiency in glioblastoma cell lines can be reversed by KO143.J Photochem Photobiol B. 2018 Jan;178:182-191. doi: 10.1016/j.jphotobiol.2017.10.035. Epub 2017 Oct 28.
• [312] Brain Targeting of Acyl-CoA:Cholesterol O-Acyltransferase-1 Inhibitor K-604 via the Intranasal Route Using a Hydroxycarboxylic Acid Solution.ACS Omega. 2019 Oct 2;4(16):16943-16955. doi: 10.1021/acsomega.9b02307. eCollection 2019 Oct 15.
• [313] Metalloproteinases ADAM10 and ADAM17 Mediate Migration and Differentiation in Glioblastoma Sphere-Forming Cells.Mol Neurobiol. 2017 Jul;54(5):3893-3905. doi: 10.1007/s12035-016-0053-6. Epub 2016 Aug 19.
• [314] MicroRNA?43 inhibits proliferation, invasion and induces apoptosis of glioblastoma cells by directly targeting ADAM9.Mol Med Rep. 2017 Nov;16(5):6419-6427. doi: 10.3892/mmr.2017.7332. Epub 2017 Aug 23.
• [315] Relevance of IGFBP2 proteolysis in glioma and contribution of the extracellular protease ADAMTS1.Oncotarget. 2014 Jun 30;5(12):4295-304. doi: 10.18632/oncotarget.2009.
• [316] The differential effects of neuroleptic drugs and PACAP on the expression of BDNF mRNA and protein in a human glioblastoma cell line. Acta Neurobiol Exp (Wars). 2017;77(3):205-213.
• [317] Neuroleptic Drugs and PACAP Differentially Affect the mRNA Expression of Genes Encoding PAC1/VPAC Type Receptors. Neurochem Res. 2017 Apr;42(4):943-952. doi: 10.1007/s11064-016-2127-2. Epub 2016 Nov 30.
• [318] Interleukin-1 promotes hypoxia-induced apoptosis of glioblastoma cells by inhibiting hypoxia-inducible factor-1 mediated adrenomedullin production.Cell Death Dis. 2014 Jan 23;5(1):e1020. doi: 10.1038/cddis.2013.562.
• [319] Evaluation of a (64)Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphavbeta3 integrin.J Nucl Med. 2010 Feb;51(2):251-258. doi: 10.2967/jnumed.109.069831.
• [320] Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma.Br J Cancer. 2004 Mar 8;90(5):1059-68. doi: 10.1038/sj.bjc.6601646.
• [321] Loss of Pericytes in Radiation Necrosis after Glioblastoma Treatments.Mol Neurobiol. 2018 Jun;55(6):4918-4926. doi: 10.1007/s12035-017-0695-z. Epub 2017 Aug 2.
• [322] Tumor-treating fields induce autophagy by blocking the Akt2/miR29b axis in glioblastoma cells.Oncogene. 2019 Sep;38(39):6630-6646. doi: 10.1038/s41388-019-0882-7. Epub 2019 Aug 2.
• [323] ALKBH5 inhibited autophagy of epithelial ovarian cancer through miR-7 and BCL-2.J Exp Clin Cancer Res. 2019 Apr 15;38(1):163. doi: 10.1186/s13046-019-1159-2.
• [324] Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism.Cell Death Dis. 2018 Nov 1;9(11):1112. doi: 10.1038/s41419-018-1160-2.
• [325] Prospective identification of glioblastoma cells generating dormant tumors.PLoS One. 2012;7(9):e44395. doi: 10.1371/journal.pone.0044395. Epub 2012 Sep 6.
• [326] Angiogenin Upregulation Independently Predicts Unfavorable Overall Survival in Proneural Subtype of Glioblastoma.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819846636. doi: 10.1177/1533033819846636.
• [327] Np73/ETS2 complex drives glioblastoma pathogenesis- targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma.Neuro Oncol. 2020 Mar 5;22(3):345-356. doi: 10.1093/neuonc/noz190.
• [328] ANGPTL4 Induces TMZ Resistance of Glioblastoma by Promoting Cancer Stemness Enrichment via the EGFR/AKT/4E-BP1 Cascade.Int J Mol Sci. 2019 Nov 11;20(22):5625. doi: 10.3390/ijms20225625.
• [329] Capillary morphogenesis protein 2 is a novel prognostic biomarker and plays oncogenic roles in glioma.J Pathol. 2018 Jun;245(2):160-171. doi: 10.1002/path.5062. Epub 2018 Apr 2.
• [330] Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma.Cancer Res. 2019 May 1;79(9):2298-2313. doi: 10.1158/0008-5472.CAN-18-0881. Epub 2019 Feb 4.
• [331] RNAi for contactin 2 inhibits proliferation of U87-glioma stem cells by downregulating AICD, EGFR, and HES1.Onco Targets Ther. 2017 Feb 13;10:791-801. doi: 10.2147/OTT.S113390. eCollection 2017.
• [332] AQP9 expression in glioblastoma multiforme tumors is limited to a small population of astrocytic cells and CD15(+)/CalB(+) leukocytes.PLoS One. 2013 Sep 25;8(9):e75764. doi: 10.1371/journal.pone.0075764. eCollection 2013.
• [333] Aspirin inhibits proliferation and promotes differentiation of neuroblastoma cells via p21(Waf1) protein up-regulation and Rb1 pathway modulation.J Cell Mol Med. 2019 Oct;23(10):7078-7087. doi: 10.1111/jcmm.14610. Epub 2019 Aug 20.
• [334] Integration of gene expression and methylation to unravel biological networks in glioblastoma patients.Genet Epidemiol. 2017 Feb;41(2):136-144. doi: 10.1002/gepi.22028. Epub 2016 Dec 26.
• [335] Inhibition of ATM kinase upregulates levels of cell death induced by cannabidiol and -irradiation in human glioblastoma cells.Oncotarget. 2019 Jan 25;10(8):825-846. doi: 10.18632/oncotarget.26582. eCollection 2019 Jan 25.
• [336] Targeting Aurora kinase B attenuates chemoresistance in glioblastoma via a synergistic manner with temozolomide.Pathol Res Pract. 2019 Nov;215(11):152617. doi: 10.1016/j.prp.2019.152617. Epub 2019 Aug 23.
• [337] Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma.CNS Neurosci Ther. 2020 Jul;26(7):777. doi: 10.1111/cns.13227. Epub 2019 Oct 2.
• [338] miR-125b inhibitor enhance the chemosensitivity of glioblastoma stem cells to temozolomide by targeting Bak1.Tumour Biol. 2014 Jul;35(7):6293-302. doi: 10.1007/s13277-014-1821-4. Epub 2014 Mar 19.
• [339] Expression of alternatively terminated unusual human butyrylcholinesterase messenger RNA transcripts, mapping to chromosome 3q26-ter, in nervous system tumors.Cancer Res. 1990 Apr 1;50(7):1983-7.
• [340] miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2.Oncotarget. 2015 Jul 30;6(21):18429-44. doi: 10.18632/oncotarget.4384.
• [341] MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy.Autophagy. 2019 Jun;15(6):1100-1111. doi: 10.1080/15548627.2019.1569947. Epub 2019 Jan 31.
• [342] BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats.Sci Rep. 2017 Aug 24;7(1):9350. doi: 10.1038/s41598-017-09503-8.
• [343] Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma.Oncotarget. 2015 May 10;6(13):10950-63. doi: 10.18632/oncotarget.3459.
• [344] PI3K and STAT3: a new alliance.Cancer Discov. 2011 Nov;1(6):481-6. doi: 10.1158/2159-8290.CD-11-0218.
• [345] Reshaping acetylated peptide selectivity between human BET Brd2 bromodomains BD-I and BD-II in glioblastoma by rationally grafting secondary anchor residues.Gen Physiol Biophys. 2018 Jul;37(4):411-419. doi: 10.4149/gpb_2017063. Epub 2018 Jun 29.
• [346] PUM2 Promotes Glioblastoma Cell Proliferation and Migration via Repressing BTG1 Expression.Cell Struct Funct. 2019;44(1):29-39. doi: 10.1247/csf.18030.
• [347] Intratumoral spatial heterogeneity of BTK kinomic activity dictates distinct therapeutic response within a single glioblastoma tumor.J Neurosurg. 2019 Oct 18;133(6):1683-1694. doi: 10.3171/2019.7.JNS191376.
• [348] Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein-Mediated Resistance to Temozolomide in Glioblastoma.Mol Cancer Ther. 2018 Dec;17(12):2598-2609. doi: 10.1158/1535-7163.MCT-18-0533. Epub 2018 Sep 25.
• [349] Comparative Transcriptomic Analysis of Temozolomide Resistant Primary GBM Stem-Like Cells and Recurrent GBM Identifies Up-Regulation of the Carbonic Anhydrase CA2 Gene as Resistance Factor.Cancers (Basel). 2019 Jun 30;11(7):921. doi: 10.3390/cancers11070921.
• [350] Expression and activity of the calcitonin receptor family in a sample of primary human high-grade gliomas.BMC Cancer. 2019 Feb 18;19(1):157. doi: 10.1186/s12885-019-5369-y.
• [351] Transcriptomic analysis unveils correlations between regulative apoptotic caspases and genes of cholesterol homeostasis in human brain.PLoS One. 2014 Oct 16;9(10):e110610. doi: 10.1371/journal.pone.0110610. eCollection 2014.
• [352] MEG-3-mediated Wnt/-catenin signaling pathway controls the inhibition of tunicamycin-mediated viability in glioblastoma.Oncol Lett. 2018 Sep;16(3):2797-2804. doi: 10.3892/ol.2018.9048. Epub 2018 Jun 28.
• [353] Multiparametric magnetic resonance imaging in the assessment of anti-EGFRvIII chimeric antigen receptor T cell therapy in patients with recurrent glioblastoma.Br J Cancer. 2019 Jan;120(1):54-56. doi: 10.1038/s41416-018-0342-0. Epub 2018 Nov 27.
• [354] Correlation of the invasive potential of glioblastoma and expression of caveola-forming proteins caveolin-1 and CAVIN1.J Neurooncol. 2019 Jun;143(2):207-220. doi: 10.1007/s11060-019-03161-8. Epub 2019 Apr 4.
• [355] Deleterious c-Cbl Exon Skipping Contributes to Human Glioma.Neoplasia. 2015 Jun;17(6):518-24. doi: 10.1016/j.neo.2015.06.003.
• [356] The malignancy of miR-18a in human glioblastoma via directly targeting CBX7.Am J Cancer Res. 2017 Jan 1;7(1):64-76. eCollection 2017.
• [357] Methylated of genes behaving as potential biomarkers in evaluating malignant degree of glioblastoma.J Cell Physiol. 2017 Dec;232(12):3622-3630. doi: 10.1002/jcp.25831. Epub 2017 Mar 27.
• [358] Prognostic significance and mechanism of Treg infiltration in human brain tumors.J Neuroimmunol. 2010 Aug 25;225(1-2):195-9. doi: 10.1016/j.jneuroim.2010.05.020.
• [359] PIK3R1Met326Ile germline mutation correlates with cysteine-rich protein 61 expression and poor prognosis in glioblastoma.Sci Rep. 2017 Aug 7;7(1):7391. doi: 10.1038/s41598-017-07745-0.
• [360] Inhibition of human cytomegalovirus immediate-early gene expression by cyclin A2-dependent kinase activity.J Virol. 2012 Sep;86(17):9369-83. doi: 10.1128/JVI.07181-11. Epub 2012 Jun 20.
• [361] The effects of cucurbitacin E on GADD45-trigger G2/M arrest and JNK-independent pathway in brain cancer cells.J Cell Mol Med. 2019 May;23(5):3512-3519. doi: 10.1111/jcmm.14250. Epub 2019 Mar 25.
• [362] MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion.Neuro Oncol. 2012 Mar;14(3):278-87. doi: 10.1093/neuonc/nor216. Epub 2012 Jan 4.
• [363] Inhibition of cyclin E1 overcomes temozolomide resistance in glioblastoma by Mcl-1 degradation.Mol Carcinog. 2019 Aug;58(8):1502-1511. doi: 10.1002/mc.23034. Epub 2019 May 2.
• [364] CCL5, CCR1 and CCR5 in murine glioblastoma: immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5.J Neuroimmunol. 2012 May 15;246(1-2):10-7. doi: 10.1016/j.jneuroim.2012.02.009. Epub 2012 Mar 16.
• [365] Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma.Cancers (Basel). 2019 Jan 24;11(2):137. doi: 10.3390/cancers11020137.
• [366] Characterization of TEM1/endosialin in human and murine brain tumors.BMC Cancer. 2009 Nov 30;9:417. doi: 10.1186/1471-2407-9-417.
• [367] B7H3 regulates differentiation and serves as a potential biomarker and theranostic target for human glioblastoma.Lab Invest. 2019 Jul;99(8):1117-1129. doi: 10.1038/s41374-019-0238-5. Epub 2019 Mar 26.
• [368] Isocitrate dehydrogenase1 mutation reduces the pericyte coverage of microvessels in astrocytic tumours.J Neurooncol. 2019 Jun;143(2):187-196. doi: 10.1007/s11060-019-03156-5. Epub 2019 Apr 19.
• [369] CD44-associated radioresistance of glioblastoma in irradiated brain areas with optimal tumor coverage.Cancer Med. 2020 Jan;9(1):350-360. doi: 10.1002/cam4.2714. Epub 2019 Nov 19.
• [370] MIF Receptor CD74 is Restricted to Microglia/Macrophages, Associated with a M1-Polarized Immune Milieu and Prolonged Patient Survival in Gliomas.Brain Pathol. 2015 Jul;25(4):491-504. doi: 10.1111/bpa.12194. Epub 2014 Nov 20.
• [371] Infective capacity of Cryptococcus neoformans and Cryptococcus gattii in a human astrocytoma cell line.Mycoses. 2017 Jul;60(7):447-453. doi: 10.1111/myc.12619. Epub 2017 Mar 24.
• [372] Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells.Oncotarget. 2016 Jan 5;7(1):593-609. doi: 10.18632/oncotarget.5477.
• [373] A miR-21 inhibitor enhances apoptosis and reduces G(2)-M accumulation induced by ionizing radiation in human glioblastoma U251 cells.Brain Tumor Pathol. 2011 Jul;28(3):209-14. doi: 10.1007/s10014-011-0037-1. Epub 2011 May 27.
• [374] Proteasome mediated degradation of CDC25C and Cyclin B1 in Demethoxycurcumin treated human glioma U87 MG cells to trigger G2/M cell cycle arrest.Toxicol Appl Pharmacol. 2018 Oct 1;356:76-89. doi: 10.1016/j.taap.2018.07.012. Epub 2018 Aug 4.
• [375] Interactions between cadherin-11 and platelet-derived growth factor receptor-alpha signaling link cell adhesion and proliferation.Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1516-1524. doi: 10.1016/j.bbadis.2019.03.001. Epub 2019 Mar 13.
• [376] CDH2 expression is of prognostic significance in glioma and predicts the efficacy of temozolomide therapy in patients with glioblastoma.Oncol Lett. 2018 May;15(5):7415-7422. doi: 10.3892/ol.2018.8227. Epub 2018 Mar 9.
• [377] CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia.Neuro Oncol. 2013 Jul;15(7):865-79. doi: 10.1093/neuonc/not029. Epub 2013 May 3.
• [378] Phenethyl isothiocyanate alters the gene expression and the levels of protein associated with cell cycle regulation in human glioblastoma GBM 8401 cells. Environ Toxicol. 2017 Jan;32(1):176-187.
• [379] Cyclin-dependent kinase 3-mediated activating transcription factor 1 phosphorylation enhances cell transformation.Cancer Res. 2008 Sep 15;68(18):7650-60. doi: 10.1158/0008-5472.CAN-08-1137.
• [380] Cytoplasmic cyclin D1 regulates glioblastoma dissemination.J Pathol. 2019 Aug;248(4):501-513. doi: 10.1002/path.5277. Epub 2019 May 16.
• [381] CDK5-dependent phosphorylation and nuclear translocation of TRIM59 promotes macroH2A1 ubiquitination and tumorigenicity.Nat Commun. 2019 Sep 5;10(1):4013. doi: 10.1038/s41467-019-12001-2.
• [382] CDK7 inhibition is a novel therapeutic strategy against GBM both in vitro and in vivo.Cancer Manag Res. 2018 Nov 15;10:5747-5758. doi: 10.2147/CMAR.S183696. eCollection 2018.
• [383] Novel Targeting of Transcription and Metabolism in Glioblastoma.Clin Cancer Res. 2018 Mar 1;24(5):1124-1137. doi: 10.1158/1078-0432.CCR-17-2032. Epub 2017 Dec 18.
• [384] P27/Kip1 is responsible for magnolol-induced U373 apoptosis in vitro and in vivo.J Agric Food Chem. 2013 Mar 20;61(11):2811-9. doi: 10.1021/jf400542m. Epub 2013 Mar 7.
• [385] Feedback circuit among INK4 tumor suppressors constrains human glioblastoma development.Cancer Cell. 2008 Apr;13(4):355-64. doi: 10.1016/j.ccr.2008.02.010.
• [386] CEA-negative glioblastoma and melanoma cells are sensitive to cytosine deaminase/5-fluorocytosine therapy directed by the carcinoembryonic antigen promoter.Acta Biochim Pol. 2004;51(3):723-32.
• [387] Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.J Neurosurg. 2018 Dec 1;129(6):1446-1455. doi: 10.3171/2017.7.JNS17668.
• [388] Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells.Cell Death Dis. 2019 Feb 11;10(2):118. doi: 10.1038/s41419-019-1383-x.
• [389] Polycomb complex mediated epigenetic reprogramming alters TGF- signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.Int J Cancer. 2019 Sep 1;145(5):1254-1269. doi: 10.1002/ijc.32360. Epub 2019 May 10.
• [390] Role of GalNAc4S-6ST in astrocytic tumor progression.PLoS One. 2013;8(1):e54278. doi: 10.1371/journal.pone.0054278. Epub 2013 Jan 17.
• [391] Zerumbone suppresses IKK, Akt, and FOXO1 activation, resulting in apoptosis of GBM 8401 cells.J Biomed Sci. 2012 Oct 5;19(1):86. doi: 10.1186/1423-0127-19-86.
• [392] Retinoic acid-induced apoptotic pathway in T-cell lymphoma: Identification of four groups of genes with differential biological functions.Exp Hematol. 2000 Dec;28(12):1441-50. doi: 10.1016/s0301-472x(00)00546-4.
• [393] Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity.Front Oncol. 2019 Mar 13;9:135. doi: 10.3389/fonc.2019.00135. eCollection 2019.
• [394] Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin.Cell Rep. 2017 Jan 24;18(4):977-990. doi: 10.1016/j.celrep.2017.01.003.
• [395] [(68)Ga]RGD Versus [(18)F]FDG PET Imaging in Monitoring Treatment Response of a Mouse Model of Human Glioblastoma Tumor with Bevacizumab and/or Temozolomide.Mol Imaging Biol. 2019 Apr;21(2):297-305. doi: 10.1007/s11307-018-1224-9.
• [396] Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage.J Biol Chem. 2013 Feb 1;288(5):3097-111. doi: 10.1074/jbc.M112.362954. Epub 2012 Nov 30.
• [397] Effects of soluble CPE on glioma cell migration are associated with mTOR activation and enhanced glucose flux.Oncotarget. 2017 Jun 27;8(40):67567-67591. doi: 10.18632/oncotarget.18747. eCollection 2017 Sep 15.
• [398] NMDA Receptor-Mediated Signaling Pathways Enhance Radiation Resistance, Survival and Migration in Glioblastoma Cells-A Potential Target for Adjuvant Radiotherapy.Cancers (Basel). 2019 Apr 9;11(4):503. doi: 10.3390/cancers11040503.
• [399] Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.Nat Biotechnol. 2016 Feb;34(2):155-63. doi: 10.1038/nbt.3391. Epub 2015 Nov 30.
• [400] A kinome-wide RNAi screen in Drosophila Glia reveals that the RIO kinases mediate cell proliferation and survival through TORC2-Akt signaling in glioblastoma.PLoS Genet. 2013;9(2):e1003253. doi: 10.1371/journal.pgen.1003253. Epub 2013 Feb 14.
• [401] Suppression of astrocytic autophagy by B-crystallin contributes to -synuclein inclusion formation.Transl Neurodegener. 2019 Jan 18;8:3. doi: 10.1186/s40035-018-0143-7. eCollection 2019.
• [402] NADPH/quinone oxidoreductase is a priority target of glioblastoma chemotherapy. Int J Oncol. 2000 Feb;16(2):295-303.
• [403] MIR-137 suppresses growth and invasion, is downregulated in oligodendroglial tumors and targets CSE1L.Brain Pathol. 2013 Jul;23(4):426-39. doi: 10.1111/bpa.12015. Epub 2013 Jan 10.
• [404] Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas.Oncogene. 2017 Oct 26;36(43):6049-6058. doi: 10.1038/onc.2017.261. Epub 2017 Jul 31.
• [405] Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma.Clin Cancer Res. 2013 Dec 1;19(23):6484-94. doi: 10.1158/1078-0432.CCR-13-0265. Epub 2013 Sep 13.
• [406] Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors.PLoS One. 2019 Jan 9;14(1):e0210608. doi: 10.1371/journal.pone.0210608. eCollection 2019.
• [407] Current Trends in Clinical Development of Gene and Cellular Therapeutic Products for Cancer in Japan.Clin Ther. 2019 Jan;41(1):174-184.e3. doi: 10.1016/j.clinthera.2018.11.003. Epub 2018 Dec 7.
• [408] RARRES1 is a novel immune-related biomarker in GBM.Am J Transl Res. 2019 Sep 15;11(9):5655-5663. eCollection 2019.
• [409] Regorafenib induces lethal autophagy arrest by stabilizing PSAT1 in glioblastoma.Autophagy. 2020 Jan;16(1):106-122. doi: 10.1080/15548627.2019.1598752. Epub 2019 Apr 9.
• [410] Cathepsin L silencing increases As(2)O(3) toxicity in malignantly transformed pilocytic astrocytoma MPA58 cells by activating caspases 3/7.Exp Cell Res. 2017 Jul 1;356(1):64-73. doi: 10.1016/j.yexcr.2017.04.013. Epub 2017 Apr 12.
• [411] Inhibition of cathepsin S induces autophagy and apoptosis in human glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K and JNK signaling pathways.Toxicol Lett. 2014 Aug 4;228(3):248-59. doi: 10.1016/j.toxlet.2014.05.015. Epub 2014 May 27.
• [412] Identifying the Ubiquitin Ligase complex that regulates the NF1 tumor suppressor and Ras.Cancer Discov. 2013 Aug;3(8):880-93. doi: 10.1158/2159-8290.CD-13-0146. Epub 2013 May 9.
• [413] Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma.EMBO Mol Med. 2020 Jan 9;12(1):e10924. doi: 10.15252/emmm.201910924. Epub 2019 Nov 28.
• [414] Mouse cytochrome b561: cDNA cloning and expression in rat brain, mouse embryos, and human glioma cell lines.DNA Cell Biol. 1998 Sep;17(9):771-7. doi: 10.1089/dna.1998.17.771.
• [415] Chondroitin sulfate content and decorin expression in glioblastoma are associated with proliferative activity of glioma cells and disease prognosis.Cell Tissue Res. 2020 Jan;379(1):147-155. doi: 10.1007/s00441-019-03127-2. Epub 2019 Nov 26.
• [416] Targeting the cytosolic innate immune receptors RIG-I and MDA5 effectively counteracts cancer cell heterogeneity in glioblastoma.Stem Cells. 2013 Jun;31(6):1064-74. doi: 10.1002/stem.1350.
• [417] Dynamic Contrast-Enhanced T1-Weighted Perfusion Magnetic Resonance Imaging Identifies Glioblastoma Immunohistochemical Biomarkers via Tumoral and Peritumoral Approach: A Pilot Study.World Neurosurg. 2019 Aug;128:e195-e208. doi: 10.1016/j.wneu.2019.04.089. Epub 2019 Apr 16.
• [418] Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.PLoS One. 2012;7(8):e43468. doi: 10.1371/journal.pone.0043468. Epub 2012 Aug 21.
• [419] B-cell CLL/lymphoma 3 promotes glioma cell proliferation and inhibits apoptosis through the oncogenic STAT3 pathway.Int J Oncol. 2016 Dec;49(6):2471-2479. doi: 10.3892/ijo.2016.3729. Epub 2016 Oct 12.
• [420] Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth.Oncotarget. 2017 Jun 20;8(25):40115-40131. doi: 10.18632/oncotarget.16969.
• [421] Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma.Cancer Invest. 2019;37(3):144-155. doi: 10.1080/07357907.2019.1582060. Epub 2019 Mar 25.
• [422] Inhibition of Ubc9-Induced CRMP2 SUMOylation Disrupts Glioblastoma Cell Proliferation.J Mol Neurosci. 2019 Nov;69(3):391-398. doi: 10.1007/s12031-019-01368-y. Epub 2019 Jul 2.
• [423] Biological activity of weekly ONC201 in adult recurrent glioblastoma patients.Neuro Oncol. 2020 Jan 11;22(1):94-102. doi: 10.1093/neuonc/noz164.
• [424] Synthesis and in vitro evaluation of diverse heterocyclic diphenolic compounds as inhibitors of DYRK1A.Bioorg Med Chem. 2018 Dec 1;26(22):5852-5869. doi: 10.1016/j.bmc.2018.10.034. Epub 2018 Oct 28.
• [425] Cancer-testis specific gene OIP5: a downstream gene of E2F1 that promotes tumorigenesis and metastasis in glioblastoma by stabilizing E2F1 signaling.Neuro Oncol. 2018 Aug 2;20(9):1173-1184. doi: 10.1093/neuonc/noy037.
• [426] Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC.JCI Insight. 2019 Apr 4;4(7):e126140. doi: 10.1172/jci.insight.126140. eCollection 2019 Apr 4.
• [427] Overexpression of oncostatin M receptor regulates local immune response in glioblastoma.J Cell Physiol. 2019 Sep;234(9):15496-15509. doi: 10.1002/jcp.28197. Epub 2019 Jan 28.
• [428] The endothelin system in human glioblastoma.Lab Invest. 2000 Nov;80(11):1681-9. doi: 10.1038/labinvest.3780178.
• [429] BQ123 selectively improved tumor perfusion and enhanced nanomedicine delivery for glioblastomas treatment.Pharmacol Res. 2018 Jun;132:211-219. doi: 10.1016/j.phrs.2017.12.017. Epub 2017 Dec 22.
• [430] Transcription Factor NFAT5 Promotes Glioblastoma Cell-driven Angiogenesis via SBF2-AS1/miR-338-3p-Mediated EGFL7 Expression Change.Front Mol Neurosci. 2017 Sep 21;10:301. doi: 10.3389/fnmol.2017.00301. eCollection 2017.
• [431] Prolyl-4-hydroxylase 2 enhances hypoxia-induced glioblastoma cell death by regulating the gene expression of hypoxia-inducible factor-.Cell Death Dis. 2014 Jul 10;5(7):e1322. doi: 10.1038/cddis.2014.295.
• [432] Furanodienone overcomes temozolomide resistance in glioblastoma through the downregulation of CSPG4-Akt-ERK signalling by inhibiting EGR1-dependent transcription.Phytother Res. 2019 Jun;33(6):1736-1747. doi: 10.1002/ptr.6363. Epub 2019 Apr 21.
• [433] A cellular screening assay to test the ability of PKR to induce cell death in mammalian cells.Mol Ther. 2005 Nov;12(5):969-75. doi: 10.1016/j.ymthe.2005.06.442. Epub 2005 Aug 8.
• [434] GCN2 is essential for CD8(+) T cell survival and function in murine models of malignant glioma.Cancer Immunol Immunother. 2020 Jan;69(1):81-94. doi: 10.1007/s00262-019-02441-6. Epub 2019 Dec 16.
• [435] Hypoxia activates cadherin-22 synthesis via eIF4E2 to drive cancer cell migration, invasion and adhesion.Oncogene. 2018 Feb 1;37(5):651-662. doi: 10.1038/onc.2017.372. Epub 2017 Oct 9.
• [436] Inhibiting 4EBP1 in Glioblastoma.Clin Cancer Res. 2018 Jan 1;24(1):14-21. doi: 10.1158/1078-0432.CCR-17-0042. Epub 2017 Jul 10.
• [437] LncRNA FOXD1-AS1 acts as a potential oncogenic biomarker in glioma.CNS Neurosci Ther. 2020 Jan;26(1):66-75. doi: 10.1111/cns.13152. Epub 2019 May 17.
• [438] HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs.Cancer Res. 2001 Mar 1;61(5):2154-61.
• [439] Neurofibromin knockdown in glioma cell lines is associated with changes in cytokine and chemokine secretion in vitro.Sci Rep. 2018 Apr 11;8(1):5805. doi: 10.1038/s41598-018-24046-2.
• [440] CFIm25 links alternative polyadenylation to glioblastoma tumour suppression.Nature. 2014 Jun 19;510(7505):412-6. doi: 10.1038/nature13261. Epub 2014 May 11.
• [441] Development of an ENPP1 Fluorescence Probe for Inhibitor Screening, Cellular Imaging, and Prognostic Assessment of Malignant Breast Cancer.J Med Chem. 2019 Oct 24;62(20):9254-9269. doi: 10.1021/acs.jmedchem.9b01213. Epub 2019 Oct 3.
• [442] Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39.Nat Neurosci. 2019 May;22(5):729-740. doi: 10.1038/s41593-019-0370-y. Epub 2019 Apr 8.
• [443] The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models.Cancers (Basel). 2019 Mar 13;11(3):359. doi: 10.3390/cancers11030359.
• [444] The cystine/glutamate antiporter xCT is a key regulator of EphA2 S897 phosphorylation under glucose-limited conditions.Cell Signal. 2019 Oct;62:109329. doi: 10.1016/j.cellsig.2019.05.014. Epub 2019 May 29.
• [445] EphA3 is up-regulated by epidermal growth factor and promotes formation of glioblastoma cell aggregates.Biochem Biophys Res Commun. 2019 Jan 15;508(3):715-721. doi: 10.1016/j.bbrc.2018.12.002. Epub 2018 Dec 6.
• [446] Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4.Oncotarget. 2017 Apr 4;8(14):23750-23759. doi: 10.18632/oncotarget.16077.
• [447] Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients.BMC Cancer. 2008 Mar 25;8:79. doi: 10.1186/1471-2407-8-79.
• [448] Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers.Clin Chem. 2004 Mar;50(3):490-9. doi: 10.1373/clinchem.2003.026849. Epub 2004 Jan 15.
• [449] cMyc and ERK activity are associated with resistance to ALK inhibitory treatment in glioblastoma.J Neurooncol. 2020 Jan;146(1):9-23. doi: 10.1007/s11060-019-03348-z. Epub 2019 Nov 28.
• [450] PHF3 expression is frequently reduced in glioma.Cytogenet Cell Genet. 2001;94(3-4):131-6. doi: 10.1159/000048804.
• [451] High epiregulin expression in human U87 glioma cells relies on IRE1 and promotes autocrine growth through EGF receptor.BMC Cancer. 2013 Dec 13;13:597. doi: 10.1186/1471-2407-13-597.
• [452] Dual IRE1 RNase functions dictate glioblastoma development.EMBO Mol Med. 2018 Mar;10(3):e7929. doi: 10.15252/emmm.201707929.
• [453] Decreased FBP1 expression rewires metabolic processes affecting aggressiveness of glioblastoma.Oncogene. 2020 Jan;39(1):36-49. doi: 10.1038/s41388-019-0974-4. Epub 2019 Aug 23.
• [454] Coagulation Factor X Regulated by CASC2c Recruited Macrophages and Induced M2 Polarization in Glioblastoma Multiforme.Front Immunol. 2018 Jul 6;9:1557. doi: 10.3389/fimmu.2018.01557. eCollection 2018.
• [455] miR-204 reverses temozolomide resistance and inhibits cancer initiating cells phenotypes by degrading FAP- in glioblastoma.Oncol Lett. 2018 May;15(5):7563-7570. doi: 10.3892/ol.2018.8301. Epub 2018 Mar 20.
• [456] Translational PBPK Modeling of the Protein Therapeutic and CD95L Inhibitor Asunercept to Develop Dose Recommendations for Its First Use in Pediatric Glioblastoma Patients.Pharmaceutics. 2019 Apr 1;11(4):152. doi: 10.3390/pharmaceutics11040152.
• [457] FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells.Cancer Sci. 2018 Apr;109(4):1001-1011. doi: 10.1111/cas.13528.
• [458] Identification of an interferon-gamma response region 5' of the human histocompatibility leukocyte antigen DR alpha chain gene which is active in human glioblastoma multiforme lines.J Immunol. 1987 Feb 15;138(4):1275-80.
• [459] Farnesyl diphosphate synthase is important for the maintenance of glioblastoma stemness.Exp Mol Med. 2018 Oct 17;50(10):1-12. doi: 10.1038/s12276-018-0166-2.
• [460] Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.J Clin Invest. 1996 Sep 1;98(5):1165-73. doi: 10.1172/JCI118900.
• [461] Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy.Br J Cancer. 2011 Mar 1;104(5):798-807. doi: 10.1038/bjc.2011.12. Epub 2011 Feb 8.
• [462] The sulfation of biomimetic glycosaminoglycan substrates controls binding of growth factors and subsequent neural and glial cell growth.Biomater Sci. 2019 Oct 1;7(10):4283-4298. doi: 10.1039/c9bm00964g. Epub 2019 Aug 13.
• [463] Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.PLoS One. 2013;8(4):e60930. doi: 10.1371/journal.pone.0060930. Epub 2013 Apr 5.
• [464] Acetylcholine Receptor Activation as a Modulator of Glioblastoma Invasion.Cells. 2019 Oct 5;8(10):1203. doi: 10.3390/cells8101203.
• [465] Fibroblast growth factor receptor (FGFR) 4 correlated with the malignancy of human astrocytomas.Neurol Res. 2002 Apr;24(3):244-8. doi: 10.1179/016164102101199864.
• [466] FGL2 promotes tumor progression in the CNS by suppressing CD103(+) dendritic cell differentiation.Nat Commun. 2019 Jan 25;10(1):448. doi: 10.1038/s41467-018-08271-x.
• [467] FHL-1/reconectin and factor H: two human complement regulators which are encoded by the same gene are differently expressed and regulated.Mol Immunol. 1999 Sep-Oct;36(13-14):809-18. doi: 10.1016/s0161-5890(99)00101-7.
• [468] IQGAP1, AmotL2, and FKBP51 Scaffoldins in the Glioblastoma Microenvironment.J Histochem Cytochem. 2019 Jul;67(7):481-494. doi: 10.1369/0022155419833334. Epub 2019 Feb 22.
• [469] 18F-PSMA 1007 Brain PET/CT Imaging in Glioma Recurrence.Clin Nucl Med. 2020 Jan;45(1):e61-e62. doi: 10.1097/RLU.0000000000002668.
• [470] Targeted Delivery of Nanoparticulate Cytochrome C into Glioma Cells Through the Proton-Coupled Folate Transporter.Biomolecules. 2019 Apr 18;9(4):154. doi: 10.3390/biom9040154.
• [471] Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013 Apr 11;153(2):320-34. doi: 10.1016/j.cell.2013.03.036.
• [472] FOXC2 often overexpressed in glioblastoma enhances proliferation and invasion in glioblastoma cells.Oncol Res. 2013;21(2):111-20. doi: 10.3727/096504013X13814233062171.
• [473] Alpha6-Integrin Regulates FGFR1 Expression through the ZEB1/YAP1 Transcription Complex in Glioblastoma Stem Cells Resulting in Enhanced Proliferation and Stemness.Cancers (Basel). 2019 Mar 22;11(3):406. doi: 10.3390/cancers11030406.
• [474] FOXO1 associated with sensitivity to chemotherapy drugs and glial-mesenchymal transition in glioma.J Cell Biochem. 2019 Jan;120(1):882-893. doi: 10.1002/jcb.27450. Epub 2018 Sep 14.
• [475] Microenvironment involved in FPR1 expression by human glioblastomas.J Neurooncol. 2015 May;123(1):53-63. doi: 10.1007/s11060-015-1777-2. Epub 2015 Apr 19.
• [476] Robo1 and vimentin regulate radiation-induced motility of human glioblastoma cells.PLoS One. 2018 Jun 4;13(6):e0198508. doi: 10.1371/journal.pone.0198508. eCollection 2018.
• [477] Expression of activin A and follistatin in glioblastoma and their effects on U87 in vitro.J Int Med Res. 2010 Jul-Aug;38(4):1343-53. doi: 10.1177/147323001003800416.
• [478] Novel positioning from obesity to cancer: FTO, an m(6)A RNA demethylase, regulates tumour progression.J Cancer Res Clin Oncol. 2019 Jan;145(1):19-29. doi: 10.1007/s00432-018-2796-0. Epub 2018 Nov 21.
• [479] Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis.Front Cell Dev Biol. 2019 Oct 2;7:217. doi: 10.3389/fcell.2019.00217. eCollection 2019.
• [480] Cell surface Nestin is a biomarker for glioma stem cells.Biochem Biophys Res Commun. 2013 Apr 19;433(4):496-501. doi: 10.1016/j.bbrc.2013.03.021. Epub 2013 Mar 21.
• [481] Frizzled-10, up-regulated in primary colorectal cancer, is a positive regulator of the WNT - beta-catenin - TCF signaling pathway.Int J Mol Med. 2002 Feb;9(2):107-12.
• [482] miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt--catenin pathway.J Exp Clin Cancer Res. 2019 Aug 16;38(1):358. doi: 10.1186/s13046-019-1370-1.
• [483] G3BP1 knockdown sensitizes U87 glioblastoma cell line to Bortezomib by inhibiting stress granules assembly and potentializing apoptosis.J Neurooncol. 2019 Sep;144(3):463-473. doi: 10.1007/s11060-019-03252-6. Epub 2019 Aug 7.
• [484] miR-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting GABA receptors.Int J Oncol. 2012 Jul;41(1):228-34. doi: 10.3892/ijo.2012.1420. Epub 2012 Mar 28.
• [485] Nuclear factor kappa B dependent induction of gamma glutamylcysteine synthetase by ionizing radiation in T98G human glioblastoma cells.Free Radic Biol Med. 1998 May;24(7-8):1256-68. doi: 10.1016/s0891-5849(97)00443-7.
• [486] Growth and differentiation factor 15 regulates PD-L1 expression in glioblastoma.Cancer Manag Res. 2019 Apr 2;11:2653-2661. doi: 10.2147/CMAR.S192095. eCollection 2019.
• [487] Glial Cell Line-Derived Neurotrophic Factor (GDNF) Promotes Angiogenesis through the Demethylation of the Fibromodulin (FMOD) Promoter in Glioblastoma.Med Sci Monit. 2018 Sep 3;24:6137-6143. doi: 10.12659/MSM.911669.
• [488] Platelet-derived growth factor receptor /glial fibrillary acidic protein expressing peritumoral astrocytes associate with shorter median overall survival in glioblastoma patients.Glia. 2020 May;68(5):979-988. doi: 10.1002/glia.23756. Epub 2019 Nov 26.
• [489] Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin.Oncogene. 2004 Aug 26;23(39):6621-9. doi: 10.1038/sj.onc.1207861.
• [490] -Glutamyl transferase 7 is a novel regulator of glioblastoma growth. BMC Cancer. 2015 Apr 7;15:225.
• [491] Development of a Cx46 Targeting Strategy for Cancer Stem Cells.Cell Rep. 2019 Apr 23;27(4):1062-1072.e5. doi: 10.1016/j.celrep.2019.03.079.
• [492] Connexin 30 expression inhibits growth of human malignant gliomas but protects them against radiation therapy.Neuro Oncol. 2015 Mar;17(3):392-406. doi: 10.1093/neuonc/nou215. Epub 2014 Aug 25.
• [493] Insulin-like growth factor binding protein related protein 1 knockdown attenuates hepatic fibrosis via the regulation of MMPs/TIMPs in mice.Hepatobiliary Pancreat Dis Int. 2019 Feb;18(1):38-47. doi: 10.1016/j.hbpd.2018.08.008. Epub 2018 Aug 29.
• [494] GLI pathogenesis-related 1 functions as a tumor-suppressor in lung cancer.Mol Cancer. 2016 Mar 18;15:25. doi: 10.1186/s12943-016-0508-4.
• [495] Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone.Oncotarget. 2013 Mar;4(3):422-32. doi: 10.18632/oncotarget.917.
• [496] The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and Metastasis.Front Endocrinol (Lausanne). 2017 Aug 4;8:187. doi: 10.3389/fendo.2017.00187. eCollection 2017.
• [497] GPD1 Specifically Marks Dormant Glioma Stem Cells with a Distinct Metabolic Profile.Cell Stem Cell. 2019 Aug 1;25(2):241-257.e8. doi: 10.1016/j.stem.2019.06.004. Epub 2019 Jul 11.
• [498] The secreted glycolytic enzyme GPI/AMF stimulates glioblastoma cell migration and invasion in an autocrine fashion but can have anti-proliferative effects.Neuro Oncol. 2018 Nov 12;20(12):1594-1605. doi: 10.1093/neuonc/noy117.
• [499] Transcriptional modulation of calcium-permeable AMPA receptor subunits in glioblastoma by MEK-ERK1/2 inhibitors and their role in invasion.Cell Biol Int. 2020 Mar;44(3):830-837. doi: 10.1002/cbin.11279. Epub 2019 Dec 19.
• [500] Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells.Nat Med. 2002 Sep;8(9):971-8. doi: 10.1038/nm746. Epub 2002 Aug 12.
• [501] Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth.Mol Cancer Res. 2012 Jan;10(1):156-66. doi: 10.1158/1541-7786.MCR-11-0411. Epub 2011 Nov 15.
• [502] G-protein-coupled receptor kinase-5 promotes glioblastoma progression by targeting the nuclear factor kappa B pathway.Am J Transl Res. 2018 Nov 15;10(11):3370-3384. eCollection 2018.
• [503] Matched-pair, (86)Y/(90)Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer.Nucl Med Biol. 2018 Jul-Aug;62-63:71-77. doi: 10.1016/j.nucmedbio.2018.06.001. Epub 2018 Jun 8.
• [504] Survival of glioblastoma cells in response to endogenous and exogenous oxidative challenges: possible implication of NMDA receptor-mediated regulation of redox homeostasis.Cell Biol Int. 2019 Dec;43(12):1443-1452. doi: 10.1002/cbin.11193. Epub 2019 Jun 24.
• [505] Corrigendum: HAX-1 Protects Glioblastoma Cells From Apoptosis Through the Akt1 Pathway.Front Cell Neurosci. 2019 Jan 31;13:13. doi: 10.3389/fncel.2019.00013. eCollection 2019.
• [506] DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling.PLoS One. 2018 Jun 4;13(6):e0198364. doi: 10.1371/journal.pone.0198364. eCollection 2018.
• [507] Primary glioblastoma transcriptome data analysis for screening survival-related genes.J Cell Biochem. 2020 Feb;121(2):1901-1910. doi: 10.1002/jcb.29425. Epub 2019 Oct 21.
• [508] Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma.Front Oncol. 2019 Feb 1;9:33. doi: 10.3389/fonc.2019.00033. eCollection 2019.
• [509] Abnormal methylation of histone deacetylase genes: implications on etiology and epigenetic therapy of astrocytomas.Anticancer Res. 2011 Apr;31(4):1337-43.
• [510] Histone deacetylase 6 promotes growth of glioblastoma through the MKK7/JNK/c-Jun signaling pathway.J Neurochem. 2020 Jan;152(2):221-234. doi: 10.1111/jnc.14849. Epub 2019 Aug 25.
• [511] Paeoniflorin Inhibits Hepatocyte Growth Factor- (HGF-) Induced Migration and Invasion and Actin Rearrangement via Suppression of c-Met-Mediated RhoA/ROCK Signaling in Glioblastoma.Biomed Res Int. 2019 Feb 11;2019:9053295. doi: 10.1155/2019/9053295. eCollection 2019.
• [512] Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo.Int J Cancer. 2006 Feb 1;118(3):583-92. doi: 10.1002/ijc.21362.
• [513] Measles virus-specific dsRNAs are targets for unwinding/modifying activity in neural cells in vitro.J Neurovirol. 1995 Mar;1(1):92-100. doi: 10.3109/13550289509111013.
• [514] HIF-1 Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma.Cell Rep. 2019 Apr 2;27(1):226-237.e4. doi: 10.1016/j.celrep.2019.03.029.
• [515] The SIAH1-HIPK2-p53ser46 Damage Response Pathway is Involved in Temozolomide-Induced Glioblastoma Cell Death.Mol Cancer Res. 2019 May;17(5):1129-1141. doi: 10.1158/1541-7786.MCR-18-1306. Epub 2019 Feb 22.
• [516] Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells.Clin Cancer Res. 2019 Jan 15;25(2):844-855. doi: 10.1158/1078-0432.CCR-18-1854. Epub 2018 Oct 15.
• [517] Haplotypes of the HLA-G 3' Untranslated Region Respond to Endogenous Factors of HLA-G+ and HLA-G- Cell Lines Differentially.PLoS One. 2017 Jan 3;12(1):e0169032. doi: 10.1371/journal.pone.0169032. eCollection 2017.
• [518] HMGA1 negatively regulates NUMB expression at transcriptional and post transcriptional level in glioblastoma stem cells.Cell Cycle. 2019 Jul;18(13):1446-1457. doi: 10.1080/15384101.2019.1618541. Epub 2019 May 22.
• [519] Identification of a novel fusion gene HMGA2-EGFR in glioblastoma.Int J Cancer. 2018 Apr 15;142(8):1627-1639. doi: 10.1002/ijc.31179. Epub 2017 Dec 11.
• [520] High mobility group box2 promoter-controlled suicide gene expression enables targeted glioblastoma treatment.Mol Ther. 2009 Jun;17(6):1003-11. doi: 10.1038/mt.2009.22. Epub 2009 Feb 24.
• [521] Expression of heme oxygenase isozyme mRNAs in the human brain and induction of heme oxygenase-1 by nitric oxide donors.J Neurochem. 1996 Aug;67(2):482-9. doi: 10.1046/j.1471-4159.1996.67020482.x.
• [522] HIF-1/Wnt signaling-dependent control of gene transcription regulates neuronal differentiation of glioblastoma stem cells.Theranostics. 2019 Jul 9;9(17):4860-4877. doi: 10.7150/thno.35882. eCollection 2019.
• [523] Phosphomimetic substitution of heterogeneous nuclear ribonucleoprotein A1 at serine 199 abolishes AKT-dependent internal ribosome entry site-transacting factor (ITAF) function via effects on strand annealing and results in mammalian target of rapamycin complex 1 (mTORC1) inhibitor sensitivity.J Biol Chem. 2011 May 6;286(18):16402-13. doi: 10.1074/jbc.M110.205096. Epub 2011 Mar 16.
• [524] Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma.Cancer Res Treat. 2017 Apr;49(2):387-398. doi: 10.4143/crt.2016.106. Epub 2016 Jul 19.
• [525] HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF- pathways.Oncotarget. 2015 Sep 29;6(29):27778-93. doi: 10.18632/oncotarget.4813.
• [526] Discovery of Small-Molecule Inhibitors of the HSP90-Calcineurin-NFAT Pathway against Glioblastoma.Cell Chem Biol. 2019 Mar 21;26(3):352-365.e7. doi: 10.1016/j.chembiol.2018.11.009. Epub 2019 Jan 10.
• [527] Glucose-regulated protein 94 is a novel glioma biomarker and promotes the aggressiveness of glioma via Wnt/-catenin signaling pathway.Tumour Biol. 2015 Dec;36(12):9357-64. doi: 10.1007/s13277-015-3635-4. Epub 2015 Jun 25.
• [528] GRP78-targeted in-silico virtual screening of novel anticancer agents.Chem Biol Drug Des. 2018 Aug;92(2):1555-1566. doi: 10.1111/cbdd.13322. Epub 2018 May 31.
• [529] Cytoplasmic sequestration of the tumor suppressor p53 by a heat shock protein 70 family member, mortalin, in human colorectal adenocarcinoma cell lines.Biochem Biophys Res Commun. 2012 Jun 29;423(2):411-6. doi: 10.1016/j.bbrc.2012.05.139. Epub 2012 Jun 5.
• [530] Hsp22 (HspB8/H11) knockdown induces Sam68 expression and stimulates proliferation of glioblastoma cells.J Cell Physiol. 2011 Nov;226(11):2747-51. doi: 10.1002/jcp.22868.
• [531] Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma.Crit Rev Oncol Hematol. 2018 Aug;128:96-109. doi: 10.1016/j.critrevonc.2018.06.004. Epub 2018 Jun 11.
• [532] ICOSLG-mediated regulatory T-cell expansion and IL-10 production promote progression of glioblastoma.Neuro Oncol. 2020 Mar 5;22(3):333-344. doi: 10.1093/neuonc/noz204.
• [533] ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma.Cancer Res. 2019 Aug 15;79(16):4057-4071. doi: 10.1158/0008-5472.CAN-18-1357. Epub 2019 Jul 10.
• [534] ID2 promotes survival of glioblastoma cells during metabolic stress by regulating mitochondrial function.Cell Death Dis. 2017 Feb 16;8(2):e2615. doi: 10.1038/cddis.2017.14.
• [535] IGFBP2 promotes neural stem cell maintenance and proliferation differentially associated with glioblastoma subtypes.Brain Res. 2019 Feb 1;1704:174-186. doi: 10.1016/j.brainres.2018.10.018. Epub 2018 Oct 19.
• [536] IGFBP6 controls the expansion of chemoresistant glioblastoma through paracrine IGF2/IGF-1R signaling.Cell Commun Signal. 2018 Sep 19;16(1):61. doi: 10.1186/s12964-018-0273-7.
• [537] Isoalantolactone inhibits IKK kinase activity to interrupt the NF-B/COX-2-mediated signaling cascade and induces apoptosis regulated by the mitochondrial translocation of cofilin in glioblastoma.Cancer Med. 2019 Apr;8(4):1655-1670. doi: 10.1002/cam4.2013. Epub 2019 Feb 10.
• [538] A novel interleukin-13 receptor alpha 2-targeted hybrid peptide for effective glioblastoma therapy.Chem Biol Drug Des. 2019 Jul;94(1):1402-1413. doi: 10.1111/cbdd.13517. Epub 2019 Apr 22.
• [539] Expression of interleukin-16 by tumor-associated macrophages/activated microglia in high-grade astrocytic brain tumors.Arch Immunol Ther Exp (Warsz). 2007 Jan-Feb;55(1):41-7. doi: 10.1007/s00005-007-0003-0.
• [540] The effects of interleukin 2 and rAd-p53 as a treatment for glioblastoma.Mol Med Rep. 2018 Mar;17(3):4853-4859. doi: 10.3892/mmr.2018.8408. Epub 2018 Jan 9.
• [541] IL-20 is regulated by hypoxia-inducible factor and up-regulated after experimental ischemic stroke.J Immunol. 2009 Apr 15;182(8):5003-12. doi: 10.4049/jimmunol.0803653.
• [542] PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cells.Cancer Res. 2010 Feb 1;70(3):1120-9. doi: 10.1158/0008-5472.CAN-09-4043. Epub 2010 Jan 26.
• [543] Differential effects of ferritin, calcium, zinc, and gallic acid on in vitro proliferation of human glioblastoma cells and normal astrocytes.J Lab Clin Med. 1994 Apr;123(4):547-55.
• [544] IL13RA2 Is Differentially Regulated in Papillary Thyroid Carcinoma vs Follicular Thyroid Carcinoma.J Clin Endocrinol Metab. 2019 Nov 1;104(11):5573-5584. doi: 10.1210/jc.2019-00040.
• [545] Thymosin beta-4 regulates activation of hepatic stellate cells via hedgehog signaling. Sci Rep. 2017 Jun 19;7(1):3815.
• [546] IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma.Nat Cell Biol. 2019 Aug;21(8):1003-1014. doi: 10.1038/s41556-019-0363-9. Epub 2019 Aug 1.
• [547] Molecular and Structural Traits of Insulin Receptor Substrate 1/LC3 Nuclear Structures and Their Role in Autophagy Control and Tumor Cell Survival.Mol Cell Biol. 2018 Apr 30;38(10):e00608-17. doi: 10.1128/MCB.00608-17. Print 2018 May 15.
• [548] Chromatin-modifying drugs induce miRNA-153 expression to suppress Irs-2 in glioblastoma cell lines.Int J Cancer. 2011 Nov 15;129(10):2527-31. doi: 10.1002/ijc.25917. Epub 2011 Apr 1.
• [549] Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme.Cancer Res. 2010 Jun 15;70(12):5046-53. doi: 10.1158/0008-5472.CAN-09-3979. Epub 2010 May 18.
• [550] ITGA2 as a potential nanotherapeutic target for glioblastoma.Sci Rep. 2019 Apr 17;9(1):6195. doi: 10.1038/s41598-019-42643-7.
• [551] The Role of Integrin 6 (CD49f) in Stem Cells: More than a Conserved Biomarker.Stem Cells Dev. 2017 Aug 1;26(15):1090-1099. doi: 10.1089/scd.2016.0319. Epub 2017 Jun 12.
• [552] Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody.Mol Imaging Biol. 2020 Jun;22(3):685-694. doi: 10.1007/s11307-019-01427-1.
• [553] EGFRvIII/integrin 3 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis.Oncotarget. 2016 Jan 26;7(4):4680-94. doi: 10.18632/oncotarget.6730.
• [554] MiR-296-3p regulates cell growth and multi-drug resistance of human glioblastoma by targeting ether--go-go (EAG1). Eur J Cancer. 2013 Feb;49(3):710-24.
• [555] Administration of Non-Torsadogenic human Ether--go-go-Related Gene Inhibitors Is Associated with Better Survival for High hERG-Expressing Glioblastoma Patients.Clin Cancer Res. 2017 Jan 1;23(1):73-80. doi: 10.1158/1078-0432.CCR-15-3169. Epub 2016 Sep 15.
• [556] Silencing of GLS and overexpression of GLS2 genes cooperate in decreasing the proliferation and viability of glioblastoma cells.Tumour Biol. 2014 Mar;35(3):1855-62. doi: 10.1007/s13277-013-1247-4. Epub 2013 Oct 6.
• [557] The two-pore domain potassium channel TASK3 functionally impacts glioma cell death.J Neurooncol. 2008 May;87(3):263-70. doi: 10.1007/s11060-008-9517-5. Epub 2008 Jan 24.
• [558] Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells.Oncotarget. 2017 May 23;8(21):34896-34910. doi: 10.18632/oncotarget.16820.
• [559] Targeting of Histone Demethylases KDM5A and KDM6B Inhibits the Proliferation of Temozolomide-Resistant Glioblastoma Cells.Cancers (Basel). 2019 Jun 24;11(6):878. doi: 10.3390/cancers11060878.
• [560] HMGB1-Induced p62 Overexpression Promotes Snail-Mediated Epithelial-Mesenchymal Transition in Glioblastoma Cells via the Degradation of GSK-3.Theranostics. 2019 Mar 16;9(7):1909-1922. doi: 10.7150/thno.30578. eCollection 2019.
• [561] KIF11 inhibition for glioblastoma treatment: reason to hope or a struggle with the brain?.BMC Cancer. 2009 Jun 22;9:196. doi: 10.1186/1471-2407-9-196.
• [562] NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.J Immunol. 2014 Dec 15;193(12):6192-206. doi: 10.4049/jimmunol.1400859. Epub 2014 Nov 7.
• [563] Practical Bioinformatic DNA-Sequencing Pipeline for Detecting Oncogene Amplification and EGFRvIII Mutational Status in Clinical Glioblastoma Samples.J Mol Diagn. 2019 May;21(3):514-524. doi: 10.1016/j.jmoldx.2019.02.001. Epub 2019 Apr 15.
• [564] Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.Neuro Oncol. 2013 Mar;15(3):305-18. doi: 10.1093/neuonc/nos313. Epub 2013 Jan 10.
• [565] In vivo CRISPR screening in CD8 T cells with AAV-Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma.Nat Biotechnol. 2019 Nov;37(11):1302-1313. doi: 10.1038/s41587-019-0246-4. Epub 2019 Sep 23.
• [566] Lanthionine synthetase components C-like 2 increases cellular sensitivity to adriamycin by decreasing the expression of P-glycoprotein through a transcription-mediated mechanism.Cancer Res. 2003 Feb 1;63(3):723-7.
• [567] LAPTM4B-35 is a novel prognostic factor for glioblastoma.J Neurooncol. 2017 Apr;132(2):295-303. doi: 10.1007/s11060-017-2369-0. Epub 2017 Jan 18.
• [568] Immunogenomic analysis reveals LGALS1 contributes to the immune heterogeneity and immunosuppression in glioma.Int J Cancer. 2019 Jul 15;145(2):517-530. doi: 10.1002/ijc.32102. Epub 2019 Jan 22.
• [569] Clinical relevance of molecular subgrouping of gliomatosis cerebri per 2016 WHO classification: a clinicopathological study of 89 cases.Brain Pathol. 2020 Mar;30(2):235-245. doi: 10.1111/bpa.12782. Epub 2019 Oct 7.
• [570] Upregulation of LGMNP1 confers radiotherapy resistance in glioblastoma.Oncol Rep. 2019 Jun;41(6):3435-3443. doi: 10.3892/or.2019.7128. Epub 2019 Apr 18.
• [571] Bidirectional Regulation between NDRG1 and GSK3 Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.Cancer Res. 2020 Jan 15;80(2):234-248. doi: 10.1158/0008-5472.CAN-19-0438. Epub 2019 Nov 13.
• [572] The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.Cell Death Differ. 2015 Sep;22(9):1517-25. doi: 10.1038/cdd.2015.7. Epub 2015 Feb 27.
• [573] Protein Toxin Chaperoned by LRP-1-Targeted Virus-Mimicking Vesicles Induces High-Efficiency Glioblastoma Therapy In Vivo.Adv Mater. 2018 Jul;30(30):e1800316. doi: 10.1002/adma.201800316. Epub 2018 Jun 11.
• [574] Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival.Clin Cancer Res. 2017 Nov 1;23(21):6650-6660. doi: 10.1158/1078-0432.CCR-17-0120. Epub 2017 Jul 27.
• [575] Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation.Sci Transl Med. 2017 Apr 12;9(385):eaak9679. doi: 10.1126/scitranslmed.aak9679.
• [576] HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells.Cancer Res. 2004 Jul 15;64(14):4980-6. doi: 10.1158/0008-5472.CAN-03-3504.
• [577] The adherens junction-associated protein 1 is a negative transcriptional regulator of MAGEA2, which potentiates temozolomide-induced apoptosis in GBM.Int J Oncol. 2014 Apr;44(4):1243-51. doi: 10.3892/ijo.2014.2277. Epub 2014 Jan 24.
• [578] Paracaspase MALT1 regulates glioma cell survival by controlling endo-lysosome homeostasis.EMBO J. 2020 Jan 2;39(1):e102030. doi: 10.15252/embj.2019102030. Epub 2019 Nov 27.
• [579] Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma.CNS Neurosci Ther. 2020 Mar;26(3):297-308. doi: 10.1111/cns.13197. Epub 2019 Jul 18.
• [580] Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-B-dependent Manner.Cancer Cell. 2016 Feb 8;29(2):201-13. doi: 10.1016/j.ccell.2016.01.005.
• [581] Inhibition of SAPK2/p38 enhances sensitivity to mTORC1 inhibition by blocking IRES-mediated translation initiation in glioblastoma.Mol Cancer Ther. 2011 Dec;10(12):2244-56. doi: 10.1158/1535-7163.MCT-11-0478. Epub 2011 Sep 12.
• [582] TNF inhibitor C87 sensitizes EGFRvIII transfected glioblastoma cells to gefitinib by a concurrent blockade of TNF signaling.Cancer Biol Med. 2019 Aug;16(3):606-617. doi: 10.20892/j.issn.2095-3941.2019.0011.
• [583] Inhibition of basal JNK activity by small interfering RNAs enhances cisplatin sensitivity and decreases DNA repair in T98G glioblastoma cells.Oncol Rep. 2015 Jan;33(1):413-8. doi: 10.3892/or.2014.3570. Epub 2014 Oct 24.
• [584] Effects of nitric oxide donors on cybrids harbouring the mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) A3243G mitochondrial DNA mutation.Biochem J. 2005 Oct 15;391(Pt 2):191-202. doi: 10.1042/BJ20050272.
• [585] PAR1 inhibition suppresses the self-renewal and growth of A2B5-defined glioma progenitor cells and their derived gliomas in vivo.Oncogene. 2016 Jul 21;35(29):3817-28. doi: 10.1038/onc.2015.452. Epub 2015 Nov 30.
• [586] Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma.FASEB J. 2012 Jun;26(6):2639-47. doi: 10.1096/fj.11-202820. Epub 2012 Mar 13.
• [587] Site-1 protease, a novel metabolic target for glioblastoma.Biochem Biophys Res Commun. 2017 Aug 26;490(3):760-766. doi: 10.1016/j.bbrc.2017.06.114. Epub 2017 Jun 20.
• [588] Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy.Mol Neurobiol. 2018 Feb;55(2):1396-1404. doi: 10.1007/s12035-017-0414-9. Epub 2017 Feb 1.
• [589] Overexpression of MCM6 predicts poor survival in patients with glioma.Hum Pathol. 2018 Aug;78:182-187. doi: 10.1016/j.humpath.2018.04.024. Epub 2018 May 9.
• [590] Transient Receptor Potential Mucolipin-1 Channels in Glioblastoma: Role in Patient's Survival.Cancers (Basel). 2019 Apr 12;11(4):525. doi: 10.3390/cancers11040525.
• [591] MerTK as a therapeutic target in glioblastoma. Neuro Oncol. 2018 Jan 10;20(1):92-102.
• [592] Suppression of glioblastoma growth and angiogenesis through molecular targeting of methionine aminopeptidase-2.J Neurooncol. 2018 Jan;136(2):243-254. doi: 10.1007/s11060-017-2663-x. Epub 2017 Nov 8.
• [593] N-acetylglucosaminyltransferase I promotes glioma cell proliferation and migration through increasing the stability of the glucose transporter GLUT1.FEBS Lett. 2020 Jan;594(2):358-366. doi: 10.1002/1873-3468.13596. Epub 2019 Sep 17.
• [594] Synthesis and Cytotoxicity of Octahydroepoxyisoindole-7-carboxylic Acids and Norcantharidin-Amide Hybrids as Norcantharidin Analogues.ChemMedChem. 2019 Jun 18;14(12):1152-1161. doi: 10.1002/cmdc.201900180. Epub 2019 May 14.
• [595] Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach.Oncotarget. 2018 Apr 3;9(25):17951-17970. doi: 10.18632/oncotarget.24885. eCollection 2018 Apr 3.
• [596] Multicentric Glioma Develops via a Mutant IDH1-Independent Pathway: Immunohistochemical Study of Multicentric Glioma.Pathobiology. 2017;84(2):99-107. doi: 10.1159/000447951. Epub 2016 Aug 24.
• [597] Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas.Neurosci Res. 2008 Jan;60(1):40-9. doi: 10.1016/j.neures.2007.09.009. Epub 2007 Sep 29.
• [598] Matrix metalloproteinase-12 deficiency attenuates experimental crescentic anti-glomerular basement membrane glomerulonephritis.Nephrology (Carlton). 2018 Feb;23(2):183-189. doi: 10.1111/nep.12964.
• [599] TMZ regulates GBM stemness via MMP14-DLL4-Notch3 pathway.Int J Cancer. 2020 Apr 15;146(8):2218-2228. doi: 10.1002/ijc.32636. Epub 2019 Oct 1.
• [600] Romiplostim for temozolomide-induced thrombocytopenia in glioblastoma: The PLATUM trial.Neurology. 2019 Nov 5;93(19):e1799-e1806. doi: 10.1212/WNL.0000000000008440. Epub 2019 Oct 4.
• [601] Whole exome sequencing-based analysis to identify DNA damage repair deficiency as a major contributor to gliomagenesis in adult diffuse gliomas.J Neurosurg. 2019 Apr 5;132(5):1435-1446. doi: 10.3171/2019.1.JNS182938.
• [602] Musashi1 enhances chemotherapy resistance of pediatric glioblastoma cells in vitro.Pediatr Res. 2020 Mar;87(4):669-676. doi: 10.1038/s41390-019-0628-9. Epub 2019 Nov 22.
• [603] Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma.Oncotarget. 2017 Aug 16;8(46):80208-80222. doi: 10.18632/oncotarget.20303. eCollection 2017 Oct 6.
• [604] The cellular myb oncogene is amplified, rearranged and activated in human glioblastoma cell lines.Cancer Lett. 1990 Jun 30;52(1):57-62. doi: 10.1016/0304-3835(90)90077-b.
• [605] The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1.Cell Death Differ. 2019 Sep;26(9):1813-1831. doi: 10.1038/s41418-018-0248-7. Epub 2018 Dec 11.
• [606] The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-... Mol Cell Biol. 2009 Nov;29(21):5872-88.
• [607] NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors.Nat Med. 2012 Dec;18(12):1827-34. doi: 10.1038/nm.3013. Epub 2012 Nov 25.
• [608] GRIM-19 opposes reprogramming of glioblastoma cell metabolism via HIF1 destabilization.Carcinogenesis. 2013 Aug;34(8):1728-36. doi: 10.1093/carcin/bgt125. Epub 2013 Apr 11.
• [609] The Protein Neddylation Inhibitor MLN4924 Suppresses Patient-Derived Glioblastoma Cells via Inhibition of ERK and AKT Signaling.Cancers (Basel). 2019 Nov 22;11(12):1849. doi: 10.3390/cancers11121849.
• [610] NFKB1: a suppressor of inflammation, ageing and cancer.FEBS J. 2016 May;283(10):1812-22. doi: 10.1111/febs.13627. Epub 2016 Jan 13.
• [611] A mechanism of c-raf-1 activation: fusion of the lipocortin II amino-terminal sequence with the c-raf-1 kinase domain.Oncogene. 1989 Apr;4(4):437-42.
• [612] NEK9 depletion induces catastrophic mitosis by impairment of mitotic checkpoint control and spindle dynamics.Biochem Biophys Res Commun. 2013 Dec 13;442(3-4):139-46. doi: 10.1016/j.bbrc.2013.04.105. Epub 2013 May 9.
• [613] A Novel Multi-Target Small Molecule, LCC-09, Inhibits Stemness and Therapy-Resistant Phenotypes of Glioblastoma Cells by Increasing miR-34a and Deregulating the DRD4/Akt/mTOR Signaling Axis.Cancers (Basel). 2019 Sep 26;11(10):1442. doi: 10.3390/cancers11101442.
• [614] miR-93-5p suppresses cellular senescence by directly targeting Bcl-w and p21.Biochem Biophys Res Commun. 2018 Nov 10;505(4):1134-1140. doi: 10.1016/j.bbrc.2018.10.010. Epub 2018 Oct 11.
• [615] Cancer stem cell markers in glioblastoma - an update.Eur Rev Med Pharmacol Sci. 2017 Jul;21(14):3207-3211.
• [616] A DNA methylation prognostic signature of glioblastoma: identification of NPTX2-PTEN-NF-B nexus.Cancer Res. 2013 Nov 15;73(22):6563-73. doi: 10.1158/0008-5472.CAN-13-0298. Epub 2013 Sep 27.
• [617] Nuclear receptor 4A2 (NR4A2) is a druggable target for glioblastomas.J Neurooncol. 2020 Jan;146(1):25-39. doi: 10.1007/s11060-019-03349-y. Epub 2019 Nov 21.
• [618] miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS.Oncotarget. 2016 Apr 12;7(15):19531-47. doi: 10.18632/oncotarget.6968.
• [619] miR-331-3p regulates expression of neuropilin-2 in glioblastoma.J Neurooncol. 2014 Jan;116(1):67-75. doi: 10.1007/s11060-013-1271-7. Epub 2013 Oct 19.
• [620] Anaplastic Lymphoma Kinase in Glioblastoma: Detection/Diagnostic Methods and Therapeutic Options.Recent Pat Anticancer Drug Discov. 2018;13(2):209-223. doi: 10.2174/1574892813666180115151554.
• [621] Interference with NTSR1 Expression Exerts an Anti-Invasion Effect via the Jun/miR-494/SOCS6 Axis of Glioblastoma Cells.Cell Physiol Biochem. 2018;49(6):2382-2395. doi: 10.1159/000493838. Epub 2018 Sep 27.
• [622] miR-143 inhibits oncogenic traits by degrading NUAK2 in glioblastoma.Int J Mol Med. 2016 Jun;37(6):1627-35. doi: 10.3892/ijmm.2016.2562. Epub 2016 Apr 13.
• [623] Modeled microgravity suppressed invasion and migration of human glioblastoma U87 cells through downregulating store-operated calcium entry.Biochem Biophys Res Commun. 2015 Feb 13;457(3):378-84. doi: 10.1016/j.bbrc.2014.12.120. Epub 2015 Jan 9.
• [624] Genomic analyses reveal broad impact of miR-137 on genes associated with malignant transformation and neuronal differentiation in glioblastoma cells.PLoS One. 2014 Jan 22;9(1):e85591. doi: 10.1371/journal.pone.0085591. eCollection 2014.
• [625] Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.Oncogene. 2019 May;38(21):4154-4168. doi: 10.1038/s41388-019-0714-9. Epub 2019 Jan 31.
• [626] Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol.BMC Cancer. 2019 Mar 4;19(1):198. doi: 10.1186/s12885-019-5413-y.
• [627] Co-Localization and Interaction of Pax5 with Iba1 in Brain of Mice.Cell Mol Neurobiol. 2018 May;38(4):919-927. doi: 10.1007/s10571-017-0566-1. Epub 2017 Nov 13.
• [628] Identification and functional validation of CDH11, PCSK6 and SH3GL3 as novel glioma invasion-associated candidate genes.Neuropathol Appl Neurobiol. 2012 Apr;38(2):201-12. doi: 10.1111/j.1365-2990.2011.01207.x.
• [629] Identification of novel genetic alterations in samples of malignant glioma patients.PLoS One. 2013 Dec 16;8(12):e82108. doi: 10.1371/journal.pone.0082108. eCollection 2013.
• [630] MicroRNA-29a inhibits glioblastoma stem cells and tumor growth by regulating the PDGF pathway.J Neurooncol. 2019 Oct;145(1):23-34. doi: 10.1007/s11060-019-03275-z. Epub 2019 Sep 3.
• [631] PDGFR and IGF-1R Inhibitors Induce a G2/M Arrest and Subsequent Cell Death in Human Glioblastoma Cell Lines.Cells. 2018 Sep 6;7(9):131. doi: 10.3390/cells7090131.
• [632] IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism.Cancer Res. 2015 Aug 1;75(15):2999-3009. doi: 10.1158/0008-5472.CAN-15-0840. Epub 2015 Jun 4.
• [633] Chronophin regulates active vitamin B6 levels and transcriptomic features of glioblastoma cell lines cultured under non-adherent, serum-free conditions.BMC Cancer. 2018 May 3;18(1):524. doi: 10.1186/s12885-018-4440-4.
• [634] TGF- induces oncofetal fibronectin that, in turn, modulates TGF- superfamily signaling in endothelial cells.J Cell Sci. 2018 Jan 9;131(1):jcs209619. doi: 10.1242/jcs.209619.
• [635] Long non-coding RNA UCA1/miR-182/PFKFB2 axis modulates glioblastoma-associated stromal cells-mediated glycolysis and invasion of glioma cells.Biochem Biophys Res Commun. 2018 Jun 7;500(3):569-576. doi: 10.1016/j.bbrc.2018.04.091. Epub 2018 Apr 25.
• [636] The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.J Exp Clin Cancer Res. 2017 Aug 10;36(1):106. doi: 10.1186/s13046-017-0577-2.
• [637] Cannabidiol Affects Extracellular Vesicle Release, miR21 and miR126, and Reduces Prohibitin Protein in Glioblastoma Multiforme Cells.Transl Oncol. 2019 Mar;12(3):513-522. doi: 10.1016/j.tranon.2018.12.004. Epub 2018 Dec 28.
• [638] PIM kinases mediate resistance of glioblastoma cells to TRAIL by a p62/SQSTM1-dependent mechanism.Cell Death Dis. 2019 Jan 18;10(2):51. doi: 10.1038/s41419-018-1293-3.
• [639] The Multiple Roles of Peptidyl Prolyl Isomerases in Brain Cancer.Biomolecules. 2018 Oct 11;8(4):112. doi: 10.3390/biom8040112.
• [640] Evaluation of Glycolytic Response to Multiple Classes of Anti-glioblastoma Drugs by Noninvasive Measurement of Pyruvate Kinase M2 Using [(18)F]DASA-23.Mol Imaging Biol. 2020 Feb;22(1):124-133. doi: 10.1007/s11307-019-01353-2.
• [641] The Urokinase Receptor Induces a Mesenchymal Gene Expression Signature in Glioblastoma Cells and Promotes Tumor Cell Survival in Neurospheres.Sci Rep. 2018 Feb 14;8(1):2982. doi: 10.1038/s41598-018-21358-1.
• [642] Phospholipase C Beta 1: a Candidate Signature Gene for Proneural Subtype High-Grade Glioma.Mol Neurobiol. 2016 Nov;53(9):6511-6525. doi: 10.1007/s12035-015-9518-2. Epub 2015 Nov 28.
• [643] Feedback circuitry between miR-218 repression and RTK activation in glioblastoma.Sci Signal. 2015 May 5;8(375):ra42. doi: 10.1126/scisignal.2005978.
• [644] Phospholipase D2 mediates survival signaling through direct regulation of Akt in glioblastoma cells.J Biol Chem. 2014 Jan 10;289(2):600-16. doi: 10.1074/jbc.M113.532978. Epub 2013 Nov 20.
• [645] Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme.PeerJ. 2019 Nov 19;7:e7974. doi: 10.7717/peerj.7974. eCollection 2019.
• [646] Pololike kinase4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma.Oncol Rep. 2019 Apr;41(4):2159-2167. doi: 10.3892/or.2019.7012. Epub 2019 Feb 14.
• [647] Reduced expression of proteolipid protein 2 increases ER stress-induced apoptosis and autophagy in glioblastoma.J Cell Mol Med. 2020 Mar;24(5):2847-2856. doi: 10.1111/jcmm.14840. Epub 2019 Nov 28.
• [648] The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis.Oncotarget. 2015 Sep 8;6(26):22653-65. doi: 10.18632/oncotarget.4248.
• [649] Quantification of telomere features in tumor tissue sections by an automated 3D imaging-based workflow.Methods. 2017 Feb 1;114:60-73. doi: 10.1016/j.ymeth.2016.09.014. Epub 2016 Oct 7.
• [650] Experimental therapy of allogeneic solid tumors induced in athymic mice with suicide gene-transducing replication-competent foamy virus vectors.Cancer Gene Ther. 2005 Dec;12(12):947-53. doi: 10.1038/sj.cgt.7700855.
• [651] Identification of Periostin as a Potential Biomarker in Gliomas by Database Mining.World Neurosurg. 2020 Mar;135:e137-e163. doi: 10.1016/j.wneu.2019.11.077. Epub 2019 Nov 28.
• [652] shRNA-mediated PPAR knockdown in human glioma stem cells reduces in vitro proliferation and inhibits orthotopic xenograft tumour growth.J Pathol. 2019 Apr;247(4):422-434. doi: 10.1002/path.5201. Epub 2018 Dec 27.
• [653] Cyclophilin B supports Myc and mutant p53-dependent survival of glioblastoma multiforme cells.Cancer Res. 2014 Jan 15;74(2):484-96. doi: 10.1158/0008-5472.CAN-13-0771. Epub 2013 Nov 22.
• [654] Glioblastoma-specific protein interaction network identifies PP1A and CSK21 as connecting molecules between cell cycle-associated genes.Cancer Res. 2010 Aug 15;70(16):6437-47. doi: 10.1158/0008-5472.CAN-10-0819. Epub 2010 Jul 27.
• [655] Cooperative Blockade of PKC and JAK2 Drives Apoptosis in Glioblastoma.Cancer Res. 2020 Feb 15;80(4):709-718. doi: 10.1158/0008-5472.CAN-18-2808. Epub 2019 Dec 5.
• [656] Phorbol 12-myristate 13-acetate induces epidermal growth factor receptor transactivation via protein kinase Cdelta/c-Src pathways in glioblastoma cells.J Biol Chem. 2005 Mar 4;280(9):7729-38. doi: 10.1074/jbc.M409056200. Epub 2004 Dec 23.
• [657] Genistein sensitizes glioblastoma cells to carbon ions via inhibiting DNA-PKcs phosphorylation and subsequently repressing NHEJ and delaying HR repair pathways.Radiother Oncol. 2018 Oct;129(1):84-94. doi: 10.1016/j.radonc.2018.04.005. Epub 2018 Apr 21.
• [658] The Protein Arginine Methyltransferases 1 and 5 affect Myc properties in glioblastoma stem cells.Sci Rep. 2019 Nov 4;9(1):15925. doi: 10.1038/s41598-019-52291-6.
• [659] Prion Protein in Glioblastoma Multiforme.Int J Mol Sci. 2019 Oct 15;20(20):5107. doi: 10.3390/ijms20205107.
• [660] Methylation of hypoxia-inducible factor (HIF)-1 by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration.Nucleic Acids Res. 2018 Jul 27;46(13):6576-6591. doi: 10.1093/nar/gky449.
• [661] A dimeric bicyclic RGD ligand displays enhanced integrin binding affinity and strong biological effects on U-373 MG glioblastoma cells.Org Biomol Chem. 2019 Oct 21;17(39):8913-8917. doi: 10.1039/c9ob01811e. Epub 2019 Sep 26.
• [662] Interplay of VEGFa and MMP2 regulates invasion of glioblastoma.Tumour Biol. 2014 Dec;35(12):11879-85. doi: 10.1007/s13277-014-2438-3. Epub 2014 Sep 12.
• [663] Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth.Nat Commun. 2017 Jun 1;8:15080. doi: 10.1038/ncomms15080.
• [664] PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.Theranostics. 2018 Feb 7;8(6):1527-1539. doi: 10.7150/thno.22699. eCollection 2018.
• [665] miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma. Oncogene. 2019 Apr;38(16):2923-2936.
• [666] Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas.J Neuroinflammation. 2018 May 15;15(1):145. doi: 10.1186/s12974-018-1187-4.
• [667] Combined inhibition of RAC1 and Bcl-2/Bcl-xL synergistically induces glioblastoma cell death through down-regulation of the Usp9X/Mcl-1 axis.Cell Oncol (Dordr). 2019 Jun;42(3):287-301. doi: 10.1007/s13402-019-00425-3. Epub 2019 Mar 11.
• [668] Small G protein Rac GTPases regulate the maintenance of glioblastoma stem-like cells in vitro and in vivo.Oncotarget. 2017 Mar 14;8(11):18031-18049. doi: 10.18632/oncotarget.14949.
• [669] CREB regulates AChE-R-induced proliferation of human glioblastoma cells.Neoplasia. 2004 May-Jun;6(3):279-86. doi: 10.1593/neo.3424.
• [670] Increased RLIP76 expression in IDH1 wildtype glioblastoma multiforme is associated with worse prognosis.Oncol Rep. 2020 Jan;43(1):188-200. doi: 10.3892/or.2019.7394. Epub 2019 Oct 30.
• [671] The HIF-2alpha dependent induction of PAP and adenosine synthesis regulates glioblastoma stem cell function through the A2B adenosine receptor.Int J Biochem Cell Biol. 2014 Apr;49:8-16. doi: 10.1016/j.biocel.2014.01.007. Epub 2014 Jan 13.
• [672] Regulation of glioblastoma cell invasion by PKC iota and RhoB.Oncogene. 2008 Jun 5;27(25):3587-95. doi: 10.1038/sj.onc.1211027. Epub 2008 Jan 21.
• [673] RIP2 promotes glioma cell growth by regulating TRAF3 and activating the NFB and p38 signaling pathways.Oncol Rep. 2018 Jun;39(6):2915-2923. doi: 10.3892/or.2018.6397. Epub 2018 Apr 23.
• [674] RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas.Genome Res. 2014 Nov;24(11):1765-73. doi: 10.1101/gr.165126.113. Epub 2014 Aug 18.
• [675] Cancer-selective nanoparticles for combinatorial siRNA delivery to primary human GBM in vitro and in vivo.Biomaterials. 2019 Jul;209:79-87. doi: 10.1016/j.biomaterials.2019.04.020. Epub 2019 Apr 12.
• [676] Three-dimensional hydrogel is suitable for targeted investigation of amoeboid migration of glioma cells.Mol Med Rep. 2018 Jan;17(1):250-256. doi: 10.3892/mmr.2017.7888. Epub 2017 Oct 26.
• [677] GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors.J Neuropathol Exp Neurol. 2019 Dec 1;78(12):1089-1099. doi: 10.1093/jnen/nlz093.
• [678] Aberrant expression of RSK1 characterizes high-grade gliomas with immune infiltration.Mol Oncol. 2020 Jan;14(1):159-179. doi: 10.1002/1878-0261.12595. Epub 2019 Dec 11.
• [679] Pharmacologic Targeting of S6K1 in PTEN-Deficient Neoplasia.Cell Rep. 2017 Feb 28;18(9):2088-2095. doi: 10.1016/j.celrep.2017.02.022.
• [680] Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules.J Pathol. 2018 Jun;245(2):209-221. doi: 10.1002/path.5080. Epub 2018 Apr 20.
• [681] RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGF pathway-dependent manner.Cell Death Dis. 2019 Nov 21;10(12):877. doi: 10.1038/s41419-019-2108-x.
• [682] The contrasting epigenetic role of RUNX3 when compared with that of MGMT and TIMP3 in glioblastoma multiforme clinical outcomes.J Neurol Sci. 2014 Dec 15;347(1-2):325-31. doi: 10.1016/j.jns.2014.10.043. Epub 2014 Nov 7.
• [683] S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma.Cancer Res. 2017 Oct 1;77(19):5360-5373. doi: 10.1158/0008-5472.CAN-17-1294. Epub 2017 Aug 14.
• [684] Cancer stem cells are enriched in the side population cells in a mouse model of glioma.Cancer Res. 2008 Dec 15;68(24):10051-9. doi: 10.1158/0008-5472.CAN-08-0786.
• [685] Serum biomarkers identification by iTRAQ and verification by MRM: S100A8/S100A9 levels predict tumor-stroma involvement and prognosis in Glioblastoma.Sci Rep. 2019 Feb 26;9(1):2749. doi: 10.1038/s41598-019-39067-8.
• [686] With GBM, T Cells May Be Stuck in Bone Marrow.Cancer Discov. 2018 Oct;8(10):1203-1204. doi: 10.1158/2159-8290.CD-NB2018-117. Epub 2018 Sep 5.
• [687] Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome.Elife. 2017 Oct 4;6:e25281. doi: 10.7554/eLife.25281.
• [688] Statins affect human glioblastoma and other cancers through TGF- inhibition.Oncotarget. 2019 Mar 1;10(18):1716-1728. doi: 10.18632/oncotarget.26733. eCollection 2019 Mar 1.
• [689] Upregulation of C1-inhibitor in pancreatic cancer.Oncotarget. 2019 Oct 1;10(55):5703-5712. doi: 10.18632/oncotarget.27191. eCollection 2019 Oct 1.
• [690] Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-B signaling pathway.Oncogene. 2018 Jun;37(23):3070-3087. doi: 10.1038/s41388-018-0182-7. Epub 2018 Mar 14.
• [691] Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma.Cancers (Basel). 2018 Dec 27;11(1):25. doi: 10.3390/cancers11010025.
• [692] Interplay between TRAP1 and Sirtuin-3 Modulates Mitochondrial Respiration and Oxidative Stress to Maintain Stemness of Glioma Stem Cells.Cancer Res. 2019 Apr 1;79(7):1369-1382. doi: 10.1158/0008-5472.CAN-18-2558. Epub 2019 Jan 25.
• [693] SIRT5 downregulation is associated with poor prognosis in glioblastoma.Cancer Biomark. 2019;24(4):449-459. doi: 10.3233/CBM-182197.
• [694] Transcriptional activation of SIRT6 via FKHRL1/FOXO3a inhibits the Warburg effect in glioblastoma cells.Cell Signal. 2019 Aug;60:100-113. doi: 10.1016/j.cellsig.2019.04.009. Epub 2019 Apr 17.
• [695] NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways.J Cell Physiol. 2019 Feb;234(2):1630-1642. doi: 10.1002/jcp.27033. Epub 2018 Aug 29.
• [696] Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins.Eur J Neurosci. 2003 May;17(10):2106-18. doi: 10.1046/j.1460-9568.2003.02657.x.
• [697] Altered function of the glutamate-aspartate transporter GLAST, a potential therapeutic target in glioblastoma.Int J Cancer. 2019 May 15;144(10):2539-2554. doi: 10.1002/ijc.31985. Epub 2019 Jan 5.
• [698] Increased expression of a glutamine transporter SNAT3 is a marker of malignant gliomas. Neuroreport. 2004 Mar 22;15(4):575-8.
• [699] Positron emission tomography of sodium glucose cotransport activity in high grade astrocytomas.J Neurooncol. 2018 Jul;138(3):557-569. doi: 10.1007/s11060-018-2823-7. Epub 2018 Mar 10.
• [700] Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects.Curr Cancer Drug Targets. 2018;18(2):177-187. doi: 10.2174/1568009617666170222125035.
• [701] New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma.Sci Rep. 2019 Feb 27;9(1):2878. doi: 10.1038/s41598-019-40013-x.
• [702] Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas.J Exp Clin Cancer Res. 2018 Oct 17;37(1):255. doi: 10.1186/s13046-018-0923-z.
• [703] Over-expression of BMPR-IB reduces the malignancy of glioblastoma cells by upregulation of p21 and p27Kip1.J Exp Clin Cancer Res. 2012 May 31;31(1):52. doi: 10.1186/1756-9966-31-52.
• [704] Phytochemical, antioxidant, anti-proliferative and antimicrobial properties of Catharanthus roseus root extract, saponin-enriched and aqueous fractions.Mol Biol Rep. 2019 Jun;46(3):3265-3273. doi: 10.1007/s11033-019-04786-8. Epub 2019 Apr 3.
• [705] Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3.PLoS One. 2019 Feb 27;14(2):e0212581. doi: 10.1371/journal.pone.0212581. eCollection 2019.
• [706] miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/-catenin signaling via targeting SOX2.Life Sci. 2019 Jun 1;226:98-106. doi: 10.1016/j.lfs.2019.04.023. Epub 2019 Apr 10.
• [707] Cross-talk between sphingosine-1-phosphate and EGFR signaling pathways enhances human glioblastoma cell invasiveness.FEBS Lett. 2018 Mar;592(6):949-961. doi: 10.1002/1873-3468.13000. Epub 2018 Feb 23.
• [708] Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization.Oncogene. 2006 May 4;25(19):2818-26. doi: 10.1038/sj.onc.1209305.
• [709] TLK2 enhances aggressive phenotypes of glioblastoma cells through the activation of SRC signaling pathway.Cancer Biol Ther. 2019;20(1):101-108. doi: 10.1080/15384047.2018.1507257. Epub 2018 Sep 12.
• [710] Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression.Oncotarget. 2017 Apr 11;8(15):24815-24827. doi: 10.18632/oncotarget.15820.
• [711] The Critical Role of SRPK1 in EMT of Human Glioblastoma in the Spinal Cord.Mol Neurobiol. 2017 Apr;54(3):1818-1824. doi: 10.1007/s12035-016-9784-7. Epub 2016 Feb 18.
• [712] Phostine 3.1a as a pharmacological compound with antiangiogenic properties against diseases with excess vascularization.FASEB J. 2019 May;33(5):5864-5875. doi: 10.1096/fj.201801450RRR. Epub 2019 Feb 28.
• [713] MicroRNA regulating stanniocalcin-1 is a metastasis and dissemination promoting factor in glioblastoma.J Neurooncol. 2019 Apr;142(2):241-251. doi: 10.1007/s11060-019-03113-2. Epub 2019 Jan 30.
• [714] Serine/threonine kinase 17A is a novel candidate for therapeutic targeting in glioblastoma.PLoS One. 2013 Nov 28;8(11):e81803. doi: 10.1371/journal.pone.0081803. eCollection 2013.
• [715] Measuring sulfatase expression and invasion in glioblastoma.Methods Mol Biol. 2015;1229:507-16. doi: 10.1007/978-1-4939-1714-3_39.
• [716] Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with (213)Bi-substance P analogue.Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1636-1644. doi: 10.1007/s00259-018-4015-2. Epub 2018 Apr 30.
• [717] Rescue of MHC-1 antigen processing machinery by down-regulation in expression of IGF-1 in human glioblastoma cells.PLoS One. 2013;8(3):e58428. doi: 10.1371/journal.pone.0058428. Epub 2013 Mar 20.
• [718] Investigating the role of CRIPTO-1 (TDGF-1) in glioblastoma multiforme U87 cell line.J Cell Biochem. 2019 May;120(5):7412-7427. doi: 10.1002/jcb.28015. Epub 2018 Nov 13.
• [719] Ionizing radiation induces endothelial transdifferentiation of glioblastoma stem-like cells through the Tie2 signaling pathway.Cell Death Dis. 2019 Oct 28;10(11):816. doi: 10.1038/s41419-019-2055-6.
• [720] Inhibition of Human DNA Polymerases Eta and Kappa by Indole-Derived Molecules Occurs through Distinct Mechanisms.ACS Chem Biol. 2019 Jun 21;14(6):1337-1351. doi: 10.1021/acschembio.9b00304. Epub 2019 May 22.
• [721] Multiple cancer pathways regulate telomereprotection.EMBO Mol Med. 2019 Jul;11(7):e10292. doi: 10.15252/emmm.201910292. Epub 2019 Jun 13.
• [722] Molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblastoma stem cells.Glia. 2014 Oct;62(10):1687-98. doi: 10.1002/glia.22708. Epub 2014 Jun 7.
• [723] Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma.J Control Release. 2018 May 10;277:89-101. doi: 10.1016/j.jconrel.2018.03.006. Epub 2018 Mar 6.
• [724] Distinct cellular responses induced by saporin and a transferrin-saporin conjugate in two different human glioblastoma cell lines.J Cell Physiol. 2012 Mar;227(3):939-51. doi: 10.1002/jcp.22805.
• [725] TGF-2 Induces Gli1 in a Smad3-Dependent Manner Against Cerebral Ischemia/Reperfusion Injury After Isoflurane Post-conditioning in Rats.Front Neurosci. 2019 Jun 26;13:636. doi: 10.3389/fnins.2019.00636. eCollection 2019.
• [726] Deciphering the complex role of thrombospondin-1 in glioblastoma development.Nat Commun. 2019 Mar 8;10(1):1146. doi: 10.1038/s41467-019-08480-y.
• [727] Plant thymidine kinase 1: a novel efficient suicide gene for malignant glioma therapy.Neuro Oncol. 2010 Jun;12(6):549-58. doi: 10.1093/neuonc/nop067. Epub 2010 Feb 13.
• [728] Expression of transketolase-like 1 and activation of Akt in grade IV glioblastomas compared with grades II and III astrocytic gliomas.Am J Clin Pathol. 2008 Jul;130(1):50-7. doi: 10.1309/6H9844AMMET82DBJ.
• [729] T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma.Clin Cancer Res. 2018 Sep 1;24(17):4175-4186. doi: 10.1158/1078-0432.CCR-17-1846. Epub 2018 Feb 7.
• [730] Thymosin 4 gene silencing decreases stemness and invasiveness in glioblastoma.Brain. 2014 Feb;137(Pt 2):433-48. doi: 10.1093/brain/awt333. Epub 2013 Dec 18.
• [731] Nano-mediated delivery of double-stranded RNA for gene therapy of glioblastoma multiforme.PLoS One. 2019 Mar 19;14(3):e0213852. doi: 10.1371/journal.pone.0213852. eCollection 2019.
• [732] Epigenetic silencing of death receptor 4 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in gliomas.Clin Cancer Res. 2009 Sep 1;15(17):5457-65. doi: 10.1158/1078-0432.CCR-09-1125. Epub 2009 Aug 25.
• [733] DR5 related autophagy can promote apoptosis in gliomas after irradiation.Biochem Biophys Res Commun. 2020 Feb 19;522(4):910-916. doi: 10.1016/j.bbrc.2019.11.161. Epub 2019 Dec 3.
• [734] Epigenetic reactivation of RANK in glioblastoma cells by curcumin: involvement of STAT3 inhibition.DNA Cell Biol. 2013 Jun;32(6):292-7. doi: 10.1089/dna.2013.2042. Epub 2013 Apr 27.
• [735] Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas.J Neurooncol. 2018 Jun;138(2):241-250. doi: 10.1007/s11060-018-2799-3. Epub 2018 Feb 16.
• [736] CSF TACI and BAFF levels in patients with primary CNS lymphoma as novel diagnostic biomarkers.Ann Clin Transl Neurol. 2018 Oct 19;5(12):1611-1616. doi: 10.1002/acn3.668. eCollection 2018 Dec.
• [737] The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors.Am J Pathol. 2003 Apr;162(4):1313-21. doi: 10.1016/S0002-9440(10)63927-2.
• [738] Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe.Cell Death Dis. 2014 Oct 2;5(10):e1435. doi: 10.1038/cddis.2014.412.
• [739] TRAF6 correlated to invasion and poor prognosis of glioblastoma via elevating MMP9 expression.Neuroreport. 2019 Jan 16;30(2):127-133. doi: 10.1097/WNR.0000000000001171.
• [740] Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia.Eur J Neurosci. 2004 Nov;20(10):2617-28. doi: 10.1111/j.1460-9568.2004.03729.x.
• [741] Expression of TRH and TRH-like peptides in a human glioblastoma-astrocytoma cell line (U-373-MG).J Endocrinol. 2000 Sep;166(3):697-703. doi: 10.1677/joe.0.1660697.
• [742] TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma.Nat Commun. 2017 Nov 13;8(1):1454. doi: 10.1038/s41467-017-01731-w.
• [743] Aberrant Active cis-Regulatory Elements Associated with Downregulation of RET Finger Protein Overcome Chemoresistance in Glioblastoma.Cell Rep. 2019 Feb 26;26(9):2274-2281.e5. doi: 10.1016/j.celrep.2019.01.109.
• [744] TRIM28 activates autophagy and promotes cell proliferation in glioblastoma.Onco Targets Ther. 2019 Jan 3;12:397-404. doi: 10.2147/OTT.S188101. eCollection 2019.
• [745] TRIM59 Promotes Gliomagenesis by Inhibiting TC45 Dephosphorylation of STAT3.Cancer Res. 2018 Apr 1;78(7):1792-1804. doi: 10.1158/0008-5472.CAN-17-2774. Epub 2018 Jan 31.
• [746] Selenium Enhances the Apoptotic Efficacy of Docetaxel Through Activation of TRPM2 Channel in DBTRG Glioblastoma Cells.Neurotox Res. 2019 May;35(4):797-808. doi: 10.1007/s12640-019-0009-5. Epub 2019 Feb 22.
• [747] Inhibitions of anandamide transport and FAAH synthesis decrease apoptosis and oxidative stress through inhibition of TRPV1channel in an in vitro seizure model.Mol Cell Biochem. 2019 Mar;453(1-2):143-155. doi: 10.1007/s11010-018-3439-0. Epub 2018 Aug 29.
• [748] TSPO deficiency induces mitochondrial dysfunction, leading to hypoxia, angiogenesis, and a growth-promoting metabolic shift toward glycolysis in glioblastoma.Neuro Oncol. 2020 Feb 20;22(2):240-252. doi: 10.1093/neuonc/noz183.
• [749] FUS1 acts as a tumor-suppressor gene by upregulating miR-197 in human glioblastoma.Oncol Rep. 2015 Aug;34(2):868-76. doi: 10.3892/or.2015.4069. Epub 2015 Jun 16.
• [750] Interferons upregulate thymidine phosphorylase expression via JAK-STAT-dependent transcriptional activation and mRNA stabilization in human glioblastoma cells. J Neurooncol. 2005 May;72(3):217-23. doi: 10.1007/s11060-004-3012-4.
• [751] Gene expressions of TRP channels in glioblastoma multiforme and relation with survival.Tumour Biol. 2015 Dec;36(12):9209-13. doi: 10.1007/s13277-015-3577-x. Epub 2015 Jun 19.
• [752] Glucosylceramide synthase silencing combined with the receptor tyrosine kinase inhibitor axitinib as a new multimodal strategy for glioblastoma.Hum Mol Genet. 2019 Nov 1;28(21):3664-3679. doi: 10.1093/hmg/ddz152.
• [753] NCoR controls glioblastoma tumor cell characteristics.Neuro Oncol. 2014 Jan;16(2):241-9. doi: 10.1093/neuonc/not214. Epub 2013 Dec 12.
• [754] Aberrant Activation of -Catenin Signaling Drives Glioma Tumorigenesis via USP1-Mediated Stabilization of EZH2.Cancer Res. 2019 Jan 1;79(1):72-85. doi: 10.1158/0008-5472.CAN-18-1304. Epub 2018 Nov 13.
• [755] Increased expression of thymidylate synthetase (TS), ubiquitin specific protease 10 (USP10) and survivin is associated with poor survival in glioblastoma multiforme (GBM).J Neurooncol. 2006 Dec;80(3):261-74. doi: 10.1007/s11060-006-9191-4. Epub 2006 Jun 14.
• [756] Stabilization of LSD1 by deubiquitinating enzyme USP7 promotes glioblastoma cell tumorigenesis and metastasis through suppression of the p53 signaling pathway.Oncol Rep. 2016 Nov;36(5):2935-2945. doi: 10.3892/or.2016.5099. Epub 2016 Sep 16.
• [757] Involvement of Drp1 in hypoxia-induced migration of human glioblastoma U251 cells.Oncol Rep. 2014 Aug;32(2):619-26. doi: 10.3892/or.2014.3235. Epub 2014 Jun 5.
• [758] Retinoid receptor turnover mediated by sumoylation, ubiquitination and the valosin-containing protein is disrupted in glioblastoma.Sci Rep. 2019 Nov 7;9(1):16250. doi: 10.1038/s41598-019-52696-3.
• [759] Rewiring of Cancer Cell Metabolism by Mitochondrial VDAC1 Depletion Results in Time-Dependent Tumor Reprogramming: Glioblastoma as a Proof of Concept.Cells. 2019 Oct 28;8(11):1330. doi: 10.3390/cells8111330.
• [760] Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas.J Pathol. 2006 May;209(1):34-43. doi: 10.1002/path.1943.
• [761] Targeting VPAC1 Receptors for Imaging Glioblastoma.Mol Imaging Biol. 2020 Apr;22(2):293-302. doi: 10.1007/s11307-019-01388-5.
• [762] miR-375 inhibits the proliferation and invasion of glioblastoma by regulating Wnt5a.Neoplasma. 2019 May 23;66(3):350-356. doi: 10.4149/neo_2018_180714N484. Epub 2019 Feb 14.
• [763] Expression and function of ABCG2 and XIAP in glioblastomas.J Neurooncol. 2017 May;133(1):47-57. doi: 10.1007/s11060-017-2422-z. Epub 2017 Apr 21.
• [764] Yes and PI3K bind CD95 to signal invasion of glioblastoma.Cancer Cell. 2008 Mar;13(3):235-48. doi: 10.1016/j.ccr.2008.02.003.
• [765] Overexpression of ZNF217 in glioblastoma contributes to the maintenance of glioma stem cells regulated by hypoxia-inducible factors.Lab Invest. 2011 Jul;91(7):1068-78. doi: 10.1038/labinvest.2011.56. Epub 2011 Apr 11.
• [766] Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.Lancet Oncol. 2017 Oct;18(10):1373-1385. doi: 10.1016/S1470-2045(17)30517-X. Epub 2017 Aug 23.
• [767] The involvement of anterior gradient 2 in the stromal cell-derived factor 1-induced epithelial-mesenchymal transition of glioblastoma.Tumour Biol. 2016 May;37(5):6091-7. doi: 10.1007/s13277-015-4481-0. Epub 2015 Nov 25.
• [768] Fetuin-A (alpha 2HS glycoprotein) modulates growth, motility, invasion, and senescence in high-grade astrocytomas.Cancer Med. 2016 Dec;5(12):3532-3543. doi: 10.1002/cam4.940. Epub 2016 Nov 23.
• [769] Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression.Stem Cells. 2014 May;32(5):1110-23. doi: 10.1002/stem.1614.
• [770] Promoter methylation of AREG, HOXA11, hMLH1, NDRG2, NPTX2 and Tes genes in glioblastoma.J Neurooncol. 2013 Jul;113(3):441-9. doi: 10.1007/s11060-013-1133-3. Epub 2013 Apr 28.
• [771] MicroRNA-613 is downregulated in HCMV-positive glioblastoma and inhibits tumour progression by targeting arginase-2.Tumour Biol. 2017 Jul;39(7):1010428317712512. doi: 10.1177/1010428317712512.
• [772] Regulation of ASIC1 by Ca2+/calmodulin-dependent protein kinase II in human glioblastoma multiforme.Oncol Rep. 2013 Dec;30(6):2852-8. doi: 10.3892/or.2013.2777. Epub 2013 Oct 2.
• [773] Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma.J Exp Clin Cancer Res. 2017 Jul 17;36(1):96. doi: 10.1186/s13046-017-0549-6.
• [774] ATP7B expression in human glioblastoma is related to temozolomide resistance.Oncol Lett. 2017 Dec;14(6):7777-7782. doi: 10.3892/ol.2017.7249. Epub 2017 Oct 23.
• [775] MicroRNA-339-5p down-regulates protein expression of -site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects.J Biol Chem. 2014 Feb 21;289(8):5184-98. doi: 10.1074/jbc.M113.518241. Epub 2013 Dec 18.
• [776] Knockdown of BCL6 Inhibited Malignant Phenotype and Enhanced Sensitivity of Glioblastoma Cells to TMZ through AKT Pathway.Biomed Res Int. 2018 Oct 18;2018:6953506. doi: 10.1155/2018/6953506. eCollection 2018.
• [777] Bradykinin B1 receptor contributes to interleukin-8 production and glioblastoma migration through interaction of STAT3 and SP-1.Neuropharmacology. 2019 Jan;144:143-154. doi: 10.1016/j.neuropharm.2018.10.033. Epub 2018 Oct 23.
• [778] Calpain 2 is required for the invasion of glioblastoma cells in the zebrafish brain microenvironment.J Neurosci Res. 2012 Apr;90(4):769-81. doi: 10.1002/jnr.22794. Epub 2011 Dec 20.
• [779] Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.Nature. 2015 Mar 19;519(7543):366-9. doi: 10.1038/nature14320. Epub 2015 Mar 11.
• [780] Expression and prognostic significance of CCL11/CCR3 in glioblastoma.Oncotarget. 2016 May 31;7(22):32617-27. doi: 10.18632/oncotarget.8958.
• [781] Downregulation of TLX induces TET3 expression and inhibits glioblastoma stem cell self-renewal and tumorigenesis.Nat Commun. 2016 Feb 3;7:10637. doi: 10.1038/ncomms10637.
• [782] EBP1 protein modulates the expression of human MHC class II molecules in non-hematopoietic cancer cells.Int J Oncol. 2015 Aug;47(2):481-9. doi: 10.3892/ijo.2015.3051. Epub 2015 Jun 16.
• [783] Expression and clinical significance of CPS1 in glioblastoma multiforme.Curr Res Transl Med. 2019 Nov;67(4):123-128. doi: 10.1016/j.retram.2019.08.003. Epub 2019 Sep 3.
• [784] Periarteriolar Glioblastoma Stem Cell Niches Express Bone Marrow Hematopoietic Stem Cell Niche Proteins.J Histochem Cytochem. 2018 Mar;66(3):155-173. doi: 10.1369/0022155417749174. Epub 2018 Jan 3.
• [785] Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.Cell Signal. 2014 Dec;26(12):2896-902. doi: 10.1016/j.cellsig.2014.08.027. Epub 2014 Sep 6.
• [786] DGK Plays Crucial Roles in the Proliferation and Tumorigenicity of Human glioblastoma.Int J Biol Sci. 2019 Jul 20;15(9):1872-1881. doi: 10.7150/ijbs.35193. eCollection 2019.
• [787] High expression of XIAP and Bcl-2 may inhibit programmed cell death in glioblastomas.Arq Neuropsiquiatr. 2017 Dec;75(12):875-880. doi: 10.1590/0004-282X20170156.
• [788] Common genetic variations of deiodinase genes and prognosis of brain tumor patients.Endocrine. 2019 Dec;66(3):563-572. doi: 10.1007/s12020-019-02016-6. Epub 2019 Aug 26.
• [789] ER stress and UPR activation in glioblastoma: identification of a noncanonical PERK mechanism regulating GBM stem cells through SOX2 modulation.Cell Death Dis. 2019 Sep 18;10(10):690. doi: 10.1038/s41419-019-1934-1.
• [790] Screening prognosis-related genes in glioblastoma by microarray analysis.Anticancer Drugs. 2020 Feb;31(2):150-157. doi: 10.1097/CAD.0000000000000839.
• [791] Molecular features of pleomorphic xanthoastrocytoma.Hum Pathol. 2019 Apr;86:38-48. doi: 10.1016/j.humpath.2018.08.038. Epub 2018 Nov 26.
• [792] Liposomal delivery of ferritin heavy chain 1 (FTH1) siRNA in patient xenograft derived glioblastoma initiating cells suggests different sensitivities to radiation and distinct survival mechanisms.PLoS One. 2019 Sep 6;14(9):e0221952. doi: 10.1371/journal.pone.0221952. eCollection 2019.
• [793] Galanin and galanin receptors in human gliomas.Acta Neuropathol. 2003 Jun;105(6):555-60. doi: 10.1007/s00401-003-0680-7. Epub 2003 Feb 26.
• [794] Putting Glioblastoma in Its Place: IRF3 Inhibits Invasion.Trends Mol Med. 2017 Sep;23(9):773-776. doi: 10.1016/j.molmed.2017.07.008. Epub 2017 Jul 31.
• [795] Inhibiting Integrin 8 to Differentiate and Radiosensitize Glioblastoma-Initiating Cells.Mol Cancer Res. 2019 Feb;17(2):384-397. doi: 10.1158/1541-7786.MCR-18-0386. Epub 2018 Sep 28.
• [796] Inhibition of notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres.Genes Cancer. 2010 Aug;1(8):822-35. doi: 10.1177/1947601910383564.
• [797] MicroRNA?666 suppresses the growth and migration of glioblastoma cells by targeting KDM2A.Mol Med Rep. 2019 Feb;19(2):1049-1055. doi: 10.3892/mmr.2018.9698. Epub 2018 Nov 27.
• [798] Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-B pathways.Oncogene. 2020 Jan;39(2):428-442. doi: 10.1038/s41388-019-0996-y. Epub 2019 Sep 4.
• [799] Blocking LDHA glycolytic pathway sensitizes glioblastoma cells to radiation and temozolomide.Biochem Biophys Res Commun. 2017 Sep 30;491(4):932-938. doi: 10.1016/j.bbrc.2017.07.138. Epub 2017 Jul 26.
• [800] Common variation in genes related to innate immunity and risk of adult glioma.Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1651-8. doi: 10.1158/1055-9965.EPI-08-1041.
• [801] Circular RNA circ-PITX1 promotes the progression of glioblastoma by acting as a competing endogenous RNA to regulate miR-379-5p/MAP3K2 axis.Eur J Pharmacol. 2019 Nov 15;863:172643. doi: 10.1016/j.ejphar.2019.172643. Epub 2019 Sep 4.
• [802] Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion.Sci Rep. 2019 Sep 30;9(1):14020. doi: 10.1038/s41598-019-50160-w.
• [803] miR-146b-5p inhibits glioma migration and invasion by targeting MMP16.Cancer Lett. 2013 Oct 10;339(2):260-9. doi: 10.1016/j.canlet.2013.06.018. Epub 2013 Jun 22.
• [804] Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas.Brain Pathol. 2019 Jul;29(4):513-529. doi: 10.1111/bpa.12690. Epub 2019 Jan 15.
• [805] Expression and clinicopathological significance of Nck1 in human astrocytoma progression.Int J Neurosci. 2019 Feb;129(2):171-178. doi: 10.1080/00207454.2018.1516655. Epub 2018 Nov 22.
• [806] Interleukin-8 Secreted by Glioblastoma Cells Induces Microvascular Hyperpermeability Through NO Signaling Involving S-Nitrosylation of VE-Cadherin and p120 in Endothelial Cells.Front Physiol. 2019 Aug 8;10:988. doi: 10.3389/fphys.2019.00988. eCollection 2019.
• [807] Nasal Administration of Cationic Nanoemulsions as CD73-siRNA Delivery System for Glioblastoma Treatment: a New Therapeutical Approach.Mol Neurobiol. 2020 Feb;57(2):635-649. doi: 10.1007/s12035-019-01730-6. Epub 2019 Aug 12.
• [808] Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness.J Exp Clin Cancer Res. 2017 Jan 9;36(1):9. doi: 10.1186/s13046-016-0482-0.
• [809] LOX-1+ PMN-MDSC enhances immune suppression which promotes glioblastoma multiforme progression.Cancer Manag Res. 2019 Aug 2;11:7307-7315. doi: 10.2147/CMAR.S210545. eCollection 2019.
• [810] MicroRNA-485 inhibits malignant biological behaviour of glioblastoma cells by directly targeting PAK4.Int J Oncol. 2017 Nov;51(5):1521-1532. doi: 10.3892/ijo.2017.4122. Epub 2017 Sep 14.
• [811] Cyclic nucleotide phosphodiesterase-1C (PDE1C) drives cell proliferation, migration and invasion in glioblastoma multiforme cells in vitro.Mol Carcinog. 2016 Mar;55(3):268-79. doi: 10.1002/mc.22276. Epub 2015 Jan 25.
• [812] Knockdown of Pim-3 suppresses the tumorigenicity of glioblastoma by regulating cell cycle and apoptosis.Cell Mol Biol (Noisy-le-grand). 2015 Mar 9;61(1):42-50.
• [813] Protein kinase D2 regulates migration and invasion of U87MG glioblastoma cells in vitro.Exp Cell Res. 2013 Aug 1;319(13):2037-2048. doi: 10.1016/j.yexcr.2013.03.029. Epub 2013 Apr 4.
• [814] KAP regulates ROCK2 and Cdk2 in an RNA-activated glioblastoma invasion pathway.Oncogene. 2015 Mar 12;34(11):1432-41. doi: 10.1038/onc.2014.49. Epub 2014 Apr 7.
• [815] Feedback Loop Regulation of SCAP/SREBP-1 by miR-29 Modulates EGFR Signaling-Driven Glioblastoma Growth.Cell Rep. 2016 Aug 9;16(6):1527-1535. doi: 10.1016/j.celrep.2016.07.017. Epub 2016 Jul 28.
• [816] System L amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-L-tyrosine (FET).Amino Acids. 2015 Feb;47(2):335-44. doi: 10.1007/s00726-014-1863-3. Epub 2014 Nov 11.
• [817] TROP2 promotes the proliferation and metastasis of glioblastoma cells by activating the JAK2/STAT3 signaling pathway.Oncol Rep. 2019 Feb;41(2):753-764. doi: 10.3892/or.2018.6859. Epub 2018 Nov 9.
• [818] Tyrosyl-DNA Phosphodiesterase 1 and Topoisomerase I Activities as Predictive Indicators for Glioblastoma Susceptibility to Genotoxic Agents.Cancers (Basel). 2019 Sep 23;11(10):1416. doi: 10.3390/cancers11101416.
• [819] Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes.J Control Release. 2020 Jan 10;317:273-281. doi: 10.1016/j.jconrel.2019.11.009. Epub 2019 Nov 12.
• [820] The Prognostic Landscape of Tumor-Infiltrating Immune Cells and Immune Checkpoints in Glioblastoma.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819869949. doi: 10.1177/1533033819869949.
• [821] Telomerase subunits expression variation between biopsy samples and cell lines derived from malignant glioma.Brain Res. 2007 Feb 23;1134(1):45-52. doi: 10.1016/j.brainres.2006.11.093. Epub 2007 Jan 2.
• [822] Alpha lipoic acid attenuates hypoxia-induced apoptosis, inflammation and mitochondrial oxidative stress via inhibition of TRPA1 channel in human glioblastoma cell line.Biomed Pharmacother. 2019 Mar;111:292-304. doi: 10.1016/j.biopha.2018.12.077. Epub 2018 Dec 24.
• [823] MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma.Oncogene. 2017 Aug 31;36(35):5006-5022. doi: 10.1038/onc.2017.129. Epub 2017 May 1.
• [824] Wilms' tumor 1 is involved in tumorigenicity of glioblastoma by regulating cell proliferation and apoptosis.Anticancer Res. 2014 Jan;34(1):61-7.
• [825] High Expression of PTPN3 Predicts Progression and Unfavorable Prognosis of Glioblastoma.Med Sci Monit. 2018 Oct 23;24:7556-7562. doi: 10.12659/MSM.911531.
• [826] Large Amino Acid Transporter 1 Selective Liposomes of l-DOPA Functionalized Amphiphile for Combating Glioblastoma.Mol Pharm. 2017 Nov 6;14(11):3834-3847. doi: 10.1021/acs.molpharmaceut.7b00569. Epub 2017 Oct 10.
• [827] Global analysis of H3K4me3 and H3K27me3 profiles in glioblastoma stem cells and identification of SLC17A7 as a bivalent tumor suppressor gene.Oncotarget. 2015 Mar 10;6(7):5369-81. doi: 10.18632/oncotarget.3030.
• [828] Gefitinib inhibits sodium phosphate co-transporter III isoform 1 in a model of human malignant glioma.Anticancer Res. 2014 Nov;34(11):6527-35.
• [829] Expression of the zinc importer protein ZIP9/SLC39A9 in glioblastoma cells affects phosphorylation states of p53 and GSK-3 and causes increased cell migration.Biometals. 2016 Dec;29(6):995-1004. doi: 10.1007/s10534-016-9971-z. Epub 2016 Sep 21.
• [830] The human ABCB6 protein is the functional homologue of HMT-1 proteins mediating cadmium detoxification.Cell Mol Life Sci. 2019 Oct;76(20):4131-4144. doi: 10.1007/s00018-019-03105-5. Epub 2019 May 3.
• [831] MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma.Mol Cancer Res. 2016 Oct;14(10):984-993. doi: 10.1158/1541-7786.MCR-16-0172. Epub 2016 Jun 30.
• [832] Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.Nat Genet. 2017 May;49(5):789-794. doi: 10.1038/ng.3823. Epub 2017 Mar 27.
• [833] Genome-wide ChIP-seq analysis of EZH2-mediated H3K27me3 target gene profile highlights differences between low- and high-grade astrocytic tumors. Carcinogenesis. 2017 Feb 1;38(2):152-161.
• [834] HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells.Cancer Lett. 2010 Apr 1;290(1):58-67. doi: 10.1016/j.canlet.2009.08.028. Epub 2009 Sep 17.
• [835] In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma.Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7601-5. doi: 10.1073/pnas.89.16.7601.
• [836] Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity.BMC Cancer. 2014 Jun 4;14:401. doi: 10.1186/1471-2407-14-401.
• [837] Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma.Cancer Cell. 2017 Dec 11;32(6):856-868.e5. doi: 10.1016/j.ccell.2017.10.016. Epub 2017 Nov 30.
• [838] Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets.Neuro Oncol. 2013 Feb;15(2):172-88. doi: 10.1093/neuonc/nos298. Epub 2012 Dec 20.
• [839] Overexpression of SLC7A7 predicts poor progression-free and overall survival in patients with glioblastoma.Med Oncol. 2013 Mar;30(1):384. doi: 10.1007/s12032-012-0384-8. Epub 2013 Feb 14.
• [840] The Candidate Tumor Suppressor Gene SLC8A2 Inhibits Invasion, Angiogenesis and Growth of Glioblastoma.Mol Cells. 2017 Oct;40(10):761-772. doi: 10.14348/molcells.2017.0104. Epub 2017 Oct 17.
• [841] A gain of function paradox: Targeted therapy for glioblastoma associated with abnormal NHE9 expression.J Cell Mol Med. 2019 Nov;23(11):7859-7872. doi: 10.1111/jcmm.14665. Epub 2019 Sep 18.
• [842] Vesicle amine transport protein-1 (VAT-1) is upregulated in glioblastomas and promotes migration.Neuropathol Appl Neurobiol. 2009 Aug;35(4):342-52. doi: 10.1111/j.1365-2990.2009.00993.x.
• [843] L-Carnitine-Mediated Tumor Cell Protection and Poor Patient Survival Associated with OCTN2 Overexpression in Glioblastoma Multiforme.Clin Cancer Res. 2019 May 1;25(9):2874-2886. doi: 10.1158/1078-0432.CCR-18-2380. Epub 2019 Jan 22.
• [844] Local histone acetylation by ACSS2 promotes gene transcription for lysosomal biogenesis and autophagy.Autophagy. 2017 Oct 3;13(10):1790-1791. doi: 10.1080/15548627.2017.1349581. Epub 2017 Aug 18.
• [845] miR-204 functions as a tumor suppressor gene, at least partly by suppressing CYP27A1 in glioblastoma.Oncol Lett. 2018 Aug;16(2):1439-1448. doi: 10.3892/ol.2018.8846. Epub 2018 May 30.
• [846] Depletion of gamma-glutamylcyclotransferase inhibits cancer cell growth by activating the AMPK-FOXO3a-p21 axis.Biochem Biophys Res Commun. 2019 Sep 17;517(2):238-243. doi: 10.1016/j.bbrc.2019.07.049. Epub 2019 Jul 22.
• [847] Preclinical analysis of human mesenchymal stem cells: tumor tropism and therapeutic efficiency of local HSV-TK suicide gene therapy in glioblastoma.Oncotarget. 2019 Oct 22;10(58):6049-6061. doi: 10.18632/oncotarget.27071. eCollection 2019 Oct 22.
• [848] Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression.Oncotarget. 2017 Feb 28;8(9):14666-14679. doi: 10.18632/oncotarget.14716.
• [849] Proline oxidase controls proline, glutamate, and glutamine cellular concentrations in a U87 glioblastoma cell line.PLoS One. 2018 Apr 25;13(4):e0196283. doi: 10.1371/journal.pone.0196283. eCollection 2018.
• [850] Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma.Mol Oncol. 2018 Jun;12(7):1188-1202. doi: 10.1002/1878-0261.12320. Epub 2018 May 29.
• [851] Targeting UDP--D-glucose 6-dehydrogenase inhibits glioblastoma growth and migration.Oncogene. 2018 May;37(20):2615-2629. doi: 10.1038/s41388-018-0138-y. Epub 2018 Feb 26.
• [852] Author Correction: AMP kinase promotes glioblastoma bioenergetics and tumour growth.Nat Cell Biol. 2018 Nov;20(11):1328. doi: 10.1038/s41556-018-0203-3.
• [853] Progenitor/Stem Cell Markers in Brain Adjacent to Glioblastoma: GD3 Ganglioside and NG2 Proteoglycan Expression.J Neuropathol Exp Neurol. 2016 Feb;75(2):134-47. doi: 10.1093/jnen/nlv012.
• [854] Expression of glutathione S-transferase T1 (GSTT1) in human brain tumours. Histol Histopathol. 2006 Nov;21(11):1199-207.
• [855] Cytotoxicity against tumor cell lines and anti-inflammatory properties of chitinases from Calotropis procera latex.Naunyn Schmiedebergs Arch Pharmacol. 2017 Oct;390(10):1005-1013. doi: 10.1007/s00210-017-1397-9. Epub 2017 Jul 11.
• [856] TGX-221 inhibits proliferation and induces apoptosis in human glioblastoma cells.Oncol Rep. 2017 Nov;38(5):2836-2842. doi: 10.3892/or.2017.5991. Epub 2017 Sep 22.
• [857] HARP111-136 enhances radiation-induced apoptosis of U87MG glioblastoma by induction of the proapoptotic protein CHOP.Int J Oncol. 2011 Jan;38(1):179-88.
• [858] Expression analysis of CYP27B1 in tumor biopsies and cell cultures.Anticancer Res. 2006 Jul-Aug;26(4A):2683-6.
• [859] Rabbit cytochrome P450 4B1: A novel prodrug activating gene for pharmacogene therapy of hepatocellular carcinoma.Cancer Gene Ther. 2000 Jul;7(7):1008-14. doi: 10.1038/sj.cgt.7700190.
• [860] Transfection with GLS2 Glutaminase (GAB) Sensitizes Human Glioblastoma Cell Lines to Oxidative Stress by a Common Mechanism Involving Suppression of the PI3K/AKT Pathway.Cancers (Basel). 2019 Jan 19;11(1):115. doi: 10.3390/cancers11010115.
• [861] Hypermethylated gene ANKDD1A is a candidate tumor suppressor that interacts with FIH1 and decreases HIF1 stability to inhibit cell autophagy in the glioblastoma multiforme hypoxia microenvironment.Oncogene. 2019 Jan;38(1):103-119. doi: 10.1038/s41388-018-0423-9. Epub 2018 Aug 6.
• [862] The dystroglycan receptor maintains glioma stem cells in the vascular niche.Acta Neuropathol. 2019 Dec;138(6):1033-1052. doi: 10.1007/s00401-019-02069-x. Epub 2019 Aug 28.
• [863] Metallothionein Genes are Highly Expressed in Malignant Astrocytomas and Associated with Patient Survival.Sci Rep. 2019 Apr 1;9(1):5406. doi: 10.1038/s41598-019-41974-9.
• [864] Oxidative stress and apoptosis in homocystinuria patients with genetic remethylation defects.J Cell Biochem. 2013 Jan;114(1):183-91. doi: 10.1002/jcb.24316.
• [865] DJ-1 expression in glioblastomas shows positive correlation with p53 expression and negative correlation with epidermal growth factor receptor amplification.Neuropathology. 2011 Feb;31(1):29-37. doi: 10.1111/j.1440-1789.2010.01124.x.
• [866] Expression of cancer/testis antigens is correlated with improved survival in glioblastoma.Oncotarget. 2013 Apr;4(4):636-46. doi: 10.18632/oncotarget.950.
• [867] Loss of prostaglandin D2 synthase: a key molecular event in the transition of a low-grade astrocytoma to an anaplastic astrocytoma.Mol Cancer Ther. 2008 Oct;7(10):3420-8. doi: 10.1158/1535-7163.MCT-08-0629.
• [868] Identification of UGP2 as a progression marker that promotes cell growth and motility in human glioma.J Cell Biochem. 2019 Aug;120(8):12489-12499. doi: 10.1002/jcb.28515. Epub 2019 Feb 28.
• [869] Suicide gene therapy with an adenovirus expressing the fusion gene CD::UPRT in human glioblastomas: different sensitivities correlate with p53 status.J Gene Med. 2004 Dec;6(12):1320-32. doi: 10.1002/jgm.611.
• [870] Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma.PLoS One. 2015 May 1;10(5):e0123544. doi: 10.1371/journal.pone.0123544. eCollection 2015.
• [871] Nicotinamide metabolism regulates glioblastoma stem cell maintenance.JCI Insight. 2017 May 18;2(10):e90019. doi: 10.1172/jci.insight.90019. eCollection 2017 May 18.
• [872] The polyamine catabolic enzyme SAT1 modulates tumorigenesis and radiation response in GBM.Cancer Res. 2014 Dec 1;74(23):6925-34. doi: 10.1158/0008-5472.CAN-14-1249. Epub 2014 Oct 2.
• [873] ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.J Neurooncol. 2018 Jul;138(3):479-486. doi: 10.1007/s11060-018-2819-3. Epub 2018 Mar 8.
• [874] MiR-145 inhibits the epithelial-to-mesenchymal transition via targeting ADAM19 in human glioblastoma.Oncotarget. 2017 Sep 30;8(54):92545-92554. doi: 10.18632/oncotarget.21442. eCollection 2017 Nov 3.
• [875] PI3K/AKT/Afadin signaling pathway contributes to pathological vascularization in glioblastomas.Oncol Lett. 2018 Feb;15(2):1893-1899. doi: 10.3892/ol.2017.7461. Epub 2017 Nov 21.
• [876] Paucimannosidic glycoepitopes inhibit tumorigenic processes in glioblastoma multiforme.Oncotarget. 2019 Jul 9;10(43):4449-4465. doi: 10.18632/oncotarget.27056. eCollection 2019 Jul 9.
• [877] Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma.Acta Neuropathol Commun. 2018 Aug 21;6(1):81. doi: 10.1186/s40478-018-0583-4.
• [878] Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.PLoS One. 2017 Aug 2;12(8):e0180541. doi: 10.1371/journal.pone.0180541. eCollection 2017.
• [879] ALG2 regulates glioblastoma cell proliferation, migration and tumorigenicity.Biochem Biophys Res Commun. 2017 Apr 29;486(2):300-306. doi: 10.1016/j.bbrc.2017.03.032. Epub 2017 Mar 12.
• [880] N(6)-methyladenine DNA Modification in Glioblastoma.Cell. 2018 Nov 15;175(5):1228-1243.e20. doi: 10.1016/j.cell.2018.10.006. Epub 2018 Nov 1.
• [881] Potential role of annexin A7 in cancers.Clin Chim Acta. 2013 Aug 23;423:83-9. doi: 10.1016/j.cca.2013.04.018. Epub 2013 Apr 29.
• [882] Improving the estimation of prognosis for glioblastoma patients by MR based hemodynamic tissue signatures.NMR Biomed. 2018 Dec;31(12):e4006. doi: 10.1002/nbm.4006. Epub 2018 Sep 21.
• [883] Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness.Acta Neuropathol. 2018 Feb;135(2):267-283. doi: 10.1007/s00401-017-1783-x. Epub 2017 Nov 17.
• [884] ATP5A1 and ATP5B are highly expressed in glioblastoma tumor cells and endothelial cells of microvascular proliferation.J Neurooncol. 2016 Feb;126(3):405-13. doi: 10.1007/s11060-015-1984-x. Epub 2015 Nov 2.
• [885] Bag-1 and Bcl-2 gene transfer in malignant glioma: modulation of cell cycle regulation and apoptosis.Brain Pathol. 2000 Apr;10(2):223-34. doi: 10.1111/j.1750-3639.2000.tb00256.x.
• [886] Basic transcription factor 3 (BTF3) regulates transcription of tumor-associated genes in pancreatic cancer cells.Cancer Biol Ther. 2007 Mar;6(3):367-76. doi: 10.4161/cbt.6.3.3704. Epub 2007 Mar 13.
• [887] Trifluoperazine, a Well-Known Antipsychotic, Inhibits Glioblastoma Invasion by Binding to Calmodulin and Disinhibiting Calcium Release Channel IP3R.Mol Cancer Ther. 2017 Jan;16(1):217-227. doi: 10.1158/1535-7163.MCT-16-0169-T. Epub 2016 Nov 9.
• [888] Targeting of BMI-1 with PTC-209 inhibits glioblastoma development.Cell Cycle. 2018;17(10):1199-1211. doi: 10.1080/15384101.2018.1469872. Epub 2018 Jul 23.
• [889] Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8.J Extracell Vesicles. 2018 Mar 13;7(1):1446660. doi: 10.1080/20013078.2018.1446660. eCollection 2018.
• [890] Identification of WISP1 as a novel oncogene in glioblastoma.Int J Oncol. 2017 Oct;51(4):1261-1270. doi: 10.3892/ijo.2017.4119. Epub 2017 Sep 5.
• [891] Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation.Cell Rep. 2019 Feb 12;26(7):1893-1905.e7. doi: 10.1016/j.celrep.2019.01.076.
• [892] Cord blood natural killer cells expressing a dominant negative TGF- receptor: Implications for adoptive immunotherapy for glioblastoma.Cytotherapy. 2017 Mar;19(3):408-418. doi: 10.1016/j.jcyt.2016.12.005. Epub 2017 Jan 19.
• [893] Tax-interacting protein 1 coordinates the spatiotemporal activation of Rho GTPases and regulates the infiltrative growth of human glioblastoma.Oncogene. 2014 Mar 20;33(12):1558-69. doi: 10.1038/onc.2013.97. Epub 2013 Apr 8.
• [894] Regulation of myeloid leukemia factor-1 interacting protein (MLF1IP) expression in glioblastoma.Brain Res. 2005 Jun 14;1047(1):56-64. doi: 10.1016/j.brainres.2005.04.017.
• [895] Characterization of a FOXG1:TLE1 transcriptional network in glioblastoma-initiating cells.Mol Oncol. 2018 Jun;12(6):775-787. doi: 10.1002/1878-0261.12168. Epub 2018 Apr 27.
• [896] MiR?00a?p promotes glioblastoma cell proliferation, migration and invasion by targeting chromodomain helicase DNA binding protein 5.Mol Med Rep. 2018 Sep;18(3):2689-2696. doi: 10.3892/mmr.2018.9259. Epub 2018 Jul 9.
• [897] CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR.Oncogene. 2017 Feb 23;36(8):1134-1144. doi: 10.1038/onc.2016.280. Epub 2016 Aug 22.
• [898] A pathogenic CtBP1 missense mutation causes altered cofactor binding and transcriptional activity.Neurogenetics. 2019 Aug;20(3):129-143. doi: 10.1007/s10048-019-00578-1. Epub 2019 Apr 30.
• [899] Knockdown of Collagen Triple Helix Repeat Containing 1 (CTHRC1) Inhibits Epithelial-Mesenchymal Transition and Cellular Migration in Glioblastoma Cells.Oncol Res. 2017 Jan 26;25(2):225-232. doi: 10.3727/096504016X14732772150587.
• [900] CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide.Neuro Oncol. 2018 Mar 27;20(4):484-493. doi: 10.1093/neuonc/nox178.
• [901] Overexpression and Nucleolar Localization of -Tubulin Small Complex Proteins GCP2 and GCP3 in Glioblastoma.J Neuropathol Exp Neurol. 2015 Jul;74(7):723-42. doi: 10.1097/NEN.0000000000000212.
• [902] Daam1 activates RhoA to regulate Wnt5ainduced glioblastoma cell invasion.Oncol Rep. 2018 Feb;39(2):465-472. doi: 10.3892/or.2017.6124. Epub 2017 Dec 1.
• [903] Loss of DCC expression and glioma progression.Cancer Res. 1997 Feb 1;57(3):382-6.
• [904] Ectopic doublecortin gene expression suppresses the malignant phenotype in glioblastoma cells.Cancer Res. 2006 Dec 15;66(24):11726-35. doi: 10.1158/0008-5472.CAN-06-1978.
• [905] Dihydroceramide desaturase inhibitors induce autophagy via dihydroceramide-dependent and independent mechanisms.Biochim Biophys Acta Gen Subj. 2017 Feb;1861(2):264-275. doi: 10.1016/j.bbagen.2016.11.033. Epub 2016 Nov 25.
• [906] Differential Toxicity of mDia Formin-Directed Functional Agonists and Antagonists in Developing Zebrafish.Front Pharmacol. 2018 Apr 10;9:340. doi: 10.3389/fphar.2018.00340. eCollection 2018.
• [907] Identification of a novel gene product, RIG, that is down-regulated in human glioblastoma.Oncogene. 1997 Mar 6;14(9):1075-81. doi: 10.1038/sj.onc.1200925.
• [908] Death-associated protein 3 (Dap-3) is overexpressed in invasive glioblastoma cells in vivo and in glioma cell lines with induced motility phenotype in vitro.Clin Cancer Res. 2001 Aug;7(8):2480-9.
• [909] DOCK4 promotes loss of proliferation in glioblastoma progenitor cells through nuclear beta-catenin accumulation and subsequent miR-302-367 cluster expression.Oncogene. 2018 Jan 11;37(2):241-254. doi: 10.1038/onc.2017.323. Epub 2017 Sep 18.
• [910] Impact of oxygen status on 10B-BPA uptake into human glioblastoma cells, referring to significance in boron neutron capture therapy.J Radiat Res. 2018 Mar 1;59(2):122-128. doi: 10.1093/jrr/rrx080.
• [911] NADPH Oxidases NOXs and DUOXs as putative targets for cancer therapy.Anticancer Agents Med Chem. 2013 Mar;13(3):502-14.
• [912] Amplification and expression of splice variants of the gene encoding the P450 cytochrome 25-hydroxyvitamin D(3) 1,alpha-hydroxylase (CYP 27B1) in human malignant glioma.Clin Cancer Res. 2001 Apr;7(4):868-75.
• [913] Dual-specificity phosphatase DUSP6 has tumor-promoting properties in human glioblastomas.Oncogene. 2011 Sep 1;30(35):3813-20. doi: 10.1038/onc.2011.99. Epub 2011 Apr 18.
• [914] Expression Levels and Localizations of DVL3 and sFRP3 in Glioblastoma.Dis Markers. 2017;2017:9253495. doi: 10.1155/2017/9253495. Epub 2017 Oct 19.
• [915] Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2.Brain. 2019 Aug 1;142(8):2352-2366. doi: 10.1093/brain/awz202.
• [916] Development of a Function-Blocking Antibody Against Fibulin-3 as a Targeted Reagent for Glioblastoma.Clin Cancer Res. 2018 Feb 15;24(4):821-833. doi: 10.1158/1078-0432.CCR-17-1628. Epub 2017 Nov 16.
• [917] Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma.Neuro Oncol. 2018 Mar 27;20(4):506-518. doi: 10.1093/neuonc/nox182.
• [918] EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis.Mol Cancer. 2018 Nov 23;17(1):166. doi: 10.1186/s12943-018-0911-0.
• [919] 15-methoxypuupehenol Induces Antitumor Effects In Vitro and In Vivo against Human Glioblastoma and Breast Cancer Models.Mol Cancer Ther. 2017 Apr;16(4):601-613. doi: 10.1158/1535-7163.MCT-16-0291. Epub 2017 Jan 9.
• [920] LINC00470 Coordinates the Epigenetic Regulation of ELFN2 to Distract GBM Cell Autophagy.Mol Ther. 2018 Sep 5;26(9):2267-2281. doi: 10.1016/j.ymthe.2018.06.019. Epub 2018 Jun 27.
• [921] Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.Int J Biochem Cell Biol. 2012 Feb;44(2):302-10. doi: 10.1016/j.biocel.2011.10.025. Epub 2011 Nov 7.
• [922] HGF-induced formation of the MET-AXL-ELMO2-DOCK180 complex promotes RAC1 activation, receptor clustering, and cancer cell migration and invasion.J Biol Chem. 2018 Oct 5;293(40):15397-15418. doi: 10.1074/jbc.RA118.003063. Epub 2018 Aug 14.
• [923] Epithelial Membrane Protein-2 (EMP2) Antibody Blockade Reduces Corneal Neovascularization in an In Vivo Model.Invest Ophthalmol Vis Sci. 2019 Jan 2;60(1):245-254. doi: 10.1167/iovs.18-24345.
• [924] High EMP3 expression might independently predict poor overall survival in glioblastoma and its expression is related to DNA methylation.Medicine (Baltimore). 2018 Jan;97(1):e9538. doi: 10.1097/MD.0000000000009538.
• [925] Alterations of the RRAS and ERCC1 genes at 19q13 in gemistocytic astrocytomas.J Neuropathol Exp Neurol. 2014 Oct;73(10):908-15. doi: 10.1097/NEN.0000000000000110.
• [926] Cytotoxic stress induces transfer of mitochondria-associated human endogenous retroviral RNA and proteins between cancer cells.Oncotarget. 2017 Oct 7;8(56):95945-95964. doi: 10.18632/oncotarget.21606. eCollection 2017 Nov 10.
• [927] Investigating tumor perfusion by hyperpolarized (13) C MRI with comparison to conventional gadolinium contrast-enhanced MRI and pathology in orthotopic human GBM xenografts.Magn Reson Med. 2017 Feb;77(2):841-847. doi: 10.1002/mrm.26155. Epub 2016 Feb 19.
• [928] Expression signatures of DNA repair genes correlate with survival prognosis of astrocytoma patients.Tumour Biol. 2017 Apr;39(4):1010428317694552. doi: 10.1177/1010428317694552.
• [929] Prognostic value of DNA repair genes based on stratification of glioblastomas.Oncotarget. 2017 Apr 27;8(35):58222-58230. doi: 10.18632/oncotarget.17452. eCollection 2017 Aug 29.
• [930] Potential mechanisms of microRNA-129-5p in inhibiting cell processes including viability, proliferation, migration and invasiveness of glioblastoma cells U87 through targeting FNDC3B.Biomed Pharmacother. 2017 Mar;87:405-411. doi: 10.1016/j.biopha.2016.12.100. Epub 2017 Jan 6.
• [931] Combinatorial Synthesis of New Pyrimidine- and Purine--d-Ribonucleoside Nucleolipids: Their Distribution Between Aqueous and Organic Phases and Their In Vitro Activity Against Human- and Rat Glioblastoma Cells In Vitro.Chem Biodivers. 2018 Sep;15(9):e1800173. doi: 10.1002/cbdv.201800173. Epub 2018 Aug 20.
• [932] Silencing of Forkhead box D1 inhibits proliferation and migration in glioma cells.Oncol Rep. 2017 Feb;37(2):1196-1202. doi: 10.3892/or.2017.5344. Epub 2017 Jan 2.
• [933] MicroRNA-1 suppresses glioblastoma in preclinical models by targeting fibronectin.Cancer Lett. 2019 Nov 28;465:59-67. doi: 10.1016/j.canlet.2019.08.021. Epub 2019 Sep 3.
• [934] Mitochondrial enzyme GLUD2 plays a critical role in glioblastoma progression.EBioMedicine. 2018 Nov;37:56-67. doi: 10.1016/j.ebiom.2018.10.008. Epub 2018 Oct 9.
• [935] -3 and -6 Fatty Acids Modulate Conventional and Atypical Protein Kinase C Activities in a Brain Fatty Acid Binding Protein Dependent Manner in Glioblastoma Multiforme.Nutrients. 2018 Apr 6;10(4):454. doi: 10.3390/nu10040454.
• [936] Effective treatment of experimental U-87MG human glioblastoma in nude mice with a targeted cytotoxic bombesin analogue, AN-215.Br J Cancer. 2002 Apr 22;86(8):1322-7. doi: 10.1038/sj.bjc.6600235.
• [937] HBP1 phosphorylation by AKT regulates its transcriptional activity and glioblastoma cell proliferation.Cell Signal. 2018 Apr;44:158-170. doi: 10.1016/j.cellsig.2018.01.014. Epub 2018 Feb 16.
• [938] Signal Peptide Peptidase, Encoded by HM13, Contributes to Tumor Progression by Affecting EGFRvIII Secretion Profiles in Glioblastoma.CNS Neurosci Ther. 2017 Mar;23(3):257-265. doi: 10.1111/cns.12672.
• [939] HMGB3 promotes the proliferation and metastasis of glioblastoma and is negatively regulated by miR-200b-3p and miR-200c-3p.Cell Biochem Funct. 2018 Oct;36(7):357-365. doi: 10.1002/cbf.3355. Epub 2018 Sep 19.
• [940] Targeting Long Noncoding RNA HMMR-AS1 Suppresses and Radiosensitizes Glioblastoma.Neoplasia. 2018 May;20(5):456-466. doi: 10.1016/j.neo.2018.02.010. Epub 2018 Mar 22.
• [941] Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.J Exp Clin Cancer Res. 2018 Oct 30;37(1):265. doi: 10.1186/s13046-018-0941-x.
• [942] A Risk Classification System With Five-Gene for Survival Prediction of Glioblastoma Patients.Front Neurol. 2019 Jul 16;10:745. doi: 10.3389/fneur.2019.00745. eCollection 2019.
• [943] Homeobox C9 suppresses Beclin1-mediated autophagy in glioblastoma by directly inhibiting the transcription of death-associated protein kinase 1.Neuro Oncol. 2016 Jun;18(6):819-29. doi: 10.1093/neuonc/nov281. Epub 2015 Nov 17.
• [944] miR-23a promotes invasion of glioblastoma via HOXD10-regulated glial-mesenchymal transition.Signal Transduct Target Ther. 2018 Dec 28;3:33. doi: 10.1038/s41392-018-0033-6. eCollection 2018.
• [945] MCCK1 enhances the anticancer effect of temozolomide in attenuating the invasion, migration and epithelial-mesenchymal transition of glioblastoma cells in vitro and in vivo.Cancer Med. 2019 Feb;8(2):751-760. doi: 10.1002/cam4.1951. Epub 2019 Jan 18.
• [946] ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways.Oncogene. 2018 Jan 18;37(3):286-301. doi: 10.1038/onc.2017.324. Epub 2017 Sep 18.
• [947] Targeting glioma stem-like cell survival and chemoresistance through inhibition of lysine-specific histone demethylase KDM2B.Mol Oncol. 2018 Mar;12(3):406-420. doi: 10.1002/1878-0261.12174. Epub 2018 Feb 12.
• [948] Increased expression of the histone H3 lysine 4 methyltransferase MLL4 and the histone H3 lysine 27 demethylase UTX prolonging the overall survival of patients with glioblastoma and a methylated MGMT promoter.J Neurosurg. 2017 May;126(5):1461-1471. doi: 10.3171/2016.4.JNS1652. Epub 2016 Jul 1.
• [949] Label-Free Protein-RNA Interactome Analysis Identifies Khsrp Signaling Downstream of the p38/Mk2 Kinase Complex as a Critical Modulator of Cell Cycle Progression.PLoS One. 2015 May 20;10(5):e0125745. doi: 10.1371/journal.pone.0125745. eCollection 2015.
• [950] Long noncoding RNA-RNCR3 overexpression deleteriously affects the growth of glioblastoma cells through miR-185-5p/Krppel-like factor 16 axis.J Cell Biochem. 2018 Nov;119(11):9081-9089. doi: 10.1002/jcb.27167. Epub 2018 Jun 28.
• [951] KLRC3, a Natural Killer receptor gene, is a key factor involved in glioblastoma tumourigenesis and aggressiveness.J Cell Mol Med. 2017 Feb;21(2):244-253. doi: 10.1111/jcmm.12960. Epub 2016 Sep 19.
• [952] MLL5 Orchestrates a Cancer Self-Renewal State by Repressing the Histone Variant H3.3 and Globally Reorganizing Chromatin.Cancer Cell. 2015 Dec 14;28(6):715-729. doi: 10.1016/j.ccell.2015.10.005. Epub 2015 Nov 25.
• [953] Downregulation of Leucine-Rich Repeat-Containing 8A Limits Proliferation and Increases Sensitivity of Glioblastoma to Temozolomide and Carmustine.Front Oncol. 2018 May 7;8:142. doi: 10.3389/fonc.2018.00142. eCollection 2018.
• [954] Clonal evolution of glioblastoma under therapy.Nat Genet. 2016 Jul;48(7):768-76. doi: 10.1038/ng.3590. Epub 2016 Jun 6.
• [955] A molecular cascade modulates MAP1B and confers resistance to mTOR inhibition in human glioblastoma.Neuro Oncol. 2018 May 18;20(6):764-775. doi: 10.1093/neuonc/nox215.
• [956] Sinomenine Hydrochloride Inhibits the Metastasis of Human Glioblastoma Cells by Suppressing the Expression of Matrix Metalloproteinase-2/-9 and Reversing the Endogenous and Exogenous Epithelial-Mesenchymal Transition.Int J Mol Sci. 2018 Mar 14;19(3):844. doi: 10.3390/ijms19030844.
• [957] Hydrogen sulfide generation from l-cysteine in the human glioblastoma-astrocytoma U-87 MG and neuroblastoma SHSY5Y cell lines.Acta Biochim Pol. 2017;64(1):171-176. doi: 10.18388/abp.2016_1394. Epub 2017 Mar 14.
• [958] Suppression of p53-inducible gene 3 is significant for glioblastoma progression and predicts poor patient prognosis.Tumour Biol. 2017 Mar;39(3):1010428317694572. doi: 10.1177/1010428317694572.
• [959] Targeting dual specificity protein kinase TTK attenuates tumorigenesis of glioblastoma.Oncotarget. 2017 Dec 11;9(3):3081-3088. doi: 10.18632/oncotarget.23152. eCollection 2018 Jan 9.
• [960] MTSS1 is epigenetically regulated in glioma cells and inhibits glioma cell motility.Transl Oncol. 2017 Feb;10(1):70-79. doi: 10.1016/j.tranon.2016.11.006. Epub 2016 Dec 15.
• [961] Overexpression of human MX2 gene suppresses cell proliferation, migration, and invasion via ERK/P38/NF-B pathway in glioblastoma cells.J Cell Biochem. 2019 Nov;120(11):18762-18770. doi: 10.1002/jcb.29189. Epub 2019 Jul 2.
• [962] Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma.J Clin Pathol. 2019 Oct;72(10):677-681. doi: 10.1136/jclinpath-2019-205834. Epub 2019 Jul 3.
• [963] Gene amplification in human gliomas.Glia. 1995 Nov;15(3):289-96. doi: 10.1002/glia.440150309.
• [964] Genetic alterations of the NRP/B gene are associated with human brain tumors.Oncogene. 2004 Aug 5;23(35):5890-900. doi: 10.1038/sj.onc.1207776.
• [965] Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor.Cell. 2018 Jan 25;172(3):534-548.e19. doi: 10.1016/j.cell.2017.11.037. Epub 2017 Dec 21.
• [966] NDRG2 and NDRG4 Expression Is Altered in Glioblastoma and Influences Survival in Patients with MGMT-methylated Tumors.Anticancer Res. 2016 Mar;36(3):887-97.
• [967] MiRNA-191 functions as an oncogene in primary glioblastoma by directly targeting NDST1.Eur Rev Med Pharmacol Sci. 2019 Jul;23(14):6242-6249. doi: 10.26355/eurrev_201907_18443.
• [968] The NFL-TBS.40-63 peptide targets and kills glioblastoma stem cells derived from human patients and also targets nanocapsules into these cells.Int J Pharm. 2019 Jul 20;566:218-228. doi: 10.1016/j.ijpharm.2019.05.060. Epub 2019 May 24.
• [969] Differences between phosphotyrosine accumulation and Neu/ErbB-2 receptor expression in astrocytic proliferative processes. Implications for glial oncogenesis.Cancer. 1996 Sep 15;78(6):1272-83. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1272::AID-CNCR16>3.0.CO;2-Y.
• [970] p53 and miR-210 regulated NeuroD2, a neuronal basic helix-loop-helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironment.Int J Cancer. 2018 May 1;142(9):1817-1828. doi: 10.1002/ijc.31209. Epub 2017 Dec 23.
• [971] NFAT2-HDAC1 signaling contributes to the malignant phenotype of glioblastoma.Neuro Oncol. 2020 Jan 11;22(1):46-57. doi: 10.1093/neuonc/noz136.
• [972] The lncRNA H19 positively affects the tumorigenic properties of glioblastoma cells and contributes to NKD1 repression through the recruitment of EZH2 on its promoter.Oncotarget. 2018 Feb 14;9(21):15512-15525. doi: 10.18632/oncotarget.24496. eCollection 2018 Mar 20.
• [973] In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma.Oncotarget. 2015 Aug 21;6(24):20145-59. doi: 10.18632/oncotarget.3980.
• [974] Naphthalene diimide-derivatives G-quadruplex ligands induce cell proliferation inhibition, mild telomeric dysfunction and cell cycle perturbation in U251MG glioma cells.FEBS J. 2018 Oct;285(20):3769-3785. doi: 10.1111/febs.14628. Epub 2018 Sep 24.
• [975] Circadian regulator NR1D2 regulates glioblastoma cell proliferation and motility.Oncogene. 2018 Aug;37(35):4838-4853. doi: 10.1038/s41388-018-0319-8. Epub 2018 May 18.
• [976] New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection.Oncotarget. 2018 Jan 9;9(6):7219-7270. doi: 10.18632/oncotarget.24102. eCollection 2018 Jan 23.
• [977] Analysis of the bHLH transcription factors Olig1 and Olig2 in brain tumors.J Neurooncol. 2004 May;67(3):265-71. doi: 10.1023/b:neon.0000024190.56750.81.
• [978] Design, Synthesis, and Biological Evaluation of Novel Allosteric Protein Disulfide Isomerase Inhibitors.J Med Chem. 2019 Apr 11;62(7):3447-3474. doi: 10.1021/acs.jmedchem.8b01951. Epub 2019 Apr 2.
• [979] Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.J Neurooncol. 2017 Jan;131(2):233-244. doi: 10.1007/s11060-016-2298-3. Epub 2016 Oct 21.
• [980] Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors.Neuro Oncol. 2017 Feb 1;19(2):219-228. doi: 10.1093/neuonc/now160.
• [981] PDIA6 regulation of ADAM17 shedding activity and EGFR-mediated migration and invasion of glioblastoma cells.J Neurosurg. 2017 Jun;126(6):1829-1838. doi: 10.3171/2016.5.JNS152831. Epub 2016 Aug 19.
• [982] PHF19 promotes the proliferation, migration, and chemosensitivity of glioblastoma to doxorubicin through modulation of the SIAH1/-catenin axis.Cell Death Dis. 2018 Oct 15;9(11):1049. doi: 10.1038/s41419-018-1082-z.
• [983] PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicing.Cancer Med. 2019 May;8(5):2429-2441. doi: 10.1002/cam4.2115. Epub 2019 Apr 1.
• [984] Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients.Mol Biol Rep. 2020 Feb;47(2):877-886. doi: 10.1007/s11033-019-05178-8. Epub 2019 Nov 12.
• [985] TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3.Mol Oncol. 2017 Mar;11(3):280-294. doi: 10.1002/1878-0261.12034. Epub 2017 Feb 15.
• [986] MiRNA-154-5p inhibits cell proliferation and metastasis by targeting PIWIL1 in glioblastoma.Brain Res. 2017 Dec 1;1676:69-76. doi: 10.1016/j.brainres.2017.08.014. Epub 2017 Aug 24.
• [987] Pharmacological effects of asiatic acid in glioblastoma cells under hypoxia.Mol Cell Biochem. 2017 Jun;430(1-2):179-190. doi: 10.1007/s11010-017-2965-5. Epub 2017 Feb 15.
• [988] Oncogenic miR?32 sustains proliferation and selfrenewal potential by inhibition of polypyrimidine tractbinding protein 2 in glioblastoma cells.Mol Med Rep. 2017 Nov;16(5):7221-7228. doi: 10.3892/mmr.2017.7572. Epub 2017 Sep 21.
• [989] The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme.Cancer Lett. 2019 Oct 10;462:33-42. doi: 10.1016/j.canlet.2019.07.018. Epub 2019 Aug 1.
• [990] Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6.Oncotarget. 2017 Apr 11;8(15):24949-24963. doi: 10.18632/oncotarget.15327.
• [991] Knockdown of Ras-Related Protein 25 (Rab25) Inhibits the In Vitro Cytotoxicity and In Vivo Antitumor Activity of Human Glioblastoma Multiforme Cells.Oncol Res. 2017 Mar 13;25(3):331-340. doi: 10.3727/096504016X14736286083065.
• [992] Functional Blockade of Small GTPase RAN Inhibits Glioblastoma Cell Viability.Front Oncol. 2019 Jan 8;8:662. doi: 10.3389/fonc.2018.00662. eCollection 2018.
• [993] RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1.Biochem Biophys Res Commun. 2019 Aug 27;516(3):999-1006. doi: 10.1016/j.bbrc.2019.06.097. Epub 2019 Jul 2.
• [994] Silencing LncRNA LOXL1-AS1 attenuates mesenchymal characteristics of glioblastoma via NF-B pathway.Biochem Biophys Res Commun. 2018 Jun 2;500(2):518-524. doi: 10.1016/j.bbrc.2018.04.133. Epub 2018 Apr 21.
• [995] RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastoma.Oncotarget. 2018 Sep 18;9(73):33788-33803. doi: 10.18632/oncotarget.26082. eCollection 2018 Sep 18.
• [996] RNF138-mediated ubiquitination of rpS3 is required for resistance of glioblastoma cells to radiation-induced apoptosis.Exp Mol Med. 2018 Jan 26;50(1):e434. doi: 10.1038/emm.2017.247.
• [997] The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types.Oncotarget. 2017 Feb 28;8(9):14462-14478. doi: 10.18632/oncotarget.14895.
• [998] Identification of Key Candidate Proteins and Pathways Associated with Temozolomide Resistance in Glioblastoma Based on Subcellular Proteomics and Bioinformatical Analysis.Biomed Res Int. 2018 Mar 1;2018:5238760. doi: 10.1155/2018/5238760. eCollection 2018.
• [999] Identification of an alternatively spliced RNA for the Ras suppressor RSU-1 in human gliomas.J Neurooncol. 2002 Dec;60(3):201-11. doi: 10.1023/a:1021130620178.
• [1000] Knockdown of RWD domain containing 3 inhibits the malignant phenotypes of glioblastoma cells via inhibition of phosphoinositide 3-kinase/protein kinase B signaling.Exp Ther Med. 2018 Jul;16(1):384-393. doi: 10.3892/etm.2018.6135. Epub 2018 May 7.
• [1001] Preliminary SAR on indole-3-carbinol and related fragments reveals a novel anticancer lead compound against resistant glioblastoma cells.Bioorg Med Chem Lett. 2017 Apr 1;27(7):1561-1565. doi: 10.1016/j.bmcl.2017.02.033. Epub 2017 Feb 17.
• [1002] miR-135a-5p and miR-124-3p Inhibit Malignancy of Glioblastoma by Downregulation of Syndecan Binding Protein.J Biomed Nanotechnol. 2018 Jul 1;14(7):1317-1329. doi: 10.1166/jbn.2018.2579.
• [1003] Traceable Nanoparticles with Dual Targeting and ROS Response for RNAi-Based Immunochemotherapy of Intracranial Glioblastoma Treatment.Adv Mater. 2018 May;30(18):e1705054. doi: 10.1002/adma.201705054. Epub 2018 Mar 25.
• [1004] The integrated landscape of driver genomic alterations in glioblastoma.Nat Genet. 2013 Oct;45(10):1141-9. doi: 10.1038/ng.2734. Epub 2013 Aug 5.
• [1005] SETMAR isoforms in glioblastoma: A matter of protein stability.Oncotarget. 2017 Feb 7;8(6):9835-9848. doi: 10.18632/oncotarget.14218.
• [1006] A tumor-targeting nanomedicine carrying the p53 gene crosses the blood-brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma.Int J Cancer. 2019 Nov 1;145(9):2535-2546. doi: 10.1002/ijc.32531. Epub 2019 Jul 8.
• [1007] Schlafen 11 Restricts Flavivirus Replication.J Virol. 2019 Jul 17;93(15):e00104-19. doi: 10.1128/JVI.00104-19. Print 2019 Aug 1.
• [1008] CCAAT/enhancer binding protein negatively regulates progesterone receptor expression in human glioblastoma cells.Mol Cell Endocrinol. 2017 Jan 5;439:317-327. doi: 10.1016/j.mce.2016.09.018. Epub 2016 Sep 20.
• [1009] Polyethylenimine-Spherical Nucleic Acid Nanoparticles against Gli1 Reduce the Chemoresistance and Stemness of Glioblastoma Cells.Mol Pharm. 2018 Nov 5;15(11):5135-5145. doi: 10.1021/acs.molpharmaceut.8b00707. Epub 2018 Oct 11.
• [1010] miR-152-3p Sensitizes Glioblastoma Cells Towards Cisplatin Via Regulation Of SOS1.Onco Targets Ther. 2019 Nov 11;12:9513-9525. doi: 10.2147/OTT.S210732. eCollection 2019.
• [1011] Roles of Kunitz domains in the anti-invasive effect of hepatocyte growth factor activator inhibitor type 1 in human glioblastoma cells.Hum Cell. 2007 Nov;20(4):100-6. doi: 10.1111/j.1749-0774.2007.00035.x.
• [1012] SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activation.J Neurooncol. 2019 May;142(3):423-434. doi: 10.1007/s11060-019-03126-x. Epub 2019 Mar 5.
• [1013] Sprouty2 enhances the tumorigenic potential of glioblastoma cells.Neuro Oncol. 2018 Jul 5;20(8):1044-1054. doi: 10.1093/neuonc/noy028.
• [1014] MicroRNA-145 Promotes the Phenotype of Human Glioblastoma Cells Selected for Invasion.Anticancer Res. 2015 Jun;35(6):3209-15.
• [1015] Knockdown of arsenic resistance protein 2 inhibits human glioblastoma cell proliferation through the MAPK/ERK pathway.Oncol Rep. 2018 Dec;40(6):3313-3322. doi: 10.3892/or.2018.6777. Epub 2018 Oct 9.
• [1016] Glioblastoma cells containing mutations in the cohesin component STAG2 are sensitive to PARP inhibition.Mol Cancer Ther. 2014 Mar;13(3):724-32. doi: 10.1158/1535-7163.MCT-13-0749. Epub 2013 Dec 19.
• [1017] LncRNA TRG-AS1 promotes glioblastoma cell proliferation by competitively binding with miR-877-5p to regulate SUZ12 expression.Pathol Res Pract. 2019 Aug;215(8):152476. doi: 10.1016/j.prp.2019.152476. Epub 2019 May 28.
• [1018] Tbx2 confers poor prognosis in glioblastoma and promotes temozolomide resistance with change of mitochondrial dynamics.Onco Targets Ther. 2017 Feb 20;10:1059-1069. doi: 10.2147/OTT.S124012. eCollection 2017.
• [1019] Analysis of chromatin accessibility uncovers TEAD1 as a regulator of migration in human glioblastoma.Nat Commun. 2018 Oct 1;9(1):4020. doi: 10.1038/s41467-018-06258-2.
• [1020] TET1 regulates DNA repair in human glial cells.Toxicol Appl Pharmacol. 2019 Oct 1;380:114646. doi: 10.1016/j.taap.2019.114646. Epub 2019 Jul 3.
• [1021] Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas.Neuropathol Appl Neurobiol. 2005 Oct;31(5):486-90. doi: 10.1111/j.1365-2990.2005.00660.x.
• [1022] TIGAR promotes growth, survival and metastasis through oxidation resistance and AKT activation in glioblastoma.Oncol Lett. 2019 Sep;18(3):2509-2517. doi: 10.3892/ol.2019.10574. Epub 2019 Jul 5.
• [1023] Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma.Neurosci Lett. 2017 Apr 3;645:106-112. doi: 10.1016/j.neulet.2017.02.076. Epub 2017 Mar 2.
• [1024] Potential targets of TMEM176A in the growth of glioblastoma cells.Onco Targets Ther. 2018 Nov 2;11:7763-7775. doi: 10.2147/OTT.S179725. eCollection 2018.
• [1025] The antitumor effect of TAT-DCF1 peptide in glioma cells.Neuropeptides. 2018 Oct;71:21-31. doi: 10.1016/j.npep.2018.06.004. Epub 2018 Jun 25.
• [1026] A Novel Signaling Complex between TROY and EGFR Mediates Glioblastoma Cell Invasion.Mol Cancer Res. 2018 Feb;16(2):322-332. doi: 10.1158/1541-7786.MCR-17-0454. Epub 2017 Nov 8.
• [1027] Frequent gene amplification and overexpression of decoy receptor 3 in glioblastoma.Acta Neuropathol. 2005 Mar;109(3):294-8. doi: 10.1007/s00401-004-0956-6. Epub 2004 Dec 31.
• [1028] TPD52L2 impacts proliferation, invasiveness and apoptosis of glioblastoma cells via modulation of wnt/-catenin/snail signaling.Carcinogenesis. 2018 Feb 9;39(2):214-224. doi: 10.1093/carcin/bgx125.
• [1029] Prognostic Significance of TNFR-Associated Factor 1 and 2 (TRAF1 and TRAF2) in Glioblastoma.Med Sci Monit. 2017 Sep 19;23:4506-4512. doi: 10.12659/msm.903397.
• [1030] TRAF3IP2, a novel therapeutic target in glioblastoma multiforme.Oncotarget. 2018 Jul 3;9(51):29772-29788. doi: 10.18632/oncotarget.25710. eCollection 2018 Jul 3.
• [1031] Ca2+-Activated IK K+ Channel Blockade Radiosensitizes Glioblastoma Cells.Mol Cancer Res. 2015 Sep;13(9):1283-95. doi: 10.1158/1541-7786.MCR-15-0075. Epub 2015 Jun 3.
• [1032] Mutual Stabilization between TRIM9 Short Isoform and MKK6 Potentiates p38 Signaling to Synergistically Suppress Glioblastoma Progression.Cell Rep. 2018 Apr 17;23(3):838-851. doi: 10.1016/j.celrep.2018.03.096.
• [1033] GPR124 regulates microtubule assembly, mitotic progression, and glioblastoma cell proliferation.Glia. 2019 Aug;67(8):1558-1570. doi: 10.1002/glia.23628. Epub 2019 May 6.
• [1034] Safety, tolerability, and pharmacokinetics of anti-EGFRvIII antibody-drug conjugate AMG 595 in patients with recurrent malignant glioma expressing EGFRvIII.Cancer Chemother Pharmacol. 2019 Aug;84(2):327-336. doi: 10.1007/s00280-019-03879-2. Epub 2019 Jun 1.
• [1035] Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction.Int J Cancer. 2006 Nov 15;119(10):2330-8. doi: 10.1002/ijc.22108.
• [1036] Involvement of BIG1 and BIG2 in regulating VEGF expression and angiogenesis.FASEB J. 2019 Sep;33(9):9959-9973. doi: 10.1096/fj.201900342RR. Epub 2019 Jun 14.
• [1037] Molecular Mechanism of Inhibition of Acid Ceramidase by Carmofur.J Med Chem. 2019 Jan 24;62(2):987-992. doi: 10.1021/acs.jmedchem.8b01723. Epub 2018 Dec 19.
• [1038] MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma.Cancer Cell. 2017 Dec 11;32(6):840-855.e8. doi: 10.1016/j.ccell.2017.11.005.
• [1039] Identification of CTRP1 as a Prognostic Biomarker and Oncogene in Human Glioblastoma.Biomed Res Int. 2019 Apr 30;2019:2582416. doi: 10.1155/2019/2582416. eCollection 2019.
• [1040] Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma.J Transl Med. 2019 May 28;17(1):179. doi: 10.1186/s12967-019-1930-3.
• [1041] Impaired circulating myeloid CD1c+ dendritic cell function in human glioblastoma is restored by p38 inhibition - implications for the next generation of DC vaccines.Oncoimmunology. 2019 Apr 13;8(7):1593803. doi: 10.1080/2162402X.2019.1593803. eCollection 2019.
• [1042] CDCA7L promotes glioma proliferation by targeting CCND1 and predicts an unfavorable prognosis.Mol Med Rep. 2019 Aug;20(2):1149-1156. doi: 10.3892/mmr.2019.10349. Epub 2019 Jun 5.
• [1043] Primary Glioblastoma of Cerebellopontine Angle in Adult Mimicking Acoustic Neuroma.World Neurosurg. 2019 Feb;122:48-52. doi: 10.1016/j.wneu.2018.10.073. Epub 2018 Oct 19.
• [1044] Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy.J Neurooncol. 2007 Jan;81(2):139-48. doi: 10.1007/s11060-006-9220-3. Epub 2006 Sep 27.
• [1045] Intron 1-Mediated Regulation of EGFR Expression in EGFR-Dependent Malignancies Is Mediated by AP-1 and BET Proteins.Mol Cancer Res. 2019 Nov;17(11):2208-2220. doi: 10.1158/1541-7786.MCR-19-0747. Epub 2019 Aug 23.
• [1046] Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells.Mol Cancer Res. 2012 Jul;10(7):958-68. doi: 10.1158/1541-7786.MCR-11-0616. Epub 2012 May 9.
• [1047] LINC01579 promotes cell proliferation by acting as a ceRNA of miR-139-5p to upregulate EIF4G2 expression in glioblastoma.J Cell Physiol. 2019 Dec;234(12):23658-23666. doi: 10.1002/jcp.28933. Epub 2019 Jun 11.
• [1048] Assessment of ApoC1, LuzP6, C12orf75 and OCC-1 in cystic glioblastoma using MALDI-TOF mass spectrometry, immunohistochemistry and qRT-PCR.Med Mol Morphol. 2019 Dec;52(4):217-225. doi: 10.1007/s00795-019-00223-8. Epub 2019 Apr 20.
• [1049] Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44.Cancer Res. 2018 May 15;78(10):2589-2600. doi: 10.1158/0008-5472.CAN-17-2933. Epub 2018 Feb 20.
• [1050] HJURP knockdown disrupts clonogenic capacity and increases radiation-induced cell death of glioblastoma cells.Cancer Gene Ther. 2020 May;27(5):319-329. doi: 10.1038/s41417-019-0103-0. Epub 2019 May 29.
• [1051] The association of HLA-DQB1, -DQA1 and -DPB1 alleles with anti- glomerular basement membrane (GBM) disease in Chinese patients.BMC Nephrol. 2011 May 13;12:21. doi: 10.1186/1471-2369-12-21.
• [1052] Inhibition of 13-cis retinoic acid-induced gene expression of homeobox B7 by thalidomide.Int J Cancer. 2007 Sep 15;121(6):1205-11. doi: 10.1002/ijc.22815.
• [1053] Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo.Neuro Oncol. 2010 Nov;12(11):1088-101. doi: 10.1093/neuonc/noq079. Epub 2010 Aug 2.
• [1054] Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1.Cancer Res. 2007 Mar 15;67(6):2552-8. doi: 10.1158/0008-5472.CAN-06-3870.
• [1055] Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH mutations in glioblastoma.PLoS One. 2011;6(5):e19868. doi: 10.1371/journal.pone.0019868. Epub 2011 May 23.
• [1056] [Corrigendum] LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFR signaling.Int J Oncol. 2019 Jun;54(6):2257. doi: 10.3892/ijo.2019.4769. Epub 2019 Apr 2.
• [1057] MicroRNA-139-3p suppresses growth and metastasis of glioblastoma via inhibition of NIN1/RPNI2 binding protein 1 homolog.Eur Rev Med Pharmacol Sci. 2019 May;23(10):4264-4274. doi: 10.26355/eurrev_201905_17931.
• [1058] Scaffolds biomimicking macrophages for a glioblastoma NIR-Ib imaging guided photothermal therapeutic strategy by crossing Blood-Brain Barrier.Biomaterials. 2019 Aug;211:48-56. doi: 10.1016/j.biomaterials.2019.04.026. Epub 2019 May 6.
• [1059] Nucleobindin-2 Promotes the Growth and Invasion of Glioblastoma.Cancer Biother Radiopharm. 2019 Nov;34(9):581-588. doi: 10.1089/cbr.2019.2829.
• [1060] ADARs and editing: The role of A-to-I RNA modification in cancer progression.Semin Cell Dev Biol. 2018 Jul;79:123-130. doi: 10.1016/j.semcdb.2017.11.018. Epub 2017 Nov 16.
• [1061] Expression of cellular adhesion molecule 'OPCML' is down-regulated in gliomas and other brain tumours.Neuropathol Appl Neurobiol. 2007 Feb;33(1):77-85. doi: 10.1111/j.1365-2990.2006.00786.x.
• [1062] lncRNAs combine and crosstalk with NSPc1 in ATRA-induced differentiation of U87 glioma cells.Oncol Lett. 2019 Jun;17(6):5821-5829. doi: 10.3892/ol.2019.10254. Epub 2019 Apr 15.
• [1063] Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis.J Neurooncol. 2010 Dec;100(3):449-57. doi: 10.1007/s11060-010-0201-1. Epub 2010 May 9.
• [1064] Genetic and bioinformatic analyses of the expression and function of PI3K regulatory subunit PIK3R3 in an Asian patient gastric cancer library.BMC Med Genomics. 2012 Aug 9;5:34. doi: 10.1186/1755-8794-5-34.
• [1065] Mislocalization of the E3 ligase, -transducin repeat-containing protein 1 (-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt.J Biol Chem. 2011 Jun 3;286(22):19777-88. doi: 10.1074/jbc.M111.237081. Epub 2011 Mar 28.
• [1066] Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial.J Neurooncol. 2019 Jul;143(3):447-455. doi: 10.1007/s11060-019-03175-2. Epub 2019 May 4.
• [1067] Oncogenic Role of MicroRNA-30b-5p in Glioblastoma Through Targeting Proline-Rich Transmembrane Protein 2.Oncol Res. 2018 Mar 5;26(2):219-230. doi: 10.3727/096504017X14944585873659. Epub 2017 May 17.
• [1068] EFA6A enhances glioma cell invasion through ADP ribosylation factor 6/extracellular signal-regulated kinase signaling.Cancer Res. 2006 Feb 1;66(3):1583-90. doi: 10.1158/0008-5472.CAN-05-2424.
• [1069] Knockdown of RAD18 inhibits glioblastoma development.J Cell Physiol. 2019 Nov;234(11):21100-21112. doi: 10.1002/jcp.28713. Epub 2019 May 12.
• [1070] PD-L1/PD-1 Axis in Glioblastoma Multiforme.Int J Mol Sci. 2019 Oct 28;20(21):5347. doi: 10.3390/ijms20215347.
• [1071] Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma.Med Sci Monit. 2019 May 16;25:3624-3635. doi: 10.12659/MSM.916648.
• [1072] Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas.Cancer Gene Ther. 2006 Apr;13(4):385-92. doi: 10.1038/sj.cgt.7700898.
• [1073] GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma.Cell Rep. 2017 Nov 21;21(8):2183-2197. doi: 10.1016/j.celrep.2017.10.083.
• [1074] Evidence of MTCBP-1 interaction with the cytoplasmic domain of MT1-MMP: Implications in the autophagy cell index of high-grade glioblastoma.Mol Carcinog. 2016 Feb;55(2):148-60. doi: 10.1002/mc.22264. Epub 2015 Jan 15.
• [1075] Mitochondrial AKAP1 supports mTOR pathway and tumor growth.Cell Death Dis. 2017 Jun 1;8(6):e2842. doi: 10.1038/cddis.2017.241.
• [1076] Hyperphosphorylation of CDH1 in Glioblastoma Cancer Stem Cells Attenuates APC/C(CDH1) Activity and Pharmacologic Inhibition of APC/C(CDH1/CDC20) Compromises Viability.Mol Cancer Res. 2019 Jul;17(7):1519-1530. doi: 10.1158/1541-7786.MCR-18-1361. Epub 2019 Apr 29.
• [1077] CD151-31 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion.Oncotarget. 2015 Oct 6;6(30):29675-93. doi: 10.18632/oncotarget.4896.
• [1078] Autophagy suppression potentiates the anti-glioblastoma effect of asparaginase in vitro and in vivo.Oncotarget. 2017 Jul 20;8(53):91052-91066. doi: 10.18632/oncotarget.19409. eCollection 2017 Oct 31.
• [1079] The ATF6 pathway of the ER stress response contributes to enhanced viability in glioblastoma.Oncotarget. 2016 Jan 12;7(2):2080-92. doi: 10.18632/oncotarget.6712.
• [1080] Regulation of hypoxia-induced autophagy in glioblastoma involves ATG9A.Br J Cancer. 2017 Sep 5;117(6):813-825. doi: 10.1038/bjc.2017.263. Epub 2017 Aug 10.
• [1081] Inactivation of the ATMIN/ATM pathway protects against glioblastoma formation.Elife. 2016 Mar 17;5:e08711. doi: 10.7554/eLife.08711.
• [1082] miR-30e Blocks Autophagy and Acts Synergistically with Proanthocyanidin for Inhibition of AVEN and BIRC6 to Increase Apoptosis in Glioblastoma Stem Cells and Glioblastoma SNB19 Cells.PLoS One. 2016 Jul 7;11(7):e0158537. doi: 10.1371/journal.pone.0158537. eCollection 2016.
• [1083] Interference with the HSF1/HSP70/BAG3 Pathway Primes Glioma Cells to Matrix Detachment and BH3 Mimetic-Induced Apoptosis.Mol Cancer Ther. 2017 Jan;16(1):156-168. doi: 10.1158/1535-7163.MCT-16-0262. Epub 2016 Oct 24.
• [1084] Inhibition of Bevacizumab-induced Epithelial-Mesenchymal Transition by BATF2 Overexpression Involves the Suppression of Wnt/-Catenin Signaling in Glioblastoma Cells.Anticancer Res. 2017 Aug;37(8):4285-4294. doi: 10.21873/anticanres.11821.
• [1085] miR?7a suppresses the clonogenic growth and migration of human glioblastoma multiforme cells by targeting BTG2.Int J Oncol. 2015 Apr;46(4):1601-8. doi: 10.3892/ijo.2015.2843. Epub 2015 Jan 22.
• [1086] Analysis of clinical characteristics of macrophage capping protein (CAPG) gene expressed in glioma based on TCGA data and clinical experiments.Oncol Lett. 2019 Aug;18(2):1344-1350. doi: 10.3892/ol.2019.10396. Epub 2019 May 23.
• [1087] Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151.Neoplasia. 2016 Mar;18(3):185-98. doi: 10.1016/j.neo.2016.02.003.
• [1088] Tumor image-derived texture features are associated with CD3 T-cell infiltration status in glioblastoma.Oncotarget. 2017 Sep 5;8(60):101244-101254. doi: 10.18632/oncotarget.20643. eCollection 2017 Nov 24.
• [1089] Myelin-forming cell-specific cadherin-19 is a marker for minimally infiltrative glioblastoma stem-like cells.J Neurosurg. 2015 Jan;122(1):69-77. doi: 10.3171/2014.9.JNS132373.
• [1090] Intersectin1-S, a multidomain adapter protein, is essential for malignant glioma proliferation.Glia. 2015 Sep;63(9):1595-605. doi: 10.1002/glia.22830. Epub 2015 Apr 2.
• [1091] A PTEN-COL17A1 fusion gene and its novel regulatory role in Collagen XVII expression and GBM malignance.Oncotarget. 2017 Aug 24;8(49):85794-85803. doi: 10.18632/oncotarget.20526. eCollection 2017 Oct 17.
• [1092] Promotion of Cancer Cell Proliferation by Cleaved and Secreted Luminal Domains of ER Stress Transducer BBF2H7.PLoS One. 2015 May 8;10(5):e0125982. doi: 10.1371/journal.pone.0125982. eCollection 2015.
• [1093] CREBRF is a potent tumor suppressor of glioblastoma by blocking hypoxia-induced autophagy via the CREB3/ATG5 pathway.Int J Oncol. 2016 Aug;49(2):519-28. doi: 10.3892/ijo.2016.3576. Epub 2016 Jun 9.
• [1094] The regulation of cysteine cathepsins and cystatins in human gliomas.Int J Cancer. 2012 Oct 15;131(8):1779-89. doi: 10.1002/ijc.27453. Epub 2012 Mar 9.
• [1095] Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines.BMC Cancer. 2016 Mar 16;16:226. doi: 10.1186/s12885-016-2273-6.
• [1096] Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma.Acta Neuropathol. 2015 Oct;130(4):587-97. doi: 10.1007/s00401-015-1470-8. Epub 2015 Sep 1.
• [1097] Molecularly Targeted Drugs Plus Radiotherapy and Temozolomide Treatment for Newly Diagnosed Glioblastoma: A Meta-Analysis and Systematic Review.Oncol Res. 2016;24(2):117-28. doi: 10.3727/096504016X14612603423511.
• [1098] Preclinical characterization of signal transducer and activator of transcription 3 small molecule inhibitors for primary and metastatic brain cancer therapy.J Pharmacol Exp Ther. 2014 Jun;349(3):458-69. doi: 10.1124/jpet.114.214619. Epub 2014 Apr 2.
• [1099] Involvement of DDX6 gene in radio- and chemoresistance in glioblastoma.Int J Oncol. 2016 Mar;48(3):1053-62. doi: 10.3892/ijo.2016.3328. Epub 2016 Jan 11.
• [1100] DNM3, p65 and p53 from exosomes represent potential clinical diagnosis markers for glioblastoma multiforme.Ther Adv Med Oncol. 2017 Dec;9(12):741-754. doi: 10.1177/1758834017737471. Epub 2017 Nov 6.
• [1101] Cell proliferation and drug sensitivity of human glioblastoma cells are altered by the stable modulation of cytosolic 5'-nucleotidase II.Int J Biochem Cell Biol. 2015 Aug;65:222-9. doi: 10.1016/j.biocel.2015.06.011. Epub 2015 Jun 14.
• [1102] Engineering toxin-resistant therapeutic stem cells to treat brain tumors.Stem Cells. 2015 Feb;33(2):589-600. doi: 10.1002/stem.1874.
• [1103] Inhibition of eukaryotic initiation factor 3B suppresses proliferation and promotes apoptosis of chronic myeloid leukemia cells.Adv Clin Exp Med. 2019 Dec;28(12):1639-1645. doi: 10.17219/acem/110323.
• [1104] EMC6/TMEM93 suppresses glioblastoma proliferation by modulating autophagy.Cell Death Dis. 2016 Jan 14;7(1):e2043. doi: 10.1038/cddis.2015.408.
• [1105] Targeted Treatment of Experimental Spinal Cord Glioma With Dual Gene-Engineered Human Neural Stem Cells.Neurosurgery. 2016 Sep;79(3):481-91. doi: 10.1227/NEU.0000000000001174.
• [1106] The tumor suppressor FOXO3a mediates the response to EGFR inhibition in glioblastoma cells.Cell Oncol (Dordr). 2019 Aug;42(4):521-536. doi: 10.1007/s13402-019-00443-1. Epub 2019 Apr 13.
• [1107] Expression of Ferritin Light Chain (FTL) Is Elevated in Glioblastoma, and FTL Silencing Inhibits Glioblastoma Cell Proliferation via the GADD45/JNK Pathway.PLoS One. 2016 Feb 12;11(2):e0149361. doi: 10.1371/journal.pone.0149361. eCollection 2016.
• [1108] MicroRNA-197 inhibits cell proliferation by targeting GAB2 in glioblastoma.Mol Med Rep. 2016 May;13(5):4279-88. doi: 10.3892/mmr.2016.5076. Epub 2016 Mar 31.
• [1109] GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.Cell Death Differ. 2020 Jun;27(6):1862-1877. doi: 10.1038/s41418-019-0466-7. Epub 2019 Dec 4.
• [1110] A novel NFIA-NFB feed-forward loop contributes to glioblastoma cell survival.Neuro Oncol. 2017 Apr 1;19(4):524-534. doi: 10.1093/neuonc/now233.
• [1111] High Expression of Glypican-1 Predicts Dissemination and Poor Prognosis in Glioblastomas.World Neurosurg. 2017 Sep;105:282-288. doi: 10.1016/j.wneu.2017.05.165.
• [1112] Dormant glioblastoma cells acquire stem cell characteristics and are differentially affected by Temozolomide and AT101 treatment.Oncotarget. 2017 Nov 18;8(64):108064-108078. doi: 10.18632/oncotarget.22514. eCollection 2017 Dec 8.
• [1113] Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells.Sci Rep. 2015 Nov 13;5:15494. doi: 10.1038/srep15494.
• [1114] Search for new loci and low-frequency variants influencing glioma risk by exome-array analysis.Eur J Hum Genet. 2016 May;24(5):717-24. doi: 10.1038/ejhg.2015.170. Epub 2015 Aug 12.
• [1115] ZNF131 suppresses centrosome fragmentation in glioblastoma stem-like cells through regulation of HAUS5.Oncotarget. 2017 Jul 25;8(30):48545-48562. doi: 10.18632/oncotarget.18153.
• [1116] Ubiquitin Specific Peptidase 15 (USP15) suppresses glioblastoma cell growth via stabilization of HECTD1 E3 ligase attenuating WNT pathway activity.Oncotarget. 2017 Nov 30;8(66):110490-110502. doi: 10.18632/oncotarget.22798. eCollection 2017 Dec 15.
• [1117] A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide.Oncotarget. 2015 Apr 10;6(10):7657-74. doi: 10.18632/oncotarget.3150.
• [1118] Lentivirus-mediated silencing of HSDL2 suppresses cell proliferation in human gliomas.Tumour Biol. 2016 Nov;37(11):15065-15077. doi: 10.1007/s13277-016-5402-6. Epub 2016 Sep 22.
• [1119] High-mobility group AT-hook protein 2 expression and its prognostic significance in MGMT methylated and unmethylated glioblastoma.Int J Oncol. 2016 Apr;48(4):1485-92. doi: 10.3892/ijo.2016.3397. Epub 2016 Feb 17.
• [1120] IGF2 mRNA binding protein 3 (IMP3) promotes glioma cell migration by enhancing the translation of RELA/p65.Oncotarget. 2017 Jun 20;8(25):40469-40485. doi: 10.18632/oncotarget.17118.
• [1121] INSM1 promoter-driven adenoviral herpes simplex virus thymidine kinase cancer gene therapy for the treatment of primitive neuroectodermal tumors.Hum Gene Ther. 2009 Nov;20(11):1308-18. doi: 10.1089/hum.2008.168.
• [1122] Jagged1 is Clinically Prognostic and Promotes Invasion of Glioma-Initiating Cells by Activating NF-B(p65) Signaling.Cell Physiol Biochem. 2018;51(6):2925-2937. doi: 10.1159/000496044. Epub 2018 Oct 11.
• [1123] Transcription elongation factors represent in vivo cancer dependencies in glioblastoma.Nature. 2017 Jul 20;547(7663):355-359. doi: 10.1038/nature23000. Epub 2017 Jul 5.
• [1124] Epidermal growth factor receptor-mediated regulation of urokinase plasminogen activator expression and glioblastoma invasion via C-SRC/MAPK/AP-1 signaling pathways.J Neuropathol Exp Neurol. 2010 Jun;69(6):582-92. doi: 10.1097/NEN.0b013e3181e008fe.
• [1125] Tip60 regulates MT1-MMP transcription and invasion of glioblastoma cells through NF-B pathway.Clin Exp Metastasis. 2016 Jan;33(1):45-52. doi: 10.1007/s10585-015-9756-8.
• [1126] Inhibition of KIF14 Suppresses Tumor Cell Growth and Promotes Apoptosis in Human Glioblastoma.Cell Physiol Biochem. 2015;37(5):1659-70. doi: 10.1159/000438532. Epub 2015 Nov 5.
• [1127] Disruption of KIF3A in patient-derived glioblastoma cells: effects on ciliogenesis, hedgehog sensitivity, and tumorigenesis.Oncotarget. 2016 Feb 9;7(6):7029-43. doi: 10.18632/oncotarget.6854.
• [1128] Krppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells.BMC Cancer. 2018 Oct 22;18(1):1025. doi: 10.1186/s12885-018-4874-8.
• [1129] The Disruption of the -Catenin/TCF-1/STAT3 Signaling Axis by 4-Acetylantroquinonol B Inhibits the Tumorigenesis and Cancer Stem-Cell-Like Properties of Glioblastoma Cells, In Vitro and In Vivo.Cancers (Basel). 2018 Dec 5;10(12):491. doi: 10.3390/cancers10120491.
• [1130] Galectin-8 promotes migration and proliferation and prevents apoptosis in U87 glioblastoma cells.Biol Res. 2016 Jul 27;49(1):33. doi: 10.1186/s40659-016-0091-6.
• [1131] Increased expression of LGI1 gene triggers growth inhibition and apoptosis of neuroblastoma cells.J Cell Physiol. 2006 Jun;207(3):711-21. doi: 10.1002/jcp.20627.
• [1132] LRP1B deletion is associated with poor outcome for glioblastoma patients.J Neurol Sci. 2015 Nov 15;358(1-2):440-3. doi: 10.1016/j.jns.2015.09.345. Epub 2015 Sep 11.
• [1133] Novel Therapy for Glioblastoma Multiforme by Restoring LRRC4 in Tumor Cells: LRRC4 Inhibits Tumor-Infitrating Regulatory T Cells by Cytokine and Programmed Cell Death 1-Containing Exosomes.Front Immunol. 2017 Dec 11;8:1748. doi: 10.3389/fimmu.2017.01748. eCollection 2017.
• [1134] Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation.Mol Cancer Res. 2017 Oct;15(10):1376-1387. doi: 10.1158/1541-7786.MCR-17-0120. Epub 2017 Jun 20.
• [1135] Eva1 Maintains the Stem-like Character of Glioblastoma-Initiating Cells by Activating the Noncanonical NF-B Signaling Pathway.Cancer Res. 2016 Jan 1;76(1):171-81. doi: 10.1158/0008-5472.CAN-15-0884. Epub 2015 Dec 17.
• [1136] MSX1 inhibits cell migration and invasion through regulating the Wnt/-catenin pathway in glioblastoma.Tumour Biol. 2016 Jan;37(1):1097-104. doi: 10.1007/s13277-015-3892-2. Epub 2015 Aug 15.
• [1137] Upstream stimulating factor1 (USF1) enhances the proliferation of glioblastoma stem cells mainly by activating the transcription of mucin13 (MUC13).Pharmazie. 2017 Feb 1;72(2):98-102. doi: 10.1691/ph.2017.6788.
• [1138] Using Cystine Knot Proteins as a Novel Approach to Retarget Oncolytic Measles Virus.Mol Ther Oncolytics. 2017 Sep 29;7:57-66. doi: 10.1016/j.omto.2017.09.005. eCollection 2017 Dec 15.
• [1139] The SHIP2 interactor Myo1c is required for cell migration in 1321 N1 glioblastoma cells.Biochem Biophys Res Commun. 2016 Aug 5;476(4):508-514. doi: 10.1016/j.bbrc.2016.05.154. Epub 2016 May 28.
• [1140] Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cells.Mol Cancer. 2015 Aug 21;14:160. doi: 10.1186/s12943-015-0432-z.
• [1141] Case Report: Next generation sequencing identifies a NAB2-STAT6 fusion in Glioblastoma.Diagn Pathol. 2016 Jan 27;11:13. doi: 10.1186/s13000-016-0455-9.
• [1142] Chimeric NANOG repressors inhibit glioblastoma growth in vivo in a context-dependent manner.Sci Rep. 2019 Mar 7;9(1):3891. doi: 10.1038/s41598-019-39473-y.
• [1143] L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1.EMBO J. 2011 Mar 2;30(5):800-13. doi: 10.1038/emboj.2011.10. Epub 2011 Feb 4.
• [1144] Silencing NUDT21 Attenuates the Mesenchymal Identity of Glioblastoma Cells via the NF-B Pathway.Front Mol Neurosci. 2017 Dec 19;10:420. doi: 10.3389/fnmol.2017.00420. eCollection 2017.
• [1145] Sensitive Tumorigenic Potential Evaluation of Adult Human Multipotent Neural Cells Immortalized by hTERT Gene Transduction.PLoS One. 2016 Jul 8;11(7):e0158639. doi: 10.1371/journal.pone.0158639. eCollection 2016.
• [1146] GLTSCR2 contributes to the death resistance and invasiveness of hypoxia-selected cancer cells.FEBS Lett. 2012 Sep 21;586(19):3435-40. doi: 10.1016/j.febslet.2012.07.064. Epub 2012 Jul 28.
• [1147] HIN-1: a New Epigenetic Biomarker Crucial for Therapy Selection in Glioblastoma Multiforme.Mol Neurobiol. 2016 Apr;53(3):1802-1807. doi: 10.1007/s12035-015-9127-0. Epub 2015 Mar 11.
• [1148] Preferential Association of Lissencephaly-1 Gene Expression with CD133+ Glioblastoma Cells.J Cancer. 2017 May 11;8(7):1284-1291. doi: 10.7150/jca.17635. eCollection 2017.
• [1149] MicroRNA-365 suppressed cell proliferation and migration via targeting PAX6 in glioblastoma.Am J Transl Res. 2019 Jan 15;11(1):361-369. eCollection 2019.
• [1150] High expression of PCBP2 is associated with progression and poor prognosis in patients with glioblastoma.Biomed Pharmacother. 2017 Oct;94:659-665. doi: 10.1016/j.biopha.2017.07.103. Epub 2017 Aug 5.
• [1151] miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis.Cancer Res. 2016 Jul 15;76(14):4293-304. doi: 10.1158/0008-5472.CAN-15-3073. Epub 2016 May 31.
• [1152] Identification of genes and pathways potentially related to PHF20 by gene expression profile analysis of glioblastoma U87 cell line.Cancer Cell Int. 2017 Oct 4;17:87. doi: 10.1186/s12935-017-0459-x. eCollection 2017.
• [1153] Chromosomal Instability and Phosphoinositide Pathway Gene Signatures in Glioblastoma Multiforme.Mol Neurobiol. 2016 Jan;53(1):621-630. doi: 10.1007/s12035-014-9034-9. Epub 2014 Dec 15.
• [1154] Protein interacting with C kinase 1 suppresses invasion and anchorage-independent growth of astrocytic tumor cells.Mol Biol Cell. 2015 Dec 15;26(25):4552-61. doi: 10.1091/mbc.E15-05-0270. Epub 2015 Oct 14.
• [1155] MicroRNA-182 targets protein phosphatase 1 regulatory inhibitor subunit 1C in glioblastoma.Oncotarget. 2017 Sep 27;8(70):114677-114684. doi: 10.18632/oncotarget.21309. eCollection 2017 Dec 29.
• [1156] Cbx7 is epigenetically silenced in glioblastoma and inhibits cell migration by targeting YAP/TAZ-dependent transcription.Sci Rep. 2016 Jun 13;6:27753. doi: 10.1038/srep27753.
• [1157] A PRDX1-p38 heterodimer amplifies MET-driven invasion of IDH-wildtype and IDH-mutant gliomas.Int J Cancer. 2018 Sep 1;143(5):1176-1187. doi: 10.1002/ijc.31404. Epub 2018 Apr 16.
• [1158] PRMT1 and PRMT8 regulate retinoic acid-dependent neuronal differentiation with implications to neuropathology.Stem Cells. 2015 Mar;33(3):726-41. doi: 10.1002/stem.1894.
• [1159] MicroRNA-210 regulates cell proliferation and apoptosis by targeting regulator of differentiation 1 in glioblastoma cells.Folia Neuropathol. 2015;53(3):236-44. doi: 10.5114/fn.2015.54424.
• [1160] Cucurbitacin B induces inhibitory effects via CIP2A/PP2A/Akt pathway in glioblastoma multiforme.Mol Carcinog. 2018 Jun;57(6):687-699. doi: 10.1002/mc.22789. Epub 2018 Feb 26.
• [1161] Retinoblastoma Binding Protein 4 Modulates Temozolomide Sensitivity in Glioblastoma by Regulating DNA Repair Proteins.Cell Rep. 2016 Mar 22;14(11):2587-98. doi: 10.1016/j.celrep.2016.02.045. Epub 2016 Mar 10.
• [1162] c-Myc-miR-29c-REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma.Brain. 2015 Dec;138(Pt 12):3654-72. doi: 10.1093/brain/awv287. Epub 2015 Oct 8.
• [1163] The Role of RhoA, RhoB and RhoC GTPases in Cell Morphology, Proliferation and Migration in Human Cytomegalovirus (HCMV) Infected Glioblastoma Cells.Cell Physiol Biochem. 2016;38(1):94-109. doi: 10.1159/000438612. Epub 2016 Jan 8.
• [1164] Romo1 is associated with ROS production and cellular growth in human gliomas.J Neurooncol. 2015 Jan;121(1):73-81. doi: 10.1007/s11060-014-1608-x. Epub 2014 Sep 6.
• [1165] Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients.PLoS One. 2015 Oct 27;10(10):e0141334. doi: 10.1371/journal.pone.0141334. eCollection 2015.
• [1166] Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway.Biochem Biophys Res Commun. 2015 Sep 18;465(2):194-9. doi: 10.1016/j.bbrc.2015.07.149. Epub 2015 Aug 1.
• [1167] MicroRNA-124 expression counteracts pro-survival stress responses in glioblastoma.Oncogene. 2015 Apr 23;34(17):2204-14. doi: 10.1038/onc.2014.168. Epub 2014 Jun 23.
• [1168] Loss of SH3GL2 promotes the migration and invasion behaviours of glioblastoma cells through activating the STAT3/MMP2 signalling.J Cell Mol Med. 2017 Nov;21(11):2685-2694. doi: 10.1111/jcmm.13184. Epub 2017 May 4.
• [1169] Lentivirus-mediated silencing of spindle and kinetochore-associated protein 1 inhibits the proliferation and invasion of neuronal glioblastoma cells.Mol Med Rep. 2015 May;11(5):3533-8. doi: 10.3892/mmr.2015.3175. Epub 2015 Jan 9.
• [1170] Computational quantitative MR image features - a potential useful tool in differentiating glioblastoma from solitary brain metastasis.Eur J Radiol. 2019 Oct;119:108634. doi: 10.1016/j.ejrad.2019.08.003. Epub 2019 Aug 9.
• [1171] Intratumoral heterogeneity of genomic imbalance in a case of epithelioid glioblastoma with BRAF V600E mutation.Brain Pathol. 2014 Apr;24(3):239-46. doi: 10.1111/bpa.12114. Epub 2014 Jan 13.
• [1172] Genome-wide methylation profiling reveals new biomarkers for prognosis prediction of glioblastoma.J Cancer Res Ther. 2015 Oct;11 Suppl 2:C212-5. doi: 10.4103/0973-1482.168188.
• [1173] Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma.Genome Biol. 2016 Jun 10;17(1):125. doi: 10.1186/s13059-016-0990-4.
• [1174] MiR-595 targeting regulation of SOX7 expression promoted cell proliferation of human glioblastoma.Biomed Pharmacother. 2016 May;80:121-126. doi: 10.1016/j.biopha.2016.03.008. Epub 2016 Mar 19.
• [1175] Downregulation of GLS2 in glioblastoma cells is related to DNA hypermethylation but not to the p53 status.Mol Carcinog. 2016 Sep;55(9):1309-16. doi: 10.1002/mc.22372. Epub 2015 Aug 10.
• [1176] A Short Region of Connexin43 Reduces Human Glioma Stem Cell Migration, Invasion, and Survival through Src, PTEN, and FAK.Stem Cell Reports. 2017 Aug 8;9(2):451-463. doi: 10.1016/j.stemcr.2017.06.007. Epub 2017 Jul 14.
• [1177] Dysregulation of TFDP1 and of the cell cycle pathway in high-grade glioblastoma multiforme: a bioinformatic analysis.Genet Mol Res. 2016 Jun 10;15(2). doi: 10.4238/gmr.15027646.
• [1178] Inhibition of TFEB oligomerization by co-treatment of melatonin with vorinostat promotes the therapeutic sensitivity in glioblastoma and glioma stem cells.J Pineal Res. 2019 Apr;66(3):e12556. doi: 10.1111/jpi.12556. Epub 2019 Feb 14.
• [1179] PKM2 uses control of HuR localization to regulate p27 and cell cycle progression in human glioblastoma cells.Int J Cancer. 2016 Jul 1;139(1):99-111. doi: 10.1002/ijc.30041. Epub 2016 Mar 2.
• [1180] Depletion of thymopoietin inhibits proliferation and induces cell cycle arrest/apoptosis in glioblastoma cells.World J Surg Oncol. 2016 Oct 19;14(1):267. doi: 10.1186/s12957-016-1018-y.
• [1181] Musashi-1 Enhances Glioblastoma Cell Migration and Cytoskeletal Dynamics through Translational Inhibition of Tensin3.Sci Rep. 2017 Aug 18;7(1):8710. doi: 10.1038/s41598-017-09504-7.
• [1182] Four individually druggable MET hotspots mediate HGF-driven tumor progression.J Clin Invest. 2014 Jul;124(7):3172-86. doi: 10.1172/JCI72316. Epub 2014 May 27.
• [1183] TRM6/61 connects PKC with translational control through tRNAi(Met) stabilization: impact on tumorigenesis.Oncogene. 2016 Apr 7;35(14):1785-96. doi: 10.1038/onc.2015.244. Epub 2015 Aug 3.
• [1184] Histochemical analysis of testis specific gene 13 in human normal and malignant tissues.Cell Tissue Res. 2015 Dec;362(3):653-63. doi: 10.1007/s00441-015-2227-3. Epub 2015 Jun 27.
• [1185] Classification of subpopulations of cells within human primary brain tumors by single cell gene expression profiling.Neurochem Res. 2015 Feb;40(2):336-52. doi: 10.1007/s11064-014-1431-y. Epub 2014 Sep 24.
• [1186] Polysaccharide sulphated derivative from Aconitumcoreanum induces cell apoptosis in the human brain glioblastoma U87MG cell line via the NF-B/Bcl-2 cell apoptotic signaling pathway.Oncol Rep. 2018 Mar;39(3):1469-1474. doi: 10.3892/or.2017.6165. Epub 2017 Dec 19.
• [1187] Fatty acid induced glioma cell growth is mediated by the acyl-CoA synthetase 5 gene located on chromosome 10q25.1-q25.2, a region frequently deleted in malignant gliomas.Oncogene. 2000 Nov 30;19(51):5919-25. doi: 10.1038/sj.onc.1203981.
• [1188] On the influence of cannabinoids on cell morphology and motility of glioblastoma cells.PLoS One. 2019 Feb 12;14(2):e0212037. doi: 10.1371/journal.pone.0212037. eCollection 2019.
• [1189] Actin, alpha, cardiac muscle 1 (ACTC1) knockdown inhibits the migration of glioblastoma cells in vitro.J Neurol Sci. 2018 Sep 15;392:117-121. doi: 10.1016/j.jns.2018.07.013. Epub 2018 Jul 17.
• [1190] High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.Mol Med Rep. 2019 Feb;19(2):877-884. doi: 10.3892/mmr.2018.9716. Epub 2018 Dec 3.
• [1191] Long Noncoding RNA SChLAP1 Forms a Growth-Promoting Complex with HNRNPL in Human Glioblastoma through Stabilization of ACTN4 and Activation of NF-B Signaling.Clin Cancer Res. 2019 Nov 15;25(22):6868-6881. doi: 10.1158/1078-0432.CCR-19-0747. Epub 2019 Sep 6.
• [1192] RasGRP3 regulates the migration of glioma cells via interaction with Arp3.Oncotarget. 2015 Jan 30;6(3):1850-64. doi: 10.18632/oncotarget.2575.
• [1193] ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion.Nucleic Acids Res. 2018 Feb 28;46(4):2045-2059. doi: 10.1093/nar/gkx1257.
• [1194] ADAM23 methylation and expression analysis in brain tumors.Neurosci Lett. 2005 Jun 3;380(3):260-4. doi: 10.1016/j.neulet.2005.01.050. Epub 2005 Feb 8.
• [1195] Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis.Acta Neuropathol. 2017 Dec;134(6):905-922. doi: 10.1007/s00401-017-1774-y. Epub 2017 Oct 13.
• [1196] Dynamic inosinome profiles reveal novel patient stratification and gender-specific differences in glioblastoma.Genome Biol. 2019 Feb 13;20(1):33. doi: 10.1186/s13059-019-1647-x.
• [1197] MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells.Neuro Oncol. 2013 Oct;15(10):1302-16. doi: 10.1093/neuonc/not090. Epub 2013 Jun 28.
• [1198] Cloning and characterization of BAI2 and BAI3, novel genes homologous to brain-specific angiogenesis inhibitor 1 (BAI1).Cytogenet Cell Genet. 1997;79(1-2):103-8. doi: 10.1159/000134693.
• [1199] Network-based analysis of oligodendrogliomas predicts novel cancer gene candidates within the region of the 1p/19q co-deletion.Acta Neuropathol Commun. 2018 Jun 11;6(1):49. doi: 10.1186/s40478-018-0544-y.
• [1200] Adiponectin as novel regulator of cell proliferation in human glioblastoma.J Cell Physiol. 2014 Oct;229(10):1444-54. doi: 10.1002/jcp.24582.
• [1201] AEBP1 down regulation induced cell death pathway depends on PTEN status of glioma cells.Sci Rep. 2019 Oct 10;9(1):14577. doi: 10.1038/s41598-019-51068-1.
• [1202] Co-amplification of phosphoinositide 3-kinase enhancer A and cyclin-dependent kinase 4 triggers glioblastoma progression.Oncogene. 2017 Aug 10;36(32):4562-4572. doi: 10.1038/onc.2017.67. Epub 2017 Apr 3.
• [1203] The Effect of MCM3AP-AS1/miR-211/KLF5/AGGF1 Axis Regulating Glioblastoma Angiogenesis.Front Mol Neurosci. 2018 Jan 9;10:437. doi: 10.3389/fnmol.2017.00437. eCollection 2017.
• [1204] IRF7 promotes glioma cell invasion by inhibiting AGO2 expression.Tumour Biol. 2015 Jul;36(7):5561-9. doi: 10.1007/s13277-015-3226-4. Epub 2015 Feb 14.
• [1205] Human herpesvirus 6 (HHV-6) ORF-1 transactivating gene exhibits malignant transforming activity and its protein binds to p53.Oncogene. 1997 Jan 23;14(3):359-67. doi: 10.1038/sj.onc.1200840.
• [1206] Allograft inflammatory factor-1 defines a distinct subset of infiltrating macrophages/microglial cells in rat and human gliomas.Acta Neuropathol. 2000 Dec;100(6):673-80. doi: 10.1007/s004010000233.
• [1207] Differential Expression Profile of NLRs and AIM2 in Glioma and Implications for NLRP12 in Glioblastoma.Sci Rep. 2019 Jun 11;9(1):8480. doi: 10.1038/s41598-019-44854-4.
• [1208] Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR Signal Pathway.Front Mol Neurosci. 2017 Mar 13;10:68. doi: 10.3389/fnmol.2017.00068. eCollection 2017.
• [1209] siRNA-mediated knockdown of JUB expression suppresses the proliferation of glioblastoma cells.Cancer Biomark. 2015;15(4):477-84. doi: 10.3233/CBM-150491.
• [1210] Deubiquitinating ALDH1A3 key to maintaining the culprit of aggressive brain cancer.J Clin Invest. 2019 Apr 8;129(5):1833-1835. doi: 10.1172/JCI128742. eCollection 2019 Apr 8.
• [1211] Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro.Oncotarget. 2018 Apr 27;9(32):22703-22716. doi: 10.18632/oncotarget.25210. eCollection 2018 Apr 27.
• [1212] The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells.Neuro Oncol. 2013 Mar;15(3):269-78. doi: 10.1093/neuonc/nos301. Epub 2012 Dec 20.
• [1213] Association between autocrine motility factor receptor gene polymorphism (rs2440472, rs373191257) and glioblastoma multiform in a representative Iranian population.J Res Med Sci. 2018 Nov 28;23:96. doi: 10.4103/jrms.JRMS_305_18. eCollection 2018.
• [1214] Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell lines.Mol Cancer Ther. 2008 Jun;7(6):1461-71. doi: 10.1158/1535-7163.MCT-07-2010.
• [1215] Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis.Cancer Res. 2010 Sep 15;70(18):7283-93. doi: 10.1158/0008-5472.CAN-09-4125. Epub 2010 Sep 7.
• [1216] A DNA vaccine expressing tyrosinase-related protein-2 induces T-cell-mediated protection against mouse glioblastoma.Cancer Gene Ther. 2003 Sep;10(9):678-88. doi: 10.1038/sj.cgt.7700620.
• [1217] ANO6 promotes cell proliferation and invasion in glioma through regulating the ERK signaling pathway.Onco Targets Ther. 2019 Aug 20;12:6721-6731. doi: 10.2147/OTT.S211725. eCollection 2019.
• [1218] Anosmin-1 contributes to brain tumor malignancy through integrin signal pathways.Endocr Relat Cancer. 2013 Dec 20;21(1):85-99. doi: 10.1530/ERC-13-0181. Print 2014 Feb.
• [1219] Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor.Oncogene. 2004 Apr 15;23(17):3005-12. doi: 10.1038/sj.onc.1207350.
• [1220] MiR-224 expression increases radiation sensitivity of glioblastoma cells.Biochem Biophys Res Commun. 2014 May 30;448(2):225-30. doi: 10.1016/j.bbrc.2014.04.095. Epub 2014 Apr 29.
• [1221] Expression of amyloid precursor-like protein 2 (APLP2) in glioblastoma is associated with patient prognosis.Folia Neuropathol. 2018;56(1):30-38. doi: 10.5114/fn.2018.74657.
• [1222] Multifunctional protein APPL2 contributes to survival of human glioma cells.Mol Oncol. 2013 Feb;7(1):67-84. doi: 10.1016/j.molonc.2012.08.003. Epub 2012 Sep 5.
• [1223] Expression of aquaporin8 in human astrocytomas: correlation with pathologic grade.Biochem Biophys Res Commun. 2013 Oct 11;440(1):168-72. doi: 10.1016/j.bbrc.2013.09.057. Epub 2013 Sep 18.
• [1224] Identification of ADP-ribosylation factor 4 as a suppressor of N-(4-hydroxyphenyl)retinamide-induced cell death.Cancer Lett. 2009 Apr 8;276(1):53-60. doi: 10.1016/j.canlet.2008.10.031. Epub 2008 Nov 28.
• [1225] ARHGAP21 is a RhoGAP for RhoA and RhoC with a role in proliferation and migration of prostate adenocarcinoma cells.Biochim Biophys Acta. 2013 Feb;1832(2):365-74. doi: 10.1016/j.bbadis.2012.11.010. Epub 2012 Nov 28.
• [1226] PDZ-RhoGEF Is a Signaling Effector for TROY-Induced Glioblastoma Cell Invasion and Survival.Neoplasia. 2018 Oct;20(10):1045-1058. doi: 10.1016/j.neo.2018.08.008. Epub 2018 Sep 13.
• [1227] SGEF Is Regulated via TWEAK/Fn14/NF-B Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide.Mol Cancer Res. 2016 Mar;14(3):302-12. doi: 10.1158/1541-7786.MCR-15-0183. Epub 2016 Jan 13.
• [1228] Expression of ADP-ribosyltransferase 1 Is Associated with Poor Prognosis of Glioma Patients.Tohoku J Exp Med. 2016 Aug;239(4):269-78. doi: 10.1620/tjem.239.269.
• [1229] ASPM gene expression in medulloblastoma.Childs Nerv Syst. 2011 Jan;27(1):71-4. doi: 10.1007/s00381-010-1252-5. Epub 2010 Aug 6.
• [1230] Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM.BMC Cancer. 2018 Feb 8;18(1):167. doi: 10.1186/s12885-018-4040-3.
• [1231] ATAD2B is a phylogenetically conserved nuclear protein expressed during neuronal differentiation and tumorigenesis.Dev Growth Differ. 2010 Dec;52(9):747-55. doi: 10.1111/j.1440-169X.2010.01211.x.
• [1232] Astrocytes enhance glioblastoma growth.Glia. 2020 Feb;68(2):316-327. doi: 10.1002/glia.23718. Epub 2019 Sep 11.
• [1233] Gamabufotalin induces a negative feedback loop connecting ATP1A3 expression and the AQP4 pathway to promote temozolomide sensitivity in glioblastoma cells by targeting the amino acid Thr794.Cell Prolif. 2020 Jan;53(1):e12732. doi: 10.1111/cpr.12732. Epub 2019 Nov 20.
• [1234] Targeting 2 subunit of Na(+)/K(+)-ATPase induces glioblastoma cell apoptosis through elevation of intracellular Ca(2).Am J Cancer Res. 2019 Jun 1;9(6):1293-1308. eCollection 2019.
• [1235] (Pro)renin receptor is crucial for glioma development via the Wnt/-catenin signaling pathway.J Neurosurg. 2017 Oct;127(4):819-828. doi: 10.3171/2016.9.JNS16431. Epub 2017 Jan 6.
• [1236] Regeneration and tolerance factor: a novel mediator of glioblastoma-associated immunosuppression.Cancer Res. 2006 Apr 1;66(7):3852-8. doi: 10.1158/0008-5472.CAN-05-3062.
• [1237] The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomas.Acta Neuropathol Commun. 2019 Nov 9;7(1):175. doi: 10.1186/s40478-019-0833-0.
• [1238] Microtubule actin cross-linking factor 1, a novel target in glioblastoma.Int J Oncol. 2017 Jan;50(1):310-316. doi: 10.3892/ijo.2016.3798. Epub 2016 Dec 9.
• [1239] Evaluation of the apparent diffusion coefficient in patients with recurrent glioblastoma under treatment with bevacizumab with radiographic pseudoresponse.J Neuroradiol. 2019 Feb;46(1):36-43. doi: 10.1016/j.neurad.2018.04.002. Epub 2018 May 4.
• [1240] DNA methylation in glioblastoma: impact on gene expression and clinical outcome. BMC Genomics. 2010 Dec 14;11:701.
• [1241] Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia.Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6668-73. doi: 10.1073/pnas.1203756109. Epub 2012 Apr 9.
• [1242] PTPN12/PTP-PEST Regulates Phosphorylation-Dependent Ubiquitination and Stability of Focal Adhesion Substrates in Invasive Glioblastoma Cells.Cancer Res. 2018 Jul 15;78(14):3809-3822. doi: 10.1158/0008-5472.CAN-18-0085. Epub 2018 May 9.
• [1243] Alterations of BCCIP, a BRCA2 interacting protein, in astrocytomas.BMC Cancer. 2009 Aug 4;9:268. doi: 10.1186/1471-2407-9-268.
• [1244] Flavopiridol's antiproliferative effects in glioblastoma multiforme.J Cancer Res Ther. 2016 Apr-Jun;12(2):811-7. doi: 10.4103/0973-1482.172132.
• [1245] miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics.Cell Cycle. 2015;14(24):3794-800. doi: 10.1080/15384101.2015.1093711.
• [1246] Bcl2L13 is a ceramide synthase inhibitor in glioblastoma.Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5682-7. doi: 10.1073/pnas.1316700111. Epub 2014 Mar 31.
• [1247] BCL3 expression promotes resistance to alkylating chemotherapy in gliomas.Sci Transl Med. 2018 Jul 4;10(448):eaar2238. doi: 10.1126/scitranslmed.aar2238.
• [1248] Molecular functions of brain expressed X-linked 2 (BEX2) in malignancies.Exp Cell Res. 2019 Mar 15;376(2):221-226. doi: 10.1016/j.yexcr.2019.02.014. Epub 2019 Feb 16.
• [1249] Emerging microtubule targets in glioma therapy.Semin Pediatr Neurol. 2015 Mar;22(1):49-72. doi: 10.1016/j.spen.2015.03.009. Epub 2015 Apr 4.
• [1250] Dec1 expression predicts prognosis and the response to temozolomide chemotherapy in patients with glioma.Mol Med Rep. 2016 Dec;14(6):5626-5636. doi: 10.3892/mmr.2016.5921. Epub 2016 Nov 3.
• [1251] BHLHE41 promotes U87 and U251 cell proliferation via ERK/cyclinD1 signaling pathway.Cancer Manag Res. 2019 Aug 14;11:7657-7672. doi: 10.2147/CMAR.S214697. eCollection 2019.
• [1252] Bcl-2 family member Mcl-1 expression is reduced under hypoxia by the E3 ligase FBW7 contributing to BNIP3 induced cell death in glioma cells.Cancer Biol Ther. 2016 Jun 2;17(6):604-13. doi: 10.1080/15384047.2015.1095399. Epub 2015 Oct 15.
• [1253] Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide.Oncotarget. 2014 Nov 15;5(21):10901-15. doi: 10.18632/oncotarget.2543.
• [1254] Decreased BRMS1L expression is correlated with glioma grade and predicts poor survival in glioblastoma via an invasive phenotype.Cancer Biomark. 2018;22(2):311-316. doi: 10.3233/CBM-171019.
• [1255] Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival.J Clin Oncol. 2010 May 10;28(14):2467-74. doi: 10.1200/JCO.2009.26.6213. Epub 2010 Apr 5.
• [1256] Betacellulin drives therapy resistance in glioblastoma.Neuro Oncol. 2020 Apr 15;22(4):457-469. doi: 10.1093/neuonc/noz206.
• [1257] PKM2 regulates chromosome segregation and mitosis progression of tumor cells.Mol Cell. 2014 Jan 9;53(1):75-87. doi: 10.1016/j.molcel.2013.11.001. Epub 2013 Dec 5.
• [1258] Epigenetic regulation of embryonic stem cell marker miR302C in human chondrosarcoma as determinant of antiproliferative activity of proline-rich polypeptide 1.Int J Oncol. 2015 Aug;47(2):465-72. doi: 10.3892/ijo.2015.3054. Epub 2015 Jun 18.
• [1259] Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental Glioblastoma.Clin Cancer Res. 2018 Jun 1;24(11):2574-2584. doi: 10.1158/1078-0432.CCR-17-2954. Epub 2018 Mar 6.
• [1260] SynCAM, a novel putative tumor suppressor, suppresses growth and invasiveness of glioblastoma.Mol Biol Rep. 2013 Sep;40(9):5469-75. doi: 10.1007/s11033-013-2645-9. Epub 2013 Aug 2.
• [1261] Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction.Am J Pathol. 2003 Sep;163(3):1033-43. doi: 10.1016/S0002-9440(10)63463-3.
• [1262] CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells.EMBO J. 2011 Aug 19;30(20):4309-22. doi: 10.1038/emboj.2011.301.
• [1263] Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient.Eur Radiol. 2017 Apr;27(4):1344-1351. doi: 10.1007/s00330-016-4484-2. Epub 2016 Jul 19.
• [1264] Increased expression of Capn4 is associated with the malignancy of human glioma.CNS Neurosci Ther. 2014 Jun;20(6):521-7. doi: 10.1111/cns.12248. Epub 2014 Mar 15.
• [1265] NFAT1-Mediated Regulation of NDEL1 Promotes Growth and Invasion of Glioma Stem-like Cells.Cancer Res. 2019 May 15;79(10):2593-2603. doi: 10.1158/0008-5472.CAN-18-3297. Epub 2019 Apr 2.
• [1266] Calpastatin phosphorylation regulates radiation-induced calpain activity in glioblastoma.Oncotarget. 2018 Feb 19;9(18):14597-14607. doi: 10.18632/oncotarget.24523. eCollection 2018 Mar 6.
• [1267] Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae.Oncogene. 2004 Sep 9;23(41):6967-79. doi: 10.1038/sj.onc.1207911.
• [1268] TRIM8-driven transcriptomic profile of neural stem cells identified glioma-related nodal genes and pathways.Biochim Biophys Acta Gen Subj. 2019 Feb;1863(2):491-501. doi: 10.1016/j.bbagen.2018.12.001. Epub 2018 Dec 5.
• [1269] CCL8 secreted by tumor-associated macrophages promotes invasion and stemness of glioblastoma cells via ERK1/2 signaling.Lab Invest. 2020 Apr;100(4):619-629. doi: 10.1038/s41374-019-0345-3. Epub 2019 Nov 20.
• [1270] NOVH increases MMP3 expression and cell migration in glioblastoma cells via a PDGFR-alpha-dependent mechanism.FASEB J. 2003 Oct;17(13):1919-21. doi: 10.1096/fj.02-1023fje. Epub 2003 Aug 15.
• [1271] Cyclin G2 promotes hypoxia-driven local invasion of glioblastoma by orchestrating cytoskeletal dynamics.Neoplasia. 2013 Nov;15(11):1272-81. doi: 10.1593/neo.131440.
• [1272] Rechallenge with bevacizumab in patients with glioblastoma progressing off therapy.J Neurooncol. 2018 May;138(1):141-145. doi: 10.1007/s11060-018-2780-1. Epub 2018 Jan 31.
• [1273] Upregulation of chemokine receptor CCR10 is essential for glioma proliferation, invasion and patient survival.Oncotarget. 2014 Aug 30;5(16):6576-83. doi: 10.18632/oncotarget.2134.
• [1274] Extracellular Vesicles from Neurosurgical Aspirates Identifies Chaperonin Containing TCP1 Subunit 6A as a Potential Glioblastoma Biomarker with Prognostic Significance.Proteomics. 2019 Jan;19(1-2):e1800157. doi: 10.1002/pmic.201800157.
• [1275] Overexpression of CCT8 and its significance for tumor cell proliferation, migration and invasion in glioma.Pathol Res Pract. 2015 Oct;211(10):717-25. doi: 10.1016/j.prp.2015.04.012. Epub 2015 May 19.
• [1276] CD164 regulates proliferation, progression, and invasion of human glioblastoma cells.Oncotarget. 2019 Mar 12;10(21):2041-2054. doi: 10.18632/oncotarget.26724. eCollection 2019 Mar 12.
• [1277] Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas.BMC Cancer. 2018 Mar 9;18(1):270. doi: 10.1186/s12885-018-4179-y.
• [1278] Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.Cancer Res. 2015 Nov 1;75(21):4504-16. doi: 10.1158/0008-5472.CAN-14-3636. Epub 2015 Sep 11.
• [1279] CD99 Expression in Glioblastoma Molecular Subtypes and Role in Migration and Invasion.Int J Mol Sci. 2019 Mar 6;20(5):1137. doi: 10.3390/ijms20051137.
• [1280] ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis.Oncogene. 2013 Feb 21;32(8):998-1009. doi: 10.1038/onc.2012.125. Epub 2012 Apr 23.
• [1281] Cysteine catabolism: a novel metabolic pathway contributing to glioblastoma growth.Cancer Res. 2014 Feb 1;74(3):787-96. doi: 10.1158/0008-5472.CAN-13-1423. Epub 2013 Dec 18.
• [1282] RNASEQR--a streamlined and accurate RNA-seq sequence analysis program.Nucleic Acids Res. 2012 Mar;40(6):e42. doi: 10.1093/nar/gkr1248. Epub 2011 Dec 22.
• [1283] CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction.Carcinogenesis. 2020 May 14;41(3):377-389. doi: 10.1093/carcin/bgz113.
• [1284] On the role of 25-hydroxycholesterol synthesis by glioblastoma cell lines. Implications for chemotactic monocyte recruitment.Exp Cell Res. 2013 Jul 15;319(12):1828-1838. doi: 10.1016/j.yexcr.2013.03.025. Epub 2013 Mar 26.
• [1285] Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma.Clin Cancer Res. 2018 Dec 15;24(24):6471-6482. doi: 10.1158/1078-0432.CCR-18-1052. Epub 2018 Aug 31.
• [1286] CHD7 promotes glioblastoma cell motility and invasiveness through transcriptional modulation of an invasion signature.Sci Rep. 2019 Mar 8;9(1):3952. doi: 10.1038/s41598-019-39564-w.
• [1287] CHL1 Is Expressed and Functions as a Malignancy Promoter in Glioma Cells.Front Mol Neurosci. 2017 Oct 17;10:324. doi: 10.3389/fnmol.2017.00324. eCollection 2017.
• [1288] Loss of CHSY1, a secreted FRINGE enzyme, causes syndromic brachydactyly in humans via increased NOTCH signaling. Am J Hum Genet. 2010 Dec 10;87(6):768-78. doi: 10.1016/j.ajhg.2010.11.005.
• [1289] CIC protein instability contributes to tumorigenesis in glioblastoma.Nat Commun. 2019 Feb 8;10(1):661. doi: 10.1038/s41467-018-08087-9.
• [1290] Mutational analysis of the CITED4 gene in glioblastomas.Cancer Genet Cytogenet. 2008 Sep;185(2):114-6. doi: 10.1016/j.cancergencyto.2008.05.013.
• [1291] TLR-4/Wnt modulation as new therapeutic strategy in the treatment of glioblastomas.Oncotarget. 2018 Dec 25;9(101):37564-37580. doi: 10.18632/oncotarget.26500. eCollection 2018 Dec 25.
• [1292] Overexpression of CLEC18B Associates With the Proliferation, Migration, and Prognosis of Glioblastoma.ASN Neuro. 2018 Jan-Dec;10:1759091418781949. doi: 10.1177/1759091418781949.
• [1293] Establishment and genetic characterization of ANGM-CSS, a novel, immortal cell line derived from a human glioblastoma multiforme.Int J Oncol. 2014 Mar;44(3):717-24. doi: 10.3892/ijo.2013.2224. Epub 2013 Dec 23.
• [1294] Systematic investigation of CMTM family genes suggests relevance to glioblastoma pathogenesis and CMTM1 and CMTM3 as priority targets.Genes Chromosomes Cancer. 2015 Jul;54(7):433-43. doi: 10.1002/gcc.22255. Epub 2015 Apr 30.
• [1295] Autocrine platelet-derived growth factor-dependent gene expression in glioblastoma cells is mediated largely by activation of the transcription factor sterol regulatory element binding protein and is associated with altered genotype and patient survival in human brain tumors.Cancer Res. 2005 Jul 1;65(13):5523-34. doi: 10.1158/0008-5472.CAN-04-2582.
• [1296] Proteins with altered levels in plasma from glioblastoma patients as revealed by iTRAQ-based quantitative proteomic analysis.PLoS One. 2012;7(9):e46153. doi: 10.1371/journal.pone.0046153. Epub 2012 Sep 28.
• [1297] Molecular mechanisms of regulation and action of microRNA-199a in testicular germ cell tumor and glioblastomas.PLoS One. 2013 Dec 31;8(12):e83980. doi: 10.1371/journal.pone.0083980. eCollection 2013.
• [1298] Collagen XVI expression is upregulated in glioblastomas and promotes tumor cell adhesion.FEBS Lett. 2008 Oct 15;582(23-24):3293-300. doi: 10.1016/j.febslet.2008.09.017. Epub 2008 Sep 17.
• [1299] The importance of cell-mediated immunity in the course and severity of autoimmune anti-glomerular basement membrane disease in mice.FASEB J. 2003 May;17(8):860-8. doi: 10.1096/fj.02-0746com.
• [1300] A drug combination targeting hypoxia induced chemoresistance and stemness in glioma cells.Oncotarget. 2018 Apr 6;9(26):18351-18366. doi: 10.18632/oncotarget.24839. eCollection 2018 Apr 6.
• [1301] The role of p-Stat3 Y705 immunohistochemistry in glioblastoma prognosis.Diagn Pathol. 2019 Nov 5;14(1):124. doi: 10.1186/s13000-019-0903-4.
• [1302] Identification of COX5B as a novel biomarker in high-grade glioma patients.Onco Targets Ther. 2017 Nov 15;10:5463-5470. doi: 10.2147/OTT.S139243. eCollection 2017.
• [1303] Overexpression of COX7A2 is associated with a good prognosis in patients with glioma.J Neurooncol. 2018 Jan;136(1):41-50. doi: 10.1007/s11060-017-2637-z. Epub 2017 Oct 27.
• [1304] miR?54?p suppresses cell migration and invasion by targeting CPEB1 in human glioblastoma.Mol Med Rep. 2018 Oct;18(4):3965-3972. doi: 10.3892/mmr.2018.9386. Epub 2018 Aug 14.
• [1305] CPEB4 regulates glioblastoma cell proliferation and predicts poor outcome of patients.Clin Neurol Neurosurg. 2018 Jun;169:92-97. doi: 10.1016/j.clineuro.2018.04.008. Epub 2018 Apr 3.
• [1306] High grade glioblastoma is associated with aberrant expression of ZFP57, a protein involved in gene imprinting, and of CPT1A and CPT1C that regulate fatty acid metabolism.Cancer Biol Ther. 2014 Jun 1;15(6):735-41. doi: 10.4161/cbt.28408. Epub 2014 Mar 11.
• [1307] Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastoma.FASEB J. 2018 Jun 1:fj201701568R. doi: 10.1096/fj.201701568R. Online ahead of print.
• [1308] cDNA cloning of a novel trypsin inhibitor with similarity to pathogenesis-related proteins, and its frequent expression in human brain cancer cells.Biochim Biophys Acta. 1998 Jan 21;1395(2):202-8. doi: 10.1016/s0167-4781(97)00149-8.
• [1309] The role of CT10 regulation of kinase-like in cancer.Future Oncol. 2014 Dec;10(16):2687-97. doi: 10.2217/fon.14.199.
• [1310] Deltex-1 activates mitotic signaling and proliferation and increases the clonogenic and invasive potential of U373 and LN18 glioblastoma cells and correlates with patient survival.PLoS One. 2013;8(2):e57793. doi: 10.1371/journal.pone.0057793. Epub 2013 Feb 25.
• [1311] Expression of N-cadherin and alpha-catenin in astrocytomas and glioblastomas.Br J Cancer. 1995 Sep;72(3):627-33. doi: 10.1038/bjc.1995.384.
• [1312] Cullin1 regulates proliferation, migration and invasion of glioma cells.Med Oncol. 2014 Oct;31(10):227. doi: 10.1007/s12032-014-0227-x. Epub 2014 Sep 9.
• [1313] The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma Cells.Int J Mol Sci. 2019 May 21;20(10):2496. doi: 10.3390/ijms20102496.
• [1314] Selection of suitable reference genes for expression analysis in human glioma using RT-qPCR.J Neurooncol. 2015 May;123(1):35-42. doi: 10.1007/s11060-015-1772-7. Epub 2015 Apr 11.
• [1315] Old proteins - new locations: myoglobin, haemoglobin, neuroglobin and cytoglobin in solid tumours and cancer cells.Acta Physiol (Oxf). 2011 Jul;202(3):563-81. doi: 10.1111/j.1748-1716.2010.02205.x. Epub 2010 Nov 12.
• [1316] RELN signaling modulates glioblastoma growth and substrate-dependent migration.Brain Pathol. 2018 Sep;28(5):695-709. doi: 10.1111/bpa.12584. Epub 2018 Jan 10.
• [1317] Tiling resolution array comparative genomic hybridization, expression and methylation analyses of dup(1q) in Burkitt lymphomas and pediatric high hyperdiploid acute lymphoblastic leukemias reveal clustered near-centromeric breakpoints and overexpression of genes in 1q22-32.3.Hum Mol Genet. 2007 Sep 15;16(18):2215-25. doi: 10.1093/hmg/ddm173. Epub 2007 Jul 5.
• [1318] Publisher Correction: PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3.Nat Commun. 2018 May 25;9:16217. doi: 10.1038/ncomms16217.
• [1319] Acyl-CoA-Binding Protein Fuels Gliomagenesis.Cell Metab. 2019 Aug 6;30(2):229-230. doi: 10.1016/j.cmet.2019.07.007.
• [1320] The role of drebrin in glioma migration and invasion.Exp Cell Res. 2013 Feb 15;319(4):517-28. doi: 10.1016/j.yexcr.2012.11.008. Epub 2012 Nov 29.
• [1321] Novel cancer vaccine based on genes of Salmonella pathogenicity island 2.Int J Cancer. 2010 Jun 1;126(11):2622-34. doi: 10.1002/ijc.24957.
• [1322] Repositioning of the antipsychotic trifluoperazine: Synthesis, biological evaluation and in silico study of trifluoperazine analogs as anti-glioblastoma agents.Eur J Med Chem. 2018 May 10;151:186-198. doi: 10.1016/j.ejmech.2018.03.055. Epub 2018 Mar 23.
• [1323] Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.Cancer Res. 2007 Dec 15;67(24):11886-95. doi: 10.1158/0008-5472.CAN-07-2964.
• [1324] C-27-carboxylated oleanane triterpenoids up-regulate TRAIL DISC assembly via p38 MAPK and CHOP-mediated DR5 expression in human glioblastoma cells.Biochem Pharmacol. 2018 Dec;158:243-260. doi: 10.1016/j.bcp.2018.10.019. Epub 2018 Oct 22.
• [1325] Molecular characterization of DDX26, a human DEAD-box RNA helicase, located on chromosome 7p12.Braz J Med Biol Res. 2001 Oct;34(10):1237-45. doi: 10.1590/s0100-879x2001001000002.
• [1326] Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21).Genes Chromosomes Cancer. 2003 May;37(1):58-71. doi: 10.1002/gcc.10207.
• [1327] A schizophrenia associated CMYA5 allele displays differential binding with desmin.J Psychiatr Res. 2019 Apr;111:8-15. doi: 10.1016/j.jpsychires.2019.01.007. Epub 2019 Jan 10.
• [1328] DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomide.PLoS One. 2014 Sep 18;9(9):e104455. doi: 10.1371/journal.pone.0104455. eCollection 2014.
• [1329] Mammalian diaphanous-related formin 1 is required for motility and invadopodia formation in human U87 glioblastoma cells.Int J Mol Med. 2014 Feb;33(2):383-91. doi: 10.3892/ijmm.2013.1577. Epub 2013 Dec 5.
• [1330] Oncogenic Ras is downregulated by ARHI and induces autophagy by Ras/AKT/mTOR pathway in glioblastoma.BMC Cancer. 2019 May 14;19(1):441. doi: 10.1186/s12885-019-5643-z.
• [1331] Haptoglobin gene expression in human glioblastoma cell lines.Neurosci Lett. 2001 May 11;303(3):181-4. doi: 10.1016/s0304-3940(01)01748-7.
• [1332] DR4-Ser424 O-GlcNAcylation Promotes Sensitization of TRAIL-Tolerant Persisters and TRAIL-Resistant Cancer Cells to Death.Cancer Res. 2019 Jun 1;79(11):2839-2852. doi: 10.1158/0008-5472.CAN-18-1991. Epub 2019 Apr 15.
• [1333] Upregulation of DLX2 confers a poor prognosis in glioblastoma patients by inducing a proliferative phenotype.Curr Mol Med. 2013 Mar;13(3):438-45.
• [1334] Isolation of immunoresistant human glioma cell clones after selection with alloreactive cytotoxic T lymphocytes: cytogenetic and molecular cytogenetic characterization.Cancer Genet Cytogenet. 2006 Mar;165(2):121-34. doi: 10.1016/j.cancergencyto.2005.08.009.
• [1335] Guanine nucleotide exchange factor Dock7 mediates HGF-induced glioblastoma cell invasion via Rac activation.Br J Cancer. 2014 Mar 4;110(5):1307-15. doi: 10.1038/bjc.2014.39. Epub 2014 Feb 11.
• [1336] In vivo fluorescence resonance energy transfer imaging reveals differential activation of Rho-family GTPases in glioblastoma cell invasion.J Cell Sci. 2012 Feb 15;125(Pt 4):858-68. doi: 10.1242/jcs.089995. Epub 2012 Mar 7.
• [1337] The role of the SWI/SNF chromatin remodeling complex in maintaining the stemness of glioma initiating cells.Sci Rep. 2017 Apr 18;7(1):889. doi: 10.1038/s41598-017-00982-3.
• [1338] The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma.Neuro Oncol. 2018 Jun 18;20(7):930-941. doi: 10.1093/neuonc/noy007.
• [1339] Ulip/CRMP proteins are recognized by autoantibodies in paraneoplastic neurological syndromes.Eur J Neurosci. 1999 Dec;11(12):4226-32. doi: 10.1046/j.1460-9568.1999.00864.x.
• [1340] CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling.Cancer Res. 2015 Sep 1;75(17):3519-28. doi: 10.1158/0008-5472.CAN-14-0631. Epub 2015 Jun 29.
• [1341] DRAM1 regulates the migration and invasion of hepatoblastoma cells via autophagy-EMT pathway.Oncol Lett. 2018 Aug;16(2):2427-2433. doi: 10.3892/ol.2018.8937. Epub 2018 Jun 8.
• [1342] Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.Eur Radiol. 2019 Oct;29(10):5539-5548. doi: 10.1007/s00330-019-06097-9. Epub 2019 Mar 15.
• [1343] Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cells.Cancer Res. 2010 Feb 15;70(4):1689-99. doi: 10.1158/0008-5472.CAN-09-3218. Epub 2010 Feb 2.
• [1344] Dishevelled 2 signaling promotes self-renewal and tumorigenicity in human gliomas.Cancer Res. 2011 Dec 1;71(23):7280-90. doi: 10.1158/0008-5472.CAN-11-1531. Epub 2011 Oct 11.
• [1345] MicroRNA-129-3p suppresses tumor growth by targeting E2F5 in glioblastoma.Eur Rev Med Pharmacol Sci. 2018 Feb;22(4):1044-1050. doi: 10.26355/eurrev_201802_14387.
• [1346] Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.J Exp Clin Cancer Res. 2015 Jan 22;34(1):4. doi: 10.1186/s13046-014-0118-1.
• [1347] Suppression of virus replication via down-modulation of mitochondrial short chain enoyl-CoA hydratase in human glioblastoma cells.Antiviral Res. 2007 Aug;75(2):152-8. doi: 10.1016/j.antiviral.2007.02.002. Epub 2007 Mar 16.
• [1348] Autocrine endothelin-3/endothelin receptor B signaling maintains cellular and molecular properties of glioblastoma stem cells.Mol Cancer Res. 2011 Dec;9(12):1668-85. doi: 10.1158/1541-7786.MCR-10-0563. Epub 2011 Oct 19.
• [1349] EGFLAM correlates with cell proliferation, migration, invasion and poor prognosis in glioblastoma.Cancer Biomark. 2019;24(3):343-350. doi: 10.3233/CBM-181740.
• [1350] c-erbB-2 in astrocytomas: infrequent overexpression by immunohistochemistry and absence of gene amplification by fluorescence in situ hybridization.Br J Cancer. 1996 Mar;73(5):620-3. doi: 10.1038/bjc.1996.107.
• [1351] Analysis of the close relationship between human astrocytoma-specific antigens detected by murine monoclonal antibodies and c-kit proto-oncogene product.Biochem Biophys Res Commun. 1992 Jan 31;182(2):474-80. doi: 10.1016/0006-291x(92)91756-g.
• [1352] Epigenetic Control of Fatty-Acid Metabolism Sustains Glioma Stem Cells.Cancer Discov. 2019 Sep;9(9):1161-1163. doi: 10.1158/2159-8290.CD-19-0733.
• [1353] hHSS1: a novel secreted factor and suppressor of glioma growth located at chromosome 19q13.33.J Neurooncol. 2011 Apr;102(2):197-211. doi: 10.1007/s11060-010-0314-6. Epub 2010 Jul 31.
• [1354] The expression of EMX2 lead to cell cycle arrest in glioblastoma cell line.BMC Cancer. 2018 Dec 4;18(1):1213. doi: 10.1186/s12885-018-5094-y.
• [1355] The effect of GHRH antagonists on human glioblastomas and their mechanism of action.Int J Cancer. 2010 Nov 15;127(10):2313-22. doi: 10.1002/ijc.25259.
• [1356] Identifying small molecule probes of ENTPD5 through high throughput screening.PLoS One. 2019 Jun 26;14(6):e0210305. doi: 10.1371/journal.pone.0210305. eCollection 2019.
• [1357] Overexpression of Epsin3 enhances migration and invasion of glioma cells by inducing epithelialmesenchymal transition.Oncol Rep. 2018 Nov;40(5):3049-3059. doi: 10.3892/or.2018.6691. Epub 2018 Sep 10.
• [1358] EPS8 is a Potential Oncogene in Glioblastoma.Onco Targets Ther. 2019 Dec 2;12:10523-10534. doi: 10.2147/OTT.S227739. eCollection 2019.
• [1359] Structure and mechanism of activity-based inhibition of the EGF receptor by Mig6.Nat Struct Mol Biol. 2015 Sep;22(9):703-711. doi: 10.1038/nsmb.3074. Epub 2015 Aug 17.
• [1360] HIV-1 Envelope Protein gp120 Promotes Proliferation and the Activation of Glycolysis in Glioma Cell.Cancers (Basel). 2018 Sep 1;10(9):301. doi: 10.3390/cancers10090301.
• [1361] A human glioblastoma line with karyotypic nullisomy 13 containing several chromosome 13-specific sequences.Cancer Genet Cytogenet. 1988 Jul 1;33(1):127-32. doi: 10.1016/0165-4608(88)90058-1.
• [1362] Cohesin gene mutations in tumorigenesis: from discovery to clinical significance.BMB Rep. 2014 Jun;47(6):299-310. doi: 10.5483/bmbrep.2014.47.6.092.
• [1363] Genome-wide association study identifies multiple susceptibility loci for glioma.Nat Commun. 2015 Oct 1;6:8559. doi: 10.1038/ncomms9559.
• [1364] ETV2 mediates endothelial transdifferentiation of glioblastoma.Signal Transduct Target Ther. 2018 Feb 9;3:4. doi: 10.1038/s41392-018-0007-8. eCollection 2018.
• [1365] Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines.Clin Cancer Res. 2001 Feb;7(2):267-76.
• [1366] EVA1A inhibits GBM cell proliferation by inducing autophagy and apoptosis.Exp Cell Res. 2017 Mar 1;352(1):130-138. doi: 10.1016/j.yexcr.2017.02.003. Epub 2017 Feb 6.
• [1367] INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy--Introgen, RPR/INGN 201.BioDrugs. 2003;17(3):216-22. doi: 10.2165/00063030-200317030-00010.
• [1368] Transcriptional activation of TRADD mediates p53-independent radiation-induced apoptosis of glioma cells.Oncogene. 2001 May 17;20(22):2826-35. doi: 10.1038/sj.onc.1204393.
• [1369] DRR1 promotes glioblastoma cell invasion and epithelial-mesenchymal transition via regulating AKT activation.Cancer Lett. 2018 Jun 1;423:86-94. doi: 10.1016/j.canlet.2018.03.015. Epub 2018 Mar 13.
• [1370] Fibulin-7 is overexpressed in glioblastomas and modulates glioblastoma neovascularization through interaction with angiopoietin-1.Int J Cancer. 2019 Oct 15;145(8):2157-2169. doi: 10.1002/ijc.32306. Epub 2019 Apr 15.
• [1371] Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma.PLoS One. 2018 Jul 5;13(7):e0199414. doi: 10.1371/journal.pone.0199414. eCollection 2018.
• [1372] FEN1 is overexpressed in testis, lung and brain tumors.Anticancer Res. 2009 Jul;29(7):2453-9.
• [1373] FERMT3 contributes to glioblastoma cell proliferation and chemoresistance to temozolomide through integrin mediated Wnt signaling.Neurosci Lett. 2017 Sep 14;657:77-83. doi: 10.1016/j.neulet.2017.07.057. Epub 2017 Aug 1.
• [1374] Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.Oncogene. 2018 Feb 8;37(6):777-786. doi: 10.1038/onc.2017.373. Epub 2017 Oct 23.
• [1375] FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities.Oncogene. 2008 Jul 10;27(30):4180-90. doi: 10.1038/onc.2008.61. Epub 2008 Mar 24.
• [1376] Expression and growth stimulatory effect of fibroblast growth factor 9 in human brain tumors.Neurosurgery. 1998 Aug;43(2):337-46. doi: 10.1097/00006123-199808000-00098.
• [1377] FHL2 interacts with EGFR to promote glioblastoma growth.Oncogene. 2018 Mar;37(10):1386-1398. doi: 10.1038/s41388-017-0068-0. Epub 2018 Jan 11.
• [1378] High filamin-C expression predicts enhanced invasiveness and poor outcome in glioblastoma multiforme.Br J Cancer. 2019 Apr;120(8):819-826. doi: 10.1038/s41416-019-0413-x. Epub 2019 Mar 14.
• [1379] KIAA1797/FOCAD encodes a novel focal adhesion protein with tumour suppressor function in gliomas.Brain. 2012 Apr;135(Pt 4):1027-41. doi: 10.1093/brain/aws045. Epub 2012 Mar 16.
• [1380] MicroRNA-652 suppresses malignant phenotypes in glioblastoma multiforme via FOXK1-mediated AKT/mTOR signaling pathway.Onco Targets Ther. 2019 Jul 10;12:5563-5575. doi: 10.2147/OTT.S204715. eCollection 2019.
• [1381] Knockdown of FRAT1 expression by RNA interference inhibits human glioblastoma cell growth, migration and invasion.PLoS One. 2013 Apr 17;8(4):e61206. doi: 10.1371/journal.pone.0061206. Print 2013.
• [1382] High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT Glioblastomas.Cancers (Basel). 2019 Jul 27;11(8):1060. doi: 10.3390/cancers11081060.
• [1383] Immunoreactivity of Wnt5a, Fzd2, Fzd6, and Ryk in glioblastoma: evaluative methodology for DAB chromogenic immunostaining.Brain Tumor Pathol. 2014 Apr;31(2):85-93. doi: 10.1007/s10014-013-0153-1. Epub 2013 Jun 9.
• [1384] Lipolytic inhibitor G0S2 modulates glioma stem-like cell radiation response.J Exp Clin Cancer Res. 2019 Apr 5;38(1):147. doi: 10.1186/s13046-019-1151-x.
• [1385] Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastoma.Oncogene. 2019 Dec;38(50):7473-7490. doi: 10.1038/s41388-019-0956-6. Epub 2019 Aug 23.
• [1386] Effects of IGFBP-3 and GalNAc-T14 on proliferation and cell cycle of glioblastoma cells and its mechanism.J Pharm Pharmacol. 2020 Feb;72(2):218-226. doi: 10.1111/jphp.13187. Epub 2019 Nov 12.
• [1387] High expression of GALNT7 promotes invasion and proliferation of glioma cells.Oncol Lett. 2018 Nov;16(5):6307-6314. doi: 10.3892/ol.2018.9498. Epub 2018 Sep 25.
• [1388] Microglia induces Gas1 expression in human brain tumor-initiating cells to reduce tumorigenecity.Sci Rep. 2018 Oct 16;8(1):15286. doi: 10.1038/s41598-018-33306-0.
• [1389] MiR-16-5p is frequently down-regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy.Neuropathol Appl Neurobiol. 2019 Aug;45(5):441-458. doi: 10.1111/nan.12532. Epub 2019 Feb 19.
• [1390] Mammalian Target of Rapamycin 2 (MTOR2) and C-MYC Modulate Glucosamine-6-Phosphate Synthesis in Glioblastoma (GBM) Cells Through Glutamine: Fructose-6-Phosphate Aminotransferase 1 (GFAT1).Cell Mol Neurobiol. 2019 Apr;39(3):415-434. doi: 10.1007/s10571-019-00659-7. Epub 2019 Feb 15.
• [1391] Magnetoelectric nanoparticles for delivery of antitumor peptides into glioblastoma cells by magnetic fields.Nanomedicine (Lond). 2018 Feb;13(4):423-438. doi: 10.2217/nnm-2017-0300. Epub 2018 Jan 18.
• [1392] MicroRNA-135b exerts oncogenic activity in glioblastoma via the inhibition of glycerol kinase 5 expression.Mol Med Rep. 2015 Aug;12(2):2721-6. doi: 10.3892/mmr.2015.3708. Epub 2015 Apr 30.
• [1393] Hedgehog signalling in medulloblastoma, glioblastoma and neuroblastoma.Oncol Rep. 2008 Mar;19(3):681-8.
• [1394] CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells.Sci Rep. 2015 Jul 9;5:11483. doi: 10.1038/srep11483.
• [1395] Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastoma.Neuro Oncol. 2019 Feb 19;21(3):337-347. doi: 10.1093/neuonc/noy185.
• [1396] Fifty Shades of -Ketoglutarate on Cellular Programming.Mol Cell. 2019 Oct 3;76(1):1-3. doi: 10.1016/j.molcel.2019.09.002.
• [1397] Association of the GNB3 825T-allele with better survival in patients with glioblastoma multiforme.J Cancer Res Clin Oncol. 2010 Sep;136(9):1423-9. doi: 10.1007/s00432-010-0797-8. Epub 2010 Feb 10.
• [1398] An off-target nucleostemin RNAi inhibits growth in human glioblastoma-derived cancer stem cells.PLoS One. 2011;6(12):e28753. doi: 10.1371/journal.pone.0028753. Epub 2011 Dec 12.
• [1399] GOLM1 silencing inhibits the proliferation and motility of human glioblastoma cells via the Wnt/-catenin signaling pathway.Brain Res. 2019 Aug 15;1717:117-126. doi: 10.1016/j.brainres.2019.03.035. Epub 2019 Mar 29.
• [1400] The knocking down of the oncoprotein Golgi phosphoprotein 3 in T98G cells of glioblastoma multiforme disrupts cell migration by affecting focal adhesion dynamics in a focal adhesion kinase-dependent manner.PLoS One. 2019 Feb 19;14(2):e0212321. doi: 10.1371/journal.pone.0212321. eCollection 2019.
• [1401] Development of a predictor for human brain tumors based on gene expression values obtained from two types of microarray technologies.OMICS. 2010 Apr;14(2):157-64. doi: 10.1089/omi.2009.0093.
• [1402] Inhibition of GPR158 by microRNA-449a suppresses neural lineage of glioma stem/progenitor cells and correlates with higher glioma grades.Oncogene. 2018 Aug;37(31):4313-4333. doi: 10.1038/s41388-018-0277-1. Epub 2018 May 3.
• [1403] Genetic ablation of Gpr37l1 delays tumor occurrence in Ptch1(+/-) mouse models of medulloblastoma.Exp Neurol. 2019 Feb;312:33-42. doi: 10.1016/j.expneurol.2018.11.004. Epub 2018 Nov 16.
• [1404] Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis.Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1409-22. doi: 10.1158/1055-9965.EPI-09-1077.
• [1405] Inhibition of human glioblastoma cell invasion involves PION@E6 mediated autophagy process.Cancer Manag Res. 2019 Mar 29;11:2643-2652. doi: 10.2147/CMAR.S200151. eCollection 2019.
• [1406] Coronarin D Induces Apoptotic Cell Death and Cell Cycle Arrest in Human Glioblastoma Cell Line.Molecules. 2019 Dec 9;24(24):4498. doi: 10.3390/molecules24244498.
• [1407] Significance of H3K27M mutation with specific histomorphological features and associated molecular alterations in pediatric high-grade glial tumors.Childs Nerv Syst. 2018 Jan;34(1):107-116. doi: 10.1007/s00381-017-3633-5. Epub 2017 Oct 24.
• [1408] Glioma-associated antigen HEATR1 induces functional cytotoxic T lymphocytes in patients with glioma.J Immunol Res. 2014;2014:131494. doi: 10.1155/2014/131494. Epub 2014 Jul 9.
• [1409] The immunoglobulin-like cell adhesion molecule hepaCAM induces differentiation of human glioblastoma U373-MG cells.J Cell Biochem. 2009 Aug 15;107(6):1129-38. doi: 10.1002/jcb.22215.
• [1410] Elucidation of the genetic and epigenetic landscape alterations in RNA binding proteins in glioblastoma.Oncotarget. 2017 Mar 7;8(10):16650-16668. doi: 10.18632/oncotarget.14287.
• [1411] Nuclear Factor I Represses the Notch Effector HEY1 in Glioblastoma.Neoplasia. 2018 Oct;20(10):1023-1037. doi: 10.1016/j.neo.2018.08.007. Epub 2018 Sep 6.
• [1412] Tetramethylpyrazine attenuates sinusoidal angiogenesis via inhibition of hedgehog signaling in liver fibrosis.IUBMB Life. 2017 Feb;69(2):115-127. doi: 10.1002/iub.1598. Epub 2017 Jan 23.
• [1413] Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres.Am J Pathol. 2010 Sep;177(3):1491-502. doi: 10.2353/ajpath.2010.091021. Epub 2010 Jul 29.
• [1414] Detailed delineation of an interferon-gamma-responsive element important in human HLA-DRA gene expression in a glioblastoma multiform line.Proc Natl Acad Sci U S A. 1988 Nov;85(22):8618-22. doi: 10.1073/pnas.85.22.8618.
• [1415] HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo.J Neuropathol Exp Neurol. 2005 Jun;64(6):523-8. doi: 10.1093/jnen/64.6.523.
• [1416] Correlation of alteration of HLA-F expression and clinical characterization in 593 brain glioma samples.J Neuroinflammation. 2019 Feb 12;16(1):33. doi: 10.1186/s12974-019-1418-3.
• [1417] Regulation of survival in adult hippocampal and glioblastoma stem cell lineages by the homeodomain-only protein HOP.Neural Dev. 2008 May 28;3:13. doi: 10.1186/1749-8104-3-13.
• [1418] Modulation of HOX2 gene expression following differentiation of neuronal cell lines.Differentiation. 1992 Sep;51(1):39-47. doi: 10.1111/j.1432-0436.1992.tb00678.x.
• [1419] Long non-coding RNA HOXB-AS1 promotes proliferation, migration and invasion of glioblastoma cells via HOXB-AS1/miR-885-3p/HOXB2 axis.Neoplasma. 2019 May 23;66(3):386-396. doi: 10.4149/neo_2018_180606N377.
• [1420] Homeobox B3 promotes tumor cell proliferation and invasion in glioblastoma.Oncol Lett. 2018 Mar;15(3):3712-3718. doi: 10.3892/ol.2018.7750. Epub 2018 Jan 8.
• [1421] Homeobox B8 Targets Sterile Alpha Motif Domain-Containing Protein 9 and Drives Glioma Progression.Neurosci Bull. 2020 Apr;36(4):359-371. doi: 10.1007/s12264-019-00436-y. Epub 2019 Oct 23.
• [1422] Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.J Drug Target. 2019 Jan;27(1):60-66. doi: 10.1080/1061186X.2018.1473408. Epub 2018 Aug 6.
• [1423] Overexpression of HOXC6 promotes cell proliferation and migration via MAPK signaling and predicts a poor prognosis in glioblastoma.Cancer Manag Res. 2019 Sep 3;11:8167-8179. doi: 10.2147/CMAR.S209904. eCollection 2019.
• [1424] Functional analysis of HOXD9 in human gliomas and glioma cancer stem cells.Mol Cancer. 2011 May 22;10:60. doi: 10.1186/1476-4598-10-60.
• [1425] HPCAL1 promotes glioblastoma proliferation via activation of Wnt/-catenin signalling pathway.J Cell Mol Med. 2019 May;23(5):3108-3117. doi: 10.1111/jcmm.14083. Epub 2019 Mar 6.
• [1426] Histidine-rich glycoprotein can prevent development of mouse experimental glioblastoma.PLoS One. 2009 Dec 31;4(12):e8536. doi: 10.1371/journal.pone.0008536.
• [1427] Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas.Acta Neuropathol. 2005 Oct;110(4):402-10. doi: 10.1007/s00401-005-1065-x. Epub 2005 Sep 10.
• [1428] Silencing of Hsp27 and Hsp72 in glioma cells as a tool for programmed cell death induction upon temozolomide and quercetin treatment. Toxicol Appl Pharmacol. 2013 Dec 15;273(3):580-9. doi: 10.1016/j.taap.2013.10.003. Epub 2013 Oct 12.
• [1429] Ex vivo Hsp70-Activated NK Cells in Combination With PD-1 Inhibition Significantly Increase Overall Survival in Preclinical Models of Glioblastoma and Lung Cancer.Front Immunol. 2019 Mar 22;10:454. doi: 10.3389/fimmu.2019.00454. eCollection 2019.
• [1430] Regulation of tumor angiogenesis by oxygen-regulated protein 150, an inducible endoplasmic reticulum chaperone.Cancer Res. 2001 May 15;61(10):4206-13.
• [1431] A cell-autonomous positive-signaling circuit associated with the PDGF-NO-ID4-regulatory axis in glioblastoma cells.Biochem Biophys Res Commun. 2017 Apr 29;486(2):564-570. doi: 10.1016/j.bbrc.2017.03.089. Epub 2017 Mar 19.
• [1432] Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma.Oncogene. 2017 Oct 26;36(43):6006-6019. doi: 10.1038/onc.2017.205. Epub 2017 Jul 3.
• [1433] Loss of heterozygosity of microsatellite loci on chromosome 9p in astrocytic tumors and its prognostic implications.J Neurooncol. 1996 Oct;30(1):19-24. doi: 10.1007/BF00177439.
• [1434] BLOC1S2 interacts with the HIPPI protein and sensitizes NCH89 glioblastoma cells to apoptosis.Apoptosis. 2008 Mar;13(3):437-47. doi: 10.1007/s10495-007-0176-3.
• [1435] ADAR RNA editing in human disease; more to it than meets the I.Hum Genet. 2017 Sep;136(9):1265-1278. doi: 10.1007/s00439-017-1837-0. Epub 2017 Sep 14.
• [1436] Insulin like growth factor binding protein 4 promotes GBM progression and regulates key factors involved in EMT and invasion.J Neurooncol. 2014 Feb;116(3):455-64. doi: 10.1007/s11060-013-1324-y. Epub 2014 Jan 7.
• [1437] Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivo.Neoplasia. 2009 Jan;11(1):77-86, 4p following 86. doi: 10.1593/neo.81180.
• [1438] Upregulated circular RNA circ_0074027 promotes glioblastoma cell growth and invasion by regulating miR-518a-5p/IL17RD signaling pathway.Biochem Biophys Res Commun. 2019 Mar 19;510(4):515-519. doi: 10.1016/j.bbrc.2019.01.140. Epub 2019 Feb 7.
• [1439] IL22 furthers malignant transformation of rat mesenchymal stem cells, possibly in association with IL22RA1/STAT3 signaling.Oncol Rep. 2019 Apr;41(4):2148-2158. doi: 10.3892/or.2019.7007. Epub 2019 Feb 11.
• [1440] Receptor-type protein-tyrosine phosphatase is a functional receptor for interleukin-34.J Biol Chem. 2013 Jul 26;288(30):21972-86. doi: 10.1074/jbc.M112.442731. Epub 2013 Jun 6.
• [1441] Nitazoxanide, an antiprotozoal drug, inhibits late-stage autophagy and promotes ING1-induced cell cycle arrest in glioblastoma.Cell Death Dis. 2018 Oct 9;9(10):1032. doi: 10.1038/s41419-018-1058-z.
• [1442] Integrin 10, a Novel Therapeutic Target in Glioblastoma, Regulates Cell Migration, Proliferation, and Survival.Cancers (Basel). 2019 Apr 25;11(4):587. doi: 10.3390/cancers11040587.
• [1443] Triacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma.Int J Cancer. 2014 Mar 15;134(6):1300-10. doi: 10.1002/ijc.28465. Epub 2013 Sep 30.
• [1444] Integrin 3 is overexpressed in glioma stem-like cells and promotes invasion.Br J Cancer. 2013 Jun 25;108(12):2516-24. doi: 10.1038/bjc.2013.218. Epub 2013 May 7.
• [1445] A rapid in vitro methodology for simultaneous target discovery and antibody generation against functional cell subpopulations.Sci Rep. 2019 Jan 29;9(1):842. doi: 10.1038/s41598-018-37462-1.
• [1446] Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma.Front Oncol. 2019 Sep 20;9:904. doi: 10.3389/fonc.2019.00904. eCollection 2019.
• [1447] Molecular mechanism of SSFA2 deletion inhibiting cell proliferation and promoting cell apoptosis in glioma.Pathol Res Pract. 2019 Mar;215(3):600-606. doi: 10.1016/j.prp.2018.12.035. Epub 2018 Dec 31.
• [1448] MYST1/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cells.Cancer Med. 2019 Dec;8(18):7793-7808. doi: 10.1002/cam4.2639. Epub 2019 Nov 5.
• [1449] Epigenetic silencing of KAZALD1 confers a better prognosis and is associated with malignant transformation/progression in glioma.Oncol Rep. 2013 Nov;30(5):2089-96. doi: 10.3892/or.2013.2706. Epub 2013 Aug 29.
• [1450] KDELR2 Promotes Glioblastoma Tumorigenesis Targeted by HIF1a via mTOR Signaling Pathway.Cell Mol Neurobiol. 2019 Nov;39(8):1207-1215. doi: 10.1007/s10571-019-00715-2. Epub 2019 Jul 25.
• [1451] Integrative analysis of KIF4A, 9, 18A, and 23 and their clinical significance in low-grade glioma and glioblastoma.Sci Rep. 2019 Mar 14;9(1):4599. doi: 10.1038/s41598-018-37622-3.
• [1452] Differential display of messenger ribonucleic acid: a useful technique for analyzing differential gene expression in human brain tumors.Neurosurgery. 1995 Sep;37(3):464-9; discussion 469-70. doi: 10.1227/00006123-199509000-00014.
• [1453] KLF6 depletion promotes NF-B signaling in glioblastoma.Oncogene. 2017 Jun 22;36(25):3562-3575. doi: 10.1038/onc.2016.507. Epub 2017 Feb 6.
• [1454] Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.Int J Cancer. 2017 Jun 15;140(12):2792-2804. doi: 10.1002/ijc.30690. Epub 2017 Apr 3.
• [1455] Laminin alpha 2 enables glioblastoma stem cell growth.Ann Neurol. 2012 Nov;72(5):766-78. doi: 10.1002/ana.23674.
• [1456] Signaling adaptor protein Crk is indispensable for malignant feature of glioblastoma cell line KMG4.Biochem Biophys Res Commun. 2007 Nov 3;362(4):976-81. doi: 10.1016/j.bbrc.2007.08.106. Epub 2007 Aug 27.
• [1457] The cyclooxygenase inhibitor indomethacin modulates gene expression and represses the extracellular matrix protein laminin gamma1 in human glioblastoma cells. Exp Cell Res. 2005 Jan 15;302(2):244-52. doi: 10.1016/j.yexcr.2004.09.021.
• [1458] Identification of RNA-Binding Protein LARP4B as a Tumor Suppressor in Glioma.Cancer Res. 2016 Apr 15;76(8):2254-64. doi: 10.1158/0008-5472.CAN-15-2308. Epub 2016 Mar 1.
• [1459] NNMT Silencing Activates Tumor Suppressor PP2A, Inactivates Oncogenic STKs, and Inhibits Tumor Forming Ability.Clin Cancer Res. 2017 May 1;23(9):2325-2334. doi: 10.1158/1078-0432.CCR-16-1323. Epub 2016 Nov 3.
• [1460] Increased LGALS3 expression independently predicts shorter overall survival in patients with the proneural subtype of glioblastoma.Cancer Med. 2019 May;8(5):2031-2040. doi: 10.1002/cam4.2075. Epub 2019 Mar 7.
• [1461] Molecular and clinical characterization of Galectin-9 in glioma through 1,027 samples.J Cell Physiol. 2020 May;235(5):4326-4334. doi: 10.1002/jcp.29309. Epub 2019 Oct 14.
• [1462] Characterization of the amplicon on chromosomal segment 4q12 in glioblastoma multiforme.Neuro Oncol. 2007 Jul;9(3):291-7. doi: 10.1215/15228517-2007-009. Epub 2007 May 15.
• [1463] Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma.Oncogenesis. 2018 Feb 2;7(2):13. doi: 10.1038/s41389-017-0012-8.
• [1464] The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma.Front Oncol. 2019 Jun 6;9:447. doi: 10.3389/fonc.2019.00447. eCollection 2019.
• [1465] GAC1, a new member of the leucine-rich repeat superfamily on chromosome band 1q32.1, is amplified and overexpressed in malignant gliomas.Oncogene. 1998 Jun 11;16(23):2997-3002. doi: 10.1038/sj.onc.1201828.
• [1466] Oligo-astrocytoma in LZTR1-related Noonan syndrome.Eur J Med Genet. 2020 Jan;63(1):103617. doi: 10.1016/j.ejmg.2019.01.007. Epub 2019 Jan 19.
• [1467] Circulating MACC1 Transcripts in Glioblastoma Patients Predict Prognosis and Treatment Response.Cancers (Basel). 2019 Jun 13;11(6):825. doi: 10.3390/cancers11060825.
• [1468] Mammalian Maf1 is a negative regulator of transcription by all three nuclear RNA polymerases.Mol Cell. 2007 May 11;26(3):367-79. doi: 10.1016/j.molcel.2007.03.021.
• [1469] RNA-Binding Protein Musashi1 Is a Central Regulator of Adhesion Pathways in Glioblastoma.Mol Cell Biol. 2015 Sep 1;35(17):2965-78. doi: 10.1128/MCB.00410-15. Epub 2015 Jun 22.
• [1470] Prolactin increases expression of cytoskeletal proteins in SK-N-SH cells.Folia Biol (Praha). 2014;60(6):281-5.
• [1471] -Elemene inhibits proliferation of human glioblastoma cells and causes cell-cycle G0/G1 arrest via mutually compensatory activation of MKK3 and MKK6.Int J Oncol. 2011 Feb;38(2):419-26. doi: 10.3892/ijo.2010.855. Epub 2010 Dec 3.
• [1472] A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma.J Neurooncol. 2020 Jan;146(1):79-89. doi: 10.1007/s11060-019-03337-2. Epub 2019 Nov 27.
• [1473] Computational Characterization of Suppressive Immune Microenvironments in Glioblastoma.Cancer Res. 2018 Oct 1;78(19):5574-5585. doi: 10.1158/0008-5472.CAN-17-3714. Epub 2018 Jun 19.
• [1474] Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance-associated protein genes.Neuroscience. 2008 Jun 23;154(2):541-50. doi: 10.1016/j.neuroscience.2008.03.054. Epub 2008 Apr 1.
• [1475] The neural progenitor-restricted isoform of the MARK4 gene in 19q13.2 is upregulated in human gliomas and overexpressed in a subset of glioblastoma cell lines.Oncogene. 2003 May 1;22(17):2581-91. doi: 10.1038/sj.onc.1206336.
• [1476] A functional yeast survival screen of tumor-derived cDNA libraries designed to identify anti-apoptotic mammalian oncogenes.PLoS One. 2013 May 22;8(5):e64873. doi: 10.1371/journal.pone.0064873. Print 2013.
• [1477] Differential expression of Csk homologous kinase (CHK) in normal brain and brain tumors.Cancer. 2004 Sep 1;101(5):1018-27. doi: 10.1002/cncr.20442.
• [1478] c-myc oncogene family expression in glioblastoma and survival.Surg Neurol. 1999 May;51(5):536-42. doi: 10.1016/s0090-3019(98)00028-7.
• [1479] Glioblastoma initiating cells are sensitive to histone demethylase inhibition due to epigenetic deregulation.Int J Cancer. 2020 Mar 1;146(5):1281-1292. doi: 10.1002/ijc.32649. Epub 2019 Oct 11.
• [1480] Overexpression of transient receptor potential mucolipin-2 ion channels in gliomas: role in tumor growth and progression.Oncotarget. 2016 Jul 12;7(28):43654-43668. doi: 10.18632/oncotarget.9661.
• [1481] RNAi-mediated inhibition of MSP58 decreases tumour growth, migration and invasion in a human glioma cell line.J Cell Mol Med. 2009 Nov-Dec;13(11-12):4608-22. doi: 10.1111/j.1582-4934.2008.00499.x.
• [1482] Effects of curcumin-loaded PLGA nanoparticles on the RG2 rat glioma model.Mater Sci Eng C Mater Biol Appl. 2017 Sep 1;78:32-38. doi: 10.1016/j.msec.2017.03.292. Epub 2017 Apr 6.
• [1483] Prognostic significance of MEOX2 in gliomas.Mod Pathol. 2019 Jun;32(6):774-786. doi: 10.1038/s41379-018-0192-6. Epub 2019 Jan 18.
• [1484] N(6)-Methyladenosine Modulates Nonsense-Mediated mRNA Decay in Human Glioblastoma.Cancer Res. 2019 Nov 15;79(22):5785-5798. doi: 10.1158/0008-5472.CAN-18-2868. Epub 2019 Sep 17.
• [1485] Inhibition of gliomagenesis and attenuation of mitotic transition by MIIP.Oncogene. 2010 Jun 17;29(24):3501-8. doi: 10.1038/onc.2010.114. Epub 2010 Apr 26.
• [1486] Morphine exacerbates HIV-1 viral protein gp120 induced modulation of chemokine gene expression in U373 astrocytoma cells.Curr HIV Res. 2005 Jul;3(3):277-88. doi: 10.2174/1570162054368048.
• [1487] Matrix metalloproteinase-19 is highly expressed in astroglial tumors and promotes invasion of glioma cells.J Neuropathol Exp Neurol. 2010 Mar;69(3):215-23. doi: 10.1097/NEN.0b013e3181ce9f67.
• [1488] Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors.Cancer Res. 1999 Jun 1;59(11):2570-6.
• [1489] Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.Cancer Res. 2000 Feb 15;60(4):877-82.
• [1490] Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.Bosn J Basic Med Sci. 2019 May 20;19(2):164-171. doi: 10.17305/bjbms.2019.3713.
• [1491] MPC1 deletion is associated with poor prognosis and temozolomide resistance in glioblastoma.J Neurooncol. 2019 Sep;144(2):293-301. doi: 10.1007/s11060-019-03226-8. Epub 2019 Jun 24.
• [1492] Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.J Neurosurg. 2018 Mar 16;130(1):56-66. doi: 10.3171/2017.9.JNS172036.
• [1493] p55 and p75 tumor necrosis factor receptor expression on human glioblastoma cells.Neurol Med Chir (Tokyo). 1995 Aug;35(8):567-74. doi: 10.2176/nmc.35.567.
• [1494] RIP3 antagonizes a TSC2-mediated pro-survival pathway in glioblastoma cell death.Biochim Biophys Acta Mol Cell Res. 2017 Jan;1864(1):113-124. doi: 10.1016/j.bbamcr.2016.10.014. Epub 2016 Oct 27.
• [1495] Knockdown of immature colon carcinoma transcript1 induces suppression of proliferation, S-phase arrest and apoptosis in leukemia cells.Oncol Rep. 2018 Mar;39(3):1269-1275. doi: 10.3892/or.2018.6185. Epub 2018 Jan 3.
• [1496] A Novel MKL Method for GBM Prognosis Prediction by Integrating Histopathological Image and Multi-Omics Data.IEEE J Biomed Health Inform. 2020 Jan;24(1):171-179. doi: 10.1109/JBHI.2019.2898471. Epub 2019 Feb 11.
• [1497] TP53, MSH4, and LATS1 germline mutations in a family with clustering of nervous system tumors.Am J Pathol. 2014 Sep;184(9):2374-81. doi: 10.1016/j.ajpath.2014.05.017. Epub 2014 Jul 18.
• [1498] Oncogenic MSH6-CXCR4-TGFB1 Feedback Loop: A Novel Therapeutic Target of Photothermal Therapy in Glioblastoma Multiforme.Theranostics. 2019 Feb 20;9(5):1453-1473. doi: 10.7150/thno.29987. eCollection 2019.
• [1499] Moesin Up-regulation Is Associated with Enhanced Tumor Progression Imaged Non-invasively in an Orthotopic Mouse Model of Human Glioblastoma.Anticancer Res. 2018 Jun;38(6):3267-3272. doi: 10.21873/anticanres.12591.
• [1500] Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide.J Neurooncol. 2011 Jun;103(2):325-32. doi: 10.1007/s11060-010-0390-7. Epub 2010 Sep 7.
• [1501] MAX and MYC: a heritable breakup.Cancer Res. 2012 Jul 1;72(13):3119-24. doi: 10.1158/0008-5472.CAN-11-3891. Epub 2012 Jun 15.
• [1502] Alternative Splicing of MXD3 and Its Regulation of MXD3 Levels in Glioblastoma.Front Mol Biosci. 2019 Feb 19;6:5. doi: 10.3389/fmolb.2019.00005. eCollection 2019.
• [1503] Dissecting the complex regulation of Mad4 in glioblastoma multiforme cells.Cancer Biol Ther. 2012 Nov;13(13):1339-48. doi: 10.4161/cbt.21814. Epub 2012 Aug 16.
• [1504] Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma.J Exp Clin Cancer Res. 2017 Aug 7;36(1):105. doi: 10.1186/s13046-017-0573-6.
• [1505] Circadian pathway genes in relation to glioma risk and outcome.Cancer Causes Control. 2014 Jan;25(1):25-32. doi: 10.1007/s10552-013-0305-y. Epub 2013 Oct 18.
• [1506] Analysis of transcriptional activity by the Myt1 and Myt1l transcription factors.J Cell Biochem. 2018 Jun;119(6):4644-4655. doi: 10.1002/jcb.26636. Epub 2018 Mar 9.
• [1507] N-CoR pathway targeting induces glioblastoma derived cancer stem cell differentiation. Cell Cycle. 2007 Feb 15;6(4):467-70. doi: 10.4161/cc.6.4.3856. Epub 2007 Feb 12.
• [1508] microRNA-100 targets SMRT/NCOR2, reduces proliferation, and improves survival in glioblastoma animal models.PLoS One. 2013 Nov 14;8(11):e80865. doi: 10.1371/journal.pone.0080865. eCollection 2013.
• [1509] Network modeling of the transcriptional effects of copy number aberrations in glioblastoma.Mol Syst Biol. 2011 Apr 26;7:486. doi: 10.1038/msb.2011.17.
• [1510] Brain specific human genes, NELL1 and NELL2, are predominantly expressed in neuroblastoma and other embryonal neuroepithelial tumors.Neurol Med Chir (Tokyo). 2001 Dec;41(12):582-8; discussion 589. doi: 10.2176/nmc.41.582.
• [1511] Overexpression of sialidase NEU3 increases the cellular radioresistance potential of U87MG glioblastoma cells.Biochem Biophys Res Commun. 2019 Jan 1;508(1):31-36. doi: 10.1016/j.bbrc.2018.11.086. Epub 2018 Nov 20.
• [1512] Sialidase NEU4 is involved in glioblastoma stem cell survival.Cell Death Dis. 2014 Aug 21;5(8):e1381. doi: 10.1038/cddis.2014.349.
• [1513] CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5.Neuro Oncol. 2019 Oct 9;21(10):1284-1296. doi: 10.1093/neuonc/noz128.
• [1514] Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma.J Neurooncol. 2020 Jan;146(1):41-53. doi: 10.1007/s11060-019-03352-3. Epub 2019 Nov 23.
• [1515] Neuroglobin functions as a prognostic marker and promotes the tumor growth of glioma via suppressing apoptosis.Biomed Pharmacother. 2017 Apr;88:173-180. doi: 10.1016/j.biopha.2017.01.029. Epub 2017 Jan 17.
• [1516] Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas.Int J Cancer. 2010 Jun 1;126(11):2584-93. doi: 10.1002/ijc.24981.
• [1517] miR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas.Cell Death Dis. 2014 Jun 5;5(6):e1279. doi: 10.1038/cddis.2014.245.
• [1518] Glioblastoma recurrence correlates with NLGN3 levels.Cancer Med. 2018 Jul;7(7):2848-2859. doi: 10.1002/cam4.1538. Epub 2018 May 18.
• [1519] Gene structure, promoter activity, and chromosomal location of the DR-nm23 gene, a related member of the nm23 gene family.Cancer Res. 1997 Mar 15;57(6):1180-7.
• [1520] High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma.Oncotarget. 2015 Mar 10;6(7):4901-19. doi: 10.18632/oncotarget.3208.
• [1521] MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.J Cell Biochem. 2019 Apr;120(4):6188-6197. doi: 10.1002/jcb.27906. Epub 2018 Oct 10.
• [1522] NPAS3 demonstrates features of a tumor suppressive role in driving the progression of Astrocytomas.Am J Pathol. 2011 Jul;179(1):462-76. doi: 10.1016/j.ajpath.2011.03.044. Epub 2011 May 19.
• [1523] Prognostic Role of Chicken Ovalbumin Upstream Promoter Transcription Factor II in Isocitrate Dehydrogenase-Mutant Glioma with 1p19q Co-Deletion.J Mol Neurosci. 2019 Jun;68(2):234-242. doi: 10.1007/s12031-019-01281-4. Epub 2019 Mar 30.
• [1524] Identification and validation of P311 as a glioblastoma invasion gene using laser capture microdissection.Cancer Res. 2001 May 15;61(10):4190-6.
• [1525] NT5DC2 promotes tumorigenicity of glioma stem-like cells by upregulating fyn.Cancer Lett. 2019 Jul 10;454:98-107. doi: 10.1016/j.canlet.2019.04.003. Epub 2019 Apr 10.
• [1526] EGF/EGFR upregulates and cooperates with Netrin-4 to protect glioblastoma cells from DNA damage-induced senescence.BMC Cancer. 2018 Dec 4;18(1):1215. doi: 10.1186/s12885-018-5056-4.
• [1527] MutT homolog 1 counteracts the effect of anti-neoplastic treatments in adult and pediatric glioblastoma cells.Oncotarget. 2018 Jun 8;9(44):27547-27563. doi: 10.18632/oncotarget.25547. eCollection 2018 Jun 8.
• [1528] Knockdown of NUPR1 inhibits the proliferation of glioblastoma cells via ERK1/2, p38 MAPK and caspase-3.J Neurooncol. 2017 Mar;132(1):15-26. doi: 10.1007/s11060-016-2337-0. Epub 2016 Dec 20.
• [1529] Identification of Driver Genes and Key Pathways of Glioblastoma Shows JNJ-7706621 as a Novel Antiglioblastoma Drug.World Neurosurg. 2018 Jan;109:e329-e342. doi: 10.1016/j.wneu.2017.09.176. Epub 2017 Oct 6.
• [1530] The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway.Oncogene. 2008 Feb 14;27(8):1155-66. doi: 10.1038/sj.onc.1210732. Epub 2007 Aug 13.
• [1531] Overexpression of hyaluronan synthase-2 reduces the tumorigenic potential of glioma cells lacking hyaluronidase activity.Neurosurgery. 2002 Jun;50(6):1311-8. doi: 10.1097/00006123-200206000-00023.
• [1532] Prognostic impact of glioblastoma stem cell markers OLIG2 and CCND2.Cancer Med. 2020 Feb;9(3):1069-1078. doi: 10.1002/cam4.2592. Epub 2019 Sep 30.
• [1533] Identification of Key Pathways and Genes in the Orai2 Mediated Classical and Mesenchymal Subtype of Glioblastoma by Bioinformatic Analyses.Dis Markers. 2019 Oct 20;2019:7049294. doi: 10.1155/2019/7049294. eCollection 2019.
• [1534] Squalene-PEG: Pyropheophorbide-a nanoconstructs for tumor theranostics.Nanomedicine. 2019 Jan;15(1):243-251. doi: 10.1016/j.nano.2018.09.013. Epub 2018 Oct 7.
• [1535] A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.Cancer Res. 2010 Mar 15;70(6):2158-64. doi: 10.1158/0008-5472.CAN-09-3458. Epub 2010 Mar 9.
• [1536] PATZ1 Is Overexpressed in Pediatric Glial Tumors and Correlates with Worse Event-Free Survival in High-grade Gliomas.Cancers (Basel). 2019 Oct 11;11(10):1537. doi: 10.3390/cancers11101537.
• [1537] PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype.Nat Commun. 2015 Dec 3;6:10068. doi: 10.1038/ncomms10068.
• [1538] PBX3/MEK/ERK1/2/LIN28/let-7b positive feedback loop enhances mesenchymal phenotype to promote glioblastoma migration and invasion.J Exp Clin Cancer Res. 2018 Jul 17;37(1):158. doi: 10.1186/s13046-018-0841-0.
• [1539] PCDH10 is required for the tumorigenicity of glioblastoma cells.Biochem Biophys Res Commun. 2014 Jan 31;444(1):13-8. doi: 10.1016/j.bbrc.2013.12.138. Epub 2014 Jan 6.
• [1540] PAF promotes stemness and radioresistance of glioma stem cells.Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):E9086-E9095. doi: 10.1073/pnas.1708122114. Epub 2017 Oct 9.
• [1541] Loss of programmed cell death 10 activates tumor cells and leads to temozolomide-resistance in glioblastoma.J Neurooncol. 2019 Jan;141(1):31-41. doi: 10.1007/s11060-018-03017-7. Epub 2018 Nov 3.
• [1542] Author Correction: TGF-1-induced miR-503 controls cell growth and apoptosis by targeting PDCD4 in glioblastoma cells.Sci Rep. 2019 Apr 17;9(1):6400. doi: 10.1038/s41598-019-42588-x.
• [1543] Characterization of inhibitors of phosphodiesterase 1C on a human cellular system.FEBS J. 2007 Sep;274(18):4812-24. doi: 10.1111/j.1742-4658.2007.06001.x. Epub 2007 Aug 14.
• [1544] Glioma invasion mediated by the p75 neurotrophin receptor (p75(NTR)/CD271) requires regulated interaction with PDLIM1.Oncogene. 2016 Mar 17;35(11):1411-22. doi: 10.1038/onc.2015.199. Epub 2015 Jun 29.
• [1545] Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression throughHIF-1 accumulation.Nat Cell Biol. 2014 May;16(5):445-56. doi: 10.1038/ncb2954. Epub 2014 Apr 20.
• [1546] PTEN Suppresses Glycolysis by Dephosphorylating and Inhibiting Autophosphorylated PGK1.Mol Cell. 2019 Nov 7;76(3):516-527.e7. doi: 10.1016/j.molcel.2019.08.006. Epub 2019 Sep 3.
• [1547] Silencing expression of PHF14 in glioblastoma promotes apoptosis, mitigates proliferation and invasiveness via Wnt signal pathway.Cancer Cell Int. 2019 Nov 27;19:314. doi: 10.1186/s12935-019-1040-6. eCollection 2019.
• [1548] Autoantibodies against GLEA2 and PHF3 in glioblastoma: tumor-associated autoantibodies correlated with prolonged survival.Int J Cancer. 2005 Nov 10;117(3):456-9. doi: 10.1002/ijc.20929.
• [1549] Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis.Sci Rep. 2014 Jun 11;4:5260. doi: 10.1038/srep05260.
• [1550] Retention of imprinting of the human apoptosis-related gene TSSC3 in human brain tumors.Hum Mol Genet. 2000 Mar 22;9(5):757-63. doi: 10.1093/hmg/9.5.757.
• [1551] Role of PHLPP1 in inflammation response: Its loss contributes to gliomas development and progression.Int Immunopharmacol. 2016 May;34:229-234. doi: 10.1016/j.intimp.2016.02.034. Epub 2016 Mar 10.
• [1552] Phytanoyl-CoA 2-Hydroxylase-Interacting Protein-Like Gene Is a Therapeutic Target Gene for Glioblastoma Multiforme.Med Sci Monit. 2019 Apr 9;25:2583-2590. doi: 10.12659/MSM.913895.
• [1553] Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma.Int J Cancer. 2008 May 15;122(10):2187-98. doi: 10.1002/ijc.23313.
• [1554] A Feedforward Mechanism Mediated by Mechanosensitive Ion Channel PIEZO1 and Tissue Mechanics Promotes Glioma Aggression.Neuron. 2018 Nov 21;100(4):799-815.e7. doi: 10.1016/j.neuron.2018.09.046. Epub 2018 Oct 18.
• [1555] Gene silencing reveals a specific function of hVps34 phosphatidylinositol 3-kinase in late versus early endosomes.J Cell Sci. 2006 Apr 1;119(Pt 7):1219-32. doi: 10.1242/jcs.02833. Epub 2006 Mar 7.
• [1556] PIP4K2A as a negative regulator of PI3K in PTEN-deficient glioblastoma.J Exp Med. 2019 May 6;216(5):1120-1134. doi: 10.1084/jem.20172170. Epub 2019 Mar 21.
• [1557] Polycystin-1 affects cancer cell behaviour and interacts with mTOR and Jak signalling pathways in cancer cell lines.J Cell Mol Med. 2019 Sep;23(9):6215-6227. doi: 10.1111/jcmm.14506. Epub 2019 Jun 28.
• [1558] Protein kinase D2 is a novel regulator of glioblastoma growth and tumor formation.Neuro Oncol. 2011 Jul;13(7):710-24. doi: 10.1093/neuonc/nor084.
• [1559] High expression of TIG3 predicts poor survival in patients with primary glioblastoma.Tumour Biol. 2017 Jun;39(6):1010428317712135. doi: 10.1177/1010428317712135.
• [1560] The hyaluronan receptor RHAMM/IHABP in astrocytoma cells: expression of a tumor-specific variant and association with microtubules.J Neurooncol. 2002 Aug;59(1):15-26. doi: 10.1023/a:1016373015569.
• [1561] Plk5, a polo box domain-only protein with specific roles in neuron differentiation and glioblastoma suppression.Mol Cell Biol. 2011 Mar;31(6):1225-39. doi: 10.1128/MCB.00607-10. Epub 2011 Jan 18.
• [1562] Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas.Oncotarget. 2018 Feb 28;9(21):15705-15720. doi: 10.18632/oncotarget.24594. eCollection 2018 Mar 20.
• [1563] Lipid phosphate phosphatase-3 regulates tumor growth via -catenin and CYCLIN-D1 signaling.Mol Cancer. 2011 May 11;10:51. doi: 10.1186/1476-4598-10-51.
• [1564] Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling.Blood. 2011 Oct 13;118(15):4285-96. doi: 10.1182/blood-2011-03-341388. Epub 2011 Aug 10.
• [1565] PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1.Oncogene. 2020 Jan;39(5):1125-1139. doi: 10.1038/s41388-019-1050-9. Epub 2019 Oct 11.
• [1566] Podocalyxin promotes glioblastoma multiforme cell invasion and proliferation by inhibiting angiotensin-(1-7)/Mas signaling.Oncol Rep. 2015 May;33(5):2583-91. doi: 10.3892/or.2015.3813. Epub 2015 Feb 20.
• [1567] Germline mutation p.N363K in POLE is associated with an increased risk of colorectal cancer and giant cell glioblastoma.Fam Cancer. 2019 Apr;18(2):173-178. doi: 10.1007/s10689-018-0102-6.
• [1568] Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells.BMC Cancer. 2019 Apr 3;19(1):300. doi: 10.1186/s12885-019-5476-9.
• [1569] GAPDH is not regulated in human glioblastoma under hypoxic conditions.BMC Mol Biol. 2007 Jun 27;8:55. doi: 10.1186/1471-2199-8-55.
• [1570] Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in STAT3/5A-Addicted Glioblastoma.Cancers (Basel). 2019 Nov 27;11(12):1888. doi: 10.3390/cancers11121888.
• [1571] DARPP32, STAT5 and STAT3 mRNA expression ratios in glioblastomas are associated with patient outcome.Pathol Oncol Res. 2013 Apr;19(2):329-43. doi: 10.1007/s12253-012-9588-7. Epub 2012 Dec 20.
• [1572] Downregulation of protein phosphatase 2A by apolipoprotein E: Implications for Alzheimer's disease.Mol Cell Neurosci. 2017 Sep;83:83-91. doi: 10.1016/j.mcn.2017.07.002. Epub 2017 Jul 15.
• [1573] Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines.Cell Mol Neurobiol. 2017 Aug;37(6):1021-1027. doi: 10.1007/s10571-016-0435-3. Epub 2016 Oct 18.
• [1574] Zeb1 potentiates genome-wide gene transcription with Lef1 to promote glioblastoma cell invasion.EMBO J. 2018 Aug 1;37(15):e97115. doi: 10.15252/embj.201797115. Epub 2018 Jun 14.
• [1575] DNA-PKcs is activated under nutrient starvation and activates Akt, MST1, FoxO3a, and NDR1.Biochem Biophys Res Commun. 2020 Jan 15;521(3):668-673. doi: 10.1016/j.bbrc.2019.10.133. Epub 2019 Nov 1.
• [1576] PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma.Nat Commun. 2018 Oct 31;9(1):4552. doi: 10.1038/s41467-018-06968-7.
• [1577] Quantitative mRNA expression of genes involved in angiogenesis, coagulation and inflammation in multiforme glioblastoma tumoral tissue versus peritumoral brain tissue: lack of correlation with clinical data.Eur Cytokine Netw. 2012 Jun;23(2):45-55. doi: 10.1684/ecn.2012.0302.
• [1578] Prop-1 gene expression in human pituitary tumors.J Clin Endocrinol Metab. 1999 Jul;84(7):2581-4. doi: 10.1210/jcem.84.7.5974.
• [1579] Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma.Cancer Res. 2018 Jun 1;78(11):3002-3013. doi: 10.1158/0008-5472.CAN-17-2433. Epub 2018 Mar 12.
• [1580] Expression of the pro-apoptotic protein ARTS in astrocytic tumors: correlation with malignancy grade and survival rate.Cancer. 2004 Dec 1;101(11):2614-21. doi: 10.1002/cncr.20675.
• [1581] Prosaposin is a biomarker of mesenchymal glioblastoma and regulates mesenchymal transition through the TGF-1/Smad signaling pathway.J Pathol. 2019 Sep;249(1):26-38. doi: 10.1002/path.5278. Epub 2019 May 21.
• [1582] Interference with PSMB4 Expression Exerts an Anti-Tumor Effect by Decreasing the Invasion and Proliferation of Human Glioblastoma Cells.Cell Physiol Biochem. 2018;45(2):819-831. doi: 10.1159/000487174. Epub 2018 Jan 31.
• [1583] Epidermal growth factor receptor vIII expression in U87 glioblastoma cells alters their proteasome composition, function, and response to irradiation.Mol Cancer Res. 2008 Mar;6(3):426-34. doi: 10.1158/1541-7786.MCR-07-0313.
• [1584] Germline mutations and new copy number variants among 40 pediatric cancer patients suspected for genetic predisposition.Clin Genet. 2019 Oct;96(4):359-365. doi: 10.1111/cge.13600. Epub 2019 Jul 15.
• [1585] Role of extracellular matrix and microenvironment in regulation of tumor growth and LAR-mediated invasion in glioblastoma.PLoS One. 2018 Oct 4;13(10):e0204865. doi: 10.1371/journal.pone.0204865. eCollection 2018.
• [1586] Large-scale analysis reveals the specific clinical and immune features of CD155 in glioma.Aging (Albany NY). 2019 Aug 4;11(15):5463-5482. doi: 10.18632/aging.102131. Epub 2019 Aug 4.
• [1587] Overexpression of Paxillin Correlates with Tumor Progression and Predicts Poor Survival in Glioblastoma.CNS Neurosci Ther. 2017 Jan;23(1):69-75. doi: 10.1111/cns.12606. Epub 2016 Sep 17.
• [1588] Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic importance in glioblastoma multiforme.J Neurooncol. 2007 Apr;82(2):133-9. doi: 10.1007/s11060-006-9264-4. Epub 2006 Oct 18.
• [1589] Immunohistochemistry analysis of Pygo2 expression in central nervous system tumors.J Cell Commun Signal. 2019 Mar;13(1):75-84. doi: 10.1007/s12079-018-0476-0. Epub 2018 Jul 5.
• [1590] Hypomethylated Rab27b is a progression-associated prognostic biomarker of glioma regulating MMP-9 to promote invasion.Oncol Rep. 2015 Sep;34(3):1503-9. doi: 10.3892/or.2015.4125. Epub 2015 Jul 13.
• [1591] RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma.Oncol Rep. 2013 Nov;30(5):2350-6. doi: 10.3892/or.2013.2730. Epub 2013 Sep 10.
• [1592] Rab3a promotes brain tumor initiation and progression.Mol Biol Rep. 2014 Sep;41(9):5903-11. doi: 10.1007/s11033-014-3465-2. Epub 2014 Jun 26.
• [1593] The Ras-related protein, Rap1A, mediates thrombin-stimulated, integrin-dependent glioblastoma cell proliferation and tumor growth.J Biol Chem. 2014 Jun 20;289(25):17689-98. doi: 10.1074/jbc.M113.536227. Epub 2014 May 1.
• [1594] Single-cell RNA-seq reveals RAD51AP1 as a potent mediator of EGFRvIII in human glioblastomas.Aging (Albany NY). 2019 Sep 18;11(18):7707-7722. doi: 10.18632/aging.102282. Epub 2019 Sep 18.
• [1595] DNA-repair gene variants are associated with glioblastoma survival.Acta Oncol. 2012 Mar;51(3):325-32. doi: 10.3109/0284186X.2011.616284. Epub 2011 Oct 21.
• [1596] EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer.Nat Commun. 2017 Dec 11;8(1):2035. doi: 10.1038/s41467-017-02185-w.
• [1597] DNA hypermethylation and histone modifications downregulate the candidate tumor suppressor gene RRP22 on 22q12 in human gliomas.Brain Pathol. 2012 Jan;22(1):17-25. doi: 10.1111/j.1750-3639.2011.00507.x. Epub 2011 Aug 16.
• [1598] Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis.Oncogene. 2011 Feb 24;30(8):978-89. doi: 10.1038/onc.2010.471. Epub 2010 Oct 18.
• [1599] Detection of Aberrant DNA Methylation Patterns in the RB1 Gene.Methods Mol Biol. 2018;1726:35-47. doi: 10.1007/978-1-4939-7565-5_5.
• [1600] Downregulation of FIP200 induces apoptosis of glioblastoma cells and microvascular endothelial cells by enhancing Pyk2 activity.PLoS One. 2011;6(5):e19629. doi: 10.1371/journal.pone.0019629. Epub 2011 May 13.
• [1601] Integrated genomic profiling identifies candidate genes implicated in glioma-genesis and a novel LEO1-SLC12A1 fusion gene.Genes Chromosomes Cancer. 2010 Jun;49(6):509-17. doi: 10.1002/gcc.20760.
• [1602] Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases.Anticancer Res. 2002 Jul-Aug;22(4):1949-57.
• [1603] RNA binding protein RBM14 promotes radio-resistance in glioblastoma by regulating DNA repair and cell differentiation.Oncotarget. 2014 May 15;5(9):2820-6. doi: 10.18632/oncotarget.1924.
• [1604] Differential expression of the RNA-binding motif protein 3 in human astrocytoma.Chin Med J (Engl). 2013;126(10):1948-52.
• [1605] Down syndrome candidate region 1 increases the stability of the IkappaBalpha protein: implications for its anti-inflammatory effects.J Biol Chem. 2006 Dec 22;281(51):39051-61. doi: 10.1074/jbc.M604659200. Epub 2006 Oct 24.
• [1606] Radixin knockdown by RNA interference suppresses human glioblastoma cell growth in vitro and in vivo.Asian Pac J Cancer Prev. 2014;15(22):9805-12. doi: 10.7314/apjcp.2014.15.22.9805.
• [1607] Lentiviral vector mediated delivery of RHBDD1 shRNA down regulated the proliferation of human glioblastoma cells.Technol Cancer Res Treat. 2014 Feb;13(1):87-93. doi: 10.7785/tcrt.2012.500362. Epub 2013 Jul 23.
• [1608] RHPN2 drives mesenchymal transformation in malignant glioma by triggering RhoA activation.Cancer Res. 2013 Aug 15;73(16):5140-50. doi: 10.1158/0008-5472.CAN-13-1168-T. Epub 2013 Jun 17.
• [1609] Integrative functional genomics identifies RINT1 as a novel GBM oncogene.Neuro Oncol. 2012 Nov;14(11):1325-31. doi: 10.1093/neuonc/nos246. Epub 2012 Oct 16.
• [1610] The Histone Demethylase NO66 Induces Glioma Cell Proliferation.Anticancer Res. 2019 Nov;39(11):6007-6014. doi: 10.21873/anticanres.13806.
• [1611] MINA53 deficiency leads to glioblastoma cell apoptosis via inducing DNA replication stress and diminishing DNA damage response.Cell Death Dis. 2018 Oct 17;9(11):1062. doi: 10.1038/s41419-018-1084-x.
• [1612] Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome.Int J Cancer. 2009 Dec 1;125(11):2624-30. doi: 10.1002/ijc.24639.
• [1613] PTPIP51, a positive modulator of the MAPK/Erk pathway, is upregulated in glioblastoma and interacts with 14-3-3 and PTP1B in situ.Histol Histopathol. 2011 Dec;26(12):1531-43. doi: 10.14670/HH-26.1531.
• [1614] RNaseH2A is involved in human gliomagenesis through the regulation of cell proliferation and apoptosis.Oncol Rep. 2016 Jul;36(1):173-80. doi: 10.3892/or.2016.4802. Epub 2016 May 10.
• [1615] Small GTPase RHOE/RND3, a new critical regulator of NF-B signalling in glioblastoma multiforme?.Cell Prolif. 2019 Sep;52(5):e12665. doi: 10.1111/cpr.12665. Epub 2019 Jul 22.
• [1616] The tumor suppressor gene TRC8/RNF139 is disrupted by a constitutional balanced translocation t(8;22)(q24.13;q11.21) in a young girl with dysgerminoma.Mol Cancer. 2009 Jul 30;8:52. doi: 10.1186/1476-4598-8-52.
• [1617] Prognostic implications of the DNA damage response pathway in glioblastoma.Oncol Rep. 2011 Aug;26(2):423-30. doi: 10.3892/or.2011.1325. Epub 2011 May 26.
• [1618] Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor.Mol Cancer. 2011 Oct 17;10:130. doi: 10.1186/1476-4598-10-130.
• [1619] Lovastatin-induced up-regulation of the BH3-only protein, Bim, and cell death in glioblastoma cells.J Neurochem. 2004 Apr;89(1):168-78. doi: 10.1111/j.1471-4159.2004.02319.x.
• [1620] miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.BMC Med. 2008 Jun 24;6:14. doi: 10.1186/1741-7015-6-14.
• [1621] S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-B positive feedback loop.J Cell Mol Med. 2019 Oct;23(10):6907-6918. doi: 10.1111/jcmm.14574. Epub 2019 Aug 20.
• [1622] Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells.Cell. 2014 Apr 24;157(3):580-94. doi: 10.1016/j.cell.2014.02.030. Epub 2014 Apr 10.
• [1623] SAMSN1 is highly expressed and associated with a poor survival in glioblastoma multiforme.PLoS One. 2013 Nov 22;8(11):e81905. doi: 10.1371/journal.pone.0081905. eCollection 2013.
• [1624] Identification of novel SNPs in glioblastoma using targeted resequencing.PLoS One. 2011;6(6):e18158. doi: 10.1371/journal.pone.0018158. Epub 2011 Jun 10.
• [1625] Frequent epigenetic inactivation of the chaperone SGNE1/7B2 in human gliomas.Int J Cancer. 2012 Aug 1;131(3):612-22. doi: 10.1002/ijc.26416. Epub 2011 Oct 5.
• [1626] Interaction of ASIC1 and ENaC subunits in human glioma cells and rat astrocytes.Am J Physiol Cell Physiol. 2011 Jun;300(6):C1246-59. doi: 10.1152/ajpcell.00199.2010. Epub 2011 Feb 23.
• [1627] Demethyl fruticulin A (SCO-1) causes apoptosis by inducing reactive oxygen species in mitochondria.J Cell Biochem. 2010 Dec 1;111(5):1149-59. doi: 10.1002/jcb.22801.
• [1628] SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy.Oncotarget. 2015 May 20;6(14):12452-67. doi: 10.18632/oncotarget.3611.
• [1629] MiR-374b targets GATA3 to promote progression and development of glioblastoma via regulating SEMA3B.Neoplasma. 2019 Jul 23;66(4):543-554. doi: 10.4149/neo_2018_180830N659. Epub 2019 Mar 7.
• [1630] The Anti-Tumorigenic Activity of Sema3C in the Chick Embryo Chorioallantoic Membrane Model.Int J Mol Sci. 2019 Nov 12;20(22):5672. doi: 10.3390/ijms20225672.
• [1631] Semaphorin-3D and semaphorin-3E inhibit the development of tumors from glioblastoma cells implanted in the cortex of the brain.PLoS One. 2012;7(8):e42912. doi: 10.1371/journal.pone.0042912. Epub 2012 Aug 24.
• [1632] Human semaphorin 6B [(HSA)SEMA6B], a novel human class 6 semaphorin gene: alternative splicing and all-trans-retinoic acid-dependent downregulation in glioblastoma cell lines.Genomics. 2001 May 1;73(3):343-8. doi: 10.1006/geno.2001.6525.
• [1633] Repression of Septin9 and Septin2 suppresses tumor growth of human glioblastoma cells.Cell Death Dis. 2018 May 1;9(5):514. doi: 10.1038/s41419-018-0547-4.
• [1634] MicroRNA-127-3p promotes glioblastoma cell migration and invasion by targeting the tumor-suppressor gene SEPT7.Oncol Rep. 2014 May;31(5):2261-9. doi: 10.3892/or.2014.3055. Epub 2014 Mar 5.
• [1635] Serine protease inhibitor (SERPIN) B1 suppresses cell migration and invasion in glioma cells.Brain Res. 2015 Mar 10;1600:59-69. doi: 10.1016/j.brainres.2014.06.017. Epub 2014 Jun 23.
• [1636] Inhibitors of urokinase and thrombin in cultured neural cells.J Neurochem. 1991 Jan;56(1):234-42. doi: 10.1111/j.1471-4159.1991.tb02586.x.
• [1637] The HIF?/miR?24?p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxiainduced protective autophagy in glioblastoma and astrocytoma.Oncol Rep. 2019 Mar;41(3):1759-1768. doi: 10.3892/or.2018.6929. Epub 2018 Dec 13.
• [1638] Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner.Genes Dev. 2013 Mar 15;27(6):654-69. doi: 10.1101/gad.212662.112.
• [1639] Expression Profiling of the MAP Kinase Phosphatase Family Reveals a Role for DUSP1 in the Glioblastoma Stem Cell Niche.Cancer Microenviron. 2017 Dec;10(1-3):57-68. doi: 10.1007/s12307-017-0197-6. Epub 2017 Aug 18.
• [1640] Static and dynamic (18)F-FET PET for the characterization of gliomas defined by IDH and 1p/19q status.Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):443-451. doi: 10.1007/s00259-017-3846-6. Epub 2017 Oct 17.
• [1641] Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.Med Oncol. 2017 Sep 26;34(11):182. doi: 10.1007/s12032-017-1043-x.
• [1642] Shc3 affects human high-grade astrocytomas survival.Oncogene. 2005 Aug 4;24(33):5198-206. doi: 10.1038/sj.onc.1208708.
• [1643] Novel tumour suppressive protein encoded by circular RNA, circ-SHPRH, in glioblastomas.Oncogene. 2018 Jul;37(30):4055-4057. doi: 10.1038/s41388-018-0230-3. Epub 2018 Apr 30.
• [1644] Single minded 2-s (SIM2-s) gene is expressed in human GBM cells and involved in GBM invasion.Cancer Biol Ther. 2010 Mar 15;9(6):430-6. doi: 10.4161/cbt.9.6.10892. Epub 2010 Mar 8.
• [1645] Epigenetically controlled Six3 expression regulates glioblastoma cell proliferation and invasion alongside modulating the activation levels of WNT pathway members.J Neurooncol. 2017 Jul;133(3):509-518. doi: 10.1007/s11060-017-2476-y. Epub 2017 Jun 22.
• [1646] Expression of CD150 in tumors of the central nervous system: identification of a novel isoform.PLoS One. 2015 Feb 24;10(2):e0118302. doi: 10.1371/journal.pone.0118302. eCollection 2015.
• [1647] Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells.Cancer Gene Ther. 2018 Dec;25(11-12):309-316. doi: 10.1038/s41417-018-0040-3. Epub 2018 Aug 24.
• [1648] Whole exome-wide association study identifies a missense variant in SLC2A4RG associated with glioblastoma risk.Am J Cancer Res. 2017 Sep 1;7(9):1937-1947. eCollection 2017.
• [1649] Expression of Slc35f1 in the murine brain.Cell Tissue Res. 2019 Aug;377(2):167-176. doi: 10.1007/s00441-019-03008-8. Epub 2019 Mar 13.
• [1650] When the guardian sleeps: Reactivation of the p53 pathway in cancer.Mutat Res Rev Mutat Res. 2017 Jul;773:1-13. doi: 10.1016/j.mrrev.2017.02.003. Epub 2017 Feb 17.
• [1651] Identification of novel LncRNA targeting Smad2/PKC signal pathway to negatively regulate malignant progression of glioblastoma.J Cell Physiol. 2020 Apr;235(4):3835-3848. doi: 10.1002/jcp.29278. Epub 2019 Oct 11.
• [1652] SWI/SNF gene variants and glioma risk and outcome.Cancer Epidemiol. 2013 Apr;37(2):162-5. doi: 10.1016/j.canep.2012.12.001. Epub 2012 Dec 29.
• [1653] The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma.Nat Commun. 2018 May 25;9(1):2087. doi: 10.1038/s41467-018-04448-6.
• [1654] siRNA-mediated knockdown of SMC1A expression suppresses the proliferation of glioblastoma cells.Mol Cell Biochem. 2013 Sep;381(1-2):209-15. doi: 10.1007/s11010-013-1704-9. Epub 2013 Jun 11.
• [1655] FDG PET/CT and MRI in Primary Spinal Cord Glioblastoma.Clin Nucl Med. 2020 Mar;45(3):e144-e145. doi: 10.1097/RLU.0000000000002800.
• [1656] SLUG Directs the Precursor State of Human Brain Tumor Stem Cells.Cancers (Basel). 2019 Oct 24;11(11):1635. doi: 10.3390/cancers11111635.
• [1657] Comparative genomics on SNAI1, SNAI2, and SNAI3 orthologs.Oncol Rep. 2005 Oct;14(4):1083-6.
• [1658] COL3A1 and SNAP91: novel glioblastoma markers with diagnostic and prognostic value.Oncotarget. 2016 Oct 25;7(43):70494-70503. doi: 10.18632/oncotarget.12038.
• [1659] Comparison of somatostatin receptor expression in human gliomas and medulloblastomas.J Neuroendocrinol. 2002 Jun;14(6):458-71. doi: 10.1046/j.1365-2826.2002.00801.x.
• [1660] Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/-catenin signaling.Mol Carcinog. 2018 Apr;57(4):494-502. doi: 10.1002/mc.22774. Epub 2018 Jan 5.
• [1661] Oncogenic activity of SOX1 in glioblastoma.Sci Rep. 2017 Apr 20;7:46575. doi: 10.1038/srep46575.
• [1662] Establishing cut-off points with clinical relevance for bcl-2, cyclin D1, p16, p21, p27, p53, Sox11 and WT1 expression in glioblastoma - a short report.Cell Oncol (Dordr). 2018 Apr;41(2):213-221. doi: 10.1007/s13402-017-0362-4. Epub 2017 Dec 7.
• [1663] Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice.J Clin Invest. 2013 Jan;123(1):418-31. doi: 10.1172/JCI64547. Epub 2012 Dec 17.
• [1664] SOX3 can promote the malignant behavior of glioblastoma cells.Cell Oncol (Dordr). 2019 Feb;42(1):41-54. doi: 10.1007/s13402-018-0405-5. Epub 2018 Sep 12.
• [1665] MicroRNA-29a activates a multi-component growth and invasion program in glioblastoma.J Exp Clin Cancer Res. 2019 Jan 25;38(1):36. doi: 10.1186/s13046-019-1026-1.
• [1666] SP100 reduces malignancy of human glioma cells.Int J Oncol. 2011 Apr;38(4):1023-30. doi: 10.3892/ijo.2011.927. Epub 2011 Jan 27.
• [1667] Human sperm-associated antigen 4 as a potential biomarker of glioblastoma progression and prognosis.Neuroreport. 2019 Apr 10;30(6):446-451. doi: 10.1097/WNR.0000000000001226.
• [1668] Spermassociated antigen 9 promotes astrocytoma cell invasion through the upregulation of podocalyxin.Mol Med Rep. 2014 Jul;10(1):417-22. doi: 10.3892/mmr.2014.2168. Epub 2014 Apr 24.
• [1669] Enhanced SPARCL1 expression in cancer stem cells improves preclinical modeling of glioblastoma by promoting both tumor infiltration and angiogenesis.Neurobiol Dis. 2020 Feb;134:104705. doi: 10.1016/j.nbd.2019.104705. Epub 2019 Dec 10.
• [1670] Sprouty3 and Sprouty4, Two Members of a Family Known to Inhibit FGF-Mediated Signaling, Exert Opposing Roles on Proliferation and Migration of Glioblastoma-Derived Cells.Cells. 2019 Aug 1;8(8):808. doi: 10.3390/cells8080808.
• [1671] CircSMARCA5 Regulates VEGFA mRNA Splicing and Angiogenesis in Glioblastoma Multiforme Through the Binding of SRSF1.Cancers (Basel). 2019 Feb 7;11(2):194. doi: 10.3390/cancers11020194.
• [1672] SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.Cancer Res. 2019 Oct 15;79(20):5288-5301. doi: 10.1158/0008-5472.CAN-19-1504. Epub 2019 Aug 28.
• [1673] Single-stranded DNA binding protein 2 expression is associated with patient survival in hepatocellular carcinoma.BMC Cancer. 2018 Dec 12;18(1):1244. doi: 10.1186/s12885-018-5158-z.
• [1674] Myt1 and Myt1l transcription factors limit proliferation in GBM cells by repressing YAP1 expression.Biochim Biophys Acta Gene Regul Mech. 2018 Nov;1861(11):983-995. doi: 10.1016/j.bbagrm.2018.10.005. Epub 2018 Oct 10.
• [1675] The role of DNA methylation in ST6Gal1 expression in gliomas.Glycobiology. 2016 Dec;26(12):1271-1283. doi: 10.1093/glycob/cww058. Epub 2016 Aug 10.
• [1676] Accumulation of unusual gangliosides G(Q3) and G(P3) in breast cancer cells expressing the G(D3) synthase.Molecules. 2012 Aug 10;17(8):9559-72. doi: 10.3390/molecules17089559.
• [1677] AdipoR1-mediated miR-3908 inhibits glioblastoma tumorigenicity through downregulation of STAT2 associated with the AMPK/SIRT1 pathway.Oncol Rep. 2017 Jun;37(6):3387-3396. doi: 10.3892/or.2017.5589. Epub 2017 Apr 20.
• [1678] Six-Transmembrane Epithelial Antigen of Prostate 3 Predicts Poor Prognosis and Promotes Glioblastoma Growth and Invasion.Neoplasia. 2018 Jun;20(6):543-554. doi: 10.1016/j.neo.2018.04.002. Epub 2018 May 3.
• [1679] Down-regulation of STIP1 regulate apoptosis and invasion of glioma cells via TRAP1/AKT signaling pathway.Cancer Genet. 2019 Sep;237:1-9. doi: 10.1016/j.cancergen.2019.05.006. Epub 2019 Jun 3.
• [1680] Overexpression of SCLIP promotes growth and motility in glioblastoma cells.Cancer Biol Ther. 2015;16(1):97-105. doi: 10.4161/15384047.2014.987037.
• [1681] Serine/threonine/tyrosine-interacting-like protein 1 (STYXL1), a pseudo phosphatase, promotes oncogenesis in glioma.Biochem Biophys Res Commun. 2019 Jul 12;515(1):241-247. doi: 10.1016/j.bbrc.2019.05.093. Epub 2019 May 27.
• [1682] The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cells.Mol Cancer Res. 2012 Jan;10(1):143-55. doi: 10.1158/1541-7786.MCR-11-0208.
• [1683] SWAP-70 promotes glioblastoma cellular migration and invasion by regulating the expression of CD44s.Cancer Cell Int. 2019 Nov 21;19:305. doi: 10.1186/s12935-019-1035-3. eCollection 2019.
• [1684] Knocking down the expression of SYF2 inhibits the proliferation of glioma cells.Med Oncol. 2014 Aug;31(8):101. doi: 10.1007/s12032-014-0101-x. Epub 2014 Jul 2.
• [1685] Synemin promotes AKT-dependent glioblastoma cell proliferation by antagonizing PP2A.Mol Biol Cell. 2012 Apr;23(7):1243-53. doi: 10.1091/mbc.E11-08-0685. Epub 2012 Feb 15.
• [1686] Downregulation of SYT7 inhibits glioblastoma growth by promoting cellular apoptosis.Mol Med Rep. 2017 Dec;16(6):9017-9022. doi: 10.3892/mmr.2017.7723. Epub 2017 Oct 4.
• [1687] FGF receptors: cancer biology and therapeutics.Med Res Rev. 2014 Mar;34(2):280-300. doi: 10.1002/med.21288. Epub 2013 May 21.
• [1688] Identification of differentially expressed genes involved in the formation of multicellular tumor spheroids by HT-29 colon carcinoma cells.Mol Ther. 2007 Jan;15(1):94-102. doi: 10.1038/sj.mt.6300003.
• [1689] A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent Kinase-1.Mol Cancer. 2019 Aug 30;18(1):131. doi: 10.1186/s12943-019-1056-5.
• [1690] The methionine synthase polymorphism c.2756A>G alters susceptibility to glioblastoma multiforme.Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2314-6. doi: 10.1158/1055-9965.EPI-05-0979.
• [1691] Expression and prognostic significance of TCTN1 in human glioblastoma.J Transl Med. 2014 Oct 11;12:288. doi: 10.1186/s12967-014-0288-9.
• [1692] Hypoxia Can Induce Migration of Glioblastoma Cells Through a Methylation-Dependent Control of ODZ1 Gene Expression.Front Oncol. 2019 Oct 10;9:1036. doi: 10.3389/fonc.2019.01036. eCollection 2019.
• [1693] Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis.Int J Cancer. 2020 Jan 15;146(2):373-387. doi: 10.1002/ijc.32520. Epub 2019 Jul 1.
• [1694] Mitochondria Transcription Factor A: A Putative Target for the Effect of Melatonin on U87MG Malignant Glioma Cell Line.Molecules. 2018 May 9;23(5):1129. doi: 10.3390/molecules23051129.
• [1695] Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas.J Transl Med. 2007 Dec 19;5:67. doi: 10.1186/1479-5876-5-67.
• [1696] Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1.Aging (Albany NY). 2019 Jun 11;11(11):3811-3823. doi: 10.18632/aging.102018.
• [1697] Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses.J Neurooncol. 2017 Jan;131(1):11-20. doi: 10.1007/s11060-016-2269-8. Epub 2016 Sep 15.
• [1698] Suppression of Angiotensin-(1-7) on the Disruption of Blood-Brain Barrier in Rat of Brain Glioma.Pathol Oncol Res. 2019 Jan;25(1):429-435. doi: 10.1007/s12253-018-0471-z. Epub 2018 Sep 18.
• [1699] Molecular and clinical characterization of TMEM71 expression at the transcriptional level in glioma.CNS Neurosci Ther. 2019 Sep;25(9):965-975. doi: 10.1111/cns.13137. Epub 2019 Jun 10.
• [1700] Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cells.Int J Cancer. 2015 Oct 15;137(8):1842-54. doi: 10.1002/ijc.29565. Epub 2015 Apr 29.
• [1701] KIAA0510, the 3'-untranslated region of the tenascin-R gene, and tenascin-R are overexpressed in pilocytic astrocytomas.Neuropathol Appl Neurobiol. 2010 Aug;36(5):399-410. doi: 10.1111/j.1365-2990.2010.01074.x. Epub 2010 Feb 25.
• [1702] Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGF2 in vascular abnormalization.J Pathol. 2012 Nov;228(3):378-90. doi: 10.1002/path.4072. Epub 2012 Aug 31.
• [1703] Molecular mechanism of cytotoxicity induced by Hsp90-targeted Antp-TPR hybrid peptide in glioblastoma cells.Mol Cancer. 2012 Aug 22;11:59. doi: 10.1186/1476-4598-11-59.
• [1704] Loss of tumor suppressive microRNA-31 enhances TRADD/NF-B signaling in glioblastoma.Oncotarget. 2015 Jul 10;6(19):17805-16. doi: 10.18632/oncotarget.4596.
• [1705] Association between RTEL1, PHLDB1, and TREH Polymorphisms and Glioblastoma Risk: A Case-Control Study.Med Sci Monit. 2015 Jul 9;21:1983-8. doi: 10.12659/MSM.893723.
• [1706] Tripartite motif-containing 14 (TRIM14) promotes epithelial-mesenchymal transition via ZEB2 in glioblastoma cells.J Exp Clin Cancer Res. 2019 Feb 6;38(1):57. doi: 10.1186/s13046-019-1070-x.
• [1707] TRIM45 functions as a tumor suppressor in the brain via its E3 ligase activity by stabilizing p53 through K63-linked ubiquitination.Cell Death Dis. 2017 May 25;8(5):e2831. doi: 10.1038/cddis.2017.149.
• [1708] The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma.Am J Pathol. 2008 Dec;173(6):1828-38. doi: 10.2353/ajpath.2008.080043. Epub 2008 Nov 13.
• [1709] The roles of TRIO and F-actin-binding protein in glioblastoma cells.Mol Med Rep. 2018 Mar;17(3):4540-4546. doi: 10.3892/mmr.2018.8458. Epub 2018 Jan 18.
• [1710] Glioblastoma in a patient with tuberous sclerosis.J Clin Neurosci. 2019 Feb;60:153-155. doi: 10.1016/j.jocn.2018.10.083. Epub 2018 Oct 24.
• [1711] Genetic alterations in primary glioblastomas in Japan.J Neuropathol Exp Neurol. 2006 Jan;65(1):12-8. doi: 10.1097/01.jnen.0000196132.66464.96.
• [1712] MiR-338-5p Promotes Glioma Cell Invasion by Regulating TSHZ3 and MMP2.Cell Mol Neurobiol. 2018 Apr;38(3):669-677. doi: 10.1007/s10571-017-0525-x. Epub 2017 Aug 5.
• [1713] Over-expression of tetraspanin 8 in malignant glioma regulates tumor cell progression.Biochem Biophys Res Commun. 2015 Mar 13;458(3):476-482. doi: 10.1016/j.bbrc.2015.01.128. Epub 2015 Feb 11.
• [1714] ADAMDEC1 Maintains a Growth Factor Signaling Loop in Cancer Stem Cells.Cancer Discov. 2019 Nov;9(11):1574-1589. doi: 10.1158/2159-8290.CD-18-1308. Epub 2019 Aug 21.
• [1715] EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target.Neuroreport. 2010 Nov 17;21(16):1018-22. doi: 10.1097/WNR.0b013e32833f19f2.
• [1716] MUDENG Expression Profiling in Cohorts and Brain Tumor Biospecimens to Evaluate Its Role in Cancer.Front Genet. 2019 Sep 19;10:884. doi: 10.3389/fgene.2019.00884. eCollection 2019.
• [1717] ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN-deficient primary human glioblastoma.J Pathol. 2019 Feb;247(2):266-278. doi: 10.1002/path.5189. Epub 2018 Dec 24.
• [1718] Arterial spin labeling perfusion-weighted imaging aids in prediction of molecular biomarkers and survival in glioblastomas.Eur Radiol. 2020 Feb;30(2):1202-1211. doi: 10.1007/s00330-019-06379-2. Epub 2019 Aug 29.
• [1719] Glioma-amplified sequence KUB3 influences double-strand break repair after ionizing radiation.Int J Oncol. 2013 Jul;43(1):50-6. doi: 10.3892/ijo.2013.1937. Epub 2013 May 13.
• [1720] miR-577 inhibits glioblastoma tumor growth via the Wnt signaling pathway.Mol Carcinog. 2016 May;55(5):575-85. doi: 10.1002/mc.22304. Epub 2015 Mar 12.
• [1721] Mitochondrial NIX Promotes Tumor Survival in the Hypoxic Niche of Glioblastoma.Cancer Res. 2019 Oct 15;79(20):5218-5232. doi: 10.1158/0008-5472.CAN-19-0198. Epub 2019 Sep 5.
• [1722] Identification of key candidate genes and pathways in glioblastoma by integrated bioinformatical analysis.Exp Ther Med. 2019 Nov;18(5):3439-3449. doi: 10.3892/etm.2019.7975. Epub 2019 Sep 5.
• [1723] Riluzole: a potential therapeutic intervention in human brain tumor stem-like cells.Oncotarget. 2017 May 20;8(57):96697-96709. doi: 10.18632/oncotarget.18043. eCollection 2017 Nov 14.
• [1724] The C/EBP protein is stabilized by estrogen receptor activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer.Oncogene. 2016 Dec 1;35(48):6166-6176. doi: 10.1038/onc.2016.156. Epub 2016 May 16.
• [1725] Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420.Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(4):878-886. doi: 10.1016/j.ijrobp.2018.11.008. Epub 2018 Nov 27.
• [1726] 5-Hydroxymethylcytosine plays a critical role in glioblastomagenesis by recruiting the CHTOP-methylosome complex.Cell Rep. 2014 Oct 9;9(1):48-60. doi: 10.1016/j.celrep.2014.08.071. Epub 2014 Oct 2.
• [1727] Down regulated expression of Claudin-1 and Claudin-5 and up regulation of -catenin: association with human glioma progression.CNS Neurol Disord Drug Targets. 2014;13(8):1413-26. doi: 10.2174/1871527313666141023121550.
• [1728] Prognostic significance of contactin 3 expression and associated genes in glioblastoma multiforme.Oncol Lett. 2019 Aug;18(2):1863-1871. doi: 10.3892/ol.2019.10482. Epub 2019 Jun 14.
• [1729] Knockdown of collagen -1(III) inhibits glioma cell proliferation and migration and is regulated by miR128-3p.Oncol Lett. 2018 Aug;16(2):1917-1923. doi: 10.3892/ol.2018.8830. Epub 2018 May 30.
• [1730] Knockdown of CREB3 activates endoplasmic reticulum stress and induces apoptosis in glioblastoma.Aging (Albany NY). 2019 Oct 13;11(19):8156-8168. doi: 10.18632/aging.102310. Epub 2019 Oct 13.
• [1731] CXCL16/CXCR6 Axis Drives Microglia/Macrophages Phenotype in Physiological Conditions and Plays a Crucial Role in Glioma.Front Immunol. 2018 Nov 27;9:2750. doi: 10.3389/fimmu.2018.02750. eCollection 2018.
• [1732] Dynamic multi-site phosphorylation by Fyn and Abl drives the interaction between CRKL and the novel scaffolding receptors DCBLD1 and DCBLD2.Biochem J. 2017 Nov 21;474(23):3963-3984. doi: 10.1042/BCJ20170615.
• [1733] The RNA helicase DHX33 is required for cancer cell proliferation in human glioblastoma and confers resistance to PI3K/mTOR inhibition.Cell Signal. 2019 Feb;54:170-178. doi: 10.1016/j.cellsig.2018.12.005. Epub 2018 Dec 12.
• [1734] Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma.Oncogene. 2019 Apr;38(15):2706-2721. doi: 10.1038/s41388-018-0596-2. Epub 2018 Dec 12.
• [1735] The role of microRNA-148a and downstream DLGAP1 on the molecular regulation and tumor progression on human glioblastoma.Oncogene. 2019 Nov;38(47):7234-7248. doi: 10.1038/s41388-019-0922-3. Epub 2019 Sep 2.
• [1736] Screening and authentication of molecular markers in malignant glioblastoma based on gene expression profiles.Oncol Lett. 2019 Nov;18(5):4593-4604. doi: 10.3892/ol.2019.10804. Epub 2019 Sep 4.
• [1737] Transcription factor C/EBP- mediates downregulation of dipeptidyl-peptidase III expression by interleukin-6 in human glioblastoma cells.FEBS J. 2014 Mar;281(6):1629-41. doi: 10.1111/febs.12728. Epub 2014 Feb 17.
• [1738] Aberrant expression of Notch1, HES1, and DTX1 genes in glioblastoma formalin-fixed paraffin-embedded tissues.Tumour Biol. 2016 May;37(5):6935-42. doi: 10.1007/s13277-015-4592-7. Epub 2015 Dec 11.
• [1739] Protein phosphatase Dusp26 associates with KIF3 motor and promotes N-cadherin-mediated cell-cell adhesion.Oncogene. 2009 Feb 5;28(5):752-61. doi: 10.1038/onc.2008.431. Epub 2008 Dec 1.
• [1740] Genome-Wide CRISPR-Cas9 Screening Identifies NF-B/E2F6 Responsible for EGFRvIII-Associated Temozolomide Resistance in Glioblastoma.Adv Sci (Weinh). 2019 Jul 24;6(17):1900782. doi: 10.1002/advs.201900782. eCollection 2019 Sep 4.
• [1741] The phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion.Int J Cancer. 2010 Mar 1;126(5):1155-65. doi: 10.1002/ijc.24849.
• [1742] ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1.Neuro Oncol. 2011 Nov;13(11):1202-12. doi: 10.1093/neuonc/nor119. Epub 2011 Aug 16.
• [1743] Attenuation of Tumor Suppressive Function of FBXO16 Ubiquitin Ligase Activates Wnt Signaling In Glioblastoma.Neoplasia. 2019 Jan;21(1):106-116. doi: 10.1016/j.neo.2018.11.005. Epub 2018 Dec 5.
• [1744] MiR-9-5p Inhibits Glioblastoma Cells Proliferation Through Directly Targeting FOXP2 (Forkhead Box P2).Front Oncol. 2019 Nov 19;9:1176. doi: 10.3389/fonc.2019.01176. eCollection 2019.
• [1745] A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways.Nat Commun. 2016 Oct 4;7:12885. doi: 10.1038/ncomms12885.
• [1746] MiR-148a increases glioma cell migration and invasion by downregulating GADD45A in human gliomas with IDH1 R132H mutations.Oncotarget. 2017 Apr 11;8(15):25345-25361. doi: 10.18632/oncotarget.15867.
• [1747] The promoter hypermethylation status of GATA6, MGMT, and FHIT in glioblastoma.Cell Mol Neurobiol. 2012 Mar;32(2):237-44. doi: 10.1007/s10571-011-9753-7. Epub 2011 Sep 18.
• [1748] Induced expression of GINS complex is an essential step for reactivation of quiescent stem-like tumor cells within the peri-necrotic niche in human glioblastoma.J Cancer Res Clin Oncol. 2019 Feb;145(2):363-371. doi: 10.1007/s00432-018-2797-z. Epub 2018 Nov 21.
• [1749] -Elemene inhibits proliferation through crosstalk between glia maturation factor and extracellular signalregulated kinase1/2 and impairs drug resistance to temozolomide in glioblastoma cells.Mol Med Rep. 2014 Aug;10(2):1122-8. doi: 10.3892/mmr.2014.2273. Epub 2014 May 27.
• [1750] Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma.Genome Biol. 2015 Jan 27;16(1):16. doi: 10.1186/s13059-015-0583-7.
• [1751] Overexpression of immediate early gene X-1 (IEX-1) enhances gamma-radiation-induced apoptosis of human glioma cell line, U87-MG.Neuropathology. 2009 Feb;29(1):20-4. doi: 10.1111/j.1440-1789.2008.00932.x. Epub 2008 Jun 17.
• [1752] The RNA Binding Protein IMP2 Preserves Glioblastoma Stem Cells by Preventing let-7 Target Gene Silencing.Cell Rep. 2016 May 24;15(8):1634-47. doi: 10.1016/j.celrep.2016.04.086. Epub 2016 May 12.
• [1753] Alpha internexin expression related with molecular characteristics in adult glioblastoma and oligodendroglioma.J Korean Med Sci. 2013 Apr;28(4):593-601. doi: 10.3346/jkms.2013.28.4.593. Epub 2013 Mar 27.
• [1754] Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers.Nat Commun. 2019 Sep 3;10(1):3974. doi: 10.1038/s41467-019-11911-5.
• [1755] MiR-148a inhibits the proliferation and migration of glioblastoma by targeting ITGA9.Hum Cell. 2019 Oct;32(4):548-556. doi: 10.1007/s13577-019-00279-9. Epub 2019 Sep 5.
• [1756] NETRIN-4 protects glioblastoma cells FROM temozolomide induced senescence.PLoS One. 2013 Nov 12;8(11):e80363. doi: 10.1371/journal.pone.0080363. eCollection 2013.
• [1757] KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc.J Exp Clin Cancer Res. 2018 Aug 16;37(1):194. doi: 10.1186/s13046-018-0861-9.
• [1758] Higher LRRFIP1 expression in glioblastoma multiforme is associated with better response to teniposide, a type II topoisomerase inhibitor.Biochem Biophys Res Commun. 2014 Apr 18;446(4):1261-7. doi: 10.1016/j.bbrc.2014.03.105. Epub 2014 Mar 29.
• [1759] Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells.Mol Med. 2019 Nov 14;25(1):49. doi: 10.1186/s10020-019-0116-z.
• [1760] Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis.Cancer. 2013 Mar 1;119(5):1004-12. doi: 10.1002/cncr.27821. Epub 2012 Nov 6.
• [1761] Loss of NEIL3 DNA glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to ATR inhibitor in glioblastoma cells.Oncotarget. 2017 Dec 4;8(68):112942-112958. doi: 10.18632/oncotarget.22896. eCollection 2017 Dec 22.
• [1762] MiR-18a regulates the proliferation, migration and invasion of human glioblastoma cell by targeting neogenin.Exp Cell Res. 2014 May 15;324(1):54-64. doi: 10.1016/j.yexcr.2014.03.009. Epub 2014 Mar 21.
• [1763] Induction Of XLF And 53BP1 Expression Is Associated With Temozolomide Resistance In Glioblastoma Cells.Onco Targets Ther. 2019 Nov 25;12:10139-10151. doi: 10.2147/OTT.S221025. eCollection 2019.
• [1764] Inhibition of Casein Kinase II by CX-4945, But Not Yes-associated protein (YAP) by Verteporfin, Enhances the Antitumor Efficacy of Temozolomide in Glioblastoma.Transl Oncol. 2020 Jan;13(1):70-78. doi: 10.1016/j.tranon.2019.09.006. Epub 2019 Dec 3.
• [1765] Carnosine influences transcription via epigenetic regulation as demonstrated by enhanced histone acetylation of the pyruvate dehydrogenase kinase 4 promoter in glioblastoma cells.Amino Acids. 2019 Jan;51(1):61-71. doi: 10.1007/s00726-018-2619-2. Epub 2018 Jul 20.
• [1766] Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis.Nat Commun. 2017 Oct 16;8(1):949. doi: 10.1038/s41467-017-00906-9.
• [1767] PID1 increases chemotherapy-induced apoptosis in medulloblastoma and glioblastoma cells in a manner that involves NFB.Sci Rep. 2017 Apr 11;7(1):835. doi: 10.1038/s41598-017-00947-6.
• [1768] BET bromodomain proteins are required for glioblastoma cell proliferation.Epigenetics. 2014 Apr;9(4):611-20. doi: 10.4161/epi.27906. Epub 2014 Feb 19.
• [1769] Sensitivity to PRIMA-1MET is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 status.Oncotarget. 2016 Sep 13;7(37):60245-60269. doi: 10.18632/oncotarget.11197.
• [1770] Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype.Cancer Res. 2018 Oct 15;78(20):5901-5916. doi: 10.1158/0008-5472.CAN-18-0320. Epub 2018 Aug 22.
• [1771] Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of glioma.Acta Neuropathol Commun. 2016 Sep 1;4(1):96. doi: 10.1186/s40478-016-0372-x.
• [1772] Parallel comparison of pre-conditioning and post-conditioning effects in human cancers and keratinocytes upon acute gamma irradiation.Int J Radiat Biol. 2019 Feb;95(2):170-178. doi: 10.1080/09553002.2019.1547850. Epub 2019 Jan 4.
• [1773] Retinoic Acid-Induced Protein 14 (RAI14) Promotes mTOR-Mediated Inflammation Under Inflammatory Stress and Chemical Hypoxia in a U87 Glioblastoma Cell Line.Cell Mol Neurobiol. 2019 Mar;39(2):241-254. doi: 10.1007/s10571-018-0644-z. Epub 2018 Dec 15.
• [1774] miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma.Oncol Rep. 2014 Sep;32(3):957-64. doi: 10.3892/or.2014.3318. Epub 2014 Jul 10.
• [1775] RECQ1 Helicase Silencing Decreases the Tumour Growth Rate of U87 Glioblastoma Cell Xenografts in Zebrafish Embryos.Genes (Basel). 2017 Sep 6;8(9):222. doi: 10.3390/genes8090222.
• [1776] Regulatory factor X1 is a new tumor suppressive transcription factor that acts via direct downregulation of CD44 in glioblastoma.Neuro Oncol. 2014 Aug;16(8):1078-85. doi: 10.1093/neuonc/nou010. Epub 2014 Feb 12.
• [1777] A multicenter randomized phase III study for newly diagnosed maximally resected glioblastoma comparing carmustine wafer implantation followed by chemoradiotherapy with temozolomide with chemoradiotherapy alone; Japan Clinical Oncology Group Study JCOG1703 (MACS study).Jpn J Clin Oncol. 2019 Dec 27;49(12):1172-1175. doi: 10.1093/jjco/hyz169.
• [1778] Down-regulation of ribosomal protein S15A inhibits proliferation of human glioblastoma cells in vivo and in vitro via AKT pathway.Tumour Biol. 2016 Apr;37(4):4979-90. doi: 10.1007/s13277-015-4323-0. Epub 2015 Nov 4.
• [1779] Generation of Rybp homozygous knockout murine ES cell line GIBHe001-A-1 by using CRISPR/Cas9 technology.Stem Cell Res. 2019 Dec;41:101638. doi: 10.1016/j.scr.2019.101638. Epub 2019 Oct 26.
• [1780] CYP17A1 Maintains the Survival of Glioblastomas by Regulating SAR1-Mediated Endoplasmic Reticulum Health and Redox Homeostasis.Cancers (Basel). 2019 Sep 16;11(9):1378. doi: 10.3390/cancers11091378.
• [1781] Cell density modulates SHC3 expression and survival of human glioblastoma cells through Fak activation.J Neurooncol. 2014 Nov;120(2):245-56. doi: 10.1007/s11060-014-1551-x. Epub 2014 Jul 26.
• [1782] Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells.J Extracell Vesicles. 2019 Aug 9;8(1):1648995. doi: 10.1080/20013078.2019.1648995. eCollection 2019.
• [1783] Multi-omics facilitated variable selection in Cox-regression model for cancer prognosis prediction.Methods. 2017 Jul 15;124:100-107. doi: 10.1016/j.ymeth.2017.06.010. Epub 2017 Jun 13.
• [1784] Preparation and investigation of indirubin-loaded SLN nanoparticles and their anti-cancer effects on human glioblastoma U87MG cells.Cell Biol Int. 2019 Jan;43(1):2-11. doi: 10.1002/cbin.11037.
• [1785] Identifying Mutually Exclusive Gene Sets with Prognostic Value and Novel Potential Driver Genes in Patients with Glioblastoma.Biomed Res Int. 2019 Nov 5;2019:4860367. doi: 10.1155/2019/4860367. eCollection 2019.
• [1786] Suppression of STIM1 inhibits human glioblastoma cell proliferation and induces G0/G1 phase arrest.J Exp Clin Cancer Res. 2013 Apr 11;32(1):20. doi: 10.1186/1756-9966-32-20.
• [1787] Stromal interaction molecule 2 (STIM2) is frequently overexpressed in colorectal tumors and confers a tumor cell growth suppressor phenotype.Mol Carcinog. 2012 Sep;51(9):746-53. doi: 10.1002/mc.20843. Epub 2011 Aug 30.
• [1788] SUMO1 modification stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression.Nat Commun. 2014 Jun 23;5:4234. doi: 10.1038/ncomms5234.
• [1789] Tapasin and human leukocyte antigen class I dysregulation correlates with survival in glioblastoma multiforme.Anticancer Agents Med Chem. 2014;14(8):1101-9. doi: 10.2174/1871520614666140825110402.
• [1790] Matrix metalloproteinase-1 expression enhances tumorigenicity as well as tumor-related angiogenesis and is inversely associated with TIMP-4 expression in a model of glioblastoma.J Neurooncol. 2012 Feb;106(3):461-71. doi: 10.1007/s11060-011-0691-5. Epub 2011 Aug 21.
• [1791] Transmembrane protein 18 enhances the tropism of neural stem cells for glioma cells.Cancer Res. 2008 Jun 15;68(12):4614-22. doi: 10.1158/0008-5472.CAN-07-5291.
• [1792] TIPE3 is a regulator of cell apoptosis in glioblastoma.Cancer Lett. 2019 Apr 1;446:1-14. doi: 10.1016/j.canlet.2018.12.019. Epub 2019 Jan 11.
• [1793] The CNS penetrating taxane TPI 287 and the AURKA inhibitor alisertib induce synergistic apoptosis in glioblastoma cells.J Neurooncol. 2018 May;137(3):481-492. doi: 10.1007/s11060-018-2755-2. Epub 2018 Feb 2.
• [1794] EGFR signaling in the HGG-02 glioblastoma cell line with an unusual loss of EGFR gene copy.Oncol Rep. 2014 Jan;31(1):480-7. doi: 10.3892/or.2013.2864. Epub 2013 Nov 20.
• [1795] MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44.J Neurooncol. 2019 Jan;141(1):19-30. doi: 10.1007/s11060-018-2973-7. Epub 2018 Dec 11.
• [1796] Overexpression of Tripartite Motif-Containing 48 (TRIM48) Inhibits Growth of Human Glioblastoma Cells by Suppressing Extracellular Signal Regulated Kinase 1/2 (ERK1/2) Pathway.Med Sci Monit. 2019 Nov 8;25:8422-8429. doi: 10.12659/MSM.916024.
• [1797] TRIP6 regulates p27 KIP1 to promote tumorigenesis.Mol Cell Biol. 2013 Apr;33(7):1394-409. doi: 10.1128/MCB.01149-12. Epub 2013 Jan 22.